Final Program ASTRO 55TH ANNUAL MEETING Meeting Dates: September 22-25, 2013 • Exhibit Dates: September 22-24, 2013 • Georgia World Congress Center • Atlanta HopePATIENTS • Guide • Heal
Download ASTROmobile - The offi cial meeting app. See 17 page for details.
ANNUAL MEETING SCIENCE BASED, PATIENT DRIVEN www.astro.org/annualmeeting
#ASTRO13 ROOM SERVICE NOW AVAILABLE
Medical centers that never considered proton therapy accessible are now installing single-room configurations of the MEVION S250™ system. Thanks to a radically smaller footprint, lower capital outlay, reduced operating costs, and complete system integration, advanced proton therapy is now available at the press of a button.
Welcome to the world of High Energy Cancer Care™... for everyone.
Visit us at ASTRO 2013 Booth #1253 mevion.com LAD130401 Final Program ASTRO 55TH ANNUAL MEETING Meeting Dates: September 22-25, 2013 • Exhibit Dates: September 22-24, 2013 • Georgia World Congress Center • Atlanta HopePATIENTS • Guide • Heal
Download ASTROmobile - The offi cial meeting app. See 17 page for details.
HELD IN CONJUNCTION WITH:
AMERICAN SOCIETY OF RADIOLOGIC TECHNOLOGISTS (ASRT) ANNUAL MEETING ASSOCIATION OF RESIDENTS IN RADIATION ONCOLOGY (ARRO) SCIENCE BASED, PATIENT DRIVEN SOCIETY FOR RADIATION ONCOLOGY ADMINISTRATORS (SROA) www.astro.org/annualmeeting
#ASTRO13 Welcome TO THE 55TH ANNUAL MEETING OF THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY “Patients: Hope, Guide, Heal”
Dear Colleagues, On behalf of the American Society for Radiation Oncology, I would like to welcome you to ASTRO’s 55th Annual Meeting. We have developed an exciting program that will provide many opportunities for exchanging scientifi c information as well as professional networking.
The theme this year is “Patients: Hope, Guide, Heal.” Given all of the changes we are facing in health care, I feel that it is extremely important to keep our focus on our patients and the best care we can provide them. With this in mind, the Annual Meeting will provide an array of education on safety, multidisciplinary care, reimbursement, technology assessments and the importance of registries.
The Annual Meeting program begins with the Presidential Symposium, “Prostate Cancer: Patient Focused Advances,” on Sunday. Moderated by Deborah A. Kuban, MD, FASTRO, and Anthony L. Zietman, MD, FASTRO, the symposium will focus on controversial and cutting-edge issues with a patient-centered view. On Sunday afternoon, guest lecturer Jeff A. Sloan, PhD, of the Mayo Clinic in Rochester, Minn., will help us better comprehend the impact of patient-reported outcomes on our ability to improve patient care.
Our keynote speakers, Darrell G. Kirch, MD, Otis W. Brawley, MD, and Peter Friedl, MD, PhD, will continue the focus on patients and help push us to better patient care (see page 45 for more details).
The Annual Meeting Scientifi c Committee chairman and vice-chairman Lynn D. Wilson, MD, MPH, FASTRO, and Benjamin Movsas, MD, FASTRO, and the Annual Meeting Education Committee chairman and vice-chairman Andrea Ng, MD, and Catherine Park, MD, have put together a fabulous program with 19 panel discussions, 50 educational sessions, 363 oral presentations, 1,460 poster presentations and 144 digital posters in 19 disease site tracks.
I invite you to join me in congratulating the 2013 Gold Medalists, Honorary Member and ASTRO Fellows during the Awards Ceremony on Tuesday at 10:15 a.m. in the Thomas Murphy Ballroom. These colleagues have impacted us all through their work, and it is a pleasure to recognize their achievements.
Be sure to take advantage of the opportunity to interact with our industry colleagues, who will display the latest developments and technology in cancer treatment in the Exhibit Hall.
I hope the Annual Meeting serves as a positive professional and educational experience, and that you are able to enjoy all of the amenities Atlanta has to off er.
Sincerely,
Colleen A. F. Lawton, MD, FASTRO President, ASTRO Chairman, Annual Meeting Steering Committee
2 ASTRO 2013 / 55TH ANNUAL MEETING Table of Contents WELCOME TO THE 55TH ANNUAL MEETING 2 Board of Directors 4 Continuing Medical Education 5 Annual Meeting Committee Members 7 Abstract Reviewers 8 Gold Medal and Honorary Member Recipients 9 Fellow Recipients 11 Awards 12
GENERAL INFORMATION 15 ASTROmobile 17 Industry-Expert Theater 21 Industry Satellite Symposia 22 Shuttle Service 26 Georgia World Congress Center Floor Plans 29
SCHEDULE OF EVENTS eContouring Learning Lab 41 Live Self-Assessment Module (SAM) Sessions 42 Presidential Symposium 44 Meeting Highlights 45 ARRO Program 48 Young Physicians’ Workshop 50 Nurses’ Program 51 International Program 52 ASTRO Accreditation Program for Excellence (APEx) 54 Schedule by Day Saturday 55 Sunday 57 Monday 68 Tuesday 84 Wednesday 105
POSTER PRESENTATIONS 127
INDEXES By Author 181 By Topic 190
EXHIBITOR LISTINGS Exhibitor List 203 Exhibitor List by Product/Service Category 212 Exhibit Hall Floor Plan 216 Board of Directors 2013 Offi cers and Board of Directors
Michael L. Steinberg, MD, FASTRO Chairman
Colleen A. F. Lawton, MD, FASTRO President
Bruce G. Haff ty, MD, FASTRO President-elect
Phillip M. Devlin, MD Secretary/Treasurer
Leonard L. Gunderson, MD, MS, FASTRO Immediate Past Chairman
Council Chairmen and Vice-chairmen
Carol H. Hahn, MD Clinical Aff airs and Quality Council Chairman
Lawrence B. Marks, MD, FASTRO Clinical Aff airs and Quality Council Vice-chairman
Laura A. Dawson, MD Education Council Chairman
Paul M. Harari, MD, FASTRO Education Council Vice-chairman
Bharat B. Mittal, MD, FASTRO Government Relations Council Chairman
Geraldine M. Jacobson, MD, MBA, MPA Government Relations Council Vice-chairman
Najeeb Mohideen, MD Health Policy Council Chairman
Brian Kavanagh, MD, MPH Health Policy Council Vice-chairman
Jacqueline Patricia Williams, PhD, FASTRO Science Council Chairman
Mary K. Martel, PhD, FASTRO Science Council Vice-chairman
Laura I. Thevenot Chief Executive Offi cer
4 ASTRO 2013 / 55TH ANNUAL MEETING Continuing Medical Education
NEEDS STATEMENT At the conclusion of this activity, the learner will be able Cancer is a leading cause of death worldwide. to: According to the World Health Organization (WHO), cancer deaths worldwide are projected to continue 1. Evaluate methods to provide multidisciplinary to rise to more than 11 million in 2030. Nearly care with a focus on improving patient two-thirds of these patients will receive radiation outcomes. therapy during their illness – most with the intent to 2. Employ quality and safety measures in the cure the cancer. Advances in the applications, delivery of radiation therapy. technologies and methodologies of radiation 3. Summarize the importance of patient-reported oncology continue to evolve rapidly and the delivery outcomes in improving patient care, and apply of radiation therapy has become more complex, lessons learned in his/her own practice. making it imperative that the radiation oncology professional remain current in state-of-the-art ELEMENTS OF COMPETENCE techniques. The American Society for Radiation The Annual Meeting program has been designed Oncology is committed to providing educational to narrow the competency gaps of patient care, programming that creates a forum for global professionalism, systems-based practice, collaboration on issues in radiation oncology to patient-centered care, medical knowledge, improve professional practice by increasing their level evidence-based practice, evaluation of performance of knowledge, as required to improve competency in in practice, interpersonal skills and communication, the fi eld of oncology. practice-based learning and improvement, utilization of informatics, work in interdisciplinary teams, quality PROGRAM DESCRIPTION AND OBJECTIVES improvement, professional standing and commitment The scientifi c program will continue to be the ideal to lifelong learning, 14 of the 15 core competencies platform to bring together clinicians, scientists and embraced by the American Board of Medical researchers from all of the oncologic disciplines to Specialties, the Accreditation Council for Graduate exchange ideas, promote multidisciplinary care Medical Education and the Institute of Medicine. and address the educational and professional development interests of our attendees. Scientifi c TARGET AUDIENCE and educational sessions will cover specifi c clinical The Annual Meeting program is intended for all areas including breast, central nervous system, health professionals in the fi eld of oncology, with gastrointestinal, genitourinary, gynecological, head particular emphasis on radiation oncologists, and neck, lymphoma, musculoskeletal, pediatric, radiation oncology residents, radiation biologists, sarcoma and thoracic cancers. Radiation biology and radiation physicists, oncological surgeons, medical radiation physics concepts will also be explored. dosimetrists, radiation therapists, pathologists and radiation oncology nurses. The 2013 Annual Meeting will focus on patient- reported outcomes and patient-centered care. CONTINUING MEDICAL EDUCATION Patient-reported outcomes have become a clear need in terms of understanding exactly what patients PHYSICIANS experience both during treatment as well as in follow The American Society for Radiation Oncology is up and in their survivorship. Physicians are well aware accredited by the Accreditation Council for that the traditional clinician-reported outcomes of the Continuing Medical Education to provide past underestimate the challenges that patients continuing medical education for physicians. experience during their treatment and beyond. CREDIT DESIGNATION Therefore, obtaining the “real results” via patient- reported outcomes becomes paramount if we want to ASTRO designates this live activity for a maximum provide the best care possible. The focus on patient- of 35 AMA PRA Category 1 Credits™. Physicians should centered care is just as important as doctor-patient claim only the credit commensurate with the extent communication and paramount in helping patients of their participation in the activity. make the best decisions for their care. PHYSICISTS This activity has been approved for a maximum of 35 We will continue to emphasize quality and safety credits by the Commission on Accreditation of issues in the delivery of radiation therapy in the areas Medical Physics Education Program. of treatment techniques, equipment, terminology and professional responsibilities. ASTRO 2013 / 55TH ANNUAL MEETING 5 DOSIMETRISTS DISCLOSURE OF VESTED INTEREST This activity has been approved for 31.5 continuing ASTRO is an accredited provider of continuing education credits by the Medical Dosimetrist medical education. Since our accreditation is Certifi cation Board. important to us, we plan activities that are compliant with the Accreditation Council for NURSES Continuing Medical Education (ACCME) and the This activity has been submitted to the Oncology content or format of CME activities and related Nursing Society (ONS) for approval to award materials will promote improvements or quality in contact hours. ONS is accredited as an approver of health care and not a specifi c proprietary business continuing nursing education by the American interest or commercial bias. Planning Committee Nurses Credentialing Center’s Commission on members and speakers are required to disclose the Accreditation. existence of any fi nancial or other relationship with PROGRAM EVALUATION PROCESS AND the manufacturer(s) of any commercial product(s) or provider(s) of any commercial services discussed in CONTINUING EDUCATION CREDITS an educational presentation. You must be a full-conference or one-day only registrant to receive continuing education credits. Any confl icts of interest are resolved prior to participation. In addition to written disclosure, To receive continuing education credits, you must presenters will disclose any vested interest submit an evaluation indicating the sessions that you or their intention to discuss off ‐label use of attended. All attendees will be able to complete this pharmaceuticals or devices, if applicable, to the evaluation online during the meeting or after the audience at the beginning of their presentation and conclusion of the meeting. in accordance with the ACCME standards and the Food and Drug Administration requirements. Keep track of the sessions you attended throughout the meeting to save time in the evaluation process. In an eff ort to increase transparency and easy access For questions regarding continuing education credits, to all disclosures, ASTRO’s Faculty, Committee and please visit the CE Central Booth located off the main Planner disclosure information will be available lobby, Level B, at the Georgia World Congress Center. online for the 2013 Annual Meeting. Go to the ASTRO Annual Meeting Program Web page Visit the CE Central Booth or Cyber Café to complete www.astro.org/soe13. In addition, disclosure slides your online evaluation form and obtain your will be shown at the beginning of each session and certifi cate. The CE Central Booth is located off the every presenter is also asked to display their main lobby B, and the Cyber Café is located in the disclosure. Disclosure information will not be Exhibit Hall. You will need your badge number to printed in paper versions of the meeting materials. complete the evaluation form. Please write your DISCLAIMER badge number here for future reference: Badge #: ______ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off -label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented.
The information contained in this program is current as of August 26, 2013, and is subject to change. Program changes will be provided in an Ann Smith, MD addendum and posted online. ASTRO Fairfax, VA 123456
Your badge number
6 ASTRO 2013 / 55TH ANNUAL MEETING 2013 Committee Members
2012-2013 Annual Meeting Steering Committee
Colleen A. F. Lawton, MD, FASTRO, Chairman Bruce G. Haff ty, MD, FASTRO, Vice-chairman Lynn D. Wilson, MD, MPH, FASTRO, Chairman, Scientifi c Committee Benjamin Movsas, MD, FASTRO, Vice-chairman, Scientifi c Committee Andrea K. Ng, MD, MPH, Chairman, Education Committee Catherine C. Park, MD, Vice-chairman, Education Committee Laura A. Dawson, MD, Chairman, Education Council
Lynn D. Wilson, MD, MPH, FASTRO Theodore L. DeWeese, MD, Chairman, Best of ASTRO Chairman, Scientifi c Committee
2012-2013 Annual Meeting Scientifi c Committee Lynn D. Wilson, MD, MPH, FASTRO, Indra Das, PhD, FASTRO Stephen Thomas Lutz, MD * Chairman Prajnan Das, MD, MS Anita Mahajan, MD Benjamin Movsas, MD, FASTRO Roy Decker, MD, PhD Nina Mayr, MD, FASTRO Vice-chairman * Jun Deng, PhD Robert Miller, MD, MS May Abdel-Wahab, MD, PhD Theodore DeWeese, MD Rolf-Peter Mueller, MD, PhD Ross A. Abrams, MD, FASTRO * Adam Dicker, MD, PhD * Arnold C. Paulino, MD * Sanjeev Aggarwal, MD Gary Freedman, MD * Kenneth Rosenzweig, MD * Kaled Alektiar, MD * Laurie Gaspar, MD, MBA, FASTRO * Lakshmi Santanam, PhD Elizabeth Baldini, MD, MPH James Hayman, MD * Ben Slotman, MD, PhD Beth Beadle, MD, PhD Susan Higgins, MD, MS Benjamin Smith, MD * Ramesh Bilimagga, MD Salma Jabbour, MD Timothy D. Solberg, PhD Kevin A. Camphausen, MD Rojymon Jacob, MD Mohan Suntharalingam, MD, MBA Allen Chen, MD David Jaff ray, PhD * Katherine S. Tzou, MD Ronald Chen, MD * Lisa Kachnic, MD Akila N. Viswanathan, MD, MPH* Julia Compton, MD Patrick Kupelian, MD * Stephanie E. Weiss, MD Louis S. Constine, MD, FASTRO * Alexander Lin, MD * Theodore E. Yaeger, MD Shari Damast, MD * Bo Lu, MD, PhD Gary Yang, MD * = Track Chairman
2012-2013 Annual Meeting Education Committee
Andrea K. Ng, MD, MPH, Chairman Jordan Kharofa, MD Baldev Patyal, PhD Catherine C. Park, MD, Krystyna Kiel, MD Narayan Sahoo, PhD Vice-chairman Patrick Kupelian, MD Roy B. Tishler, MD, PhD James Balter, PhD Joshua D. Lawson, MD Akila N. Viswanathan, MD, MPH Changhu Chen, MD Harvey Mamon, MD, PhD George D. Wilson, PhD Brian Czito, MD Brian Marples, PhD Suzanne L. Wolden, MD Robert Den, MD Loren K. Mell, MD Min Yao, MD, PhD B. Ashleigh Guadagnolo, MD, MPH Joanne M. Moar, RN, OCN James Yu, MD Daniel Hamstra, MD, PhD Arno J. Mundt III, MD, FASTRO Kun (Kim) Huang, MD Christopher F. Njeh, PhD
ASTRO 2013 / 55TH ANNUAL MEETING 7 2013 Abstract Reviewers
to the 2013 Thank You Abstract Reviewers May Abdel-Wahab Mohamed Elshaikh Joshua Lawson Simona Shaitelman Ross Abrams ** Beth Erickson Colleen Lawton Michael Sharpe Peter Ahn Suzanne Evans * Quynh Le Xinglei Shen Kevin Albuquerque * Liu Fei-Fei Larissa Lee Ke Sheng Kaled Alektiar ** Steven Feigenberg Andrew Lee David Sher Berthe Aleman Felix Feng * Percy Lee Wenyin Shi Brian Alexander Robert Foote Stanley Liauw Timothy Showalter Ozer Algan Eric Ford Steven Lin Farzan Siddiqui * Jonathan Ashman Benedick Fraass Lillie Lin Nicole Simone Elizabeth Baldini Gary Freedman ** Alexander Lin ** Charles Simone Voichita BarAd Martin Fuss Arthur Liu Heath Skinner Chris Barker Thomas Galloway Daniel Low Ben Slotman Glenn Stuart Bauman Yolanda Garces Andrew Lowy BenjaminSmith ** Beth Beadle Adam Garden Join Luh Danny Song Clair Beard Laurie Gaspar ** Stephen Thomas Lutz ** William Song Justin Bekelman * Hiram Gay C. M. Charlie Ma Jan-Jakob Sonke Jennifer Bellon * Daniel Gomez Shannon MacDonald Baldassarre Stea Stanley Benedict James Gordon Mitchell Machtay Kevin Stephans Sushil Beriwal Elizabeth Gore Gig Mageras Jonathan Strauss Lawrence Berk Alexander Gottschalk Anand Mahadevan * Erik Sulman Matt Biagioli Daila Gridley Anita Mahajan Alphonse Taghian Ranjit Bindra Katherine Griem Raymond Mak Michael Tee Sławomir Blamek Inga Grills Sheida Mani Rahul Tendulkar Jeff rey Bogart Ashleigh Guadagnolo Danielle Margalit Welela Tereff e James Bonner Vishal Gupta Rufus Mark Stephanie Terezakis Kristy Brock Daphne Haas-Kogen Mary Martel Juliette Thariat Stephen Brown Karl Haglund Neil Martin Charles Thomas Kevin Camphausen Russell Hales Vivek Mehta Wade Thorstad David Carlson Michele Halyard Loren Mell Robert Timmerman Jimmy Caudell Daniel Hamstra Joshua Meyer Roy Tishler A. Bapsi Chakravarthy* James Hansen Michael Milano Michael Tomblyn Arnab Chakravarti Paul Harari Robert Miller Wolfgang Tome Annie Chan James Hayman ** Drew Moghanaki * Javier Torres-Roca Daniel Chang Mark Henderson Radhe Mohan Phuoc Tran Eric Chang Joseph Herman Jean Moran Minh-Tam Truong Ronald Chen ** Susan Higgins Sabin Motwani Katherine Tzou Aileen Chen Ariel Hirsch Benjamin Movsas ** Neha Vapiwala Peter Chen Sarah Hoff e Sasa Mutic Greg Videtic Allen Chen Brad Hoppe Ashwatha Narayana Akila Viswanathan ** Bhisham Chera Peter Hoskin Andrea Ng Sujay Vora Indrin Chetty * David Howell Jatinder Palta Eleanor Walker Steven Chmura Dimitre Hristov Catherine Park Andrew Wang Seungtaek Choi I-Chow Hsu Abhijit Patel Stephanie Weiss * Jay Ciezki Geoff Hugo Shilpen Patel Maria Werner-Wasik * Deborah Citrin Arthur Hung Arnold Paulino ** Julia White C. Norman Coleman Mark Hurwitz Todd Pawlicki Henning Willers Louis Constine ** Zain Husain Christopher Pelloski Lynn Wilson Joseph S. Contessa Geoff rey Ibbott Mark Phillips Karen Winkfi eld Chris Crane Timothy Illidge Jean-Philippe Pignol Julia Wong Bouthaina Dabaja * David Jaff ray ** Alan Pollack Rebecca Wong Megan Daly Nora Janjan Louis Potters John W. Wong Shari Damast ** Ryan Jensen Jean Pouliot Wendy Woodward Parima Daroui Steve Jiang Deepak Pradhan Ping Xia Indra Das Candice Johnstone Robert Prosnitz Ying Xiao Laura Dawson William Jones III Rinaa Punglia Lei Xing Joseph Deasy Lisa Kachnic Rachel Rabinovitch Ted Yaeger Roy Decker Mitchell Kamrava Abram Recht Di Yan Andre Dekker Atif Khan Andreas Rimner Gary Yang Thomas Delaney Krystyna Kiel Mark Rivard Johnny Yap John DeMarco Catherine Kim Mack Roach Catheryn Yashar Robert Den Christopher King Kenneth Roberts Fang-Fang Yin Jun Deng Youlia Kirova Cliff Robinson Torunn Yock Adam Dicker ** Eric Klein Ken Rosenzweig ** Sue Yom Thomas Dilling Marisa Kollmeier Mihaela Rosu James Yu Thomas DiPetrillo Kevin Kozak Christian Rube Jennifer Yu Lei Dong David Kozono Samel Ryu Richard Zellars Jadranka Dragovic Daniel Krauss Lakshmi Santanam (Weining) Ken Zhen Jason Efstathiou * Jon Kruse Amit Sawant Hans Eich Greg Kubicek Julie Schwarz John Einck Charles Kunos David Sebag-Montefi ore Key Issam El Naqa Patrick Kupelian ** Suresh Senan ** Track chairman Rodney Ellis Nadia Laack Jan Seuntjens * Track co-chairman/vice-chairman
8 ASTRO 2013 / 55TH ANNUAL MEETING Gold Medal Recipients
The Gold Medal is ASTRO’s highest honor bestowed on revered members who have made outstanding contributions to the fi eld of radiation oncology.
2013 GOLD MEDALISTS
AMATO J. GIACCIA, PHD
Dr. Giaccia is the Jack, Lulu and Sam Willson Professor of Cancer Biology, associate chairman of the department of radiation oncology and director of the Division of Radiation and Cancer Biology at Stanford University School of Medicine in Stanford, Calif. He has made considerable contributions to radiation oncology research on the role of tumor microenvironment in tumor progression and metastasis, specifi cally tumor hypoxia.
RADHE MOHAN, PHD, FASTRO
Dr. Mohan is a professor and the Larry and Pat McNeil Chairman in Cancer Research in the department of radiation physics at The University of Texas MD Anderson Cancer Center. As a medical physicist for 42 years, he has had a major infl uence on several areas of radiation oncology, including radiation dosimetry, 3-D conformal radiation therapy, intensity modulated radiation therapy and ongoing research in proton therapy.
PRABHAKAR TRIPURANENI, MD, FASTRO
Dr. Tripuraneni serves as the head of the division of radiation oncology at Scripps Clinic in La Jolla, Calif., and the chief medical offi cer of Viewray Inc., in Cleveland. He has impacted the clinical aspect of radiation oncology with his insights in vascular brachytherapy and infl uenced enhancements to ASTRO, through leadership roles on ASTRO’s Board of Directors and his volunteer work on behalf of ASTRO in areas including practice accreditation, website development and e-learning initiatives.
ASTRO 2013 / 55TH ANNUAL MEETING 9 Honorary Member Recipient Honorary Membership is awarded annually to a distinguished cancer researcher or leader in a discipline other than radiation oncology, radiation physics or radiobiology. 2013 HONORARY MEMBER
JEAN OWEN, PHD
Dr. Owen is an accomplished researcher with more than 20 years of experience with the American College of Radiology Clinical Research Center, where she served as project director of the ACR Quality Research in Radiation Oncology (QRRO) project, formerly the Patterns of Care Study (PCS). In that role, she was involved in developing detailed clinical performance measures and survey processes to measure quality of care benchmarks in radiation oncology nationwide. Dr. Owen is currently working as an independent health care consultant and is pursuing a graduate certifi cate in research ethics from the Medical College of Wisconsin’s Graduate School of Biomedical Sciences.
2012 Honorary Member Mark P. Carol, MD
10 ASTRO 2013 / 55TH ANNUAL MEETING Fellow Recipients
The ASTRO Fellows designation honors those who have been an Active or Emeritus Member of ASTRO for at least 15 years, have given the equivalent of 10 years of service to ASTRO and have made signifi cant contributions to the fi eld of radiation oncology. ASTRO PROUDLY RECOGNIZES THE 2013 CLASS OF FELLOWS
• Jonathan J. Beitler, MD, MBA, Winship Cancer Institute of Emory University, Atlanta
• Phillip M. Devlin, MD, Harvard Medical School, Boston
• Thomas J. Eichler, MD, Thomas Johns Cancer Hospital, Richmond, Va.
• Silvia C. Formenti, MD, New York University School of Medicine, New York
• Stephen M. Hahn, MD, Perelman School of Medicine at the University of Pennsylvania, Philadelphia
• Geraldine M. Jacobson, MD, MPH, MBA, West Virginia University, Morgantown, W.Va.
• Tariq Altaf Mian, PhD, Medical Radiation Physics Inc., Scottsdale, Ariz.
• Bhudatt R. Paliwal, PhD, University of Wisconsin, Madison, Wis.
• Seth A. Rosenthal, MD, Radiation Oncology Center and Sutter Cancer Center, Roseville, Calif.
• Peter B. Schiff , MD, PhD, New York University School of Medicine, New York
Fellows Class of 2012
ASTRO 2013 / 55TH ANNUAL MEETING 11 Annual Meeting Abstract Awards 2013 ASTRO ANNUAL MEETING AWARD RECIPIENTS
RESIDENT CLINICAL/BASIC SCIENCE RESEARCH AWARD Timothy J. Harris, MD, PhD (Radiation and Cancer Biology) Michael R. Folkert, MD, PhD (Radiation Physics) Alireza Fotouhi Ghiam, MD, MSc (Clinical)
RESIDENT DIGITAL POSTER RECOGNITION AWARD Daniel Bracey, MD (Radiation and Cancer Biology) Mu-Han Lin, PhD (Radiation Physics) Ann Raldow, MD (Clinical)
RESIDENT POSTER VIEWING RECOGNITION AWARD – CLINICAL Emma Holliday, MD (1st place) Naamit Gerber, MD (2nd place) Christine Min, MD (3rd place)
RESIDENT POSTER VIEWING RECOGNITION AWARD – RADIATION AND CANCER BIOLOGY Carmen Perez, MD, PhD (1st place) Anthony Apicelli, MD, PhD (2nd place) Youssef Zeidan, MD, PhD (3rd place)
RESIDENT POSTER VIEWING RECOGNITION AWARD – RADIATION PHYSICS Junaid Pasha, MD (1st place) Shikui Tang, PhD (2nd place) Charles Wooten, MD (3rd place)
BASIC SCIENCE ABSTRACT AWARD – RADIATION PHYSICS Bin Han, PhD Teo Stanescu, PhD Seishin Takao, PhD Eric Williams, PhD Yun Yang, PhD
BASIC SCIENCE ABSTRACT AWARD – RADIATION AND CANCER BIOLOGY Anita Aiyer, MS Mekhail Anwar, MD, PhD Michael Spiotto, MD, PhD Gregory Vlacich, MD, PhD Ting Xu, MD
ANNUAL MEETING SCIENTIFIC ABSTRACT (TRAVEL) AWARD Scott Bratman, MD, PhD Christopher Chapman, MS Avani Dholakia, BS Aaron Falchook, MD Annemarie Fernandes, MD Victor Mangona, MD Ankit Modh, BS David Palma, MD, PhD Anupam Rishi, MD Roshan Sethi, BS Anand Shah, MD Arshin Sheybani, MD Terence Sio, MD, MS Christopher Tinkle, MD, PhD Ralph Vatner, MD, PhD
INTERNATIONAL – U.S. ANNUAL MEETING SCIENTIFIC ABSTRACT AWARD Antonio Zuliani, MD, PhD, MBA, MS
ANNUAL MEETING NURSE ABSTRACT AWARD Jean Hamker, RN
12 ASTRO 2013 / 55TH ANNUAL MEETING General Information
cial Meeting App
Georgia World Congress Center Floor Plans Floor Center Congress World Georgia Shuttle Bus Schedule Shuttle Bus
ASTROmobile – Offi General Information INSIDE: General Information year-round leadership and support ofradiationyear-round oncology. leadershipandsupport 2013 AmbassadorR 2013 Corporate fortheiroutstanding Ambassadors ASTRO proudly recognizes our (AS OF AUGUST 26, 2013) ecognition General Information
GEORGIA WORLD CONGRESS CENTER 285 Andrew Young International Blvd. NW Atlanta, GA 30313 AFFILIATED MEETINGS www.gwcc.com 37th ASRT RADIATION THERAPY All activities take place in Buildings A and B at the CONFERENCE Georgia World Congress Center unless stated September 22-24, 2013 otherwise. All information is current as of August 26, 2013, and is subject to change. Hyatt Regency Atlanta The 37th Annual ASRT Radiation Therapy ATTENDEE REGISTRATION Conference will take place at the Hyatt Regency Registration Hall, Building B Atlanta. ASTRO registered attendees may attend Attendee registration counters will be located in ASRT sessions by paying a reduced registration Registration Hall in Building B of the Georgia World fee of $195. Proof of registration (registration Congress Center. confi rmation or badge) is required to receive this reduced rate. If you have not registered to ATTENDEE REGISTRATION HOURS attend the ASRT conference but would like to do Saturday, September 21 7:00 a.m. - 5:00 p.m. Sunday, September 22 6:30 a.m. - 5:00 p.m. so, please register on-site at the Hyatt Regency Monday, September 23 7:00 a.m. - 6:00 p.m. Atlanta. Tuesday, September 24 7:00 a.m. - 5:00 p.m. Wednesday, September 25 7:00 a.m. - 2:00 p.m. 30TH SROA ANNUAL MEETING September 22-25, 2013 EXHIBITOR REGISTRATION InterContinental Buckhead Atlanta Registration Hall, Building B The 30th SROA Annual Meeting will take Exhibitor registration counters will be located in the place at the InterContinental Buckhead Atlanta. Registration Hall in Building B of the Georgia World Congress Center. ASTRO registered attendees may attend the SROA general sessions by paying a reduced EXHIBITOR REGISTRATION HOURS registration fee of $210. Proof of registration Thursday, September 19 8:00 a.m. - 5:00 p.m. (registration confi rmation or badge) is required Friday, September 20 8:00 a.m. - 5:00 p.m. to receive this reduced rate. If you have not Saturday, September 21 7:00 a.m. - 5:00 p.m. registered to attend the SROA conference but Sunday, September 22 7:00 a.m. - 5:00 p.m. would like to do so, please register on-site at the Monday, September 23 8:00 a.m. - 5:00 p.m. Tuesday, September 24 8:00 a.m. - 5:00 p.m. InterContinental Buckhead Atlanta.
C NNNECT Stop bbyy ASTRO Connect - the new Annual Meeting networking lounge. Main Lobby of Building B, Georgia World Congress Center New in 2013, we are introducing ASTRO Connect, a Connect with attendees. networking lounge that not only off ers charging stations but Tweet also is the perfect place to meet up with colleagues, have informal meetings, make new connections within the #ASTRO13 radiation oncology community and check in on social media sites.
ASTRO 2013 / 55TH ANNUAL MEETING 15 ASTRO CAREER FAIR ASTRO RESOURCE CENTER Room B207, Building B Booth 543, Exhibit Hall, Building B Take advantage of the ASTRO Career Fair to connect Visit the ASTRO Resource Center in the Exhibit with candidates for employment. Equipped with Hall to fi nd out about ASTRO’s products and services. computers and printers for your convenience, the The Resource Center is your one-stop-shop to learn Career Fair is available for employers to conduct about ASTRO member benefi ts, including the interviews with job applicants. Employers and Radiation Oncology -Incident Learning System applicants must register through the online ASTRO (RO-ILS) – the new medical error reporting system, Career Center in order to schedule interviews at the APEX – our new practice accreditation program, on-site Career Fair. educational meetings and webinars, advocacy and much more. ASTRO’s knowledgeable staff will be on Hours of Operation: hand to answer questions about your membership. Saturday, September 21 1:00 p.m. - 6:00 p.m. Be sure to stop by to have your picture taken and Sunday, September 22 8:00 a.m. - 6:00 p.m. uploaded to ASTRO’s online membership directory Monday, September 23 8:00 a.m. - 6:00 p.m. on ROhub. The Survivor Circle is also located in the Tuesday, September 24 8:00 a.m. - 6:00 p.m. Resource Center.
Private interview rooms are also available. These Hours of Operation: rooms are ideal if you have multiple interviews to Sunday, September 22 10:00 a.m. - 5:00 p.m. conduct or just need more privacy. A limited Monday, September 23 10:00 a.m. - 5:00 p.m. number of meeting rooms will be available to Tuesday, September 24 10:00 a.m. - 5:00 p.m. rent for three-hour periods Sunday, September 22 through Wednesday, September 25. For more information, contact Todd Karstaedt at toddk@ astro.org.
Interesting Speaker? ASTRO PAC LOUNGE Room B301, Building B Tweet ASTRO’s political action committee (PAC) is #ASTRO13 off ering access to an exclusive lounge for all ASTRO members who have donated to the ASTRO PAC in 2013. The PAC lounge will feature Internet access, coff ee and beverages, food and a place to rest between sessions. Members who have not made their contribution yet will be able to donate on-site. ASTRO PAC provides ASTRO with the opportunity to more fully participate in government and ensure your voice is heard by key policy makers on Capitol Hill. Be sure to stop by the lounge to get the most recent legislative and election updates. For more information, please email [email protected] or visit www.astro.org/ ASTROPAC.
Hours of Operation: Sunday, September 22 10:00 a.m. - 5:00 p.m. Monday, September 23 10:00 a.m. - 5:30 p.m. Happy Hour and Legislative Issue Forum 5:00 p.m. - 6:00 p.m. Tuesday, September 24 10:00 a.m. - 3:00 p.m.
16 ASTRO 2013 / 55TH ANNANNUALUAL MEETMEETINGING ASTROmobile – Your Annual Meeting Guide
ASTROmobile gives you access to the meeting program and the ability to customize your meeting experience with personalized maps and planners.
Search sessions by day, track or speaker. Search exhibitors by name, booth number or product/service category.
Session and exhibitor details with location maps. Search and view abstracts. Preview general meeting information. Access your “MyPlan” – your personal Annual Meeting schedule.
View convention center maps. Take notes on a session or exhibitor and access your notes from your mobile device.
Search and exchange messages with colleagues attending the meeting using Find a Friend. Find a Friend is integrated with your “My Plan” on the Online Conference Planner and ASTROmobile.
Funded in part by
ASTROmobile Login Instructions An account has been created for all registered attendees. Please log in as follows:
iPhone Users SmartPhone Users
1. Simply download “ASTROmobile13” 1. Go to www.astro.org/ASTROmobile in from the iTunes store. your mobile web browser.
2. Log in with the following credentials: 2. Log in with the following credentials:
Registration ID: Badge No. Registration ID: Badge No. Password: Last Name Password: Last Name Email ID: Email Address Smartphone users can also access ASTROmobile using a QR Code reader and the QR Code to the right.
Login Tips Your badge number is located on the front of your badge. Your email address is the email that you provided at the time of registration. Your last name must exactly match the spelling on your badge.
ASTRO 2013 / 55TH ANNUAL MEETING 17 ATLANTA TOURISM AND CONCIERGE DESK CE CENTRAL Main Lobby, Building B Located off Main Lobby, Building B Attendees can stop by the Atlanta tourism and Do you have questions about continuing concierge desk located in the Main Lobby of Building education or the 2013 changes to the American B at the Georgia World Congress Center to receive Board of Radiology (ABR) Maintenance of restaurant recommendations, make reservations Certifi cation (MOC) program? Staff from ASTRO and receive Atlanta visitor guides, maps, destination and the ABR will be on hand during the meeting information and local directions. to answer your individual questions about continuing education and MOC requirements. Hours of Operation: Saturday, September 21 9:00 a.m. - 5:00 p.m. CE Central computer stations provide access Sunday, September 22 9:00 a.m. - 5:30 p.m. for you to: Monday, September 23 9:00 a.m. - 5:30 p.m. • Complete your continuing education and Tuesday, September 24 9:00 a.m. - 5:30 p.m. meeting evaluation. Wednesday, September 25 9:00 a.m. - 2:00 p.m. • View/print a session tracking form. • Search abstracts. BUSINESS CENTER • Search exhibitors. Located off of the Main Lobby, Building B • Access your Online Conference Planner. A business center is conveniently located off of the Main Lobby of Building B of the Georgia World Hours of Operation: Congress Center. The business center off ers a variety Saturday, September 21 1:00 p.m. - 5:00 p.m. of services including packing and shipping, sign Sunday, September 22 8:00 a.m. - 6:00 p.m. production, copying and offi ce supplies. Monday, September 23 8:00 a.m. - 6:00 p.m. Tuesday, September 24 8:00 a.m. - 6:00 p.m. Hours of Operation: Wednesday, September 25 8:00 a.m. - 4:30 p.m. Saturday, September 21 8:30 a.m. - 5:00 p.m. Sunday, September 22 8:30 a.m. - 5:00 p.m. Monday, September 23 8:30 a.m. - 5:00 p.m. Tuesday, September 24 8:30 a.m. - 5:00 p.m. Wednesday, September 25 8:30 a.m. - 5:00 p.m. BUSINESS MEETING Tuesday, September 24 11:30 a.m. - 1:00 p.m. Room B302–B305, Building B Great Session? ASTRO voting members (Active, Affi liate, Allied and Tweet International members) are invited to attend the #ASTRO13 Business Meeting on Tuesday, September 24, from 11:30 a.m. - 1:00 p.m. Leaders of the Society will discuss important topics of interest to ASTRO members. You should not miss this important meeting. Lunch will be served.
18 ASTRO 2013 / 55TH ANNUAL MEETING SEARCHING FOR QUALIFIED RADIATION ONCOLOGY PROFESSIONALS?
Find them online on the ASTRO Career Center and in Atlanta at the ASTRO Career Fair
It’s easy to fi nd the right talent for your practice when you use the ASTRO Career Center. Advanced features allow you to search our resume database by various criteria including education, title, location and more. Planning to attend the ASTRO Annual Meeting? The ASTRO Career Fair is a perfect opportunity to interview qualifi ed candidates. Employer interview space at the Career Fair is free for ASTRO members with your purchase of an online career center posting. For more information or to purchase a posting, go to www.astro.org/careercenter.
RADIATION ONCOLOGY CAREER CENTER
JOB SEEKERS Be sure to indicate your availability for an interview at the ASTRO Annual Meeting by selecting the Career Fair option on “MyAccount” in the Career Center. Career Center jobs can also be found on the ASTRO Facebook page and on Twitter.
ASTROA STRO 2013 / 55TH55TH ANNUALANNU AL MEETINMEETINGG 1919 CYBER CAFÉ FACULTY/VIP OFFICE Booth 126, Exhibit Hall, Building B Room B401, Building B ASTRO attendees can browse the Internet and Faculty members and VIPs should check in at the check, retrieve and send email messages at the Faculty/VIP Offi ce, Room B401, to pick up Cyber Café in the Exhibit Hall. registration materials and receive last-minute updates and program changes. The Faculty/VIP Hours of Operation: Offi ce is conveniently located next to the Speaker Sunday, September 22 10:00 a.m. - 5:00 p.m. Ready Room. Faculty and VIPs are welcome in the Monday, September 23 10:00 a.m. - 5:00 p.m. Faculty/VIP Offi ce throughout the meeting. Tuesday, September 24 10:00 a.m. - 5:00 p.m. Faculty members include: ELECTRONIC BUSINESS CARD • Educational session lecturers. Included with your badge, you will receive an • Panel moderators and presenters. electronic business card equipped with a magnetic • Scientifi c session moderators and discussants. strip containing your contact information and other • eContouring Learning Lab presenters. demographic data. This card can be scanned in card • Presidential Symposium lecturers. readers located in exhibitor booths throughout the • Keynote speakers and introducers. Exhibit Hall. Simply give your electronic business • Nursing program speakers. card to the exhibitor and your contact information • International Symposium presenters. will be recorded for follow-up by the exhibitor. Note: Presenters of abstracts are not classifi ed as Note: Attendee email addresses will be included in faculty and should follow attendee registration the contact information given to exhibitors unless instructions. you indicated to exclude your email at the time of registration. Hours of Operation: Saturday, September 21 6:30 a.m. - 6:00 p.m. EXHIBIT HALL Sunday, September 22 6:30 a.m. - 6:00 p.m. Monday, September 23 6:30 a.m. - 6:00 p.m. Halls B1-B3, Building B Learn about the latest products in cancer treatment Tuesday, September 24 6:30 a.m. - 6:00 p.m. in the Exhibit Hall. Wednesday, September 25 6:30 a.m. - 4:30 p.m.
Hours of Operation: FIRST AID Sunday, September 22 10:00 a.m. - 5:00 p.m. First Aid Offi ce outside Hall B1, Building B Monday, September 23 10:00 a.m. - 5:00 p.m. First Aid is located outside of Hall B1 between the Tuesday, September 24 10:00 a.m. - 5:00 p.m. entrance of Halls B1 and B2 at the Georgia World Congress Center. The fi rst aid phone number is 404-223-4041, or dial ext. 4041 from a house phone. In an emergency, please contact fi rst aid or go to ASTRO Registration and have a staff person contact security. Connect with attendees.
Tweet Hours of Operation: #ASTRO13 Monday, September 16 8:00 a.m. - 5:00 p.m. Tuesday, September 17 8:00 a.m. - 5:00 p.m. Wednesday, September 18 8:00 a.m. - 5:00 p.m. Thursday, September 19 8:00 a.m. - 5:00 p.m. Friday, September 20 8:00 a.m. - 5:00 p.m. Saturday, September 21 7:00 a.m. - 6:00 p.m. Sunday, September 22 6:30 a.m. - 6:30 p.m. Monday, September 23 7:00 a.m. - 7:00 p.m. Tuesday, September 24 7:00 a.m. - 10:00 p.m. Wednesday, September 25 7:00 a.m. - 8:00 p.m. Thursday, September 26 8:00 a.m. - 5:00 p.m. 20 ASTRO 2013 / 55TH ANNUAL MEETING GEORGIA WORLD CONGRESS CENTER INFORMATION Main Lobby, Building B The Georgia World Congress Center’s friendly staff can help with convention center brochures and maps.
Hours of Operation: Saturday, September 21 7:00 a.m. - 5:00 p.m. Great Session? Sunday, September 22 6:30 a.m. - 5:00 p.m. Tweet Monday, September 23 7:00 a.m. - 6:00 p.m. #ASTRO13 Tuesday, September 24 7:00 a.m. - 5:00 p.m. Wednesday, September 25 7:00 a.m. - 4:30 p.m.
INDUSTRY-EXPERT THEATER* Rear of 100 Aisle, Exhibit Hall B1 This activity allows companies to present their noteworthy products and services through a live presentation in the Industry-Expert Theater located in the Exhibit Hall. Seating is available on a fi rst-come, fi rst-served basis. The Industry-Expert Theater content and views expressed therein are those of the exhibitor and not of ASTRO. *Industry-Expert Theaters are not accredited for continuing medical education credits.
Sunday, September 22 Monday, September 23 Time: 12:45 p.m. – 1:45 p.m. Time: 12:15 p.m. – 1:15 p.m. Accuray: Dynamic Technology in Motion An In-depth Look at Xofi go® (radium Ra 223 Supported by Accuray dichloride) Contact: Jim Bilich Supported by Bayer HealthCare and Algeta Phone: 925-348-2082 Contact: The Lockwood Group Box lunch provided Phone: 203-817-0951 Box lunch provided Monday, September 23 Time: 10:15 a.m. – 10:45 a.m. Tuesday, September 24 Electronic Brachytherapy Utilizing the 11:45 a.m. – 12:45 p.m. Xoft® System for the Treatment of Increasing Quality in Radiation Therapy Non-Melanoma Skin Cancer Supported by ScandiDos Supported by Xoft, A subsidiary of iCAD Inc. Contact: Marni Brown Contact: Donna Breault Phone: 608-630-9415 Phone: 978-337-2786 Box lunch provided Refreshments provided
ASTRO 2013 / 55TH ANNUAL MEETING 21 INDUSTRY SATELLITE SYMPOSIA ASTRO has reviewed and approved these symposia as appropriate for presentation. These symposia represent the content and views of the sponsors and are not part of the offi cial ASTRO Annual Meeting. Sunday, September 22, 2013 Monday, September 23, 2013
6:30 p.m. – 8:30 p.m. 6:00 p.m. – 7:45 p.m. (Registration and dinner begin at 6:00 p.m.) (Registration 5:00 p.m. – 6:00 p.m.; Reception to follow Bone-Seeking Radiopharmaceuticals for symposium.) Treatment of Prostate Cancer with Bone Hope, Guidance and Healing: Necessary Metastases: Implications of Emerging Data Components of Eff ective Proton Therapy and Showing Survival Improvements Clinical Research Omni Hotel at CNN Center, Grand Ballroom E Piedmont Driving Club This activity has been planned Accreditation: 1215 Piedmont Avenue NE and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Atlanta, GA 30309 Medical Education (ACCME) through the joint sponsorship Accreditation: The University of Florida College of Medicine of Medical Education Resources (MER) and PleXus is accredited by the Accreditation Council for Continuing Communications. MER is accredited by the ACCME to Medical Education to provide continuing medical education provide continuing medical education for physicians. for physicians.
The University of Florida College of Medicine CME Credits: Medical Education Resources designates this CME Credits: designates this live activity for a maximum of 2.0 live activity for a maximum of 2.0 AMA PRA Category 1 AMA PRA ™. Physicians should claim only the credit Credits™. Physicians should claim only the credit Category 1 Credits commensurate with the extent of their participation in the commensurate with the extent of their participation in the activity. activity.
This activity is hosted by the University of Florida and is Target Audience: This activity is intended for radiation oncologists, nuclear medicine physicians, radiation supported by an educational grant from IBA. biologists and physicists caring for patients with prostate cancer.
This activity is hosted by Medical Education Resources and PleXus Communications and is supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc/Algeta U.S. LLC.
7:00 p.m. – 9:30 p.m. (Registration begins at 6:00 p.m. in the Juniper Room.)
Radiotherapy Approaches: Is Genomic Profi ling the Answer? Omni Hotel at CNN Center, International Ballroom D Accreditation: EXCEL Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Credits: EXCEL Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is hosted by EXCEL Continuing Education and is supported by an educational grant from Genomic Health.
22 ASTRO 2013 / 55TH ANNUAL MEETING INFORMATION DESKS PARKING Outside of Registration Hall and located off Main There is self parking available at the Georgia World Lobby, Building B Congress Center. ASTRO does not validate Have a question? Stop by the Information Desk to parking. get your questions answered. Self-Parking Hours of Operation: If you plan on driving to the Georgia World Congress Saturday, September 21 7:00 a.m. - 5:00 p.m. Center, there is self-parking provided in the Red Sunday, September 22 6:30 a.m. - 5:00 p.m. (International) Deck. This parking lot is closest to Monday, September 23 7:00 a.m. - 6:00 p.m. Buildings A and B where the ASTRO Annual Meeting Tuesday, September 24 7:00 a.m. - 5:00 p.m. will be held. This lot is gated with an attendant on Wednesday, September 25 7:00 a.m. - 4:30 p.m. duty during all show/event hours. The standard rate for parking is $10, which is subject to change at any LOST AND FOUND time. Outside of Registration Hall and located off Main Lobby, Building B POSTER VIEWING To report a missing item, to check to see if an item Hall B4, Building B has been turned into security or to turn in a lost item, please stop by one of the Information Desks. Poster Set-up: Saturday, September 21 12:00 p.m. - 5:00 p.m. Hours of Operation: Sunday, September 22 7:30 a.m. - 10:00 a.m. Saturday, September 21 7:00 a.m. - 5:00 p.m. Sunday, September 22 6:30 a.m. - 5:00 p.m. Poster Viewing Hours: Monday, September 23 7:00 a.m. - 6:00 p.m. Sunday, September 22 10:00 a.m. - 5:00 p.m. Tuesday, September 24 7:00 a.m. - 5:00 p.m. Monday, September 23 10:00 a.m. - 6:30 p.m. Wednesday, September 25 7:00 a.m. - 4:30 p.m. Poster Viewing Session and Reception 5:30 p.m. - 6:30 p.m. LUNCH VOUCHER (Authors will be available for Q and A.) Attendees will receive a lunch voucher valued at Tuesday, September 24 10:00 a.m. - 5:00 p.m. $10 that can be used at food outlets in the Exhibit Hall only. This voucher is provided to all attendees Poster Removal: and exhibitors with their registration materials. Lost Tuesday, September 24 5:00 p.m. - 7:00 p. m. vouchers will not be replaced. Important: Posters not removed during this time will be thrown away. LUGGAGE/COAT CHECK Registration Hall, Building B Posters from the following categories will be Luggage and coat check will be available at the displayed: Georgia World Congress Center for $3 per item. Biology Lung Breast Lymphoma Hours of Operation: CNS Non-malignant Saturday, September 21 6:30 a.m. - 6:00 p.m. Gastrointestinal Palliative Care Sunday, September 22 6:00 a.m. - 6:30 p.m. Genitourinary Patient Reported Monday, September 23 7:00 a.m. - 7:00 p.m. Gynecologic Outcomes Tuesday, September 24 7:00 a.m. - 6:30 p.m. Head and Neck Patient Safety Wednesday, September 25 7:00 a.m. - 5:00 p.m. Health Services Research Pediatric History Physics Informatics/Bioinformatics Sarcoma
ASTRO 2013 / 55TH ANNUAL MEETING 23 PASSPORT PROGRAM
A special thank you to our Survivor Circle Passport Program Participants. Through their generous donations, the Cancer Foundation of Northeast Georgia and the South Georgia Medical Center, Pearlman Cancer Center received grants to help support their initiatives helping Georgia cancer survivors.
(As of August 28, 2013)
24 ASTRO 2013 / 55TH ANNUAL MEETING POSTER PICK-UP OFFICE: REGISTRANT LOCATOR – FIND-A-FRIEND Room: B215 Looking to connect with an attendee at the Annual For those who chose to use the poster printing Meeting? You can now use the Find-a-Friend feature service, there is a special pickup room located just with ASTROmobile, the offi cial Annual Meeting app. outside of the poster hall. Please go to Room B215 Find-a-Friend allows you to search for an attendee to pick-up your poster during regular poster set-up and send messages while at the Annual Meeting. hours and poster viewing hours as listed above. See page 17 for details.
POSTER VIEWING SESSION AND RECEPTION RADIATION ONCOLOGY INSTITUTE (ROI) Hall B4, Building B Monday, September 23 BOOTH 5:30 p.m. - 6:30 p.m. Located on Level 4, Building B
Attendees are invited to visit the Radiation During this reception, poster presenters will be Oncology Institute booth, located on Level 4 in available at their poster to answer questions and Building B of the Georgia World Congress Center. explain their research. New this year, there will be a Learn about ROI’s research initiatives and current presentation area where poster award winners will projects, including the National Radiation Oncology provide highlights of their research and be available Registry (NROR), Safety and Quality in IMRT Delivery for questions. The presentation schedule will be Accuracy and Best Practices in Toxicity available in the poster viewing area. Management.
Each full conference attendee, exhibitor and Monday Our mascot, “ROI” the gorilla, will also be on hand one-day conference attendee will receive one drink for those wishing to accept our Gorilla Challenge. ticket that can be used for complimentary Don’t miss out on this great opportunity to show beverage at the Poster Viewing Session and your support of the Institute! Reception on Monday, September 23. After your ticket has been redeemed, drinks are available for purchase. You must be 21 years of age to consume Hours of Operation: Sunday, September 22 8:00 a.m. - 5:00 p.m. alcoholic beverages. Your drink ticket is included Monday, September 23 8:00 a.m. - 5:00 p.m. with your badge in your registration materials. Tuesday, September 24 8:00 a.m. - 5:00 p.m. Wednesday, September 25 8:00 a.m. - 12:00 p.m. *This session is not accredited for continuing medical education credits.
PRESS ROOM Room B403 and B404, Building B Abstract presenters are encouraged to bring press releases promoting their presentation in Atlanta to the Press Room. For more information about ASTRO’s Interesting Speaker? Press Program and Policies, please contact ASTRO’s Tweet Press Offi ce at 703-286-1600 or [email protected]. #ASTRO13
Hours of Operation: Sunday, September 22 7:00 a.m. - 4:00 p.m. Monday, September 23 7:00 a.m. - 4:00 p.m. Tuesday, September 24 7:00 a.m. - 4:00 p.m. Wednesday, September 25 7:00 a.m. - 12:00 p.m.
For Press Room Information and Policies, visit www.astro.org/ampress.
ASTRO 2013 / 55TH ANNUAL MEETING 25 Shuttle Service Shuttle Service to the Georgia World Congress Center – Building B (GWCC) Complimentary shuttle service will be provided between the Georgia World Congress Center and offi cial ASTRO hotels. The shuttle drop-off and pick-up locations are located along Andrew Young International Blvd., just outside the Registration Hall at the Georgia World Congress Center. The shuttle schedule is subject to change at any time. Please refer to signs at the convention center, the on-site shuttle fl yer and your hotel lobby for the most current information. Hours of Operation: Saturday, September 21 7:00 a.m. - 6:00 p.m.* Sunday, September 22 6:30 a.m. - 7:00 p.m.* Monday, September 23 6:30 a.m. - 7:30 p.m.* Tuesday, September 24 6:30 a.m. - 7:00 p.m.* Wednesday, September 25 6:30 a.m. - 5:00 p.m.*
* Indicates last time buses depart the convention center returning to ASTRO offi cial hotels. Last shuttle departs hotels approximately 60 minutes prior to this last time.
HOTELS AND BOARDING LOCATIONS All travel times are approximate depending time of day, day of week and traffi c conditions.
Approximate Route Hotel Boarding Location at Hotel one-way Frequency travel time in minutes DoubleTree by Hilton Atlanta Downtown At Westin Peachtree Plaza.
Hampton Inn and Suites At Westin Peachtree Plaza. Peak 10-15 1 7-12 minutes Nonpeak 15-20 Holiday Inn Atlanta Downtown At Westin Peachtree Plaza.
Westin Peachtree Plaza Curbside on Spring.
Peak 10-15 2 Hyatt Regency Atlanta On Baker at Peachtree Street. 10-15 minutes Nonpeak 15-20 Courtyard Atlanta Downtown On Ellis at Peachtree Street. Ellis On Ellis at Peachtree Street. Peak 10-15 3 Ritz-Carlton Atlanta On Ellis at Peachtree Street. 13-17 minutes Nonpeak 15-20 Twelve Hotel Centennial Park Curbside on Spring Street. W Atlanta Downtown Curbside on Spring Street. Peak 10-15 4 Sheraton Atlanta Hotel On International at Courtland. 10-15 minutes Nonpeak 15-20 Atlanta Marriott Marquis Curbside on Peachtree Center. Peak 10-15 5 10-15 minutes Nonpeak 15-20 Hilton Atlanta At Atlanta Marriott Marquis.
Embassy Suites Atlanta
Walk Glenn Hotel, The No Shuttle Service Hotels Hilton Garden Inn Omni Hotel at CNN Center
Funded in part by
26 ASTRO 2013 / 55TH ANNUAL MEETING SMOKING TECHNOLOGY HELP DESK Georgia World Congress Center is a nonsmoking Located off Main Lobby, Building B facility. Need help using ASTROmobile, the offi cial app for the Annual Meeting? Have questions about the SPEAKER READY ROOM touch screen interactive wayfi nder stations that Room B402, Building B will help you navigate the convention center? Stop Faculty members and abstract presenters should by the Technology Help Desk located off the Main upload their PowerPoint presentation in advance Lobby in Building B at the Georgia World Congress of their session in order to have it pre-loaded Center to get your technology-related questions onto the ASTRO conference network. To ensure answered. presentations have been properly uploaded, faculty members and abstract presenters are asked to check Hours of Operation: in at the Speaker Ready Room to review the Saturday, September 21 7:00 a.m. - 5:00 p.m. information and make any last-minute edits. Sunday, September 22 6:30 a.m. - 5:00 p.m. Monday, September 23 7:00 a.m. - 6:00 p.m. Speakers should plan to save their presentation on Tuesday, September 24 7:00 a.m. - 5:00 p.m. a portable device and bring it to the Speaker Wednesday, September 25 7:00 a.m. - 4:30 p.m. Ready Room at least 24 hours in advance of their presentation or upon arrival at the Georgia World TRANSPORTATION Congress Center. Atlanta off ers a number of convenient transportation options to help attendees easily get around the city. Hours of Operation: Saturday, September 21 6:30 a.m. - 6:00 p.m. Airport Sunday, September 22 6:30 a.m. - 6:00 p.m. The Hartsfi eld-Jackson Atlanta International Airport Monday, September 23 6:30 a.m. - 6:00 p.m. is 11 miles from downtown Atlanta. Board outbound Tuesday, September 24 6:30 a.m. - 6:00 p.m. scheduled buses, shared ride and long distance vans, Wednesday, September 25 6:30 a.m. - 4:30 p.m. taxis, and hotel and rental car courtesy vans located in the arrival area of each terminal. SURVIVOR CIRCLE ASTRO Resource Center, Booth 543, Exhibit Hall, Taxi Building B A one-way taxi ride from the airport to downtown is In 2003, ASTRO created the Survivor Circle as a way a fl at rate of $30, with $2 for each additional to honor cancer survivors. Each year, ASTRO partners passenger. All areas within a 11-mile radius of with two local patient support organizations and downtown Atlanta are charged a fl at rate of $8, features them at the Survivor Circle at the Annual with $2 for each additional passenger. If you are Meeting. It was our hope that by partnering with departing to a hotel outside the 11-mile radius of local organizations in the cities that host our downtown Atlanta your taxi fare will be metered. meeting, we would be able to not only give back to the cities we visit, but also help raise awareness of MARTA these important organizations among our members. MARTA is Atlanta’s public transportation system that Through generous donations from exhibitors and provides rail and bus services throughout downtown attendees, ASTRO raises funds for the two and to and from the airport. There is a MARTA station organizations featured in the Survivor Circle. Since connected to the Hartsfi eld-Jackson Atlanta its inception, the Survivor Circle has raised more International Airport located right off of baggage than $250,000 for our partner organizations. Stop claim. The one-way fare to downtown on MARTA is by the Survivor Circle, located in Booth 543, to learn $2.50 and will get you downtown in 20 minutes. more about this year’s Survivor Circle Grant recipients: The Cancer Foundation of Northeast Georgia and the South Georgia Medical Center, Pearlman Cancer Center.
ASTRO 2013 / 55TH ANNUAL MEETING 27 VIRTUAL MEETING All full conference attendees receive the Virtual Meeting with their registration at no additional cost. With the Virtual Meeting, you can extend your learning experience with access to the 2013 ASTRO sessions long after the meeting is over. You will receive streaming content that has been digitally recorded live and published as audio synchronized to the speaker presentations*. Approximately three weeks after the meeting, full conference attendees will receive an email with a link providing access to the Virtual Meeting.
*Presentations are included in the Virtual Meeting as approved per faculty.
VIRTUAL POSTERS Hall B4, Building B Computer terminals and seating are available to view the virtual poster displays at your leisure. Correspond with presenters or forward a presentation to a colleague or your home offi ce.
Hours of Operation: Sunday, September 22 10:00 a.m. - 5:00 p.m. Monday, September 23 10:00 a.m. - 5:00 p.m. Tuesday, September 24 10:00 a.m. - 5:00 p.m.
WIRELESS INTERNET ACCESS Complimentary wireless Internet access is provided in all common areas and session rooms throughout the Georgia World Congress Center. Please note that this does not include the Exhibit Hall. Attendees can bring their laptop to check email, complete the evaluation or surf the Internet. Laptops must have a Wi-Fi card to connect.
Connect with attendees. Tweet #ASTRO13
28 ASTRO 2013 / 55TH ANNUAL MEETING Floor Plans To Omni To Hotel Level 4, Building A Level Y and ASTRO Information Booth and ASTRO Information Attendee/Exhibitor Registration Registration Attendee/Exhibitor Building B Shuttle Drop off off Shuttle Drop Level 5 - General Session 5 - General Level Level 4 Level Level 1 - Exhibit Hall and Posters Level Level 2 Level Level 3 Level Building A Building B Shuttle Buss Overall View Y
ASTRO 2013 / 55TH ANNUAL MEETING 29 Floor Plans Posters E § § c b c b c b Hall B4 Æ c b POSTERS First Aid First § F Æ § E § c b c Æ b § § § § E B1-B3 c b c b Æ Halls § E § EXHIBIT HALL EXHIBIT E § F § c c b b Restrooms Elevator Escalator TelephoneHall Exhibit Concessions Æ c Level 1, Building B Level b
30 ASTRO 2013 / 55TH ANNUAL MEETING Floor Plans B216 ce E c B215 b Poster Printing Offi Printing Poster Æ E Other B213 E Poster Hall Entrance Poster c b Æ Æ § B211 Exhibit Hall Entrance c b c b B207 ASTRO Career Fair Career Æ B206 E B205 E B204 c b B203 Restrooms Elevator Escalator TelephoneRoom Session Concessions c Level 2, Building B Level b c b B202
ASTRO 2013 / 55TH ANNUAL MEETING 31 Floor Plans E c b B313 ce/Other c Offi b E Fellows Ready Room Fellows B310 B311 Æ Contouring e Learning Lab B308 B318 B317 B319 ASTRO Job Interview Rooms E Æ B302 - 305 ASTRO PAC Lounge ASTRO PAC B301 B306 Restrooms Elevator EscalatorRoom Session Concessions c Level 3, Building B Level b
32 ASTRO 2013 / 55TH ANNUAL MEETING Floor Plans E c b ce/Other c Offi B405 B406 b E B404 Press News Briefi ng Room Briefi Press News ce Press Offi B403 Æ B402 Speaker Ready Room Speaker B411 ce B401 Radio Tour Room Radio Tour Æ Faculty/ VIP OffiFaculty/ ROI Booth Æ E Restrooms Elevator EscalatorRoom Session Concessions CE Central ASTRO c Level 4, Building B Level Help Desk b Information Information and Technology and Technology
ASTRO 2013 / 55TH ANNUAL MEETING 33 Floor Plans ce/Other Offi E § A412 A411 ASTRO Connect Hallway to Building B to Hallway Booth and Housing Desk ASTRO Information Registration and Exhibitor Attendee Check Coat Y East Plaza Entrance c § b Auditorium E Y Y Entrance Boulevard Boulevard Restrooms Elevator Escalator Shuttle Bus Telephone Session Room International International Andrew Young Young Andrew c Level 4, Building A Level b
34 ASTRO 2013 / 55TH ANNUAL MEETING Floor Plans c b 4 Murphy Murphy Ballroom E Thomas B. Thomas B. Session Room 1-3 Thomas B. Murphy Ballroom Murphy Thomas B. GENERAL SESSION GENERAL c b E Restrooms Elevator Escalator General Session c b Level 5, Building B Level
ASTRO 2013 / 55TH ANNUAL MEETING 35 NOTES
36 ASTRO 2013 / 55TH ANNUAL MEETING NOTES
ASTRO 2013 / 55TH ANNUAL MEETING 37 NOTES
38 ASTRO 2013 / 55TH ANNUAL MEETING Schedule of Events
Contouring Learning Lab Learning Contouring
Schedule of Events by Day Schedule of Events International Program Nurses’ Program Nurses’ Young Physicians’ Workshop Physicians’ Young ARRO Program Meeting Highlights Presidential Symposium Presidential e Sessions SAM Live INSIDE: Schedule of Events compassionate treatmentpossibletomorepatientsworldwide. Having helpedtreatover20000patients,IBA,theworld’s leadingmanufacturerinprotontherapy, makesthis therapy. Itenhancesthepatientandstaff experienceby fosteringasoothingenvironment. Proteus THE SAFESTWAY TOCOMPACT IMPT 6RPHIHDWXUHVDUHXQGHUGHYHORSPHQWDQGZLOOEHVXEMHFWWRUHY WWW.IBA-PROTEUSONE.COM Experience ® ONE isacompactsingle-roomsolutionthatoffers themostadvancedtreatmentmodalitiesinproton Proteus ® ONE at ASTRO |IBA BOOTH#1543 LHZE\FRPSHWHQWDXWKRULWLHV )'$1RWL¿HGERGLHVHWDO eContouring Learning Lab These sessions are designed to provide crucial, hands-on education for professionals. Attendees will have an opportunity to discuss issues such as imaging, target delineation, quality assurance and its frequency and achievable accuracy.
After the sessions, attendees should be able to: • Identify basic anatomy in the cases presented. • Evaluate normal tissue dose constraints versus target dose objectives. • Demonstrate improvement in contouring skills in the cases presented between pre- and post-activity. • Self-assess where additional contouring skills training may be needed. • Apply newly acquired contouring skills to his/her own practice.
Sarah Hoff e, MD, Program Chairman Steven Finkelstein, MD, Program Vice-chairman Room: B308 Schedule Saturday, September 21 Sunday, September 22
8:00 a.m. - 9:30 a.m. 8:00 a.m. - 9:30 a.m. Esophageal Cancers Lung Cancer Ravi Shridhar, MD, PhD, Moffi tt Cancer Center Billy W. Loo, MD, PhD, Stanford University Ken Meredith, MD, Moffi tt Cancer Center 10:00 a.m. - 11:30 a.m. 10:00 a.m. - 11:30 a.m. Lung SBRT/Sarcoma Gynecologic Cancers Billy W. Loo, MD, PhD, Stanford University Arno J. Mundt III, MD, FASTRO, University of Steven Finkelstein, MD, 21st Century Oncology California San Diego Amalia De Comas, MD, The Core Institute Beth A. Erickson, MD, FASTRO, Medical College of Wisconsin 1:45 p.m. - 3:15 p.m. Head and Neck Cancers 1:30 p.m. - 3:00 p.m. Avraham Eisbruch, MD, University of Michigan Lymphoma and Breast Cancer Health Systems Stephanie Terezakis, MD, Johns Hopkins Suresh Mukherji, MD, University of Michigan University Health Systems Frank Vicini, MD, 21st Century Oncology Matthew Stenmark, MD, University of Michigan Health Systems 3:30 p.m. - 5:00 p.m. Gastrointestinal Cancers 4:00 p.m. - 5:30 p.m. (SBRT/Abdominal) Prostate Cancers Karyn Goodman, MD, Memorial Sloan-Kettering Michael J. Zelefsky, MD, Memorial Sloan- Cancer Center Kettering Cancer Center Corinne Winston, MD, Memorial Sloan- Kettering Cancer Center
Ticketed event/Separate registration required.
ASTRO 2013 / 55TH ANNUAL MEETING 41 Live Self-Assessment Module Sessions
Special sessions have been designated as Live SAMs to help physician attendees meet the requirements of the American Board of Radiology’s Maintenance of Certifi cation program. Attendance at the Live SAM sessions is open to the general public, but only Live SAM ticket holders are eligible to earn SA-CME credit. On-site registration is available at the registration desk if seats are still available.
How to Participate On-site Live SAM registrants have two ways to participate in a Live SAM: a personal mobile device (smartphone, tablet or laptop) or a paper assessment. All registrants will receive the same assessment and evaluation questions regardless of the method they use to participate.
1. 15 minutes prior to the start of the session, visit the Live SAM table outside the designated session room. 2. Give your Live SAM ticket to ASTRO staff at the Live SAM table. In return for your ticket, ASTRO staff will give you a two-sided handout. One side of the handout contains the Live SAM Participant Directions for both the paper and mobile options and the other contains the required assessment and evaluation questions for those registrants wishing to use the paper method of participation. 3. Find any available seat in the session room and attend the entire session. 4. At the conclusion of the session, follow the directions to complete the assessment and evaluation questions on paper or via your personal mobile device. 5. Complete the required assessment and evaluation questions. A minimum score of 70 percent must be achieved on the assessment in order to receive credit. 6. ASTRO staff will email you approximately 30 days post-meeting with your individual score and directions on how to print your certifi cate of completion from the ASTRO website.
Live SAM Policy
• Live SAM registrants MUST be in the designated Live SAM room 15 minutes prior to the start of the session. If you are not in the room at this time, your seat may be given away to another attendee. • Registrants interested in using the mobile device option will need to bring their own mobile device and are responsible for ensuring that it is charged and can connect to the Internet via Wi-Fi or a cellular network connection. • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session. • Registrants must earn a minimum score of 70 percent on the assessment to earn credit. Participants who do not earn a minimum of 70 percent on the assessment questions will NOT receive SAM credit and will NOT receive a refund.
If you have any questions about the Live SAM sessions, SA-CME requirements or MOC, please visit the CE Central Booth off the Main Lobby, Building B.
Connect with attendees. Tweet #ASTRO13
42 ASTRO 2013 / 55TH ANNUAL MEETING Live SAM Sessions
Monday, September 23
7:45 a.m. - 9:00 a.m. Educational Session 210: Controversies in the Optimal Management of Regional Nodes Room: B405 Jennifer R. Bellon, MD, Dana-Farber Cancer Institute E. Shelley Hwang, MD, MPH, Duke University School of Medicine Julie R. Gralow, MD, University of Washington
4:00 p.m. - 5:30 p.m. Educational Session 214: Laryngeal Preservation in Larynx and Hypopharynx Cancer Room: B405 Robert J. Amdur, MD, University of Florida Christopher Holsinger, MD, Stanford University Quynh-Thu Le, MD, Stanford University Tuesday, September 24
7:45 a.m. - 9:00 a.m. Educational Session 301: Controversies on the Role of Radiation Therapy in the Management of Hodgkin Lymphoma (HL) Room: B405 Peter M. Mauch, MD, FASTRO, Harvard Medical School Lena Specht, MD, PhD, Rigshopitalet, University of Copenhagen Wednesday, September 25
7:45 a.m. - 9:00 a.m. Educational Session 404: Treatment Options for Patients with Early-stage Non-small Cell Lung Cancer Room: B405 Jeff rey A. Bogart, MD, State University of New York Abraham Lebenthal, MD, Brigham and Women’s Hospital
2:45 p.m. - 4:15 p.m. Educational Session 415: Management of High-risk Prostate Cancer (Including Post-operative XRT) Room: B313 Alan Pollack, MD, PhD, University of Miami - Miller School of Medicine Richard K. Valicenti, MD, University of California Davis Medical Center Yoshiya Yamada, MD, Memorial Sloan-Kettering Cancer Center
Symbol Key: ARONA Ticketed Event/ Nurses’ Award Live Interactive Separate Session Recipient SAM/ Session registration Separate required registration required
ASTRO 2013 / 55TH ANNUAL MEETING 43 Presidential Symposium “Prostate Cancer: Patient Focused Advances” Sunday, September 22 8:15 a.m. - 4:30 p.m. | Room: Thomas Murphy Ballroom 1-3 8:15 a.m. - 8:25 a.m. Welcome to Atlanta Walter J. Curran Jr., MD, Winship Cancer Institute of Emory University, Atlanta 8:25 a.m. - 8:30 a.m. Presidential Symposium – Introduction Colleen A. F. Lawton, MD, FASTRO, President, ASTRO Board of Directors 8:30 a.m. - 9:45 a.m. Presidential Symposium – Session I Moderators: Deborah A. Kuban, MD, FASTRO, and Anthony L. Zietman, MD, FASTRO Speakers: PSA Screening – Freddie Hamdy, MB, ChB, U n i v e r s i t y o f O x f o r d , H e a d i n g t o n , O x f o r d , United Kingdom Low Risk Debate – Active Surveillance vs. Treatment – Timothy J. Wilt, MD, MPH, Minneapolis VA Center for Chronic Disease Outcomes Research, University of Minnesota School of Medicine, Minneapolis vs. Michael J. Zelefsky, MD, Memorial Sloan-Kettering Cancer Center, New York
Quality of Life – Jeff M. Michalski, MD, MBA, FASTRO, Washington University School of Medicine, St. Louis 9:45 a.m. - 10:15 a.m. Break – Exhibit Hall Opens 10:15 a.m. - 11:30 a.m. Presidential Symposium – Session II Moderators: Deborah A. Kuban, MD, FASTRO, and Anthony L. Zietman, MD, FASTRO Speakers: Intermediate-risk Disease Debate – Surgery vs. Radiation – David Dearnaley, MD, Institute of Cancer Research, Royal Marsden Hospital, Surry, United Kingdom vs. Freddie Hamdy, MB, ChB, University of Oxford, Headington, Oxford, United Kingdom Fractionation for Organ Confi ned Disease – Søren M. Bentzen, DSc, PhD, University of Wisconsin School of Medicine and Public Health, Madison, Wis. Postoperative Irradiation – Chris Parker, MD, Royal Marsden Hospital, Surrey, United Kingdom 11:30 a.m. - 12:35 p.m. Presidential Symposium – Session III Moderators: Deborah A. Kuban, MD, FASTRO, and Anthony L. Zietman, MD, FASTRO Speakers: High-risk/Locally Advanced Disease – Padraig Warde, MD, Princess Margaret Hospital, Toronto, Ontario Systemic Agents/Chemotherapy What’s New – Matthew R. Smith, MD, PhD, Harvard Medical School, Massachusetts General Hospital, Boston Radiation for Metastatic Disease Dose/Fractionation and Systemic Agents – Howard M. Sandler, MD, MS, FASTRO, Cedars-Sinai Medical Center, Los Angeles Wrap Up – Deborah A. Kuban, MD, FASTRO, MD Anderson Cancer Center, Houston
3:45 p.m. - 4:30 p.m. Presidential Symposium – Session IV Patient-reported Outcomes - Making it Real Introduction by: Benjamin Movsas, MD, FASTRO Speaker: Jeff A. Sloan, PhD, Mayo Clinic, Rochester, Minn.
44 ASTRO 2013 / 55TH ANNUAL MEETING Meeting Highlights
Monday, September 23 8:00 a.m. - 9:00 a.m. Featured Lecture – “Patient Safety Organizations: An Overview” * Room: B406 William B. Munier, MD, Director, Center for Quality Improvement and Patient Safety, Agency for Healthcare Research and Quality Introduced by: Lawrence B. Marks, MD, FASTRO, University of North Carolina at Chapel Hill
Please join us for this timely presentation on patient safety organizations (PSOs). Dr. Munier is the director of the Center for Quality Improvement and Patient Safety at the Agency for Healthcare Research and Quality, where he is responsible for overseeing the implementation of the Patient Safety and Quality Improvement Act of 2005, which includes the oversight of PSOs. Dr. Munier’s perspective on PSOs is particularly relevant as ASTRO moves to implement a radiation oncology-specifi c PSO. *This session is not accredited for continuing medical education credits.
Monday, September 23 9:15 a.m. - 10:15 a.m. Keynote Address I “Is there Hope for ‘Healing’ Health Care?” Room: Thomas Murphy Ballroom 1-3 Darrell G. Kirch, MD, President and CEO, Association of American Medical Colleges Introduced by: Theodore L. DeWeese, MD, Johns Hopkins School of Medicine
Darrell G. Kirch, MD, is president and CEO of the Association of American Medical Colleges (AAMC), which represents the nation’s medical schools, teaching hospitals and academic societies. A distinguished physician, educator and medical scientist, Dr. Kirch speaks and publishes widely on the need for transformation in the nation’s health care system and how academic medicine can lead that change across medical education, medical research and patient care. Prior to becoming AAMC president in 2006, Dr. Kirch served as the dean and academic health system leader of two institutions, the Medical College of Georgia and the Penn State Milton S. Hershey Medical Center. He has co-chaired the Liaison Committee on Medical Education, the accrediting body for U.S. medical schools, and now serves as a member-at-large of the National Board of Medical Examiners and as chairman of the Department of Veterans Aff airs Special Medical Advisory Group. Dr. Kirch also is a member of the Institute of Medicine of the National Academies. A psychiatrist and clinical neuroscientist by training, Dr. Kirch began his career at the National Institute of Mental Health, becoming the acting scientifi c director in 1993 and receiving the Outstanding Service Medal of the United States Public Health Service. A native of Denver, he earned his BA and MD degrees from the University of Colorado.
Great speaker? Tweet #ASTRO13
ASTRO 2013 / 55TH ANNUAL MEETING 45 Meeting Highlights
Monday, September 23 1:15 p.m. - 2:00 p.m. Presidential Address – “Hope, Faith, Cancer: Keeping Patients First” Room: Thomas Murphy Ballroom 1-3 Colleen A. F. Lawton, MD, FASTRO, President, ASTRO Board of Directors Introduced by: J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin
Monday, September 23 4:00 p.m. - 5:00 p.m. Featured Lecture – “Update on Self-referral”* Room: B406 James Cosgrove, PhD, Director, U.S. Government Accountability Offi ce Introduced by: Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors
At ASTRO’s urging in 2010, Congress requested that the Government Accountability Offi ce, Congress’ investigative arm, report on the clinical and economic impact of self-referral in radiation oncology. Dr. Cosgrove will discuss the radiation oncology report, as well as other GAO reports on self-referral in diagnostic imaging and anatomic pathology. *This session is not accredited for continuing medical education credits.
Tuesday, September 24 9:15 am. - 10:15 a.m. Keynote Address II “Cancer Survivorship and Quality of Life” Room: Thomas Murphy Ballroom 1-3 Otis W. Brawley, MD, Chief Medical Offi cer, American Cancer Society Introduced by: J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin
Otis W. Brawley, MD, serves as the chief medical offi cer and executive vice-president of the American Cancer Society (ACS) and as a professor of hematology, oncology, medicine and epidemiology at Emory University. At the ACS Dr. Brawley is responsible for promoting the goals of cancer prevention, early detection and quality treatment through cancer research and education. He champions eff orts to decrease smoking, improve diet, detect cancer at the earliest stage and provide the critical support cancer patients need. He also guides eff orts to enhance and focus the research program, upgrade the society’s advocacy capacity and concentrate community cancer control eff orts in areas where they will be most eff ective. Further, as an acknowledged global leader in the fi eld of health disparities research, Dr. Brawley is a key leader in the society’s work to eliminate disparities in access to quality cancer care.
46 ASTRO 2013 / 55TH ANNUAL MEETING Meeting Highlights
Wednesday, September 25 9:15 am. - 10:15 a.m. Keynote Address III – Steven L. Leibel, MD, Memorial Lecture “Identifi cation and Targeting of Radioresistance Niches” Room: Thomas Murphy Ballroom 1-3 Peter Friedl, MD, PhD, St. Radboud University Nijmegen Medical Centre, University of Nijmegen, and MD Anderson Cancer Center Introduced by: Catherine C. Park, MD, University of California San Francisco
The research activities of Peter Friedl, MD, PhD, aim to identify the mechanisms of immune cell and cancer cell migration, with emphasis on routes, plasticity and outcome of migration in physiological (immune cell migration) and pathological context (cancer invasion and metastasis). Specifi c mechanisms of interest include the function of cell adhesion receptors (integrins, surface glycans), cell surface proteases (MMPs, MT-MMPs) and microenvironmental signals (tissue microanatomy, hypoxia, nutrient deprivation) and their impact on cancer invasion and metastasis, tissue destruction and anti-tumor immune defense.
The fi ndings of his laboratory contributed to establish a classifi cation on diff erent types of cell migration, their main molecular adhesion and protease pathways, and types and mechanisms of plasticity of cell migration. The data show cancer invasion and metastasis as an adaptive process in response to the microenvironment. Current basic themes include the cellular, molecular and physical plasticity of cell migration in leukocytes and cancer cells in vitro and in vivo. Therefore, Dr. Friedl’s lab monitors the preclinical response to anti-cancer therapy by intravital multiphoton microscopy. The data show the resistance of tumor microniches and highlight strategies to overcome resistance, particularly by combining radiation therapy and molecular therapy targeting integrin adhesion receptors.
ASTRO 2013 / 55TH ANNUAL MEETING 47 ARRO Program Saturday, September 21 ARRO Annual Seminar* 9:00 a.m. - 5:00 p.m. Room: B313 Refer to page 49 for program schedule. *This session is not accredited for continuing medical education credits.
6:30 p.m. - 8:30 p.m. ARRO Reception STATS 300 Marietta St., N.W. Atlanta, GA 30313 Shuttle service will not be provided to the ARRO Reception. STATS is approximately a 5-minute walk from the Georgia World Congress Center. Sunday, September 22 12:35 p.m. - 1:45 p.m. ARRO Annual Luncheon Room: B313 Guest Speaker: Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors Monday, September 23 12:15 p.m. - 1:15 p.m. ARRO Poster Walk with a Professor (Box Lunch) Room: Hall B4 – Poster Lounge
12:15 p.m. - 1:15 p.m. How to Review a Scientifi c Paper Workshop (Box Lunch)* Room: B203 W. Robert Lee, MD, MS, MEd, Moderator, Duke University
Workshop Faculty: Robert J. Amdur, MD, University of Florida Søren M. Bentzen, DSc, PhD, University of Wisconsin School of Medicine and Public Health Anthony V. D’Amico, MD, PhD, FASTRO, Brigham and Women’s Hospital Lynn D. Wilson, MD, MPH, FASTRO, Yale University School of Medicine Anthony L. Zietman, MD, FASTRO, Massachusetts General Hospital *This session is not accredited for continuing medical education credits.
5:30 p.m. - 6:30 p.m. Poster Viewing Session and Reception* Meet and Greet – Residents and Medical Students* Room: Hall B4 – Poster Lounge *This session is not accredited for continuing medical education credits. Wednesday, September 25 12:00 p.m. - 1:00 p.m. ARRO Meet the Professor Luncheon Ticketed event/Separate registration required. Room: B302-B305
48 ASTRO 2013 / 55TH ANNUAL MEETING ARRO Annual Seminar* Saturday, September 21 9:00 a.m. - 5:00 p.m. | Room: B313 This year’s program combines a variety of timely topics for residents at all stages of training. Using the audience interactive system, presentations are intended to facilitate interaction among participants from diff erent communities. *This session is not accredited for continuing medical education credits.
9:00 a.m. - 9:10 a.m. Opening Remarks – ARRO Executive Committee Jordan Kharofa, MD, ARRO Chairman, Medical College of Wisconsin Seth Miller, MD, University of North Carolina at Chapel Hill 9:10 a.m. - 9:40 a.m. Global Health Scholar Award Presentations Rachel Jimenez, MD, Harvard University, 2012 recipient - New Delhi, India Sarah Milgrom, MD, Memorial Sloan-Kettering Cancer Center, 2013 recipient - Dakar, Senegal Youssef Zeidan, MD, PhD, Stanford University, 2013 recipient - Beirut, Lebanon 9:40 a.m. - 10:00 a.m. Residency Research Time and Resources: Survey Results Josh Mackenzie, MD, University of Cincinnati 10:00 a.m. - 10:45 a.m. Legal Aspects of Entering Practice Terry Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute Break 10:50 a.m. - 11:50 a.m. Keynote Address: Radiation Oncology: Lessons from the Past to Help Guide Your Future 10:45 a.m. - 10:50 a.m. J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin 11:50 a.m. - 1:00 p.m. Break - Box Lunch 1:00 p.m. - 1:30 p.m. Fellowships in Radiation Oncology Subhakar Mutyala, MD, Texas A and M College of Medicine Panelists: Brian E. Lally, MD, University of Miami Health System Kunal Saigal, MD, Fellow, Beth Israel Deaconess Medical Center 1:30 p.m. - 2:30 p.m. Applying for Jobs: A Panel Discussion Moderator: Lisa A. Kachnic, MD, Boston Medical Center Panelists: Randy Kimple, MD, PhD, University of Wisconsin School of Medicine and Public Health Shannon Fogh, MD, University of California San Francisco Larry Daughtery, MD, Mayo Clinic, Jacksonville Anmed Ali, MD, Peachtree Radiation Oncology 2:30 p.m. - 3:30 p.m. Manuscript Writing Anthony L. Zietman, MD, FASTRO, Massachusetts General Hospital Katherine Bennett, ASTRO 3:30 p.m. - 4:20 p.m. Radiation Oncology Economics Series: Process of Care, Coding and Reimbursement in Radiation Oncology Najeeb Mohideen, MD, Northwest Community Hospital 4:20 p.m. - 5:00 p.m. Professional Evaluation of Radiation Oncology Academic and Private Practices Terry Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute
ASTRO 2013 / 55TH ANNUAL MEETING 49 Young Physicians’ Workshop* Saturday, September 21 1:00 p.m. - 5:00 p.m. | Room: B216
This workshop will address several key issues facing early career physicians and will provide an open forum for discussion among peers. The educational focus is targeted toward young physicians, less than 10 years in practice. Distinguished faculty will share their experience and insights on several exciting topics. *This session is not accredited for continuing medical education credits.
1:00 p.m. - 1:05 p.m. Welcome Shilpen Patel, MD, University of Washington 1:05 p.m. - 1:25 p.m. Keeping Your Sword Sharp – How to Stay Abreast of the Latest Developments with a Busy Practice and Life Patty Hardenberg, MD, Vail Valley Medical Center 1:25 p.m. - 1:45 p.m. Diffi cult Conversations with Patients Beth A. Erickson, MD, Medical College of Wisconsin and Akila N. Viswanaknan, MD, MPH, Brigham and Women’s Hospital 1:45 p.m. - 2:05 p.m. Negotiating a Contract When You are Established in the Field Terry Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute 2:05 p.m. - 2:25 p.m. Jumping Ship - How to Make the Transition When Changing Jobs Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors 2:25 p.m. - 2:45 p.m. Maintenance of Certifi cation - How? What? Where? When? Paul E. Wallner, DO, FASTRO, 21st Century Oncology 2:45 p.m. - 3:00 p.m. Break 3:00 p.m. - 3:20p.m. Getting Involved in Your Specialty or Organized Medicine/Leadership Development Tim R. Williams, MD, FASTRO, Lynn Cancer Institute 3:20 p.m. - 3:40 p.m. Starting Protocols and Getting Funding: The How, When and Where Walter J. Curran Jr., MD, Winship Cancer Institute of Emory University 3:40 p.m. - 4:00 p.m. Work/Life Balance Leonard L. Gunderson, MD, MS, FASTRO, Immediate Past Chairman, ASTRO Board of Directors, and Mayo Clinic Scottsdale 4:00 p.m. - 4:20 p.m. How to Build a Clinical Practice David C. Beyer, MD, FASTRO, Arizona Oncology Services 4:20 p.m. - 4:40 p.m. Case Presentations Reshma Jagsi, MD, University of Michigan 4:40 p.m. - 5:00 p.m. How to Critique, Write and Review a Scientifi c Paper W. Robert Lee, MD, MS, MEd, Duke University
Ticketed event/Separate registration required.
50 ASTRO 2013 / 55TH ANNUAL MEETING Nurses’ Program ARONA The Annual Meeting Nurses’ Committee has designed a program with sessions that are pertinent to radiation oncology nurses. The Nurses’ Luncheon is open to all Annual Meeting nurse registrants, but the option must have been added at the time of registration; therefore, you must have a ticket to attend. Saturday, September 21 10:45 a.m. - 12:00 p.m. Nurses’ Welcome and Orientation Luncheon Room: B206 Joanne Moar, RN, OCN, Massachusetts General Hospital Cindy Tomlinson, ASTRO’s New Medical Error Reporting Program The Annual Meeting Nurse Abstract Award will be presented during the luncheon.
12:00 p.m. - 1:30 p.m. HPV Changing the Paradigm in Head and Neck Cancer Room: B203 Jeanne Parzuchowski, RN, MS, OCN, William Beaumont Hospital
1:45 p.m. - 2:45 p.m. Wound and Skin Update: What’s Skin Got to Do With It Room: B203 Carole Bauer, RN, MSN, ANP-BC, OCN, CWOCN, Karmanos Cancer Center
2:45 p.m. - 3:45 p.m. Role of the Radiation Oncology Nurse in GI Oncology Room: B203 Gloria Wood, RN, MS, OCN, Moffi tt Cancer Center Sunday, September 22 1:45 p.m. - 2:45 p.m. RT the Gift That Keeps on Giving Room: B203 Vanna M. Dest, MSN, APRN, BC, AOCN, Hospital of Saint Rafael Pamela Devine, MSN, RN, Philadelphia VA Medical Center
2:45 p.m. - 3:45 p.m. Geriatric Focus in the Radiation Oncology Setting Room: B203 Diane Cope, PhD, ARNP, Florida Cancer Specialists and Research Institute Lynn Heup, MSN, BSN, Emory Healthcare
4:00 p.m. - 5:00 p.m. Integrative Health Modalities Room: B203 Marilyn Haas, PhD, Carepartners
Symbol Key: ARONA Ticketed Event/ Nurses’ Award Live Interactive Separate Session Recipient SAM/ Session registration Separate required registration required
ASTRO 2013 / 55TH ANNUAL MEETING 51 International Program A series of sessions have been identifi ed throughout the Annual Meeting Program as pertinent to our international attendees. The International Attendee Welcome Breakfast is open to all international attendees, and you must have an international attendee badge holder (black) to be admitted. The Foreign Language Poster Walks are ticketed event; therefore, you must register for them and have a ticket to attend. Sunday, September 22 7:00 a.m. - 8:15 a.m. International Attendee Welcome Breakfast Room: B302-B305 The International Abstract Award will be presented during the breakfast.
1:45 p.m. - 3:15 p.m. Best of ESTRO at ASTRO* Room: B213 Moderators: Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors Vincenzo Valentini, MD, President, ESTRO
Panelists: Phillip Poortmans, MD, President-elect, ESTRO Tommy Knöös, PhD, Physics Committee Chairman, ESTRO Vincenzo Valentini, MD, President, ESTRO *This session is not accredited for continuing medical education credits. Monday, September 23 11:00 a.m. - 12:00 p.m. Foreign Language Poster Walks Room: Hall B4, Poster Information Desk Foreign Language Poster Walks will be off ered in Chinese and Spanish, and will review selected abstracts based on disease site. Please note that this event is open to international attendees only. Please refer to the details below for further information.
CHINESE POSTER WALK Faculty: W. Ken Zhen, MD Disease Site: Head and Neck
SPANISH POSTER WALK Faculty: Adela Poitevin, MD Disease Site: Breast, CNS and Prostate
Connect with Attendees. Tweet #ASTRO13
52 ASTRO 2013 / 55TH ANNUAL MEETING International Symposium* Wednesday, September 25 1:00 p.m. - 4:15 p.m. Room: B206 *This Symposium is not accredited for continuing medical education credits.
1:00 p.m. - 2:30 p.m. International Symposium: Global Health and Radiation Oncology- Part I* Where is the Challenge and What Can We Do? Radiation Oncology in Latin America, India and Africa Moderator: Nina A. Mayr, MD, FASTRO, University of Washington
Speakers: Global Health - The Big Picture - Bhadrasain Vikram, MD, National Cancer Institute Latin America - Beatriz Amendola, MD, FASTRO, Innovative Cancer Institute Africa - Terry J. Wall, MD, JD, FASTRO, St. Luke’s Cancer Institute India - Prabhakar Tripuraneni, MD, FASTRO, Scripps Clinic
2:45 p.m. - 4:15 p.m. International Symposium II - Global Health and Radiation Oncology Part II: What are the Barriers to Delivery Optimal Therapy? Radiation Oncology in Asia Moderator: Kenneth Shung Hu, MD, Beth Israel Medical Center of New York
Speakers: Clinical and Societal Challenges - Mack Roach, MD, University of California San Francisco Infrastructure and Ancillary Services - Cynthia L. Eccles, CMD, RT, BS, University of Oxford, Gray Institute China - Nancy Lee, MD, Memorial Sloan-Kettering Cancer Center South East Asia - Miriam Calaguas, MD, St. Luke’s Medical Center
Symbol Key: ARONA Ticketed Event/ Nurses’ Award Live Interactive Separate Session Recipient SAM/ Session registration Separate required registration required
ASTRO 2013 / 55TH ANNUAL MEETING 53 ASTRO Accreditation Program for Excellence (APEx)
ASTRO’s practice accreditation program highlights the Society’s commitment to safety and quality. The program uses evidence-based guidelines and consensus statements on the practice of radiation oncology to establish standards of performance. ASTRO’s practice accreditation program will provide an objective peer review of essential functions and processes of radiation oncology practices, in addition to an on-site visit from a multidisciplinary team. The practice accreditation program consists of fi ve key areas: patient-centered care, the process of care, the radiation oncology team, safety, and quality management and assurance. Saturday, September 21 1:00 p.m. - 4:00 p.m. ASTRO Accreditation Program for Excellence (APEx) – Prospective Surveyor Training* Room: B213 This interactive session is designed to provide an overview of the program and guidance on the surveyor’s role. The target audiences for this session are radiation oncologists, physicists and radiation therapists who are interested in becoming surveyors for ASTRO’s practice accreditation program. Participants of this session will be able to: • Discuss the mission, vision and goals of the program. • Discuss the radiation oncology practice accreditation model. • Identify and discuss the program standards. • Identify the steps of the survey process. • Discuss eligibility criteria for surveyors. • Discuss surveyor training requirements.
Surveyors must be an ASTRO member; licensed; board certifi ed; experienced (fi ve years); currently practicing and fl exible to conduct one survey per quarter. Surveyors cannot conduct radiation oncology surveys for other accrediting bodies while surveying for ASTRO. *This session is not accredited for continuing medical education credits.
Monday, September 23 12:15 p.m. - 1:15 p.m. ASTRO Accreditation Program for Excellence (APEx) Highlights Luncheon Room: B405 This luncheon is designed to provide highlights of ASTRO’s practice accreditation program. Attend this session and learn about the accreditation process from the perspectives of a radiation oncologist, a physicist and a radiation therapist.
Symbol Key: Connect with attendees. ARONA Tweet Ticketed Event/ Nurses’ Award Live Interactive Separate Session Recipient SAM/ Session registration Separate #ASTRO13 required registration required
54 ASTRO 2013 / 55TH ANNUAL MEETING Schedule of Events Saturday | September 21
8:00 a.m. - 9:30 a.m. eContouring Learning Lab – Esophageal Cancers Room: B308 Refer to page 41 for program schedule.
9:00 a.m. - 5:00 p.m. ARRO Annual Seminar* Room: B313 Refer to page 49 for program schedule. *This session is not accredited for continuing medical education credits.
10:00 a.m. - 11:30 a.m. eContouring Learning Lab – Gynecologic Cancers Room: B308 Refer to page 41 for program schedule.
10:45 a.m. - 12:00 p.m. Nurses’ Welcome and Orientation Luncheon Room: B206 Refer to page 51 for program schedule.
12:00 p.m. - 3:45 p.m. Nurses’ Program Room: B203 Refer to page 51 for program schedule.
1:00 p.m. - 6:00 p.m. ASTRO Career Fair Room: B207
1:00 p.m. - 2:30 p.m. The New Accreditation System from the ACGME – A Program Director Workshop* Room: B211 This workshop is intended to provide Program Directors a comprehensive overview of the new accreditation system that will be rolled out in July 2014. The workshop will describe the Radiation Oncology Milestones and outline a process for programs to create their own Clinical Competency Committee as required by the ACGME. Additionally the workshop will highlight how to provide learners with eff ective feedback and useful evaluations.
Speakers: W. Robert Lee, MD, MS, MEd, Duke University Alisa Nagler, JD, EdD, Duke University Robert J. Amdur, MD, University of Florida *This session is not accredited for continuing medical education credits.
Ticketed Event/Separate registration required
ASTRO 2013 / 55TH ANNUAL MEETING 55 Saturday | September 21
1:00 p.m. - 4:00 p.m. ASTRO Accreditation Program for Excellence (APEx) – Prospective Surveyor Training* Room: B213 This session is designed to provide an overview of the program and guidance on the surveyor’s role. The target audiences for this session are radiation oncologists, physicists and radiation therapists who are interested in becoming surveyors for ASTRO’s practice accreditation program. Refer to page 54 for program schedule. *This session is not accredited for continuing medical education credits.
1:00 p.m. - 5:00 p.m. Young Physicians’ Workshop* Room: B216 Refer to page 50 for program schedule. *This session is not accredited for continuing medical education credits.
1:30 p.m. - 3:00 p.m. eContouring Learning Lab – Lymphoma and Breast Cancer Room: B308 Refer to page 41 for program schedule.
3:30 p.m. - 5:00 p.m. eContouring Learning Lab – Gastrointestinal Cancers (SBRT/Abdominal) Room: B308 Refer to page 41 for program schedule.
6:30 p.m. - 8:30 p.m. ARRO Reception – STATS 300 Marietta St., N.W. Atlanta, GA 30313 Shuttle service will not be provided to the ARRO Reception. STATS is approximately a 5-minute walk from the Georgia World Congress Center.
Connect with attendees. Tweet #ASTRO13
56 ASTRO 2013 / 55TH ANNUAL MEETING Sunday | September 22
7:00 a.m. - 8:15 a.m. International Attendee Welcome Breakfast Room: B302-B305 Open to international attendees. You must have a black badge holder to be admitted. Refer to page 52 for program schedule.
8:00 a.m. - 9:30 a.m. eContouring Learning Lab – Lung Cancer Room: B308 Refer to page 41 for program schedule.
8:00 a.m. - 6:00 p.m. ASTRO Career Fair Room: B207
8:15 a.m. - 8:25 a.m. Welcome Address* Room: Thomas Murphy Ballroom 1-3 Walter J. Curran Jr., MD, Winship Cancer Institute of Emory University *This session is not accredited for continuing medical education credits.
8:25 a.m. - 4:30 p.m. Presidential Symposium – “Prostate Cancer: Patient Focused Advances” Room: Thomas Murphy Ballroom 1-3 Refer to page 44 for program schedule.
10:00 a.m. - 5:00 p.m. Exhibit Hall Open Room: Halls B1–B3
10:00 a.m. - 5:00 p.m. Poster Viewing Room: Hall B4
10:00 a.m. - 11:30 a.m. eContouring Learning Lab – Lung SBRT/Sarcoma Room: B308 Refer to page 41 for program schedule.
Ticketed Event/Separate registration required
ASTRO 2013 / 55TH ANNUAL MEETING 57 Sunday | September 22
12:35 p.m. - 1:45 p.m. ARRO Annual Luncheon Room: B313 Guest Speaker: Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors
12:35 p.m. - 1:45 p.m. Health Policy Socioeconomic Luncheon* 2014 Radiation Oncology Coding and Reimbursement Update Room: Thomas Murphy Ballroom 4 Box Lunch Provided A preview of the 2014 proposed rule changes to the Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System, as well as other payment and coding changes for 2014, will be presented. This update will be followed by a review of the current payment environment, which is dominated by concerns about Medicare spending growth and the instability of the sustainable growth rate (SGR). The session will conclude with a discussion of actions taken by the Medicare agency and private payers to control health care spending and how ASTRO has actively engaged with them and other stakeholders to address these concerns.
Moderators: Joel Cherlow, MD, PhD, Long Beach Memorial Medical Center Thomas Eichler, MD, Thomas Johns Cancer Center
Speakers: David C. Beyer, MD, FASTRO, Arizona Oncology Services Najeeb Mohideen, MD, Northwest Community Hospital *This session is not accredited for continuing medical education credits.
12:35 p.m. - 1:45 p.m. Financial Planning Luncheon Hosted by the Radiation Oncology Institute (ROI)* Learn how Recent Tax Law Changes and the Health Care Reimbursement Climate Impact your Personal Financial Planning Room: B310 Box Lunch Provided This session will be aimed at educating attendees on the impact of the American Taxpayer Relief Act of 2012 and relevant planning topics that may be appropriate given the changes. Concepts such as evaluating current retirement plans and determining whether there may be an opportunity to increase deductible contributions will be explored, as well as tax effi cient investment vehicles like Roth IRAs, annuities, municipal bonds and master limited partnerships. Attendees will hear from fi nancial and estate planners who understand what planning and charitable giving strategies are available to benefi t them and the tax advantages available to eff ectively transfer wealth intergenerationally and support organizations like the Radiation Oncology Institute (ROI) that champion their profession.
Speakers: Theodore Lawrence, MD, PhD, FASTRO, President, ROI Board of Trustees Russell M. LaGreca and/or James K. Meek, Morgan Stanley Smith Barney LLC James R. Robinson,Esq. Barnes and Thornburg LLP J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin *This session is not accredited for continuing medical education credits.
58 ASTRO 2013 / 55TH ANNUAL MEETING Sunday | September 22
1:45 p.m. - 3:15 p.m. Scientifi c Session A – Clinical Trials Room: Thomas Murphy Ballroom 1-3 Moderators: Lynn Wilson, Benjamin Movsas 1:45 p.m. Maria Grazia Ghi 4 A Phase II-III Study Comparing Concomitant Chemoradiation Therapy (CRT) vs. Cetuximab/RT (CET/RT) With or Without Induction Docetaxel/Cisplatin/5Fluorouracil (TPF) in Locally Advanced Head and Neck Squamous Cell Carcinoma (LASCCHN). Effi cacy Results of the GSTTC Italian Study (NCT01086826) 1:53 p.m. Michael Folkert 5 Predictive Modeling of Outcomes Following Defi nitive Chemoradiation Therapy for Oropharyngeal Cancer Based on FDG-PET Image Characteristics Resident Clinical/Basic Science Research Award – Radiation Physics
2:01 p.m. Gregory Videtic 6 Radiation Therapy Oncology Group (RTOG) Protocol 0915: A Randomized Phase II Study Comparing Two Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients with Stage I Peripheral Non-small Cell Lung Cancer 2:09 p.m. David Palma 7 Predicting Esophagitis After Chemoradiation Therapy for Non-small Cell Lung Cancer: An Individual Patient Data Meta-Analysis of >1000 Patients 2:18 p.m. Antonio Zuliani 8 Effi cacy of Concomitant Cisplatin Plus Radiation Therapy and High-dose-rate Brachytherapy vs. Radiotherapy Alone for Stage IIIB Epidermoid Cervical Cancer: A Ten-Year Randomized Controlled Trial International Award Winner
2:26 p.m. Akila Viswanathan 9 A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) with Concurrent Cisplatin and Bevacizumab (Bev) Followed by Carboplatin and Paclitaxel for Patients with Endometrial Cancer: One-year Results from RTOG 0921 2:34 p.m. Raymond Mailhot Vega 10 Cost Eff ectiveness of Proton Therapy Compared to Photon Therapy in the Management of Pediatric Medulloblastoma 2:42 p.m. Jan Kriz 11 Relapse Analysis After Radiotherapy of PET-Positive Residual Tumors of Patients with Advanced Stage Hodgkin Lymphoma Treated in the HD15 Trial of the German Hodgkin Study Group (GHSG) 2:50 p.m. Edward Chow 12 Response and Quality of Life (QoL) Outcomes in a Randomized Trial of Single vs. Multiple Fractions (Fx) for Re-Irradiation (RE-RT) of Painful Bone Metastases (PBM): NCIC CTG SC.20 2:58 p.m. Robert Miller LBA2 N08C9 (Alliance) - A Phase III Randomized Study of Sulfasalazine vs. Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy 3:06 p.m. Arjun Sahgal LBA3 Individual Patient Data (IPD) Meta-Analysis of Randomized Controlled Trials (RCT) Comparing Stereotactic Radiosurgery Alone (SRS) to SRS Plus Whole Brain Radiotherapy (WBRT) in Patients with Brain Metastasis
ASTRO 2013 / 55TH ANNUAL MEETING 59 Sunday | September 22
1:45 p.m. - 3:15 p.m. Scientifi c Session B – Breast – Loco-regional Control Room: B302-B305 Moderators: Jennifer Yu, Youlia Kirova
1:45 p.m. Rachel Abrams Rabinovitch 13 Long Term Update of RTOG 0319: A Phase I/II Trial to Evaluate Three-dimensional Conformal Radiation Therapy (3-D CRT) Confi ned to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma (BrCa)
1:55 p.m. Jessica Wobb 14 Accelerated Partial Breast Irradiation Provides Equivalent 10-Year Outcomes to Whole Breast Irradiation: A Matched-Pair Analysis
2:05 p.m. Jayant Vaidya 15 Omitting Whole Breast Radiotherapy Did Not Increase Axillary Recurrence in the Targit-a Trial
2:15 p.m. Samuel Shin 16 Analysis of Prone Accelerated Partial Breast Irradiation After Breast-Conserving Surgery: 50 Months Follow-Up Results of 200 Patients
2:25 p.m. Atif Khan Discussant
2:35 p.m. Shulian Wang 17 Interim Analysis of 455 Breast Cancer Patients Randomly Treated with Hypofractionated or Conventional Fractionated Radiotherapy After Mastectomy
2:45 p.m. Yu-Chen Tsai 18 Post Mastectomy Radiotherapy Improves Survivals of N1 Breast Cancer Patients
2:55 p.m. Andrea Russo 19 Margin Status and the Risk of Local Recurrence (LR) in Patients with Early-stage Breast Cancer Treated with Breast-Conserving Therapy (BCT)
3:05 p.m. Betro Sadek 20 Higher Boost Dose of Radiation Instead of Mastectomy for Patients with Final Positive/Close Margins After Breast Conserving Therapy
1:45 p.m. - 3:15 p.m. Scientifi c Session C – Lung – SBRT Room: B405 Moderators: Megan Daly, Jeff rey Bogart
1:45 p.m. Hiroshi Onishi 21 Japanese Multi-institutional Study of Stereotactic Body Radiotherapy for More Than 2000 Patients with Stage I Non-small Cell Lung Cancer
1:55 p.m. Rikiya Onimaru 22 A Phase I Study of Stereotactic Body Radiotherapy (SBRT) for Peripheral T2N0M0 Non-small Cell Lung Cancer (NSCLC): Japan Clinical Oncology Group Study (JCOG0702) Sunday | September 22
2:05 p.m. Richard Hymas 23 A Matched Pair Analysis of Stage I Non-small Cell Lung Cancer Treated with Lobectomy, Stereotactic Radiotherapy (SBRT) or Wedge Resection
2:15 p.m. Inga Grills Discussant
2:25 p.m. Jeremy Harris 24 Performance of PET in Evaluating Local Recurrence after Stereotactic Ablative Radiotherapy for Early Lung Cancer
2:35 p.m. Sarah Mattonen 25 Assessment of Response After Stereotactic Ablative Radiotherapy (SABR) for Lung Cancer: Can Advanced CT Image Feature Analysis Predict Recurrence?
2:45 p.m. Brandon Mancini 26 PET Predicts Survival Following Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer
2:55 p.m. Zachary Kohutek 27 Pre-Treatment SUVmax on [18F]FDG-PET is Associated with Recurrence and Survival After SBRT for Early-stage NSCLC
3:05 p.m. Houda Bahig 28 Tumoricidal Robotic Radiation: 96% 2-Year Disease-Specifi c Survival Following Cyberknife Stereotactic Body Radiotherapy for Early-stage Non-small Cell Lung Cancer
1:45 p.m. - 3:15 p.m. Scientifi c Session D – Physics – MRI in Radiation Therapy Room: Sidney Marcus Auditorium Moderators: Daniel Low, Carri Glide-Hurst
1:45 p.m. David Jaff ray 29 Development of a Novel Platform for MR-guided Radiation Therapy
1:55 p.m. Yanle Hu 30 Image Performance Characterization of an MRI-Guided Radiotherapy System
2:05 p.m. Tony Tadic 31 A Novel Harmonic Analysis for Quantifying MRI Performance in MRIgRT
2:15 p.m. Olga Green 32 Realizing the QUANTEC Vision by Applying iWeighted Hybrid Iterative Spiral K-space Encoding Estimation (WHISKEE) to Actual dose (DA) Accumulation via Image Deformation (DAAvID)
2:25 p.m. Louise Murray 33 Isotoxic Simultaneous Integrated Boost to Dominant Intra-prostatic Lesions Using Stereotactic Ablative Radiotherapy and Volumetric Modulated Arc Therapy
ASTRO 2013 / 55TH ANNUAL MEETING 61 Sunday | September 22
2:35 p.m. Timothy Craig 34 A Clinical Process for Imaging, Planning and Delivery of Dose Escalation for Intraprostatic Gross Tumor Volumes
2:45 p.m. Alexander Chin 35 Dosimetric Accuracy of Bulk Density Assignment on MRI for Head and Neck IMRT Treatment Planning
2:55 p.m. Elisabeth Weiss 36 Diff usion-weighted MRI for Response Assessment During Radiotherapy of Lung Cancer
1:45 p.m. - 3:15 p.m. Scientifi c Session E – CNS – Glioblastomas and High Grade Gliomas Room: B406 Moderators: Charles Simone, Christina Tsien
1:45 p.m. Frank Saran 37 The Addition of Bevacizumab (BEV) to Temozolomide (TMZ) and Radiotherapy (RT) in Newly Diagnosed Glioblastoma (GBM) Improves Progression-free Survival (PFS) Without Adding to RT Toxicity
1:55 p.m. Moses Tam 38 Phase II Trial of Temozolomide Plus Bevacizumab, Lithium and Radiation Treatment for Newly Diagnosed High Grade Gliomas: Interim Analysis
2:05 p.m. Nils Arvold 39 Disconnect Between Recurrence-Free Survival and Overall Survival for Newly Diagnosed Glioblastoma Patients Receiving Adjuvant Bevacizumab
2:15 p.m. Linda Chen 40 Characterization of Glioblastoma Subventricular Recurrence Patterns
2:25 p.m. Penny Fang 41 Phase I Study of Nelfi navir Concurrent with Temozolomide and Radiation Therapy in Patients with Glioblastoma Multiforme
2:35 p.m. Daniel Spratt 42 A Validation Study of the Temporal Relation of Post-operative Radiotherapy with Temozolomide for Glioblastoma Multiforme: Is the RTOG RPA Enough?
2:45 p.m. Mekhail Anwar 43 Identifying Voxels at Risk for Progression in GBM Based on Dosimetry, Physiologic and Metabolic MRI Basic Science Abstract Award – Radiation and Cancer Biology
2:55 p.m. Hasan Danish 44 Post-radiation Diff usion MRIs May Distinguish True Progression from Pseudoprogression in GBM Patients
3:05 p.m. Kevin Camphausen Discussant Interesting session? Tweet
62 ASTRO 2013 / 55TH ANNUAL MEETING #ASTRO13 Sunday | September 22
1:45 p.m. - 3:15 p.m. Digital Poster Discussion 01 – Physics – Novel Applications Room: A411 Discussants: Kristy Brock, Laurence Court
Ruby Meredith 1001 Early Results of Phase I Trial with New Anti-HER-2 Radionuclide Conjugate
Diana Shvydka 1002 Design of a Novel Multilayer Detector Based on Thin-Film Cadmium Telluride for High Energy Photon Imaging in Radiation Therapy Applications
Rafal Tarnawski 1003 Integration of PET/CT (68) Ga-Dotate for Robotic Radiotherapy Treatment Planning in Meningioma Patients
Javad Rahimian 1004 Prediction of Pelvic Lymph Node Involvement in Patients with Prostate Cancer Using an Artifi cial Neural Network
Kristofer Kainz 1005 Deriving a Virtual Respiratory Phase-Specifi c PET Contour from Free-Breathing PET Using Respiratory Information from 4-D CT
Tsuyoshi Takanaka 1006 Breath Holding Volumetric Modulated Radiotherapy Based on Implanted Fiducial Marks Using the Image-guided Radiotherapy System with Fluoroscopic Function
Houari Korideck 1007 Dosimetric Verifi cation of the Small Animal Radiation Research Platform (SARRP) Treatment Planning System (TPS) in Mice
Bashar Al-Qaisieh 1008 Dosimetry Modeling for Focal LDR Prostate Brachytherapy
Wilfred Ngwa 1009 Towards Customizable Radiotherapy Enhancement (CuRE), with Gold Nanoparticles released, in situ, from Gold-loaded Brachytherapy Spacers
Mu-Han Lin 1010 Clinical Implementation of a Comprehensive EPID-Based 3-D/4-D Patient Dose Reconstruction Framework for Complex Treatment Validations Resident Digital Poster Discussion Award
Shungo Akita 1011 Establishment of an Easy-to-Handle Quality Assurance (QA) Tool Using Plastic Scintillator for Dynamic Parameters of VMAT
Xin Ming 1012 Monte Carlo Estimation of Dose to the Cardiac Implantable Electronic Devices from a kVCBCT System Used in Image-Guided Radiation Therapy
ASTRO 2013 / 55TH ANNUAL MEETING 63 Sunday | September 22
1:45 p.m. - 3:15 p.m. Digital Poster Discussion 02 – GU – Fractionation, Protons, Prognostic Factors and Hormones Room: A412 Discussants: Neil Martin, Mack Roach
Michael Weller 1013 Hypofractionated Intensity Modulated Radiotherapy for Localized Prostate Cancer: Long Term Outcomes and a Comparison to Standard Dose-escalated RT
Nadia Di Muzio 1014 High Dose Moderately Hypofractionated Tomotherapy for Prostate Cancer: Five Year Results
James Yu 1015 Stereotactic Radiosurgery versus Intensity Modulated Radiotherapy for Prostate Cancer: Comparison of Early Toxicity
Paul Romesser 1016 Prostate-specifi c Antigen (PSA) Doubling Time at Time of PSA Relapse is an Independent Predictor for Distant Metastasis and Survival After External Beam Radiation Therapy
Randal Henderson 1017 Early Gastrointestinal Toxicity Outcomes from a Prospective Trial of Accelerated Hypofractionation with Proton Therapy for Prostate Cancer
Tamara Smith 1018 Grade 3 Genitourinary Toxicities in Men After Proton Therapy for Prostate Cancer
Nancy Mendenhall 1019 Five-year Outcomes of Proton Therapy in Localized Prostate Cancer on Three Prospective Trials for Low-, Intermediate- and High-Risk Prostate Cancer
Tamim Niazi 1020 Testosterone Breakthrough During Luteinizing Hormone-Releasing Hormone Agonist Therapy Impacts Biochemical Disease Progression: Fact or Myth?
Jason Hearn 1021 Prostate Cancer in the Era of High-Dose Radiotherapy: Presence of Multiple Intermediate-risk Factors is Not a Valid Surrogate for High-risk Disease
Miranda Kim 1022 Defi ning the Optimal Approach to the Patient with Post-Radiation Prostate-Specifi c Antigen Recurrence Using Outcome Data from a Prospective Randomized Trial
Sindy Magnan 1023 Intermittent vs. Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis
64 ASTRO 2013 / 55TH ANNUAL MEETING Sunday | September 22
William Jackson 1024 Duration of Androgen Deprivation Therapy Infl uences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy
1:45 p.m. - 3:15 p.m. Educational Session 101 – Stem Cells, Bystander and Cell Death Mechanisms Room: B211 Frank Pajonk, MD, PhD, University of California Los Angeles Health System Kevin Prise, PhD, Queen’s University Belfast Paul F. Wilson, PhD, Brookhaven National Labratory
1:45 p.m. - 3:15 p.m. Educational Session 102 – ASTRO/PROS Session: Current Approaches for Childhood Brain Tumors Room: B206 Daniel A. Hamstra, MD, PhD, University of Michigan Nadia N. Laack, MD, MS, Mayo Clinic Anita Mahajan, MD, MD Anderson Cancer Center
1:45 p.m. - 3:15 p.m. eContouring Learning Lab – Head and Neck Cancers Room: B308 Refer to page 41 for program schedule.
1:45 p.m. - 3:15 p.m. Best of ESTRO at ASTRO* Room: B213 Refer to page 52 for program schedule. *This session is not accredited for continuing medical education credits.
1:45 p.m. - 5:00 p.m. Nurses’ Program Room: B203 Refer to page 51 for program schedule.
3:45 p.m. - 4:30 p.m. Presidential Symposium – Session IV Patient-reported Outcomes - Making it Real Room: Thomas Murphy Ballroom 1-3 Introduction by: Benjamin Movsas, MD, FASTRO Speaker: Jeff A. Sloan, PhD, Mayo Clinic, Rochester, Minn.
Ticketed Event/Separate registration required
ASTRO 2013 / 55TH ANNUAL MEETING 65 Sunday | September 22
4:00 p.m. - 5:30 p.m. eContouring Learning Lab – Prostate Cancers Room: B308 Refer to page 41 for program schedule.
4:30 p.m. - 6:00 p.m. Panel 01 - Optimal Approach to Breast Cancer in Women > 70 Years Old Room: B211 Moderator: Janet Horton, MD, Duke University Medical Center
Panelists: Kevin Hughes, MD, University of North Carolina at Chapel Hill Benjamin Smith, MD, MD Anderson Cancer Center Hyman Muss, MD, University of North Carolina at Chapel Hill
4:30 p.m. - 6:00 p.m. Panel 02 – Patient-reported Quality of Life Following Radiation Therapy for Prostate Cancer Room: B302-B305 Moderators: Daniel Hamstra, MD, PhD, University of Michigan Martin Sanda, MD, Beth Israel Deaconess Medical Center
Panelists: Deborah Watkins Bruner, PhD, RN, Emory University Martin Sanda, MD, Emory University School of Medicine Daniel Hamstra, MD, PhD, University of Michigan Jason Efstathiou, MD, PhD, Massachusetts General Hospital
4:30 p.m. - 6:00 p.m. Panel 03 – Stereotactic Body Radiation Therapy for Lung Cancer Room: Sidney Marcus Auditorium Moderators: Andrea Bezjak, MD, Princess Margaret Hospital Joe Chang, MD, MS, PhD, MD Anderson Cancer Center Panelists: Indrin J. Chetty, PhD, Henry Ford Health System Billy W. Loo, MD, PhD, Stanford University Ben Slotman, MD, PhD, VU University Hospital Center
4:30 p.m. - 6:00 p.m. Panel 04 – Overcoming the Resistance of Glioblastoma to Conventional Radiation Therapy Room: B216 Moderators: Brian Marples, PhD, William Beaumont Hospital Kevin Camphausen, MD, National Cancer Institute
66 ASTRO 2013 / 55TH ANNUAL MEETING Sunday | September 22
Panelists: Peter Huber, MD, PhD, KDFZ University Hospital, Germany William Phillips, MD, University of Texas Health Science Center San Antonio Brian Marples, PhD, William Beaumont Hospital Kevin Camphausen, MD, National Cancer Institute
4:30 p.m. - 6:00 p.m. Panel 05 – The Role of Radiotherapy in Radical/Adjuvant Non-small Cell Lung Cancer: ASTRO Practice Guideline Evidentiary Base Room: Thomas Murphy Ballroom 4 Moderator: George Rodrigues, MD, MSc, London Regional Cancer Program
Panelists: Gregory Videtic, MD, Cleveland Clinic Alexander Louie, MD, London Regional Cancer Program Maria Werner-Wasik, MD, Thomas Jeff erson University Hospital Hak Choy, MD, UT Southwestern Medical Center Jeff rey Bogart, MD, State University of New York
4:30 p.m. - 6:00 p.m. Educational Session 103 – Challenging Cases of Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma Room: B206 Bouthaina Dabaja, MD, MD Anderson Cancer Center David Hodgson, MD, Princess Margaret Hospital Richard T. Hoppe, MD, FASTRO, Stanford University Ann LaCasce, MD, Harvard Medical School Peter Mauch, MD, FASTRO, Harvard Medical School
4:30 p.m. - 6:00 p.m. Educational Session 104 – Head and Neck Case Presentations Room: B313 Robert Amdur, MD, University of Florida Avraham Eisbruch, MD, University of Michigan Health Systems Robert I. Haddad, MD, Dana-Farber Cancer Institute Louis B. Harrison, MD, FASTRO, Beth Israel Medical Center Adam Jacobson, MD, Beth Israel Medical Center
Great Speaker? Tweet #ASTRO13
ASTRO 2013 / 55TH ANNUAL MEETING 67 Monday | September 23
7:45 a.m. - 9:00 a.m. Educational Session 201 – Clinical Radiobiology of Hypofractionation Room: Thomas Murphy Ballroom 4 Michael C. Joiner, PhD, Wayne State University Robert D. Timmerman, MD, University of Texas Southwestern Medical Center
7:45 a.m. - 9:00 a.m. Educational Session 202 – Interstitial Brachytherapy for Prostate Cancer: LDR and HDR, Alone and with External Beam Radiotherapy Room: B206 Michael Ghilezan, MD, PhD, Michigan Health Professionals/21st Century Oncology I-Chow J. Hsu, MD, University of California San Francisco Mira Keyes, MD, British Columbia Cancer Agency Al V. Taira, MD, Western Radiation Oncology
7:45 a.m. - 9:00 a.m. Educational Session 203 – Updated Roles and Rules for Radiation Therapy of Indolent and Aggressive Lymphomas Room: B216 Andrea K. Ng, MD, Brigham and Women’s Hospital Joachim Yahalom, MD, FASTRO, Memorial Sloan-Kettering Cancer Center
7:45 a.m. - 9:00 a.m. Educational Session 204 – Low/High Grade Gliomas – An Update Room: B302-B305 Changhu Chen, MD, University of Toledo Medical Center Daphne Haas-Kogan, MD, University of California San Francisco John P. Kirkpatrick, MD, PhD, Duke University
7:45 a.m. - 9:00 a.m. Educational Session 205 – Proton Therapy: Basic Physics and Practice Room: B313 Annelise Giebeler, PhD, Scripps Proton Therapy Center Baldev Patyal, PhD, Loma Linda University Medical Center
7:45 a.m. - 9:00 a.m. Educational Session 206 – Controversies in the Management of Endometrial Cancer Room: B213 Ann H. Klopp, MD, PhD, MD Anderson Cancer Center Catheryn M. Yashar, MD, University of California San Diego
7:45 a.m. - 9:00 a.m. Educational Session 207 – Management of Oral Cavity Cancer and Nasopharyngeal Cancer focusing on IMRT and IGRT Room: Sidney Marcus Auditorium Nancy Lee, MD, Memorial Sloan-Kettering Cancer Center Min Yao, MD, PhD, University Hospitals Case Medical Center
68 ASTRO 2013 / 55TH ANNUAL MEETING Monday | September 23
7:45 a.m. - 9:00 a.m. Educational Session 208 – Evolution of Radiation Oncology: Technology, Techniques and Outcomes Room: B211 George T.Y. Chen, MD, FASTRO, Massachusetts General Hospital Patricia J. Eifel, MD, FASTRO, MD Anderson Cancer Center David A. Larson, MD, PhD, FASTRO, University of California San Francisco Theodore L. Phillips, MD, FASTRO, University of Arizona
7:45 a.m. - 9:00 a.m. Educational Session 209 – Advanced Treatment of Non-small Cell Lung Cancer: Using All the Tools (Imaging, Motion Correction and IMRT) Promises and Pitfalls – A Case Based Approach Room: B308 Jeff rey D. Bradley, MD, Washington University School of Medicine Indrin J. Chetty, PhD, Henry Ford Health System James J. Urbanic, MD, Wake Forest University School of Medicine
7:45 a.m. - 9:00 a.m. Educational Session 210 – Controversies in the Optimal Management of Regional Nodes Room: B405 Jennifer R. Bellon, MD, Dana-Farber Cancer Institute E. Shelley Hwang, MD, MPH, Duke University School of Medicine Julie R. Gralow, MD, University of Washington School of Medicine
8:00 a.m. - 6:00 p.m. ASTRO Career Fair Room: B207
8:00 a.m. – 9:00 a.m. Featured Lecture- Patient Safety Organizations: An Overview Room: B406 William Munier, MD, Director, Center for Quality Improvement and Patient Safety, Agency for Health- care Research and Quality Refer to page 45 for program schedule.
*This session is not accredited for continuing medical education credits.
9:15 a.m. - 10:15 a.m. Keynote Address I “Is there Hope for ‘Healing’ Health Care?” Room: Thomas Murphy Ballroom 1-3 Darrell G. Kirch, MD, President and CEO, Association of American Medical Colleges Introduced by: Theodore L. DeWeese, MD, Johns Hopkins School of Medicine Refer to page 45 for program schedule.
ASTRO 2013 / 55TH ANNUAL MEETING 69 Monday | September 23
10:00 a.m. - 5:00 p.m. Exhibit Hall Open Room: Halls B1–B3
10:00 a.m. - 5:00 p.m. Poster Viewing Room: Hall B4
10:45 a.m. - 12:15 p.m. Scientifi c Session F – Biology – DNA Damage and Repair: Novel Biological Principles and Targeted Radiosensitization Strategies Room: B213 Moderators: Phouc Tran, Simon Powell
10:45 a.m. Adam Schmitt 45 Regulation of the DNA Damage Response by an Inducible Long Noncoding RNA
10:55 a.m. Sean Pitroda 46 RPS Predicts DNA Repair Pathway Preference and Cancer Patient Outcome
11:05 a.m. Chen-Pang Soong 47 Development of a Novel Method to Create Double-strand Break Repair Fingerprints Using Next-Generation Sequencing
11:15 a.m. Robert Bristow Discussant
11:25 a.m. Gerben Borst 48 Using BRCA 1/2-Defi cient Mouse Mammary Tumors and μIGRT to Investigate Underlying Mechanisms Causing Radioresistance
11:35 a.m. Derek Zachman 49 Endothelial Cells Mitigate DNA Damage and Restore Function in Irradiated Hematopoietic Stem Cells
11:45 a.m. David Kozono 50 Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-small Cell Lung Cancer
11:55 a.m. Ikuno Nishibuchi 51 SUMO E3-ligase Regulates DNA Damage-Dependent Exchange of the Histone Variant H2A.Z-2
12:05 p.m. Hebist Berhane 52 Radiobiologic Diff erences Between Bone Marrow Stromal and Hematopoietic Progenitor Cells from Fanconi Anemia (FancD2-/-) Mice
Connect with Attendees. Tweet #ASTRO13
70 ASTRO 2013 / 55TH ANNUAL MEETING Monday | September 23
10:45 a.m. - 12:15 p.m. Scientifi c Session G – GU – Prostate Cancer: Prognostic Factors, Hormones, Hypofractionation Room: B206 Moderators: May Abdel-Wahab, Ashesh Jani
10:45 a.m. Zachary Zumsteg 53 The Natural History and Patterns of Failure Following Biochemical Relapse in Prostate Cancer (PC) Patients Treated with Dose Escalated External Beam Radiotherapy (EBRT)
10:55 a.m. Daniel Krauss 54 Inferior Clinical Outcomes for Patients with Positive Post-Radiotherapy Prostate Biopsy: Results from Prospective Randomized Trial RTOG 94-08
11:05 a.m. Mitchell Kamrava 55 Do Targeted Ultrasound/MRI Fusion Biopsies Signifi cantly Change Maximum Prostate Gleason Score Compared with Systematic Biopsies?
11:15 a.m. Nicholas Zaorsky 56 Evaluation of Biologically Equivalent Dose Escalation, Clinical Outcome and Toxicity in Prostate Cancer Radiotherapy: A Meta-Analysis of 12,000 Patients from 40 Institutions
11:25 a.m. Alan Katz 57 Stereotactic Body Radiation Therapy for Low-, Intermediate- and High-risk Prostate Cancer: Disease Control and Quality of Life at Six Years
11:35 a.m. Robert Meier 58 Patient-reported Quality of Life Outcomes in Intermediate-risk Prostate Cancer Patients Treated with Stereotactic Body Radiotherapy
11:45 a.m. Joseph Kang 59 Hypofractionated Proton Therapy for Low-risk Prostate Cancer: Preliminary Results of a Phase I/II Study
11:55 a.m. Perakaa Sethukavalan 60 Comparison of Biochemical and Toxicity Outcomes from a Contemporaneous Cohort Study of Low-risk Prostate Cancer Treated with Diff erent Radiation Techniques
12:05 p.m. Amin Mirhadi 61 Eff ect of Long-term Hormonal Therapy (vs. Short-term Hormonal Therapy): A Secondary Analysis of Intermediate-risk Prostate Cancer Patients Treated on RTOG 9202
10:45 a.m. - 12:15 p.m. Scientifi c Session H – GI – SBRT and Hypofractionation Room: B308 Moderators: Sarah Hoff e, Gary Yang
10:45 a.m. Yue Cao 62 Indocyanine Green for Individualized Assessment of Functional Liver Reserve in Patients Undergoing Liver Radiotherapy
ASTRO 2013 / 55TH ANNUAL MEETING 71 Monday | September 23
10:55 a.m. Mary Feng 63 A Phase II Trial of Individualized Adaptive Stereotactic Body Radiotherapy (SBRT) for Patients at High-risk for Liver Damage
11:05 a.m. Foster Lasley 64 Relationship of Hepatic Toxicity to Advancement of Child-Pugh Score and Overall Survival for Patients Treated with SBRT to the Liver
11:15 a.m. Theodore Hong 65 Interobserver Variability in Target Defi nition for Hepatocellular Carcinoma (Hcc) with and without Portal Vein Thrombus: Radiation Therapy Oncology Group (RTOG) Hcc Consensus Panel
11:25 a.m. Joseph Herman 66 A Phase II Multi-center Study to Evaluate Gemcitabine and Fractionated Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma
11:35 a.m. Aaron Wild 67 Stereotactic Body Radiation Therapy Results in Less Severe Treatment-related Lymphopenia Than Conventional Chemoradiation Therapy in Patients with Locally Advanced Pancreatic Cancer
11:45 a.m. Chi Lin 68 A Dosimetric Analysis of Duodenal Toxicity After Hypofractionated Stereotactic Body Radiotherapy for Pancreatic Cancer
11:55 a.m. Daniel Chang Discussant
12:05 p.m. Florence Huguet 69 Investigation of Relation of Radiation Therapy Quality Assurance Scores (RTQASc) with Toxicity and Survival in LAP07 Phase III Trial for Locally Advanced Pancreatic Carcinoma (LAPC)
10:45 a.m. - 12:15 p.m. Scientifi c Session I – GYN – Cervical Cancer Room: B211 Moderators: Charles Kunos, Matt Biagioli
10:45 a.m. Kathy Han 70 Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.
10:55 a.m. David Gaff ney 71 Consensus Contours for CT vs. MRI in Image-based Brachytherapy for Cervix Cancer to Generate an RTOG Atlas
11:05 a.m. Junzo Chino 72 Vaginal Dose and Toxicity with Image Guided Brachytherapy
11:15 a.m. Beant Gill 73 Clinical Outcomes for 3-D High-dose-rate Intracavitary Brachytherapy with MRI-Based Planning for the Treatment of Cervical Cancer
11:25 a.m. Kaled Alektiar Discussant
72 ASTRO 2013 / 55TH ANNUAL MEETING Monday | September 23
11:35 a.m. Eric Leung 74 Neutrophils Modulate Vascular Function in Locally Advanced Cervical Cancer and Impair Response to Radiotherapy
11:45 a.m. Nina Mayr 75 Is Cellular Radiosensivity Infl uenced by Tumor Perfusion Status During Radiation Therapy of Cervical Cancer?
11:55 a.m. Olgun Elicin 76 The Use of 18FDG-PET Standard Uptake Value as a Metabolic Predictor of Bone Marrow Response to Radiation: Impact on Acute and Late Hematological Toxicity in Cervical Cancer Patients Treated with Chemo-radiotherapy
12:05 p.m. Ajeet Gandhi 77 Chronic Gastrointestinal Toxicity in Locally Advanced Carcinoma Cervix Treated with Intensity-modulated vs. Conventional Pelvic Radiotherapy: Results from a Prospective Randomized Study
10:45 a.m. - 12:15 p.m. Scientifi c Session J – Lung – Toxicity and Other Topics Room: B405 Moderators: Yolanda Garces, Andreas Rimner
10:45 a.m. Ankit Modh 78 Survival and Toxicity after Stereotactic Body Radiotherapy for Central Lung Tumors
10:55 a.m. Stuart Samuels 79 Changes in DLCO Instead of FEV1 During Treatment are Correlated with Post-Treatment Reduction in Pulmonary Function and Toxicity After SBRT or 3-D CRT for Non-small Cell Lung Cancer
11:05 a.m. Andrew Aneese 80 Toxicity After Central versus Peripheral Stereotactic Lung Radiotherapy (SBRT): A Propensity Score Matched-Pair Analysis
11:15 a.m. Taro Murai 81 Stereotactic Body Radiotherapy Using a Radiobiology-based Regimen for Stage I Non-small Cell Lung Cancer: 5-Year Mature Results
11:25 a.m. Gregory Videtic Discussant
11:35 a.m. Alexandros Papachristofi lou 82 Clinical Utilization of Electromagnetic Real-time Lung Tumor Localization During Radiotherapy: A Prospective International Multicenter Study
11:45 a.m. Jean-Claude Rwigema 83 Incidental Mediastinal Dose Does Not Explain Low Mediastinal Nodal Recurrence Rates in Early-stage NSCLC Patients Treated with SBRT
11:55 a.m. Zachary Morris 84 Impact of Contralateral Tumor Nodules on Survival in Non-small Cell Lung Cancer: A SEER Database Analysis
ASTRO 2013 / 55TH ANNUAL MEETING 73 Monday | September 23
12:05 p.m. James Urbanic 85 Multiple Courses of Thoracic Radiotherapy (XRT) Using Stereotactic Body Radiotherapy (SBRT) as the First or Second Course of Treatment for Tumors Outside the Original High Dose Region
10:45 a.m. - 12:15 p.m. Scientifi c Session K – Pediatric Brain and Retinoblastoma Room: B406 Moderators: Ashwatha Narayana
10:45 a.m. Jacqueline Emrich 86 Episcleral Plaque Radiotherapy for Retinoblastoma: Treatment and Outcomes
10:55 a.m. Kent Mouw 87 Proton Radiotherapy for the Treatment of Pediatric Retinoblastoma
11:05 a.m. Anita Mahajan Discussant
11:15 a.m. Klaus Müller 88 Role of Craniospinal Radiotherapy in the Management of Recurrent Medulloblastoma - Experiences from the Prospective German HIT-REZ 1997 and 2005 Studies
11:25 a.m. Kristin Redmond 89 Prospective Study of Proton MR Spectroscopy (MRS) and Neuro-psychological Dysfunction Following Cranial Irradiation for Pediatric Malignancies
11:35 a.m. Daniel Indelicato 90 Incidence and Dosimetric Parameters of Brainstem Toxicity Following Proton Therapy
11:45 a.m. Thomas Merchant 91 Longitudinal Models of Cognitive Function in Children with Craniopharyngioma Demonstrate the Eff ect of Radiation Dose
11:55 a.m. Susan Hiniker 92 Survival and Neurocognitive Outcomes Following Addition of a Cranial or Craniospinal Boost to Total Body Irradiation Prior to Stem Cell Transplantation in Pediatric Leukemia Patients with CNS Involvement
10:45 a.m. - 12:15 p.m. Scientifi c Session L – Health Services Research Room: Thomas Murphy Ballroom 4 Moderators: Samuel Swisher-McClure, Ashleigh Guadagnolo
10:45 a.m. Kristina Maletz 93 Comparison of NCCN and ACR Guidelines Regarding Treatment of Lung, Prostate, and Head and Neck Cancers
10:55 a.m. Barbara Fowble 94 Implementing Patient-oriented Decision Support into Breast Cancer Care
11:05 a.m. Aaron Falchook 95 Multiple Pathology Reviews in Prostate Cancer Diagnosis, Prevalence of Use in the Medicare Population and Cost Implications
74 ASTRO 2013 / 55TH ANNUAL MEETING Monday | September 23
11:15 a.m. Justin Bekelman 96 Androgen Deprivation Therapy and Radiotherapy: Comparative Eff ectiveness in Real-world Clinical Practice
11:25 a.m. Lia Halasz 97 Comparative Eff ectiveness of Stereotactic Radiosurgery (SRS) vs. Whole Brain Radiation Therapy (WBRT) for Patients with Brain Metastases from Non-small Cell Lung Cancer (NSCLC)
11:35 a.m. Anand Shah 98 Cost Eff ectiveness of Stereotactic Body Radiation Therapy vs. Surgical Resection for Stage I Non-small Cell Lung Cancer
11:45 a.m. Michaela Dinan 99 Changes in Radiotherapy, Surgery and Costs for Treatment of Non-small Cell Lung Cancer After the Adoption of Positron Emission Tomography, 1998-2005
11:55 a.m. Ruben Carmona 100 Risk Stratifi cation for Non-cancer Mortality in Early-stage Endometrial Cancer
12:05 p.m. James B. Yu Discussant
10:45 a.m. - 12:15 p.m. Scientifi c Session M – Best of Physics Room: Sidney Marcus Auditorium Moderators: David Jaff ray, Indrin Chetty
10:45 a.m. Jan-Jakob Sonke 101 Improved Modeling of Radiation Pneumonitis Risk in Lung SBRT by Incorporating a Local Dose Eff ect Relation for Perfusion Reduction
10:55 a.m. Victor Mangona 102 Predictors of Chest Wall and Extrapulmonary Soft Tissue Toxicity After Stereotactic Lung Radiotherapy: A Dosimetric Analysis
11:05 a.m. Zhibin Huang 103 Patient Specifi c TCP Based on the gLQ Model - A Strong Outcome Predictor in Radiation Therapy for Cervical Cancer
11:15 a.m. Teo Stanescu 104 Quantifi cation of Magnetic Field Compatibility of Subcomponents in an MRI-Guided Radiotherapy System Basic Science Abstract Award – Radiation Physics
11:25 a.m. Reinhard Schulte 105 First Experience with an Experimental Proton CT Scanner
11:35 a.m. Eric Williams 106 Using gEUD to Model Volume Eff ects for Pneumonitis in Prospective Data from four Non-small Cell Lung Cancer (NSCLC) Dose-escalation Trials Basic Science Abstract Award – Radiation Physics
ASTRO 2013 / 55TH ANNUAL MEETING 75 Monday | September 23
11:45 a.m. Per Poulsen 107 Experimentally Validated Simulator of Dynamic MLC Tracking Treatments: A Tool for Tracking QA
11:55 a.m. Annemarie Fernandes 108 Comparative Assessment of Liver Tumor Motion Using CineMRI vs. 4-D CT
12:05 p.m. Ruijiang Li 109 First Clinical Study of On-treatment Volumetric Imaging During Respiratory Gated VMAT
10:45 a.m. - 12:15 p.m. Digital Poster Discussion 03 – CNS – Meningiomas, Gliomas and Metastases Room: A411 Discussants: Paul Brown, Stephanie Weiss
Martin Pavelic 1025 Distinguishing Grade I Meningioma from Higher Grade Meningiomas Without Biopsy
Steve Braunstein 1026 Benefi t of Adjuvant Radiotherapy (RT) in Management of Recurrent Atypical Meningioma (AM)
Robert Press 1027 Patterns of Failure for Grade II/III Meningioma Treated with Reduced Margin Intensity Modulated Radiation Therapy
Helen Shih 1028 Mixed Proton and Photon Therapy for Benign Meningiomas: Long Term Results of a Prospective Randomized Dose Escalation Study
Ariel Marciscano 1029 Benign Meningiomas with Atypical Features: Correlation of Histopathological Features with Clinical Outcomes
Joshua Siglin 1030 Combining Fractionated Stereotactic Radiotherapy and Bevacizumab for Recurrent High Grade Glioma: Outcomes Analysis
George Shenouda 1031 Results of a Phase II Clinical Trial of Neo-Adjuvant Temozolomide (TMZ), Followed by Concurrent TMZ and Hypofractionated Accelerated External Beam Radiotherapy (Ac-EBRT) with Limited Margins, and Adjuvant TMZ for Patients with Glioblastoma Multiforme (GBM)
Joshua Palmer 1032 Re-resection for Recurrent High Grade Glioma in the Setting of Re-irradiation
Kapila Kalakota 1033 Time to Intracranial Failure Following Post-resection Cavity Radiosurgery for Patients with a Single Intracranial Metastasis
Jonathan Pai 1034 Brain Metastases and Resection Cavities from Colorectal Carcinoma Treated with Stereotactic Radiosurgery Have Poor Local Control Compared to Non-colorectal Histology
76 ASTRO 2013 / 55TH ANNUAL MEETING Monday | September 23
Jennifer Rosenberg 1035 Factors Infl uencing Local Control and Survival in Patients Treated with Radiosurgery Following Surgical Resection of CNS Metastases
Menachem Yondorf 1036 Resection Cavity Dynamics Following Implantation of Cesium-131 (Cs-131) Brachytherapy for Resection Brain Metastases Based on CT-Planning
10:45 a.m. - 12:15 p.m. Digital Poster Discussion 04 – Sarcoma/Lymphoma Room: A412 Discussants: Jonathan Ashman, Stephanie Terezakis
Kyle Denniston 1037 Quantifi cation of the Eff ect of Arm Position on Normal Tissue Location and Dosimetry in Pediatric Hodgkin Lymphoma
Bradford Hoppe 1038 Phase II Study of Consolidative Involved-node Proton Therapy in Patients with Hodgkin Lymphoma: Early Outcomes
Amanda Walker 1039 18F-FDG PET SUV Thresholding for Target Volume Delineation in Pediatric Hodgkin Lymphoma
He Wang 1040 Image Guided Radiation Therapy Proves Its Benefi t in Detecting the Daily Unpredictable Shape Change of the Stomach, a Study of Patients Treated for Stomach Lymphoma
K.Ranh Voong 1041 Intensity Modulated Radiation Therapy (IMRT) Using Butterfl y Technique Off ers a Dosimetric Advantage to Critical Organs in Young Female Patients with Mediastinal Hodgkin’s Lymphoma
Gabriele Reinartz 1042 Contribution of 4-D CT and Listmode-PET-CT for Evaluation of PTV for Whole Stomach Radiation: Inter- and Intra-fractional Gastric Motion During IMRT in Gastric Lymphoma
Luke Miller 1043 Mesna-Ifosfamide Doxorubicin Chemoradiotherapy (MAI-XRT) for Large, High Grade Extremity Soft Tissue Sarcoma: Reduced Toxicity and Encouraging Early Results
Hayashi Kazuhiko 1044 Long-term Results of Intraoperative Extracorporeal Irradiation to the Autogenous Bone Grafts in Primary Bone and Soft Tissue Malignancies
Addison Willett 1045 Comparison of HDR Brachytherapy, Orthovoltage X-ray and Electron Beam Radiation in the Treatment of Non-melanoma Skin Cancers: A Single Institution Experience of Individualized Radiation Therapy
Andrew Bishop 1046 Head and Neck Merkel Cell Carcinoma: Favorable Outcomes with Radiotherapy
ASTRO 2013 / 55TH ANNUAL MEETING 77 Monday | September 23
Alfredo Polo 1047 A Dose-Response Relationship Exists for Soft Tissue Sarcomas of the Extremities Treated with Maximum Surgery and Intraoperative Electron Therapy, with or without External Beam Radiotherapy: Results of a Multicentric Pooled Analysis
Aashish Bhatt 1048 Reduction in Wound Complications with Low vs. High Dose Pre-operative Radiotherapy for Sacro-Coccygeal Chordomas
10:45 a.m. - 12:15 p.m. Educational Session 211 – Diffi cult Cases in Breast Cancer Room: B313 Thomas A. Buchholz, MD, FASTRO, MD Anderson Cancer Center Jay R. Harris, MD, FASTRO, Dana-Farber Cancer Institute Terry Mamounas, MD, MD Anderson Cancer Center Orlando Julia R. White, MD, The Ohio State University Cancer Center Eric Winer, MD, Dana-Farber Cancer Institute
10:45 a.m. – 12:15 p.m. Educational Session 212: Overuse, Underuse and Misuse of Radiation Therapy and the Future of Radiation Oncology - Impact on Quality, Payment Reform and Patient Care Announcement of ASTRO’s List for “Choosing Wisely” Initiative Room: B216 Moderator: Bharat B. Mittal, MD, FASTRO, Northwestern University Daniel B. Wolfson, MHSA, ABIM Foundation Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors James Alan Hayman, MD, University of Michigan Brian Kavanagh, MD, MPH, University of Colorado Denver
11:00 a.m. – 12:00 p.m. Foreign Language Poster Walks Room: Hall B4, Poster Information Desk Refer to page 52 for program schedule.
12:15 p.m. - 1:15 p.m. AAWR/ASTRO Luncheon* – A Mentorship Panel for Women in Radiation Oncology Room: B302-B305 Join us for the annual AAWR/ASTRO Luncheon Panel. This diverse panel of accomplished women radiation oncologists will discuss and answer questions on professional advancement in academic and community practice, opportunities and challenges, and involvement in health care politics, for women in radiation oncology.
Moderator: Chelsea Pinnix, MD, PhD, MD Anderson Cancer Center
Interesting Session? Tweet Ticketed Event/Separate registration required #ASTRO13
78 ASTRO 2013 / 55TH ANNUAL MEETING Monday | September 23
Panelists: Reshma Jagsi, MD, PhD, University of Michigan Nancy S. Tarbell, MD, FASTRO, Harvard Medical School Colleen A. F. Lawton, MD, FASTRO, President, ASTRO Board of Directors Jacqueline P. Williams PhD, FASTRO, University of Rochester Medical Center Geraldine M Jacobson MD, MPH, MBA, West Virginia University *This session is not accredited for continuing medical education credits.
12:15 p.m. - 1:15 p.m. ARRO Poster Walk with a Professor (Box Lunch) Room: Hall B4, Poster Lounge
12:15 p.m. - 1:15 p.m. How to Review a Scientifi c Paper Workshop (Box Lunch) Room: B203 Refer to page 48 for program schedule. *This session is not accredited for continuing medical education credits.
12:15 p.m. – 1:15 p.m. ASTRO Accreditation Program for Excellence (APEx) Highlights Luncheon* Room: B405 Refer to page 54 for program schedule. *This session is not accredited for continuing medical education.
1:15 p.m. - 2:00 p.m. Presidential Address – “Hope, Faith, Cancer: Keeping Patients First” Room: Thomas Murphy Ballroom 1-3 Colleen A. F. Lawton, MD, FASTRO, President, ASTRO Board of Directors Introduced by: J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin
Great Speaker? Tweet #ASTRO13
ASTRO 2013 / 55TH ANNUAL MEETING 79 Monday | September 23
2:00 p.m. - 3:10 p.m. PLENARY SESSION Room: Thomas Murphy Ballroom 1-3 Moderators: Theodore DeWeese, Lynn Wilson
2:00 p.m. Thomas Pisansky 1 RTOG 9910: Phase III Trial to Evaluate the Duration of Neoadjuvant Total Androgen Suppression and Radiation Therapy in Intermediate-risk Prostate Cancer
2:10 p.m. Daniel Hamstra Discussant
2:15 p.m. Benjamin Movsas 2 Quality of Life Analysis of the Randomized Radiation Dose Escalation NSCLC Trial (RTOG 0617): The Rest of the Story
2:25 p.m. Andrea Bezjak Discussant
2:30 p.m. William Small 3 RTOG 0841: Two Item Questionnaire Eff ectively Screens for Depression in Cancer Patients Receiving Radiotherapy
2:40 p.m Andrew Miller Discussant
2:45 p.m. Vinai Gondi LBA1 Memory Preservation with Conformal Avoidance of the Hippocampus during Whole-Brain Radiotherapy (WBRT) for Patients with Brain Metastases: Primary Endpoint Results of RTOG 0933
2:55 p.m. Laurie Gaspar Discussant
3:10 p.m. - 3:30 p.m. ASTRO Guidelines Highlight – The Adjuvant and Salvage Radiotherapy After Prostatectomy: ASTRO/AUA Guideline Room: Thomas Murphy Ballroom 1-3 Moderators: Benjamin Movas, Lynn Wilson Presenter: Richard K. Valicenti, MD, University of California Davis Medical Center Discussant: Carol Hahn, MD, Duke University Medical Center
80 ASTRO 2013 / 55TH ANNUAL MEETING Monday | September 23
4:00 p.m. - 5:00 p.m. Featured Lecture – “Update on Self-referral*” Room: B406 James Cosgrove, PhD, Director, U.S. Government Accountability Offi ce Introduced by Michael L. Steinberg, MD, FASTRO, Chairman, ASTRO Board of Directors Refer to page 46 for program schedule. *This session is not accredited for continuing medical education credits.
4:00 p.m. - 5:30 p.m. Panel 06 – The Confl uence of Radiation and Immunotherapy: From Bench to Bedside and Back Again Room: B211 Moderator: Steven Finkelstein, MD, 21st Century Oncology
Panelists: William McBride, DSc, PhD, University of California Los Angeles Health System Sylvia Formenti, MD, NYU School of Medicine Neal Shore, MD, Carolina Urologic Research Center Steven Finkelstein, MD, 21st Century Oncology
4:00 p.m. - 5:30 p.m. Panel 07 – Bringing Forth Evidence to Put Patients First: How Guidelines will Impact Practice of Radiation Oncology Room: B308 Moderator: Joshua Petit, MD, University of Colorado Health System
Panelists: Benjamin Smith, MD, MD Anderson Cancer Center Carol Hahn, MD, Duke University George Rodrigues, MD, MSc, London Regional Cancer Program William Sause, MD, International Healthcare Radiation Oncology Bryan Loy, MD, MBA, Humana Hospital-Audubon Lee Newcomer, MD, United Healthcare
4:00 p.m. - 5:30 p.m. Panel 08 – Innovative Clinical Trial Designs* Room: B206 Moderators: Brian Alexander, MD, Dana-Farber/Brigham and Women’s Cancer Center Giovanni Parmigiani, PhD, Dana-Farber/Brigham and Women’s Cancer Center
Panelists: Donald Berry, PhD, MD Anderson Cancer Center Michael Krams, MD, Janssen Pharmaceuticals Daniel Normolle, PhD, University of Pittsburgh Medical Center Lorenzo Trippa, PhD, Dana-Farber/Brigham and Women’s Cancer Center *This session is not accredited for continuing medical education credits. Monday | September 23
4:00 p.m. - 5:30 p.m. Panel 09 – Fractionated Radiotherapy for Prostate Cancer: What is the Standard of Care? Room: B313 Moderator: Mark Buyyounouski, MD, MS, Fox Chase Cancer Center
Panelists: Eric Hall, DSc, FASTRO, New York Presbyterian Hospital Howard Sandler, MD, MS, FASTRO, Cedars-Sinai Medical Center Alan Pollack, MD, PhD, University of Miami Miller School of Medicine W. Robert Lee, MD, MS, MEd, Duke University
4:00 p.m. - 5:30 p.m. Panel 10 – Safety First: Using a National Patient Safety Organization to Improve the Quality of Care Room: Thomas Murphy Ballroom 4 Moderator: Adam Dicker, MD, PhD, Jeff erson Medical College of Thomas Jeff erson University
Panelists: Eric Ford, PhD, University of Washington Thomas Piotrowski, RN, MSN, Clarity PSO Lawrence Marks, MD, FASTRO, University of North Carolina at Chapel Hill Sasa Mutic, PhD, Washington University School of Medicine
4:00 p.m. - 5:30 p.m. Educational Session 213 – Integration of Safety in Quality Assurance Programs Room: B216 Benedick A. Fraass, PhD, FASTRO, Cedars-Sinai Medical Center Ramon Alfredo C. Siochi, PhD, University of Iowa
4:00 p.m. - 5:30 p.m. Educational Session 214 – Laryngeal Preservation in Larynx and Hypopharynx Cancer Room: B405 Robert J. Amdur, MD, University of Florida Christopher Holsinger, MD, Stanford University Quynh-Thu Le, MD, Stanford University
Connect with attendees.
#ASTRO13
82 ASTRO 2013 / 55TH ANNUAL MEETING Monday | September 23
5:30 p.m. - 6:30 p.m. Poster Viewing Session and Reception* Room: Hall B4 During this session, poster presenters will be available at their poster to answer questions and explain their research. Again this year there will be a presentation area where poster award winners will provide highlights of their research and be available for questions. The presentation schedule will be available in the poster viewing area. *This session is not accredited for continuing medical education credits.
Meet and Greet - Residents and Medical Students Room: Hall B4, Poster Lounge
5:30 p.m. - 6:30 p.m. 2013 NCI/ASTRO Diversity Symposium and Reception* – Improving Cancer Care Globally: A Call to Service in Radiation Oncology Room: B203 Members of the National Cancer Institute and Cancer Disparities Research Partnership project invite you to join them for a disconcerting look at disparities in cancer care around the globe. Expert speakers who have completed groundbreaking work to improve the delivery of radiation oncology services in developing nations will share their stories and insights. *This session is not accredited for continuing medical education credits.
Moderator: Bhadrasain Vikram, MD, National Cancer Institute
ASTRO-ARRO Resident Experience in the Global Health Scholarship Program Introduction: Bhadrasain Vikram, MD, National Cancer Institute Speaker: Nina A. Mayr, MD, FASTRO, University of Washington
Desperate and Disparate in a Time of Many Transitions: Improving Research and Practice in Radiation Oncology Introduction: Nina A. Mayr, MD, FASTRO, University of Washington Speaker: Glenn Jones, MD, Credit Valley Hospital
Possible Business Models for Radiation Therapy Facilities in Bangladesh Introduction: Nina A. Mayr, MD, FASTRO, University of Washington Speaker: Richard Love, MD, MS, International Breast Cancer Research Foundation
Interesting session? Symbol Key: ARON Tweet A Ticketed Event/ Nurses’ Award Live Interactive Separate Session Recipient SAM/ Session #ASTRO13 registration Separate required registration required
ASTRO 2013 / 55TH ANNUAL MEETING 83 Tuesday | September 24
7:45 a.m. - 9:00 a.m. Educational Session 301 – Controversies on the Role of Radiation Therapy in the Management of Hodgkin Lymphoma (HL) Room: B405 Peter M. Mauch, MD, FASTRO, Harvard Medical School Lena Specht, MD, PhD, Rigshospitalet, University of Copenhagen
7:45 a.m. - 9:00 a.m. Educational Session 302 – Oncofertility and Fertility Preservation Treatment: Patient Needs and Opportunities for Radiation Oncologists Room: B206 Clarisa Gracia, MD, University of Pennsylvania Farzan Siddiqui, MD, PhD, Henry Ford Health System William Small, MD, FASTRO, Loyola University Raphael Yechieli, MD, Henry Ford Health System
7:45 a.m. - 9:00 a.m. Educational Session 303 – Best Practices in Radiation Oncology Education Room: B213 Robert J. Amdur, MD, University of Florida Joanne Alfi eri, MDCM, McGill University Health Centre Junzo P. Chino, MD, Duke University Nicholas DeNunzio, BS, Boston University School of Medicine Eric L. Khoo, MB, ChB, Radiation Oncology Queensland - Toowoomba James D. Mitchell, MD, David Grant Medical Center
7:45 a.m. - 9:00 a.m. Educational Session 304 – Molecular Radiobiology – Concepts and Clinical Applications Room: B203 Anthony Chalmers, MD, PhD, Beatson West of Scotland Cancer Centre Brian Marples, PhD, William Beaumont Hospital
7:45 a.m. - 9:00 a.m. Educational Session 305 – Advanced Treatment Technologies: Design, Control Systems, Commissioning and Clinical Applications Room: B406 James Balter, PhD, University of Michigan Timothy D. Solberg, PhD, University of Pennsylvania Lei Xing, PhD, Stanford University
7:45 a.m. - 9:00 a.m. Educational Session 306 – Cervical Cancer Management Room: B211 Nina A. Mayr, MD, FASTRO, University of Washington Medical Center Akila N. Viswanathan, MD, Brigham and Women’s Hospital
84 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
7:45 a.m. - 9:00 a.m. Educational Session 307 – Esophagus and Gastric Cancer: Contemporary Treatment Approaches Room: Thomas Murphy Ballroom 4 Michael G. Haddock, MD, Mayo Clinic Harvey J. Mamon, MD, PhD, Brigham and Women’s Hospital
7:45 a.m. - 9:00 a.m. Educational Session 308 – External Beam Radiotherapy for Prostate Cancer: Dose, Volume, Fractionation Room: Sidney Marcus Auditorium Jason A. Efstathiou, MD, PhD, Massachusetts General Hospital Eric M. Horwitz, MD, Fox Chase Cancer Center
7:45 a.m. - 9:00 a.m. Educational Session 309 – An Overview of the End-to-End Use of Images for IGRT from Simulation to Treatment – How To Make IGRT better Room: B313 Peter Balter, PhD, MD Anderson Cancer Center Mary Kara Bucci, MD, Anchorage Radiation Therapy Center
7:45 a.m. - 9:00 a.m. Educational Session 310 – Management of Adult Sarcoma Room: B216 Elizabeth H. Baldini, MD, MPH, Brigham and Women’s Hospital B. Ashleigh Guadagnolo, MD, MPH, MD Anderson Cancer Center
8:00 am. - 6:00 p.m. ASTRO Career Fair Room: B207
9:15 am. - 10:15 a.m. Keynote Address II “Cancer Survivorship and Quality Of Life” Room: Thomas Murphy Ballroom 1-3 Otis W. Brawley, MD, Chief Medical Offi cer, American Cancer Society Introduced by: J. Frank Wilson, MD, FASTRO, Medical College of Wisconsin
10:00 a.m. - 5:00 p.m. Exhibit Hall Open Room: Halls B1–B3
10:00 a.m. - 5:00 p.m. Poster Viewing Room: Hall B4
ASTRO 2013 / 55TH ANNUAL MEETING 85 Tuesday | September 24
10:15 a.m. - 11:30 a.m. AWARDS CEREMONY* – Gold Medal, Fellows, Honorary Member and Survivor Circle Room: Thomas Murphy Ballroom 1-3 The Awards Ceremony is held in honor of ASTRO’s 2013 award recipients and Fellows. Show your appreciation for these premier leaders by joining in the celebration of their accomplishments. *This session is not accredited for continuing medical education credits.
11:30 a.m. - 1:00 p.m. Business Meeting Room: B302-B305 ASTRO voting members (Active, Affi liate, Allied and International members) are invited to attend the Business Meeting. Leaders of the Society will discuss important topics of interest to ASTRO members. You should not miss this important meeting. Lunch will be served.
1:00 p.m. - 2:30 p.m. Scientifi c Session N – Breast – Toxicity Room: B313 Moderators: Ozer Algan, Welela Tereff e
1:00 p.m. Jason Ye 110 Breast Cancer (BC), Second Cancer and Cardiac Mortality in Stage T1aN0 Breast Cancer Patients with or without External Beam Radiation Therapy (XRT): NCI SEER Study
1:10 p.m. Jiayi Chen 111 Dosimetric Analysis of Cardiac Substructure Related to Cardiac Safety in Patients with Her-2 Positive Breast Cancer Receiving Concurrent Trastuaumab and Adjuvant Radiotherapy
1:20 p.m. Sagar Patel 112 Protons with Free Breathing vs. Photons with Deep Inspiration Breath Hold in Post-mastectomy Patients: A Dosimetric Comparative Analysis
1:30 p.m. Richard Zellars Discussant
1:40 p.m. Laura Warren 113 Risk of Lymphedema with the Addition of Regional Lymph Node Irradiation for Breast Cancer Therapy: A Prospective Cohort Study
1:50 p.m. Tu Dan 114 Cosmetic Outcomes and Quality of Life are Similar in Patients Receiving Breast Conservation vs. Mastectomy: 25 Year Follow-Up of the NCI Randomized Trial
2:00 p.m. Xiaofeng Yang 115 Hypofractionated Breast Cancer Radiotherapy Does Not Increase Cutaneous Toxicity: A Prospective Comparative Study Between Standard and Hypofractionated Radiotherapy Using Quantitative Ultrasound Imaging
2:10 p.m. Alice Ho 116 Pneumonitis Rates Following Comprehensive Nodal Irradiation in Breast Cancer Patients: Results of a Phase I Feasibility Trial of Intensity Modulated Radiation Therapy
86 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
2:20 p.m. Ben Wilkinson 117 Six-year Outcomes for Phase I/II Study Evaluating Hypofractionated Accelerated Partial Breast Irradiation Using a Two-day Dose Schedule
1:00 p.m. - 2:30 p.m. Scientifi c Session O – CNS – Brain Metastases Room: B211 Moderators: Baldassarre Stea, May Tsao
1:00 p.m. George Rodrigues 18 When Should Whole Brain Radiotherapy (WBRT) Be Utilized with Stereotactic Radiosurgery to Reduce Regional Failure in the Treatment of Oligometastatic Brain Disease?: Clinical Nomogram and Recursive Partitioning Analysis
1:10 p.m. John Kirkpatrick 119 Early Results of a Randomized Trial to Identify an Optimal PTV in Stereotactic Radiosurgery of Brain Metastases
1:20 p.m. Marina Kushnirsky 120 Brain Metastasis Detection Improved by Time Delayed Contrast Enhanced MRI
1:30 p.m. Christopher Tinkle 121 Lesion Location as a Predictor of Adverse Radiation Eff ect after Stereotactic Radiosurgery for Brain Metastasis
1:40 p.m. Kimberley Mak 122 Radiotherapy for Brain Metastases in Non-small Cell Lung Cancer: Signifi cance of Mutations in EGFR, ALK or KRAS on Radiotherapy Response and Survival
1:50 p.m. Paul Sperduto 123 Secondary Analysis of RTOG 9508, a Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) vs. WBRT Plus Stereotactic Radiosurgery (SRS) in Patients with 1-3 Brain Metastases; Post-Stratifi ed by the Graded Prognostic Assessment (GPA)
2:00 p.m. John Lucas 124 A Competing Risk Analysis of Neurologic vs. Non-neurologic Death in Patients Undergoing Radiosurgical Salvage Following Whole Brain Radiotherapy (WBRT) Failure: Who Actually Dies of Their Brain Metastases?
2:10 p.m. Tzu-I Jonathan Yang 125 Prognostic Implications of Receptor Status and Extracranial Disease in Patients with Breast Cancer Brain Metastases Treated with Stereotactic Radiosurgery
2:20 p.m. Penny Sneed Discussant
ASTRO 2013 / 55TH ANNUAL MEETING 87 Tuesday | September 24
1:00 p.m. - 2:30 p.m. Scientifi c Session P – Physics – Dose Eff ect Relationships Room: Thomas Murphy Ballroom 4 Moderators: Lakshmi Santanam, Mary Martel
1:00 p.m. Joel Greenberger 126 Gene Transcript Responses in 10MV Photon at 2400 MU/min Total Body Irradiated C57BL/6NTac Mice Correlate with Increased Survival Compared to the Same TBI Dose Using 6MV Photons or Lower Dose Rates
1:10 p.m. Mark Hallman 127 Dose Conformity Predictors of Symptomatic Toxicity in Patients Treated with Stereotactic Body Radiation (SBRT)
1:20 p.m. Ellen Yorke 128 Linear-quadratic Dose Correction for Chest Wall Pain in Thoracic Stereotactic Body Radiation
1:30 p.m. Katharine Aitken 129 Evaluating Small Bowel Dose Volume Tolerance Limits for SBRT Using a Pre-operative Rectal Radiotherapy Model: Are We Setting the Bar Too High?
1:40 p.m. Yelin Suh 130 Duodenal Dose Sparing with Varying Stomach Volume During IG-IMRT Treatment
1:50 p.m. Gunnar Steineck 131 Relationships Between Rectal Dose and Patient-reported Late Gastrointestinal Toxicity after Prostate Cancer Radiation Therapy
2:00 p.m. Dawn Owen 132 Cord and Thecal Sac Dosimetric Correlation with Toxicity for Spine SBRT
2:10 p.m. Yun Yang 133 Quantitative Comparison of Knowledge-guided IMRT Planning to Expert Planning for Prostate Cancer Basic Science Abstract Award - Radiation Physics
2:20 p.m. Jun Lian 134 Inter-Technique and Inter-Institutional Modeling of the Dosimetry of Organs-at-Risk in Head and Neck IMRT Plans
1:00 p.m. - 2:30 p.m. Scientifi c Session Q – Head and Neck – Clinical Trials/Target Delineation Room: Sidney Marcus Auditorium Moderators: Allen Chen, Vishal Gupta
1:00 p.m. Phuc Felix Nguyen-Tan 135 A Phase III Trial to Test Accelerated versus Standard Fractionation in Combination with Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Long Term Report of Effi cacy and Toxicity
1:10 p.m. Brian O’Sullivan 136 The Changing Profi le of Outcome in Long Term Follow-up of a Randomized Trial for Locally Advanced Head and Neck Cancer
88 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
1:20 p.m. Anupam Rishi 137 Comparison of Concomitant Boost Radiotherapy and Concurrent Chemoradiation in Locally Advanced Oropharyngeal Cancers - A Phase III Randomized Trial from a Single Institute in India
1:30 p.m. Alexandra Jensen 138 Combined IMRT and C12-Heavy Ion Boost for Malignant Salivary Gland Tumors: COSMIC
1:40 p.m. Lucien Nedzi 139 Toxicity of Continuous Course Re-irradiation Concurrent with Weekly Cisplatinum and Cetuximab for Recurrent Squamous Cell Carcinoma of the Head and Neck: Report of a Phase II Trial
1:50 p.m. Adam Garden Discussant
2:00 p.m. Peter Ahn 140 Risk of Lymph Node Metastasis and Nodal Level Involvement Based on Site and Histology in the Paranasal Sinus: A SEER Analysis
2:10 p.m. Michael Gensheimer 141 Safety of Submandibular Gland-Sparing Intensity Modulated Radiation Therapy for Head and Neck Cancer
2:20 p.m. Cornelis Raaijmakers 142 Gross Tumor Volume of Laryngeal/Hypopharyngeal Cancer Delineated on MRI is Doubled Compared to Pathology
1:00 p.m. - 2:30 p.m. Scientifi c Session R – Lymphoma – Radiation Therapy as a Critical Component of Lymphoma Therapy Room: B203 Moderators: Brad Hoppe, Karen Winkfi eld
1:00 p.m. Carolina Fasola 143 Low-dose Radiotherapy (2 Gy x 2) in the Treatment of Non-Hodgkin’s Lymphoma of the Ocular Adnexa
1:10 p.m. Andrea Ng 144 Rates and Durability of Response to Salvage Radiotherapy Among Patients with Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma
1:20 p.m. Abhishek Solanki 145 Excellent Long-term Outcomes in Patients with Early-stage Nodular Lymphocyte-predominant Hodgkins Lymphoma Treated with Radiotherapy
1:30 p.m. Tobin Strom 146 Combining Low-dose External Beam with Radioimmunotherapy for Patients with Relapsed/Refractory B-Cell Lymphoma
1:40 p.m. George Mikhaeel Discussant
1:50 p.m. Sewit Teckie 147 Clinical Outcomes and Patterns of Relapse in 300 Patients with Early- and Advanced-Stage Marginal Zone Lymphoma
ASTRO 2013 / 55TH ANNUAL MEETING 89 Tuesday | September 24
2:00 p.m. Chen Bo 148 Late Relapse in Early-stage Extranodal Natural Killer/T-cell Lymphoma, Nasal Type
2:10 p.m. Gary Walker 149 Controlling Central Nervous System Leukemia: Does the Extent of the Radiation Therapy Field Infl uence Outcomes?
2:20 p.m. Peter Petersen 150 Deep Inspiration Breath Hold Radiation Therapy Reduces Radiation Dose to the Lungs and Heart in Patients Treated for Mediastinal Hodgkin Lymphoma
1:00 p.m. - 2:30 p.m. Scientifi c Session S – Sarcoma/Cutaneous Tumors Room: B405 Moderators: Jadranka Dragovic
1:00 p.m. Dian Wang 151 Signifi cant Reduction of Radiation Related Morbidities in the Extremity Sarcoma Patients Treated with Image Guided Radiotherapy to Reduced Target Volume: Results of RTOG 0630
1:10 p.m. Kaled Alektiar 152 Local Control Comparison of Conventional and Intensity Modulated Radiation Therapy (IMRT) for Primary Soft-Tissue Sarcomas of the Extremity
1:20 p.m. Colleen Dickie 153 Dosimetric Consequences of Tumor Volume Changes During Preoperative IMRT for Lower Extremity Soft Tissue Sarcoma
1:30 p.m. Falk Roeder 154 Excellent Local Control with IOERT and Postoperative EBRT in High-grade Extremity Sarcoma: Results from a Subgroup Analysis of a Prospective Trial
1:40 p.m. Jianyang Wang 155 Postoperative Intensity Modulated Radiation Therapy Provided Favorable Local Control in Patients with Soft Tissue Sarcoma of Extremities and Trunk
1:50 p.m. Thomas Delaney Discussant
2:00 p.m. Elizabeth Pan 156 Role of Postoperative Radiation (RT) Boost for Soft Tissue Sarcomas with Positive Margins Following Preoperative RT and Resection
2:10 p.m. Ajay Bhatnagar 157 Electronic Brachytherapy for the Treatment of Non-melanoma Skin Cancer: Results at Three Years
2:20 p.m. Ulrike Hoeller 158 Treatment Planning for Merkel Cell Carcinoma Based on the Relapse Pattern
90 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
1:00 p.m. - 2:30 p.m. Scientifi c Session T – Physics – Motion Assessment and Management Room: B406 Moderators: Ying Xiao, Geoff rey Hugo
1:00 p.m. Mario Romano 159 Does Pre-radiation Oxygen Breathing Prolong Deep Inspiration Breath Hold?
1:10 p.m. Derek Tsang 160 A Randomized Controlled Trial of Lorazepam to Reduce Organ Motion in Patients Receiving Upper Abdominal Radiotherapy
1:20 p.m. Seishin Takao 161 Baseline Shift of Intrafractional Lung Tumor Motion in a Real-time Tumor-tracking Radiotherapy Basic Science Abstract Award – Radiation Physics
1:30 p.m. Keiichi Harada 162 Can 4-D CT Imaging Predict Lung Motion During Stereotactic Body Radiation Therapy?
1:40 p.m. Xiutao Shi 163 Margins Determined Using 4-D CT Often Underestimate Tumor Motion in Thoracic Tumors
1:50 p.m. Samer Salamekh 164 Inter-fraction Tumor Volume Changes During Lung Stereotactic Body Radiation Therapy
2:00 p.m. Katelyn Atkins 165 Interfraction Regional Variation of Tumor Breathing Motion in Lung Stereotactic Body Radiation Therapy (SBRT)
2:10 p.m. Li-Ming Christine Fang 166 Novel Method of Cardiac Sparing with Deep-inspiration Breath Hold Utilizing Surface Electromagnetic Transponders in Women with Left-sided Breast Cancer
2:20 p.m. Carri Glide-Hurst 167 Intra-fraction Variability and Deformation Quantifi cation for Accelerated Partial Breast Irradiation (APBI)
1:00 p.m. - 2:30 p.m. Scientifi c Session U – Peds – Sarcoma and Neuroblastoma Room: B213 Moderators: Daniel Indelicato, Mary McAleer
1:00 p.m. Matthew Krasin 168 Long-term Toxicities of a Prospective Trial Delivering Limited Margin 3-D CRT/IMRT in Children with Rhabdomyosarcoma
1:10 p.m. Henry Mandeville 169 Local Failure in Parameningeal Rhabdomyosarcoma: Does Response to Induction Chemotherapy Matter?
1:20 p.m. William Tong 170 High-dose-rate Intraoperative Radiation Therapy for Pediatric Sarcoma: Outcomes, Toxicity and Practice Recommendations ASTRO 2013 / 55TH ANNUAL MEETING 91 Tuesday | September 24
1:30 p.m. Timothy Waxweiler 171 Non-rhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology and End Results Analysis
1:40 p.m. Lindsay Brown 172 Stereotactic Body Radiotherapy (SBRT) for Pediatric Bone Tumors
1:50 p.m. Jaipreet Suri 173 Subsequent Malignancies in Patients with Li-Fraumeni Syndrome Treated with Radiotherapy
2:00 p.m. Alexei Polishchuk 174 Predilection for First Relapse in Previous Sites of Bony Disease in Patients with Metastatic High-risk Neuroblastoma
2:10 p.m. Ali Mazloom 175 Radiotherapy to the Primary and Post-induction Chemotherapy MIBG-avid Sites in High-risk Neuroblastoma
2:20 p.m. Natia Esiashvili Discussant
1:00 p.m. - 2:30 p.m. Digital Poster Discussion 05 – Biology Room: A411 Discussants: Robert Den, Henning Willers
Nan Bi 1049 Serum MicroRNA Signature Predicts Survival in Patients with Unresectable/Inoperable Non-small Cell Lung Cancer Treated with Defi nitive Radiation Therapy
Daniel Bracey 1050 The Endogenous Peptide Angiotensin-(1-7) Prevents Radiation-induced Muscle Fibrosis: An In Vivo Murine Model Resident Digital Poster Discussion Award
Alexander Stessin 1051 Fty720, Sphingosine 1-Phosphate Receptor Modulator, Attenuates Radiation-induced Neurocognitive Defi cits in Young Mice
Carmen Perez 1052 Interleukin-7 as a Candidate Agent for Mitigating Radiation-induced Hematologic Injury
Sanath Kumar 1053 Transforming Growth Factor-β1 Increases Lethality of Total Body Irradiation
Gregory Vlacich 1054 Lrig1 Marks a Basal Subpopulation in the Esophagus Epithelium that Function as Stem Cells Basic Science Abstract Award - Radiation and Cancer Biology
92 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
Phuoc Tran 1055 Twist1 Induces the Step-wise Malignant Progression of Liver Cancer in Transgenic Mice Revealing a Prognostic 19-Gene Signature for Humans
Sivarajan Thiruganasambandam 1056 Structure-function Studies of the Phosphorylated bHLH Domain of the Twist1 Oncoprotein for Prostate Cancer Metastasis
Amit Maity 1057 Targeting the PI3K/mTOR Pathway Reduces Tumor Hypoxia and Decreases Oxygen Consumption
Alan Dal Pra 1058 Metformin and Prostate Cancer Radiotherapy: Improved Outcomes Due to Enhanced Tumor Oxygenation
Michael Spiotto 1059 Image Guided Radiotherapy for Mice Developing Autochthonous Human Papillomavirus Head and Neck Tumors Basic Science Abstract Award – Radiation and Cancer Biology
Mekhail Anwar 1060 Development of a Real-time Intraoperative Fluorescent Imager for Microscopic Residual Tumor in Breast Cancer Basic Science Abstract Award – Radiation and Cancer Biology
1:00 p.m. - 2:30 p.m. Digital Poster Discussion 06 – GU – Prostate - Novel Approaches, Hormones and Postop Room: A412 Discussants: Drew Moghanaki, Neha Vapiwala
Stephen Bravo 1061 Safety and Effi cacy of Feraheme as a Lymphatic Contrast Agent
Skyler Johnson 1062 Dose to the Inferior Rectum Has the Strongest Association with Patient-reported Bowel Quality of Life (QOL) After External Beam Radiation Therapy (EBRT) for Prostate Cancer
Gaurav Shukla 1063 Dominant Intraprostatic Lesion Size is Correlated with Rate of Biochemical Relapse in Patients with High- and Intermediate-risk Prostate Cancer Treated with Intensity Modulated Radiation Therapy
Kenneth Tokita 1064 Acute Rectal Toxicities for 180 Prostate Carcinoma Patients Administered Spacer Material in Conjunction with Radiation Therapy
Olivier Chapet 1065 Hypofractionated Intensity-modulated Radiotherapy with Injection of Hyaluronic Acid for Localized Prostate Cancer: Results of a Phase II study (RPAH1)
ASTRO 2013 / 55TH ANNUAL MEETING 93 Tuesday | September 24
Warren Foltz 1066 Improved Geometric Performance of Diff usion-weighted Imaging for Prostate Tumor Delineation Using A Readout-segmented Echo-planar-imaging Technique
Aaron Wagner 1067 Adjuvant Radiotherapy after Prostatectomy: Have Randomized Clinical Trials Had Any Impact?
Sravana Chennupati 1068 Late Gastrointestinal and Genitourinary Toxicity and Quality of Life After Treatment for Localized Prostate Cancer: Redefi ning Optimal Rectal DVH parameters for Intensity Modulated Radiation Therapy
David Elliott 1069 Who Needs Adaptive Radiation Therapy When You Can Do Internal Anatomy Positioning?: A Review of Daily Cone Beam Computed Tomography (CBDT) Scans to Analyze Geometric Dose Variation Due to Daily Rectal Variation and Distension in Post-prostatectomy Radiation Therapy
Christina Son 1070 High-risk Prostate Cancer Treated with Dose Escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy
Daniel Spratt 1071 Predictors of Castration Resistant Prostate Cancer After Defi nitive Radiotherapy: Impact of Failing Neoadju- vant Androgen Deprivation Therapy
Nathan Tonlaar 1072 Use of Weekly Cone Beam CT for Adaptive Radiotherapy Decreases Toxicity for Prostate Cancer Patients Treated with IMRT
1:00 p.m. - 2:30 p.m. Educational Session 311 – Challenging Lung Cancer Cases Room: B206 Zane Hammoud, MD, Henry Ford Hospital Branislav Jeremic, MD, PhD, Stellenbosch University Corey Langer, MD, University of Pennsylvania Benjamin Movsas, MD, FASTRO, Henry Ford Health System Kenneth Rosenzweig, MD, Icahn School of Medicine at Mount Sinai
1:00 p.m. - 2:30 p.m. Educational Session 312 – Patients First: Cancer Care from the Patients’ View Room: B216 Tamika Felder, Founder and CEO, Tamika and Friends Inc. Jonny Imerman, Chief Mission Offi ce, Imerman Angels Matthew Zachary, Founder and CEO, Stupid Cancer Raphael Yechieli, MD, Henry Ford Health System
Interesting Session? Tweet #ASTRO13
94 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
2:45 p.m. - 4:15 p.m. Scientifi c Session V – Patient-reported Outcomes – Pelvic Malignancies Room: B405 Moderators: Lawrence Berk, Robert Miller
2:45 p.m. Marie-Adele Kress 176 External Beam Radiotherapy Combined with Stereotactic Body Radiation Therapy Boost: Minimal Impact on Quality of Life with Recovery by Two Years Post-treatment
2:55 p.m. Don Fuller 177 Quality of Life (QOL) Outcomes Through 3 Years After Stereotactic Body Radiation Therapy (SBRT) for Early Prostate Cancer, Results from a Multi-institutional Phase II Trial
3:05 p.m. Olusola Obayomi-Davies 178 Preserved Sexual Function After Stereotactic Body Radiation Therapy for Prostate Cancer
3:15 p.m. Andrew Lee 179 Prospective Long-term Patient-Reported Quality of Life After Proton Therapy for Prostate Cancer
3:25p.m. Howard Sandler Discussant
3:35 p.m. Kristina Mirabeau-Beale 180 Clinical and Treatment Factors Associated with Vaginal Stenosis After Defi nitive Chemoradiation for Anal Cancer
3:45 p.m. Karyn Goodman 181 Prospective Study of Vaginal Dilator Use Following Pelvic Radiotherapy for Gastrointestinal Malignancies
3:55 p.m. Surbhi Grover 182 Psychological and Social Work Encounters Predict Higher Patient-reported Functional Quality of Life in Gynecological Cancer Treatment
4:05 p.m. Deborah Watkins-Bruner Discussant
2:45 p.m. - 4:15 p.m. Scientifi c Session W – Lung – Locally Advanced Disease and Other Topics Room: B406 Moderators: Kevin Stephans, Daniel Gomez
2:45 p.m. Sung-Ja Ahn 183 Randomized, Multicenter Phase III Study of Accelerated Fraction with Concomitant Boost to the Gross Tumor Volume Compared with Conventional Fraction in Concurrent Chemoradiation in Patients with Unresectable Stage III Non-small Cell Lung Cancer: KROG 0903
2:55 p.m. Feng-Ming Kong 184 A Phase II Trial of Mid-treatment FDG-PET Adaptive, Individualized Radiation Therapy Plus Concurrent Chemotherapy in Patients with Non-small Cell Lung Cancer (NSCLC)
ASTRO 2013 / 55TH ANNUAL MEETING 95 Tuesday | September 24
3:05 p.m. Saju Rajan 185 Concurrent Carboplatin, Paclitaxel and Selenomethionine in Combination with Radiation for Patients with Unresectable Stage III Non-small Cell Lung Cancer: A Phase II, Multi-center Trial
3:15 p.m. Maria Werner-Wasik Discussant
3:25 p.m. Ling Li 186 FDG Pulmonary Uptake Changes During and Post-radiotherapy Compared to Pre-treatment in Predicting Radiation Induced Lung Toxicity in Non-small Cell Lung Cancer
3:35 p.m. Chad Tang 187 Post Radiation White Blood Cell Count is a Novel Marker of Radiation Pneumonitis in Non-small Cell Lung Cancer
3:45 p.m. Brian Lally 188 Non-small Cell Lung Cancer Disparities in a Tri-racial/Ethnic Population
3:55 p.m. Suchit Patel 189 A Meta Analysis of the Eff ect of Post-operative Radiation Therapy (PORT) Using Linear Accelerators on Patients with N2 Lung Cancer
4:05 p.m. Quynh Nguyen 190 Risk Factors Predicting Failure and Survival in Lung Cancer Patients Treated with Defi nitive Dose Escalated Proton Radiation Therapy
2:45 p.m. - 4:15 p.m. Scientifi c Session X – Head and Neck – Outcomes Room: Sidney Marcus Auditorium Moderators: Randall Kimple, Danielle Margalit
2:45 p.m. Nadeem Riaz 191 Multi-institution Analysis of Concurrent Chemo-radiotherapy with Cisplatin (CDDP) vs. Cetuximab (C225) in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-HNSCC): Can HPV Help Decide Which Agent?
2:55 p.m. Clayton Hess 192 Competing Causes of Death and Medical Comorbidities Among Patients with Human Papillomavirus-Positive vs. Negative Oropharyngeal Carcinoma and Its Impact on Compliance to Radiotherapy
3:05 p.m. Beth Beadle 193 Improved Survival Using IMRT in Head and Neck Cancers: A SEER-Medicare Analysis
3:15 p.m. Matthew Stenmark 194 High Frequency of HPV-associated Nasopharyngeal Carcinoma (NPC) in North American Patients: Association with Poor Prognosis
3:25 p.m. Kenneth Shung Hu 195 Prospective Multidisciplinary Treatment Algorithm for Head and Neck Paragangliomas
3:35 p.m. Gene-Fu Liu 196 Racial Parities in Outcomes after Radiotherapy for Head and Neck Cancer
96 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
3:45 p.m. Moses Tam 197 Long-Term Outcomes of Defi nitive Radiotherapy for Nasopharyngeal Carcinoma at a North American Institution
3:55 p.m. Joseph Lee 198 Nasopharynx Carcinoma : Outcomes with Transitioning to IMRT and Chemotherapy
4:05 p.m. Alexander Lin Discussant
2:45 p.m. - 4:15 p.m. Scientifi c Session Y – GU – Bladder, Renal, Adrenal, Testes Room: B213 Moderators: Jason Efstathiou, Javier Torres-Roca
2:45 p.m. Brian Baumann 199 Robust Risk Stratifi cation Model Predicts Local-regional Recurrence After Radical Cystectomy in Diff erent Patient Cohorts
2:55 p.m. Phillip Gray 200 Presentation, Treatment and Outcomes for Bladder Cancer Patients with Non-urothelial Histologies Treated by Radical Cystectomy: Implications for Adjuvant Radiotherapy
3:05 p.m. Shafak Aluwini 201 Bladder Preservation with Brachytherapy, External Beam Radiotherapy and Limited Surgery in Bladder Cancer Patients; Long Term Results
3:15 p.m. Rebecca Clayman 202 Outcomes of Selective Bladder Preservation in the Elderly Treated with Conservative Surgery and Chemoradiation
3:25 p.m. Ferran Ferrer 203 Acute Toxicity Report for Combined Sorafenib and Radiation Treatment in Phase I Multicentric Trial for Conservative Management of Bladder Cancer
3:35 p.m. Libni Eapen Discussant
3:45 p.m. Sean McBride 204 A Phase I Dose Escalation Study of Cyberknife Radiosurgery in Inoperable Primary Renal Cell Carcinoma
3:55 p.m. Aaron Sabolch 205 Improved Local Control with Adjuvant Radiotherapy in Localized Adrenocortical Carcinoma: A Case-Matched Retrospective Study
4:05 p.m. Swetha Sridharan 206 Contemporary Management of Stage I and Stage II Seminoma
ASTRO 2013 / 55TH ANNUAL MEETING 97 Tuesday | September 24
2:45 p.m. - 4:15 p.m. Scientifi c Session Z – GI – Prospective Clinical Trials and Retrospective Correlations Room: B216 Moderators: Ross Abrams, Join Luh
2:45 p.m. Jennifer Wo 207 Mutational Profi le of Gastroesophageal Cancer Compared to Gastric and Esophageal Cancers
2:55 p.m. Tracey Schefter 208 A Phase II Study of Neoadjuvant Therapy with Cisplatin, Docetaxel, Panitumumab Plus Radiation Therapy Followed by Surgery in Patients with Locally Advanced Adenocarcinoma of the Distal Esophagus. Results of ACOSOG Z4051 (Alliance)
3:05 p.m. Christine Min 209 Chemo-radiation Therapy vs. Chemotherapy Alone for Gastric Cancer After R0 Surgical Resection: A Meta-analysis of Randomized Trials
3:15 p.m. Jingya Wang 210 Nomogram Score of Pathologic Complete Response to Neoadjuvant Chemoradiation Predicts for Survival Outcomes in Esophageal Cancer Patients Treated with Defi nitive Chemoradiation
3:25 p.m. Bapsi Chakravarthy Discussant
3:35 p.m. Avani Dholakia 211 Mapping Patterns of Local Failure Following Pancreaticoduodenectomy for Pancreatic Cancer: A New Approach to Adjuvant Radiation Fields
3:45 p.m. Pranshu Mohindra 212 Impact of Neoadjuvant Therapy on Peri-operative Morbidity and Mortality After Pancreaticoduodectomy for Pancreatic Cancer
3:55 p.m. Jeff Olsen 213 Sequential Short Course Radiation and FOLFOX as Preoperative Therapy for Rectal Cancer: Favorable LC, PFS and QOL at 2 Years
4:05 p.m. Charles Thomas 214 Phase 2 Timing of Rectal Cancer Response to Chemoradiation: Analysis of Radiotherapy (RT)
2:45 p.m. - 4:15 p.m. Scientifi c Session AA – Palliative/Quality of Life – Quality of Care in Metastatic Cancer Room: B203 Moderators: Tracy Balboni
2:45 p.m. Robert Olson 215 Use of Single Fraction Palliative Radiotherapy for Bone Metastases: Population Based Practice Patterns in British Columbia Over a Five Year Period
2:55 p.m. Ehsan Balagamwala 216 Incidence and Risk Factors for Vertebral Compression Fractures from Spine Stereotactic Body Radiotherapy: Results of a Large Institutional Series
98 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
3:05 p.m. David Howell 217 Daily Assessment of Patient Quality of Life During 100 Courses of Radiation: Pain, Anxiety, Distress, Problems or Concerns, and Need to See Physician
3:15 p.m. Luluel Khan 218 Fatigue Scores in Patients with Brain Metastases Receiving Whole Brain Radiotherapy
3:25 p.m. Yolanda Tseng 219 How Radiation Oncologists Evaluate and Incorporate Life Expectancy Estimates into the Palliative Treatment of Cancer Patients: A Survey-Based Study
3:35 p.m. Monica Krishnan 220 The Supportive and Palliative Radiation Oncology Service: The Impact of a Dedicated Service on Palliative Cancer Care
3:45 p.m. Christopher Barker 221 Palliative Local Therapy for Skin Metastases: A Meta-analysis
3:55 p.m. Payal Soni 222 Use of Anticoagulants Predict Late Rectal Bleeding Following Defi nitive External Beam Radiation Therapy for Prostate Cancer
4:05 p.m. Candice Johnstone Discussant
2:45 p.m. - 4:15 p.m. Scientifi c Session BB – Biology – Biomarkers, Detection of Prognosis and Progression Room: B211 Moderators: Fei-Fei Liu, Hiram Gay
2:45 p.m. Scott Bratman 223 Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing
2:55 p.m. Sanjay Chandrasekaran 224 Detection of Circulating Tumor Cells of Non-epithelial Origin: A Bench to Bedside Approach
3:05 p.m. Fadlo Khuri Discussant
3:15 p.m. Lauren Colbert 225 Chromodomain-Helicase-DNA-Binding Protein 7 (CHD7), a Novel Gemcitabine Sensitivity Gene, is a Prognostic Biomarker in Patients with Early-stage Resected Pancreatic Adenocarcinoma
3:25 p.m. Ting Xu 226 Serum TGF- TGF-β1 and VEGF are Associated with Tumor Burden and Tumor Response on PET to Radio(chemo)therapy in Patients with Non-small Cell Lung Cancer Basic Science Abstract Award – Radiation and Cancer Biology
ASTRO 2013 / 55TH ANNUAL MEETING 99 Tuesday | September 24
3:35 p.m. Nan Bi 227 Serum MicroRNA as a Predictive Marker for Radiation Pneumonitis in Patients with Inoperable/Unresectable Non-small Cell Lung Cancer (NSCLC)
3:45 p.m. Ting Xu 228 Circulating miR-155 Predicts for Acute Esophageal Toxicity in Patients with Non-small Cell Lung Cancer Treated with Radiation Therapy
3:55 p.m. Jose Bazan 229 Novel Human Radiation Exposure Biomarker Panel Applicable for Patient Triage
4:05 p.m. Yoko Harima 230 Prediction of Outcome for the Patients with Advanced Cervical Cancers After Chemoradiotherapy Using Micro RNA Analysis
2:45 p.m. - 4:15 p.m. Scientifi c Session CC – Physics – Response Imaging and Modeling Room: B302-305 Moderators: Jan-Jakob Sonke, Lei Xing
2:45 p.m. Jeho Jeong 231 An Estimation of the Radiotherapy Dose-response Diff erences between FDG-avid vs. FDG-non-avid Head and Neck Tumors
2:55 p.m. Qiyong Fan 232 Simultaneous Tracking of Multiple Metastases Using FDG-PET Emission Guided Radiation Therapy (EGRT) in a Breast Cancer Patient
3:05 p.m. Carryn Anderson 233 Early Analysis of a Phase II Prospective Trial Evaluating Accuracy of Triphasic PET/CT After RT for Head and Neck Squamous Cell Carcinoma
3:15 p.m. Lifei Zhang 234 Large Tumor Shrinkage is Preceded by the Appearance of a Cavity Inside the Tumor for NSCLC Patients Treated with Chemo-radiation Therapy
3:25 p.m. Martin King 235 Validation of Image-based Biomarkers for Analyzing Long-term Pulmonary Toxicity After Radiation Therapy
3:35 p.m. Frank Van Den Heuvel 236 Using a Closed Analytical Expression to Determine Biological Eff ects Depending on Radiation Spectrum and Oxygen Level
3:45 p.m. Gilmer Valdes 237 Derivation of Optimum Biological Parameters for Non-small Cell Lung Tumors with Consideration of Interpatient Heterogeneity
3:55 p.m. Thomas Zilli 238 Salvage Reirradiation for Local Failure of Prostate Cancer After Curative Radiotherapy: Dosimetric and Radiobiological Modeling of Rectal Toxicity
100 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
4:05 p.m. Phillip Prior 239 Modeling Tumor Control Probability Based on Compiled Clinical Data from Radiotherapy for Skin Cancer
2:45 p.m. - 4:15 p.m. Digital Poster Discussion 07 – Health Services Research Room: A411 Discussants: Susan McCloskey, David Sher
Kevin Pearlstein 1073 Patient-level Characteristics of Medicare Cancer Patients in the United States, Implications for Treatment and Survivorship
Samuel Swisher-McClure 1074 Limited Use of Guideline Concordant External Beam Radiotherapy Dose for Non-metastatic Prostate Cancer in the United States
John Byun 1075 Readability Levels of Patient Education Materials in Professional Radiation Oncology Organizations
Nataniel Lester-Coll 1076 Stereotactic Radiosurgery vs. Stereotactic Radiosurgery and Whole Brain Radiation Therapy for One to Three Brain Metastases
Ann Raldow 1077 The Dissemination of New Technologies and Temporal Trends in Curative Therapy for Prostate Cancer Patients with Low Likelihood of Clinical Benefi t Resident Digital Poster Discussion Award
Mark Mishra 1078 An Evaluation of Worldwide Proton Beam Therapy Clinical Trials
Jeff rey Kuremsky 1079 Clinical and Economic Outcomes of Patients with Brain Metastases Based on Whether Metastases are Symptomatic or Not: An Argument for Routine Brain Screening
Marsha Laufer 1080 Trends in Intensity Modulated Radiotherapy Use for Locally Advanced Rectal Cancer at National Comprehensive Cancer Network (NCCN) Centers
Ronald Chen 1081 Barriers to Receiving Radiation Therapy for Localized Prostate Cancer (CaP), Results from the North Carolina Prostate Cancer Comparative Eff ectiveness and Survivorship Study (NC ProCESS)
David Sher 1082 Patient and Institutional Predictors of Trimodality Therapy for Stage III Non-small Cell Lung Cancer (NSCLC) in the National Cancer Database
Daniel Wattson 1083 Low-dose Chest CT for Lung Cancer Screening Among Hodgkin Lymphoma Survivors: A Cost Eff ectiveness Analysis
ASTRO 2013 / 55TH ANNUAL MEETING 101 Tuesday | September 24
Jacob Shabason 1084 The Role of Shared Decision Making in Patient Experiences in Radiation Oncology
2:45 p.m. - 4:15 p.m. Digital Poster Discussion 08 – Physics – SBRT Outcomes and Particle Therapies Room: A412 Discussants: Sonja Dieterich, Harald Paganetti
Jing Wang 1085 Primary Outcomes in Phase II Study of Hypofractionated Patterns by Stereotactic Ablative Radiotherapy (SABR) Understanding the Clinical Results from Contemporary Stereotactic Radiotherapy
Withdrawn 1086
Withdrawn 1087
Christy Goldsmith 1088 Stereotactic Ablative Body Radiotherapy (SABR) to Lymph Node Oligometastases - UK Experience and Clinical Outcome
Roi Dagan 1089 Initial Outcomes from the University of Florida Experience with Stereotactic Ablative Radiotherapy (SABR) for Oligometastases
Daniel Richter 1090 4-D Treatment Dose Reconstruction for Scanned Ion Beam Therapy
Huanmei Wu 1091 An Integrated Image Guided Proton Therapy Monitoring System with Real-time Imaging Processing and Treatment Intervention
Maryam Moteabbed 1092 When Does Pencil Beam Scanning Improve the Treatment Outcome of Pediatric Head and Neck/CNS Patients Over Passive Scattered Proton Therapy?
Wataru Takahashi 1093 Carbon-Ion Scanning Lung Therapy (with Respiratory-Gated Phase Controlled Rescanning): Simulation Study for 4-D Treatment Planning
Jonathan Farr 1094 In Vivo Proton Beam Centroid and Range Uncertainties Determined Empirically from Positron Emission Tomography Due to Single Uniform Field Patient Treatment Activation
Jonathan Ashman 1095 Scanning Beam Stereotactic Body Proton Therapy (SBPT) for Pancreatic Cancer: A Dosimetric Feasibility Study
Vadim Moskvin 1096 Reduced Secondary Neutrons and Occupational Exposure with Optimization of Beam Shaping Device Material in Proton Therapy
102 ASTRO 2013 / 55TH ANNUAL MEETING Tuesday | September 24
2:45 p.m. - 4:15 p.m. Educational Session 313 – Challenging Cases in the Management of Newly Diagnosed and Recurrent Prostate Cancer Room: B313 Gerald L. Andriole, MD, Washington University Juanita M. Crook, MD, University of British Columbia Anthony V. D’Amico, MD, PhD, FASTRO, Brigham and Women’s Hospital Thomas Wiegel, MD, University Hospital ulm Michael J. Zelefsky, MD, Memorial Sloan-Kettering Cancer Center
2:45 p.m. - 4:15 p.m. Educational Session 314 – Diffi cult Cases in Vulvar and Vaginal Cancer Room: B206 Patricia J. Eifel, MD, FASTRO, MD Anderson Cancer Center Beth A. Erickson, MD, FASTRO, Medical College of Wisconsin Michael Frumovitz, MD, MPH, MD Anderson Cancer Center William Small, MD, FASTRO, Loyola University Akila N. Viswanathan, MD, Brigham and Women’s Hospital
4:30 p.m. - 6:00 p.m. Panel 11 – Integrated Urology and Radiation Oncology Practices: An Analysis of the Self-Referral Landscape Room: B216 Moderator: Mitchell Anscher, MD, FASTRO, Virginia Commonwealth University Medical Center
Panelists: Jean Mitchell, PhD, Georgetown University Benjamin Falit, MD, JD, Harvard Radiation Oncology Program Michael Kuettel, MD, PhD, MBA, FASTRO, Roswell Park Cancer Institute Paul Wallner, DO, FASTRO, 21st Century Oncology
4:30 p.m. - 6:00 p.m. Panel 12 – Patient-reported Outcomes: “Hearing the Patient’s Voice” in a User-friendly and Meaningful Way Room: B203 Moderator: Benjamin Movsas, MD, FASTRO, Henry Ford Health System
Panelists: Deborah Watkins Bruner, PhD, RN, Emory University Jeff Sloan, PhD, Mayo Clinic Ronald Chen, MD, University of North Carolina at Chapel Hill Benjamin Movsas, MD, Henry Ford Health System
ASTRO 2013 / 55TH ANNUAL MEETING 103 Tuesday | September 24
4:30 p.m. - 6:00 p.m. Panel 13 – Brachytherapy Fundamentals and Evolving Paradigms Room: B211 Moderator: Robert Cormack, PhD, Harvard Medical School
Panelists: Beth A. Erickson, MD, FASTRO, Medical College of Wisconsin Atif Khan, MD, Cancer Institute of New Jersey Paul Nguyen, MD, Dana-Farber/Brigham and Women’s Cancer Center
4:30 p.m. - 6:00 p.m. Panel 14 – Medical Error Disclosure in Radiation Oncology Room: B313 Moderator: Suzanne Evans, MD, Yale University
Panelists: John Banja, PhD, Emory University Andrew White, MD, University of Washington Medical Center Kristin Hiscutt, Esq., Bendin, Sumrall and Ladner LLC
4:30 p.m. - 6:00 p.m. Panel 15 – Cancer Genesis, Treatment and Late Eff ects Across the Age Spectrum Room: B213 Moderator: Louis S. Constine, MD, FASTRO, University of Rochester Medical Center
Panelists: Jacqueline Williams, PhD, FASTRO, University of Rochester Medical Center Louis S. Constine, MD, FASTRO, University of Rochester Medical Center Lawrence Marks, MD, FASTRO, University of North Carolina at Chapel Hill Lois Travis, MD, University of Rochester Medical Center
4:30 p.m. - 6:00 p.m. Educational Session 315 – Practical Use of Image Registration and Data Fusion for Planning, Delivery and Adaptation of Radiation Therapy Room: B302-B305 Kristy K. Brock, PhD, University of Michigan Marc L. Kessler, PhD, University of Michigan Patrick A. Kupelian, MD, University of California Los Angeles Health System
4:30 p.m. - 6:00 p.m. Educational Session 316 – Challenging Cases in GI Malignancies Room: B206 Prajnan Das, MD, MS, MD Anderson Cancer Center Theodore S. Hong, MD, Massachusetts General Hospital Caio Rocha-Lima, MD, University of Miami Sam S. Yoon, MD, Memorial Sloan-Kettering Cancer Center
104 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
7:45 a.m. - 9:00 a.m. Educational Session 401 – Volumetric Modulated Arc Therapy: Planning and Quality Assurance Room: Thomas Murphy Ballroom 4 Charles Mayo, PhD, Mayo Clinic Jean M. Moran, PhD, University of Michigan Todd Pawlicki, PhD, University of California San Diego
7:45 a.m. - 9:00 a.m. Educational Session 402 – Pediatric Tumors: Update on Neuroblastoma, Wilms Tumor and Retinoblastoma Room: B203 Ranjit S. Bindra, MD, PhD, Yale School of Medicine Christopher Barker, MD, Memorial Sloan-Kettering Cancer Center John A. Kalapurakal, MD, Northwestern Memorial Hospital
7:45 a.m. - 9:00 a.m. Educational Session 403 – Advances in Treatment Planning for Prostate Cancer Room: B313 Mark K. Buyyounouski, MD, MS, Fox Chase Cancer Center Peter Chung, MB, ChB, Princess Margaret Hospital
7:45 a.m. - 9:00 a.m. Educational Session 404 – Treatment Option for Patients with Early-stage Non-small Cell Lung Cancer Room: B405 Jeff rey A. Bogart, MD, State University of New York Abraham Lebenthal, MD, Brigham and Women’s Hospital
7:45 a.m. - 9:00 a.m. Educational Session 405 – Radiation/Chemoradiation and Biological Targeting Room: B213 Robert G. Bristow, MD, PhD, Princess Margaret Hospital George D. Wilson, PhD, William Beaumont Hospital
7:45 a.m. - 9:00 a.m. Educational Session 406 – Breast Cancer Management: Early-stage Disease Room: B211 Meena S. Moran, MD, Yale University School of Medicine Julia S. Wong, MD, Dana-Farber Cancer Institute
Symbol Key: ARONA Ticketed Event/ Nurses’ Award Live Interactive Separate Session Recipient SAM/ Session registration Separate required registration required
ASTRO 2013 / 55TH ANNUAL MEETING 105 Wednesday | September 25
7:45 a.m. - 9:00 a.m. Educational Session 407 – Radiation Treatment for Hepatic Tumors: Current Treatment Approaches and Controversies Room: B302-B305 Laura A. Dawson, MD, Princess Margaret Hospital Brian Kavanagh, MD, MPH, University of Colorado Denver
7:45 a.m. - 9:00 a.m. Educational Session 408 – Survivorship Issues for Radiation Therapy Patients Room: B406 Ronald C. Chen, MD, MPH, University of North Carolina at Chapel Hill Bridget F. Koontz, MD, Duke University Medical Center Deborah Mayer, PhD, RN, UNC School of Medicine Kevin D. Stein, PhD, American Cancer Society
7:45 a.m. - 9:00 a.m. Educational Session 409 – Integration of Systemic Treatment with Radiation Therapy for Head and Neck Cancer Room: B216 Ezra Cohen, MD, University of Chicago David I. Rosenthal, MD, MD Anderson Cancer Center Roy B. Tishler, MD, PhD, Dana-Farber Cancer Institute
7:45 a.m. - 9:00 a.m. Educational Session 410 – Hypofractionation in the Management of CNS Tumors Room: B308 Eric Lin Chang, MD, University of Southern California Keck School of Medicine Michael T. Milano, MD, PhD, University of Rochester Timothy D. Solberg, PhD, University of Pennsylvania
9:15 am. - 10:15 a.m. Keynote Address III – Steven L. Leibel, MD Memorial Lecture “Identifi cation and Targeting of Radioresistance Niches“ Room: Thomas Murphy Ballroom 1-3 Peter Friedl, MD, PhD, St. Radboud University Nijmegen Medical Centre, University of Nijmegen; MD Anderson Cancer Center Introduced by: Catherine C. Park, MD, University of California San Francisco Refer to page 47 for details.
Great speaker? Tweet #ASTRO13
106 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
10:30 a.m. - 12:00 p.m. Scientifi c Session DD – Breast – Biology of Breast Cancers Room: Thomas Murphy Ballroom 4 Moderators: Simona Shaitelman, John Einck
10:30 a.m. Markus Bredel 240 Deletion of the Tumor Suppressor NFKBIA in Triple-negative Breast Cancer
10:40 a.m. Shreya Prasad 241 Patterns of Failure in Triple Negative Breast Cancer: A Retrospective Analysis in 476 women
10:50 a.m. Chi Zhang 242 Triple Negative Breast Cancer is Associated with Higher Rate of Locoregional Recurrence for Patient Achieving Less than a pCR Following Neoadjuvant Chemotherapy, Surgery and Radiotherapy
11:00 a.m. Tithi Biswas 243 Treatment Related Outcome in Triple Negative Breast Cancer (TNBC): A Multi-institutional Retrospective Analysis
11:10 a.m. Wendy Woodward Discussant
11:20 a.m. Corey Speers 244 Identifi cation and Validation of a Radiation Sensitivity Signature in Human Breast Cancer
11:30 a.m. Wil Santivasi 245 Cytosolic Mislocalization of BRCA1 is Associated with Increased Metastatic Risk in Breast Cancer
11:40 a.m. Wendy Woodward 246 Complementing Ipsilateral Breast Tumor Recurrence (IBTR) Estimates with the 21-Gene Recurrence Score (RS) in Early-stage, Hormone Receptor Positive, Her2-Normal, Lymph Node-negative Breast Cancers
11:50 a.m. Naresh Jegadeesh 247 21-Gene Recurrence Score Predicts Local Recurrence in Breast Cancer Patients Treated with Mastectomy Alone but Not in Patients Treated with Radiation
10:30 a.m. - 12:00 p.m. Scientifi c Session EE – CNS – Outcomes and Survival Room: B213 Moderators: Ben Slotman, Peter Chen
10:30 a.m. C. Ronald Kersh 248 Re-Irradiation with Stereotactic Radiosurgery Treatment for Spinal Metastases - Results from an International Multicenter Database
10:40 a.m. Matthias Guckenberger 249 Radiosurgery as Primary Treatment for Vertebral Metastases - Results from an International Multicenter Database
10:50 a.m. Samuel Ryu 250 Neurological Outcome and Survival After Radiosurgery of High-grade Epidural Spinal Cord Compression
ASTRO 2013 / 55TH ANNUAL MEETING 107 Wednesday | September 25
11:00 a.m. Stephanie E. Combs 251 Multicentric Evaluation of Long-term Outcome After Highly Advanced Single-dose or Fractionated Radiotherapy in Patients with Vestibular Schwanommas - Pooled Results from three Large German Centers
11:10 a.m. Daniel Bernad 252 Analysis of Structural Changes in Hippocampal and Amygdala Volume After Systemic Therapy and Prophylactic Cranial Irradiation in Patients with Limited Stage Small Cell Lung Cancer
11:20 a.m. Frank Giordano 253 Mapping of Brain Metastases to Evaluate the Risk of Hippocampus-sparing Prophylactic and Therapeutic Cranial Irradiation
11:30 a.m. Amol Narang 254 Predictors of High-Grade Histology in Patients with Progressive Low-grade Gliomas: Is Histology Needed to Guide Therapy?
11:40 a.m. John Hardie 255 Factors Contributing to Survival in Patients with Anaplastic Astrocytoma: A Retrospective Study of Patients Treated at One Institution
11:50 a.m. Yuta Shibamoto 256 Analysis of Radiation Therapy in 1,054 Patients with Primary Central Nervous System Lymphoma (PCNSL) Treated During 1985-2009
10:30 a.m. - 12:00 p.m. Scientifi c Session FF – GU – Prostate Cancer: High Risk, Postop and Metastatic Disease Room: B211 Moderators: Danny Song, James Yu
10:30 a.m. Xavier Maldonado 257 Late Side Eff ects in Men with Intermediate- and High-risk Prostate Cancer Treated with High-dose Radiotherapy and Androgen Deprivation (DART 01/05): Secondary Endpoints from a Phase III Clinical Trial
10:40 a.m. Alex Gottschalk 258 Outcomes of Hypofractionated SBRT Boost for Intermediate- and High-risk Prostate Cancer: A Single Institutional Prospective Study
10:50 a.m. Patrick Cheung 259 Concomitant Hypofractionated IMRT Boost for High-risk Prostate Cancer: 5 Year Results
11:00 a.m. Mack Roach 260 Radiation Therapy Oncology Group (RTOG) 9413: A Randomized Trial Comparing Whole Pelvic Radiotherapy (WPRT) to Prostate Only (PORT); Neoadjuvant Hormonal Therapy (NHT) to Adjuvant Hormonal Therapy (AHT)
11:10 a.m. Paul Nguyen 261 Meta-analysis of Long-term Results of Randomized Trials of the Impact of Adjuvant Radiation on Overall, Metastasis-free, and Biochemical Recurrence-free Survival for pT3N0 or Margin Positive Prostate Cancer
11:20 a.m. John Watkins 262 Demon in the Details: Width of Involved Margin at Prostatectomy Correlates with PSA Control
108 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
11:30 a.m. Monica Shukla 263 Redefi ning Stage IV Prostate Cancer – Is There a Subset Who May be Cured?
11:40 a.m. Piotr Milecki 264 A Comparison of the Analgesic Eff ect and Toxicity of 153sm Radioisotope Treatment in Monotherapy and Combined Therapy Including Local External Beam Radiotherapy (EBRT) Among Metastatic Castrate Resistance Prostate Cancer (MCRPC) Patients with Painful Bone Metastases
11:50 a.m. Jeff Michalski 265 Radium-223 Dichloride (Ra-223) Impact on Skeletal-related Events, External Beam Radiotherapy (EBRT) and Pain in Patients with Castration-resistant Prostate Cancer (CRPC) with Bone Metastases: Updated Results from the Phase 3 ALSYMPCA Trial
10:30 a.m. - 12:00 p.m. Scientifi c Session GG – Biology – The Interplay Between Radiation and the Immune System Room: B203 Moderators: Christopher Barker, James Hansen
10:30 a.m. Matthew Witek 266 Single Dose Tumor Irradiation Primes the Immune System for Therapeutic Cancer Vaccination
10:40 a.m. Timothy Harris 267 Tumor Vaccination Combined with Radiotherapy Mitigates Development and Progression of Metastatic Prostate Cancer: Studies in an Autochthonous Murine Prostate Cancer Model Resident Clinical/Basic Science Research Award – Radiation and Cancer Biology
10:50 a.m. Timothy Harris 268 Immune Checkpoint Upregulation Following Radiotherapy: Rationale for Combining Radiotherapy with Multiple Immune Checkpoint Blockades
11:00 a.m. Michael Bernstein 269 Radiation Therapy Alters Tumor Cell Phenotypes and Enhances the Immune Response
11:10 a.m. Adam Dicker Discussant
11:20 a.m. Anita Aiyer 270 Preparative Hepatic Irradiation (HIR) for Transplantation of Human Induced Pluripotent Stem Cell (iPSC)-Derived Hepatocyte-Like Cells (iHep) in Mouse Livers Basic Science Abstract Award – Radiation and Cancer Biology
11:30 a.m. Ralph Vatner 271 Novel Combination of Toll-like Receptor (TLR)-7 Agonist Imiquimod and Local Radiotherapy in the Treatment of Metastatic Breast Cancer Involving the Skin or Chest Wall
11:40 a.m. Arta Monjazeb 272 Combined Radiotherapy and Immunotherapy Using CPG Oligodeoxynucleotides and Indolamine 2,3 Dioxygenase (IDO) Blockade
ASTRO 2013 / 55TH ANNUAL MEETING 109 Wednesday | September 25
11:50 a.m. Jeremy Price 273 Unraveling the Mechanisms of Langerhans Cell Irradiation Resistance
10:30 a.m. - 12:00 p.m. Scientifi c Session HH – Lung – Biology and Mesothelioma Room: B405 Moderators: Heath Skinner, Roy Decker
10:30 a.m. Steven Lin 274 Circulating Tumor Cells with Markers of Epithelial-Mesenchymal Transition are Associated with Distant Metastatic Failures in Lung Cancer Patients Treated with Defi nitive Chemoradiation
10:40 a.m. Ronny Kalash 275 Signifi cant Diff erences in Thoracic Irradiation Induced Pulmonary Gene Transcripts Between Fibrosis-prone C57BL/6 Hnsd Mice and Fibrosis-resistant C3H/Hen Mice
10:50 a.m. Dmitriy Meshkov 276 ATM Gene Variations Predict Diff erences in Pretreatment Lung Infl ammation in Non-small Cell Lung Cancer (NSCLC) Patients
11:00 a.m. Lucas Gilbride 277 A Novel Circulating Tumor Cell Assay for Non-small Cell Lung Cancer Patients Undergoing Radiation Therapy
11:10 a.m. Michael Epperly 278 Late Pulmonary Fibrotic Phase Specifi c Homing of Luciferase+ Bone Marrow Stromal Cells to the Irradiated C57bl/6Hnsd Mouse Lung
11:20 a.m. Russell Hales Discussant
11:30 a.m. Marco Trovo 279 Radical Pleurectomy/Decortication Followed by High Dose of Radiation Therapy Delivered with Tomotherapy for Malignant Pleural Mesothelioma. Final Results with Long-term Follow-up
11:40 a.m. Malcolm Feigen 280 Outcomes from Radiation Pneumonectomy for Locally Advanced Malignant Pleural Mesothelioma - High Locoregional Control Rate with Acceptable Toxicity
11:50 a.m. Andreas Rimner 281 Interim Analysis of a Phase II Toxicity Study on Hemithoracic Pleural Intensity Modulated Radiation Therapy (IMRT) for Malignant Pleural Mesothelioma (MPM)
10:30 a.m. - 12:00 p.m. Scientifi c Session II – Patient-reported Outcomes – Head/Neck, Thoracic and Breast Cancers Room: B308 Moderators: Aileen Chen, Ronald Chen
10:30 a.m. Kerry Dunn 282 Mometasone Furoate Signifi cantly Reduces Radiation Dermatitis in Patients Undergoing Breast Radiotherapy: A Double-blind Randomized Control Trial in 120 Patients Wednesday | September 25
10:40 a.m. Karna Sura 283 Factors Aff ecting Breast Cancer Patient Quality of Life in Association with Radiation
10:50 a.m. Michele Halyard Discussant
11:00 a.m. Raimond Wong 284 RTOG 0537 Phase 2/3 Study Comparing Acupuncture-like Transcutaneous Electrical Nerve Stimulation (ALTENS) vs. Pilocarpine (PC) in Treating Early Radiation-induced Xerostomia (RIX): Phase 3 Preliminary Analysis
11:10 a.m. G. Gunn 285 Drivers of Patient-reported Symptom Interference During Radiation or Chemoradiation as Detected by the MD Anderson Symptom Inventory – Head and Neck Module
11:20 a.m. Roy Tishler Discussant
11:30 a.m. David Schwartz 286 Repeated Measure Analysis of Dermatitis Symptoms Evolution and Patient-reported Outcome in N06C4: A Phase III Randomized Trial of Mometasone Furoate in Breast Cancer Patients Receiving Radiotherapy
11:40 a.m. Abram Recht 287 Esophageal Symptoms Before, During, and One Year After Treatment and Sequencing of Chemotherapy (CT) and Mediastinal Radiation Therapy (MRT)
11:50 a.m. Christine Hill-Kayser 288 Patient-reported Outcomes After Treatment for Lung Cancer
10:30 a.m. - 12:00 p.m. Scientifi c Session JJ – Patient Safety Room: B216 Moderators: James Hayman, Suzanne Evans
10:30 a.m. Brett Cox 289 Prospective Contouring Rounds: A Novel, High-impact Tool for Optimizing Quality Assurance
10:40 a.m. Prithima Mosaly 290 Quantifying the Impact of Cross-coverageon Physicians Workload and Performance During Radiation Therapy Treatment Planning
10:50 a.m. David Hoopes 291 Early Results from the ASTRO Practice Patterns in Peer Review Survey Project
11:00 a.m. Eric Ford Discussant
11:10 a.m. Douglas Rahn 292 A Real-time Safety and Quality Reporting System: Initial Clinical Outcomes and Survey Results
11:20 a.m. Jing Zeng 293 Patient Safety Improvement Related to Repeat Irradiation Identifi ed with Near-miss Incidents Reporting
ASTRO 2013 / 55TH ANNUAL MEETING 111 Wednesday | September 25
11:30 a.m. Lakshmi Santanam 294 Model for Estimating Severity of Errors in Radiation Therapy
11:40 a.m. Peter Greer 295 Real-time EPID-based Dose Verifi cation System for Detection of Gross Radiation Treatment Delivery Errors
11:50 a.m. Bisham Chera Discussant
10:30 a.m. - 12:00 p.m. Scientifi c Session KK – Physics – Emerging Observations and Technologies Room: B406 Moderators: Michael Sharpe, Laura Cervino
10:30 a.m. Anna Rodrigues 296 Dynamic Electron Arc Radiotherapy (DEAR): A New Conformal Technique in Delivering Electron Beam Therapy
10:40 a.m. Bin Han 297 Meeting the Challenge of SBRT QA: Development of a High-resolution and High-speed Dosimetry Strategy Basic Science Abstract Award – Radiation Physics
10:50 a.m. Aaron Kusano 298 Measurable Improvements in Patient Safety Culture: A First-year Department Experience with Incident Learning
11:00 a.m. Ke Sheng 299 4π Non-Coplanar SBRT for Centrally Located or Larger Lung Tumors
11:10 a.m. Seungjong Oh 300 Modelling of Anisotropic PTV Margin of Cervix Cancer under Severe Target Deformation and Shrinkage using Deformable Image Registration
11:20 a.m. Dan Ruan 301 Robust Optimization for Head and Neck Cancer Radiotherapy
11:30 a.m. Lana de Souza-Lawrence 302 A Novel Radio-opaque Hydrogel Marker Can Be Used to Decrease Inter-observer Variability in the Delineation of the Lumpectomy Cavity
11:40 a.m. Rachel Sarabia-Estrada 303 Feasibility Study of Nanoparticle Thermal Therapy in a Model of Spinal
11:50 a.m. Naichang Yu 304 Eff ect of Patient Breathing on Y90 PET Dosimetry for Y90 Radioembolization of Liver Cancer
112 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
10:30 a.m. - 12:00 p.m. Digital Poster Discussion 09 – Gastrointestinal Room: A411 Discussants: Christopher Crane, Charles Thomas
Rachit Kumar 1097 ALDH-Expressing Cancer Stem Cells are Associated with Inferior Survival in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Chemoradiation
Sarah Fisher 1098 Pro-necrotic Mixed Lineage Kinase Domain-Like (MLKL) Protein Expression is a Prognostic Biomarker in Patients with Resected Pancreatic Adenocarcinoma
Shawn Shao-Lun Lu 1099 Non-dosimetric Biomarker of Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiotherapy Predicts Postoperative Pulmonary Complications in Esophageal Cancer Patients Receiving Combined Modality Therapy
Keisuke Otani 1100 Preoperative Chemoradiotherapy with Gemcitabine for Pancreatic Cancer Encountered Vertebral Compression Fractures: Multivariate Analysis for Its Risk Factors
Howard Hsu 1101 Radiation Therapy Improves Survival in Small Cell Rectal Cancer - Analysis of Surveillance Epidemiology and End Results (SEER) Data
Xiao Liu 1102 The High Expression of Epidermal Growth Factor Receptor (EGFR) is an Indicator for Poor Prognosis, Though is a Potential Indicator for Positive Outcome of Postoperative Radiation Therapy for Esophageal Squamous Cell Carcinoma
Bassem Zaki 1103 Chromosome Segregation Errors Predict Pathological Response of Rectal Adenocarcinoma to Chemoradiation
Michael Rutenberg 1104 A Comparison between Consensus Guidelines Based PTVs and 4-D CT Based PTVs for Locally Advanced Pancreatic Cancer: Implications for Therapy
Jordan Kharofa 1105 Local Control in Resectable and Borderline Resectable Pancreatic Cancer (PCa) Treated with Preoperative Chemoradiation or Chemotherapy Alone
Kelly Erickson 1106 Post-Treatment FDG-PET/CT Response is Predictive of Tumor Progression and Survival in Anal Carcinoma
Ben Goodman 1107 Survival Effi cacy Following Stereotactic Body Radiation Therapy for Limited Liver Metastases
Xiao Liu 1108 Patterns of Recurrence after Radical Esophagectomy and Impact of Postoperative Radiation for Thoracic Esophageal Squamous Cell Carcinoma with pT2-T3N0M0 Disease
ASTRO 2013 / 55TH ANNUAL MEETING 113 Wednesday | September 25
10:30 a.m. - 12:00 p.m. Digital Poster Discussion 10 – Head and Neck Room: A412 Discussants: Beth Beadle, Annie Chan
Yu-Wei Lin 1109 Patterns of Failure After Postoperative Intensity Modulated Radiotherapy for Locally-advanced Buccal Cancer
Christopher Spencer 1110 Reduction in Radiotherapy Volumes for Patients with Head and Neck Squamous Cell Carcinoma Improves Patient-reported Quality of Life
Sheela Hanasoge 1111 Predictive Accuracy of CT Imaging for Nodal Extracapsular Extension in Patients with Laryngeal or Oral Cavity Cancer Managed with Initial Surgery
Hebist Berhane 1112 Radiosensitivity of Oropharyngeal Mucosa of FancD2-/- Mice Correlates with Novel Gene Expression Response to Head and Neck Irradiation
David Louis Schwartz 1113 Metabolic Tumor Volume as a Predictive Imaging Biomarker in Head and Neck Cancer – Pilot Results from RTOG 0522
XiaoShen Wang 1114 Selective Nodal Irradiation by Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma Aiming to Reduce Dysphagia and Xerostomia
Goupei Zhu 1115 Induction Chemotherapy Followed by Concomitant Chemoradiation vs. Cetuximab with Radiation in Locally Advanced Nasopharyngeal Carcinoma: Initial Results of a Randomized Phase II Study
Noam VanderWalde 1116 The Eff ectiveness of Chemoradiation for Head and Neck Cancer in an Older Patient Population
Dorothy Gujral 1117 Arterial Stiff ness and Elasticity as Markers of Radiation-induced Atherosclerosis
Salem Alshehri 1118 Comparison of Palliative Radiotherapy Regimens for Head and Neck Cancer: A Population-based Analysis
Dominique Rash 1119 Comparison of Clinical Outcomes Among Patients Treated by Primary Surgery vs. Chemoradiation for Locally Advanced, HPV-Negative Squamous Cell Carcinoma of the Oropharynx
Michael Marquardt 1120 Analysis of Pathologic Factors from Surgical Resection Infl uences Accuracy of 3 Month Post-Radiotherapy FDG PET/CT in Resected Oral Cavity Cancer Patients
114 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
10:30 a.m. - 12:00 p.m. Educational Session 411 – Diffi cult Cases in Cervical Cancer Management Room: B206 Kristin A. Bradley, MD, University of Wisconsin School of Medicine and Public Health Colleen M. Feltmate, MD, Brigham and Women’s Hospital David K. Gaff ney, MD, PhD, University of Utah Susan Higgins, MD, MS, Yale University Catheryn M. Yashar, MD, University of California San Diego
10:30 a.m. - 12:00 p.m. Educational Session 412 – Image Guidance in the Treatment Room: Technology and Strategies Room: B313 Jean-Pierre Bissonnette, PhD, Princess Margaret Hospital Larry L. Kestin, MD, Michigan Healthcare Professionals Sasa Mutic, PhD, Washington University School of Medicine
12:00 p.m. - 1:00 p.m. ARRO Meet the Professor Luncheon Room: B302-B305
1:00 p.m. - 2:30 p.m. Scientifi c Session LL – GU – Prostate Cancer: Translational, Brachytherapy Room: B213 Moderators: Katherine Tzou, Jay Ciezki
1:00 p.m. Alireza Fotouhi Ghiam 305 Genomic Instability in Common Fragile Sites (CFSs) is Associated with Less Favorable Outcome in Patients with Intermediate-risk Prostate Cancer (IR-CaP) Resident Clinical/Basic Science Research Award – Clinical
1:10 p.m. Joseph Salama 306 Cell Cycle Progression Score Signifi cantly Predicts PSA Failure After EBRT
1:20 p.m. Felix Feng 307 Validation of a Genomic Classifi er that Predicts Metastatic Disease Progression in Men with Biochemical Recurrence Post Radical Prostatectomy
1:30 p.m. Chandan Guha Discussant
1:40 p.m. R. Charles Nichols 308 Serum Testosterone Changes in Patients Treated with Radiotherapy Alone for Prostate Cancer on RTOG 9408
Symbol Key: ARONA Ticketed Event/ Nurses’ Award Live Interactive Separate Session Recipient SAM/ Session registration Separate required registration required
ASTRO 2013 / 55TH ANNUAL MEETING 115 Wednesday | September 25
1:50 p.m. Seth Blacksburg 309 Seminal Vesicle Implantation Does Not Signifi cantly Aff ect Prostate Cancer Treatment Related Outcomes
2:00 p.m. Razvan Galalae 310 Combined High-dose-rate (HDR) Brachytherapy and External Beam Radiotherapy (EBRT) for Prostate Cancer: 5 and 10 Years Outcomes of Kiel Protocols 1 Versus 2
2:10 p.m. Daniel Spratt 311 Comparison of High-dose IMRT (86.4 Gy) to Combined Brachytherapy Plus IMRT for Intermediate-risk Prostate Cancer
2:20 p.m. Matthew Ferris 312 Interim Results of a Prospective Phase II Trial of Pelvic IMRT, Cesium-131 Brachytherapy Boost, Adjuvant Docetaxel Chemotherapy and Long Term Androgen Ablation for Patients with High-risk Prostate Cancer
1:00 p.m. - 2:30 p.m. Scientifi c Session MM – GYN – Endometrial/Vulvar Cancer Room: B211 Moderators: Sushil Beriwal, Sheida Mani
1:00 p.m. Miran Blanchard 313 Lymph Node Positive Endometrial Carcinoma (EC): There is a Role for Vaginal Brachytherapy (VB)
1:10 p.m. Sarah Milgrom 314 Quantifying the Risk of Recurrence and Death in Stage III (FIGO 2009) Endometrial Cancer
1:20 p.m. Jacob Shin 315 Secondary Uterine Corpus Cancer After Prior Pelvic Radiation Therapy is Associated with Worse Survival than Sporadic Secondary Uterine Malignancies: A SEER Population Based Study
1:30 p.m. Eric Xanthopoulos 316 Adjuvant Radiation Therapy in Node Positive Vulvar Cancer
1:40 p.m. Nikhil Thaker 317 Survival Outcomes for Patients with Pelvic Lymph Node Positive Stage IVB Vulvar Cancer: Time To Reconsider the FIGO Staging System?
1:50 p.m. Eugene Koay 318 Factors Associated with Long Term Survival in Locally Advanced Squamous Cell Carcinoma of the Vulva Treated with Defi nitive Radiotherapy
2:00 p.m. Peyman Kabolizadeh 319 Are RTOG Para-aortic Contouring Guidelines for Pancreatic Neoplasm Applicable to Other Malignancies - Assessment of Nodal Distribution in Gynecological Malignancies
2:10 p.m. Takashi Kawanaka 320 Prognostic Signifi cance of UROD Expression on Cervical Cancer with Radiotherapy
2:20 p.m. Julie Greenwalt 321 Outcomes of Defi nitive Radiation Therapy for Primary Vaginal Carcinoma
116 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
1:00 p.m. - 2:30 p.m. Scientifi c Session NN – Palliative/Quality of Life – Symptom Management of Primary Cancers Room: B216 Moderators: Anand Mahadevan, Mark Henderson
1:00 p.m. Tahir Mehmood 322 Palliative Quad Shot Radiotherapy in Advanced Oral Cancer
1:10 p.m. Paul Romesser 323 Prospective Dysphagia Quality of Life Scores and Treatment Outcomes in Oropharyngeal Cancer Patients: Is it Time to Reconsider the Prophylactic Percutaneous Endoscopic Gastrostomy?
1:20 p.m. Michele Halyard 324 Real-time Assessment of Patient Reported Outcomes in Head and Neck Cancer Patients Undergoing Radiotherapy
1:30 p.m. Kenneth Niermann 325 The Vanderbilt Head and Neck Symptom Survey Version 2.0: Responsiveness to Change Over Time
1:40 p.m. Benjamin Kann 326 Dysphagia and Dose Reduction to Dysphagia/Aspiration-Related Structures (DARS) in Patients Receiving Induction Chemotherapy (IC) Followed by Concurrent Chemoradiation Therapy (CCRT) for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LASCCHN)
1:50 p.m. Sarah Kerns 327 Genome-wide Association Study Identifi es a Region on Chromosome 11q14.3 Associated with Late Rectal Bleeding Following Radiation Therapy for Prostate Cancer
2:00 p.m. Terence Sio 328 Initial Quality of Life Defi cit in Patient-reported Outcome is Related to Cancer Stage: A Mayo Clinic Esophageal Adenocarcinoma Registry Study
2:10 p.m. William Hall 329 Health Related Quality of Life Outcomes Following Defi nitive Therapy Compared with Watchful Waiting in Localized Adenocarcinoma of the Prostate: An Analysis of the Atlanta Veterans Aff airs Prostate Database
2:20 p.m. Joshua Jones Discussant
1:00 p.m. - 2:30 p.m. Scientifi c Session OO – Physics – Automated Planning for ART Room: Sidney Marcus Auditorium Moderators: John Wong, Q. Jackie Wu
1:00 p.m. Ergun Ahunbay 330 A Fast Adaptive Replanning Method that Only Requires Target Delineation
1:10 p.m. Xiangrong Qi 331 Real Time Assessment of Dosimetric Variations in Head and Neck Radiotherapy
ASTRO 2013 / 55TH ANNUAL MEETING 117 Wednesday | September 25
1:20 p.m. Omar Mahmoud 332 Prospective Pilot Study Assessing the Need for Adaptive Radiotherapy in Unresected Bulky Disease and in Postoperative Head/Neck Cancer Patients
1:30 p.m. Irene Hazell 333 Automatic Planning of Head and Neck Treatment Plans - A Way to Optimize the Plan Quality and Reduce Workload
1:40 p.m. Jessica Schuster 334 Automatic IMRT Treatment Planning Using Templates with Automated Optimization Tuning Methods
1:50 p.m. Joseph Moore 335 Clinical Deployment of Automatic Treatment Planning for Pancreas SBRT Patients
2:00 p.m. An Qin 336 Evaluation of Three IGRT/Adaptive Approaches for Prostate Cancer Treatment
2:10 p.m. Andrew Godley 337 Automatic CBCT-Based Online Adaptive Prostate Therapy
2:20 p.m. Weiguo Lu 338 An Effi cient Workfl ow for Volume Dose Reconstruction and In Vivo Treatment Verifi cation
1:00 p.m. - 2:30 p.m. Scientifi c Session PP – Biology – Targeted Radiosensitizers Room: B203 Moderators: Nicole Simone, Roberto Diaz
1:00 p.m. Henning Willers 339 Identifi cation of Radiosensitizing Targeted Drugs and Associated Genomic Biomarkers by a Cell Line Screening Platform
1:10 p.m. Mohamed Abazeed 340 Integrative Radiogenomic Profi ling of Squamous Cell Lung Cancer
1:20 p.m. Ranjit Bindra Discussant
1:30 p.m. Srilakshmi Reddy 341 NQO1-Mediated Synergistic Lethality in Combination with β-lapachone (Tgfβ-lap) and Ionizing Radiation (IR) in Head and Neck Cancer (HNC)
1:40 p.m. Raju Raval 342 Systemic Delivery of Synthesized Aptamer-siRNA Chimeras Results in Prostate-targeted Radiosensitization
1:50 p.m. Shisuo Du 343 Biologically Augmenting Radiation Therapy by Inhibiting Tgfβ; in NSCLC from Molecular to Microenvironment
2:00 p.m. Ilenia Pellicciotta 344 Concomitant Radiotherapy and Tgfβ; Neutralizing Antibodies Alters Tumor Microenvironment and Promotes Tumor Regression
118 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
2:10 p.m. Waleed Arafat 345 Triple Therapy Using Radiotherapy (RT), Temozolamide (TMZ) and TRAIL Agonist (TRA-8) Enhances Cell Killing in Primary Glioma Cancer Stem Cells is Associated with Changes in Distinct Tyrosine Kinase Signaling Cascades Identifi ed through Kinomic Analysis
2:20 p.m. Gregory Gan 346 The Hedgehog Pathway Modulates Radiotherapy Resistance in Head and Neck Cancer
1:00 p.m. - 2:30 p.m. Scientifi c Session QQ – Head and Neck – Toxicity Room: Thomas Murphy Ballroom 4 Moderators: Thomas Galloway, Peter Ahn
1:00 p.m. Jermey Setton 347 A Multi-Institution Pooled Analysis of G-Tube Dependence in Patients with Oropharyngeal Cancer Treated with Defi nitive IMRT
1:10 p.m. Harry Quon 348 Swallow Function in Patients with Oropharyngeal Sqaumous Cell Carcinomas Treated with Radiotherapy Dose De-escalation (JHU 0988)
1:20 p.m. Chris Terhaard 349 Is Radiosensitivity of Parotid and Submandibular Glands Comparable?
1:30 p.m. Ahmed Chaudhary 350 Dysphagia and Aspiration after Chemoradiotherapy for Locoregionally Advanced Head and Neck Cancer: A Prospective Study of the Dose Eff ect Relationship in Accelerated Fractionation by Concomitant Boost with Cisplatin and Cetuximab from the Epic Trial
1:40 p.m. Harvey Quon 351 Impact of Feeding Tubes on Prospective Functional Outcomes in Patients with Locally Advanced Head and Neck Cancer Undergoing Radiotherapy
1:50 p.m. Katherine Hutcheson 352 Late Radiation-associated Dysphagia (RAD) and Lower Cranial Neuropathy After Oropharyngeal Radiotherapy: A Case-control Dosimetric Comparison
2:00 p.m. Ramadas Kunnambath 353 Management of Radiation Induced Oral Mucositis with an Herbal Mouthwash
2:10 p.m. Steven Frank 354 Gastrostomy Tubes Decrease by Over 50% with Intensity Modulated Proton Therapy (IMPT) During the Treatment of Oropharyngeal Cancer Patients - A Case-control Study
2:20 p.m. Andy Trotti Discussant
ASTRO 2013 / 55TH ANNUAL MEETING 119 Wednesday | September 25
1:00 p.m. - 2:30 p.m. Scientifi c Session RR – Physics – IGRT Process and Technologies Room: B313 Moderators: Gikas Mageras, Michaela Rosu
1:00 p.m. Jonathan Piper 355 A Novel Framework for User-intervened Correction of Deformable Registration
1:10 p.m. Bernard Jones 356 IV Contrast-Enhanced Cone-Beam CT to Enhance Image Guidance for Liver SBRT
1:20 p.m. Daniel Low 357 Improved Imaging Quality for Megavoltage CT on TomoTherapy via a Novel Iterative Reconstruction Method Based on Tensor Framelet
1:30 p.m. Lei Ren 358 A Limited-angle Intrafractional Verifi cation (LIVE) System for Intrafractional Positioning Verifi cation of Lung SBRT Treatment
1:40 p.m. Bowen Meng 359 Non-coplanar Cone Beam CT Reconstruction with Limited Angle of Projections Using Rigid Image Registration Facilitated Prior Image Constrained Compressed Sensing
1:50 p.m. John van Sornsen de Koste 360 Digital Tomosynthesis for Verifying Lung Tumor Position
2:00 p.m. Juan Diego Azcona 361 Three-dimensional Prostate Motion Assessment During VMAT with Cine-Mv Images
2:10 p.m. Russell Kincaid 362 Evaluation of Respiratory Motion-corrected Cone Beam CT in Abdominal Sites: A Prospective Study
2:20 p.m. Stephen Gardner 363 Cone-beam Computed Tomography Contouring Variability on Derivative Contours Generated with an Automated Deformable Registration Workfl ow for Prostate Cancer
1:00 p.m. - 2:30 p.m. Digital Poster Discussion 11 – Breast Room: A411 Discussants: Reshma Jagsi, Julia Wong
Shahed Badiyan 1121 Treatment Effi cacy with Accelerated Partial Breast Irradiation (APBI): Final Analysis of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial
Sigolene Galland 1122 Long Term Cosmetic Outcomes and Toxicities of Proton Compared to Photon 3-D Conformal Accelerated Partial Breast Irradiation (3-D APBI)
120 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
Rachel Lei 1123 Disease Control Effi cacy of Ductal Carcinoma in Situ (DCIS) Treated with Accelerated Partial Breast Irradiation (APBI)
Steve Braunstein 1124 Outcome in Women with Ductal Carcinoma in Situ (DCIS) > 4 cm Treated with Breast Conservation Therapy
Manjeet Chadha 1125 Frequency of Breast Conserving Therapy Following an Ipsilateral Local Relapse in Patients with Ductal Carcinoma in Situ (DCIS) Treated with Lumpectomy (l) + Radiation Therapy (RT)
Sonny Batra 1126 An analysis of Three-dimensional Breast Motion During Normal Respiration: What CTV to PTV Margin is Needed?
Nathalie Rochet 1127 Deep Inspiration Breath-hold Technique in Left Sided Breast Cancer Radiotherapy: Evaluating Cardiac Contact Distance as a Predictor of Cardiac Exposure
Michelle Gentile 1128 Contouring Guidelines for the Axillary Lymph Nodes for the Delivery of Radiotherapy in Breast Cancer: Validation of the RTOG Breast Cancer Atlas
Amany Keruakous 1129 Outcome of Patients with Breast Cancer Treated with Breast Conserving Treatment or Mastectomy and No Post-mastectomy Radiation and with Isolated Tumor Cells
Jae Myoung Noh 1130 Is Elective Nodal Irradiation Necessary in Patients with Negative Pathologic Lymph Node Status After Neoadjuvant Chemotherapy Followed by Breast Conserving Surgery for Clinically Stage II-III Breast Cancer? A Multicenter Retrospective Study (KROG 12-05)
Andrew Sharabi 1131 Dosimetric Impact and 3-D Non-deformable Modeling of Metallic Breast Expander Ports During Post-mastectomy Radiation Therapy
Sanjay Aneja 1132 The Impact of Proximity to Radiation Oncologists and General Surgeons on Receipt of Post- mastectomy Radiation Therapy
1:00 p.m. - 2:30 p.m. Digital Poster Discussion 12 – Lung Room: A412 Discussants: Thomas DiPetrillo, Shilpen Patel
John Grecula 1133 Stereotactic Body Radiation Therapy for Stage I Non-small Cell Lung Cancer: Relationship between Biological Equivalent Dose Based on the Generalized LQ Model and Local Control
ASTRO 2013 / 55TH ANNUAL MEETING 121 Wednesday | September 25
Jacob Wynne 1134 Analysis of Circulating Tumor Cells in Early-stage Non-small Cell Lung Cancer Patients Treated with Stereotactic Ablative Radiotherapy
Carey Myers 1135 Inhibition of Nit1 Decreases Growth of K-Ras-Driven Tumors
Yevgeniy Vinogradskiy 1136 Using 4-D CT-based Ventilation Imaging to Evaluate Major Ventilation Defects for Lung Cancer Patients: A Clinical Validation Study
Paul Stanton 1137 Prediction of Late Pulmonary Function Reduction and Radiation Induced Toxicity From During RT Ventilation and Perfusion Imaging in Non-small Cell Lung Cancer (NSCLC)
Ravi Parikh 1138 Factors Associated with Survival in Patients with Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Daniel Gomez 1139 The Infl uence of Positron Emission Tomography Scanning on Delay in Treatment of Non-small Cell Lung Cancer
Mary Fidler 1140 Association between Trimodality Therapy and Survival in Patients with Stage III Non-small Cell Lung Cancer (NSCLC) in the National Cancer Database
Lisa McGee 1141 Pulmonary Toxicity Following Proton Therapy for Patients with Non-small Cell Lung Cancer
Bhupesh Parashar 1142 Comparison Of Wedge Resection Versus Wedge Resection Plus Cesium-131 Brachytherapy vs. Stereotactic Body Radiation Therapy In Management Of Early-stage Lung Cancer Patients That Are Not Candidates For A Standard Lobectomy
Kitty Huang 1143 High-risk CT Features for Detection of Local Recurrence after Stereotactic Ablative Radiotherapy for Lung Cancer
Guangying Zhu 1144 A Randomized Phase ll Trial Comparing Weekly Usage And Every Tri-weekly Usage Of Docetaxel And Platinum In Concurrent Chemoradiotherapy For Patients With Locally Advanced Non-small Cell Lung Cancer
1:00 p.m. - 2:30 p.m. Educational Session 413 – Diffi cult Cases in CNS Room: B405 Tracy Batchelor, MD, MPH, Massachusetts General Hospital Clark Chen, MD, PhD, University of California San Diego Minesh P. Mehta, MB, ChB, FASTRO, University of Maryland James B. Yu, MD, Yale University School of Medicine
122 ASTRO 2013 / 55TH ANNUAL MEETING Wednesday | September 25
1:00 p.m. - 2:30 p.m. Educational Session 414 – Cancer of the Colon, Rectum, Anus Room: B406 Brian Czito, MD, Duke University Medical Center Karyn A. Goodman, MD, MS, Memorial Sloan-Kettering Cancer Center
1:00 p.m. - 2:30 p.m. International Symposium: Global Health and Radiation Oncology — Part I Where is the Challenge and What Can We Do? Radiation Oncology in Latin America, India and Africa Room: B206 Refer to page 53 for program schedule. *This session is not accredited for CME credit.
2:45 p.m. - 4:15 p.m. Panel 16 – Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy: Update on Indications for Treatment Room: B308 Moderator: Catherine Park, MD, University of California San Francisco
Panelists: Barbara Fowble, MD, FASTRO, University of California San Francisco Yunn-Yi Chen, MD, PhD, University of California San Francisco Eleftherios Mamounas, MD, MD Anderson Cancer Center, Orlando Thomas Buchholz, MD, FASTRO, MD Anderson Cancer Center
2:45 p.m. - 4:15 p.m. Panel 17 – Radiosurgery for Metastases – Improved Patient Care or Unnecessary Cost? Room: B211 Moderator: Carol Hahn, MD, Duke University Medical Center
Panelists: Simon Lo, MB, ChB, Case Western Reserve University School of Medicine Eric Lin Chang, MD, University of Southern California Keck School of Medicine Carol Hahn, MD, Duke University Medical Center
2:45 p.m. - 4:15 p.m. Panel 18 – Altering the Metabolic Achilles Heel of Cancer Room: B203 Moderator: Nicole Simone, MD, Jeff erson Hospital
Panelists: David Gius, MD, PhD, Northwestern Medical School Neil Martin, MD, Brigham and Women’s Hospital William Dahut, MD, National Cancer Institute
ASTRO 2013 / 55TH ANNUAL MEETING 123 Wednesday | September 25
2:45 p.m. - 4:15 p.m. Panel 19 – Payment Reform in Radiation Oncology: The Transition from Resource-based Reimbursement to Value-based Compensation Room: B302-B305 Moderators: Anthony L. Zietman, MD, FASTRO, Massachusetts General Hospital Brian Alexander, MD, Brigham and Women’s Hospital Brian Kavanagh, MD, MPH, University of Colorado Denver
Panelists: Benjamin Falit, MD, JD, Harvard Radiation Oncology Program Constantine Mantz, MD, 21st Century Oncology Prajnan Das, MD, MS, MD Anderson Cancer Center Lee Newcomer, MD, United Healthcare Brian Kavanagh, MD, MPH, University of Colorado Denver
2:45 p.m. - 4:15 p.m. Educational Session 415 – Management of High-risk Prostate Cancer (including postoperative XRT) Room: B313 Alan Pollack, MD, PhD, University of Miami-Miller School of Medicine Richard K. Valicenti, MD, University of Califormia Davis Medical Center Yoshiya Yamada, MD, Memorial Sloan-Kettering Cancer Center
2:45 p.m. - 4:15 p.m. Educational Session 416 – Stereotactic Body RT: Clinical, Biological and Physics/QA Update Room: Sidney Marcus Auditorium Roy H. Decker, MD, PhD, Yale University Teamour S. Nurushev, PhD, Henry Ford Health System Jan-Jakob Sonke, PhD, The Netherlands Cancer Institute (NKI-AVL)
2:45 p.m. - 4:15 p.m. International Symposium: Global Health and Radiation Oncology — Part II What are the Barriers to Delivering Optimal Therapy? Radiation Oncology in Asia Room: B206 Refer to page 53 for program schedule. *This session is not accredited for CME credit.
Symbol Key: ARONA Ticketed Event/ Nurses’ Award Live Interactive Separate Session Recipient SAM/ Session registration Separate required registration required
124 ASTRO 2013 / 55TH ANNUAL MEETING Poster Presentations NEW!! Reception on Reception Award Winner Winner Award Presentations. Join us during the Starting at 5:40 p.m. in the Poster Hall Starting in the Poster at 5:40 p.m. Monday for the Poster the Poster for Monday
Poster Viewing Session and Reception 5:30 p.m. – 6:30 p.m. 5:30 p.m. Session Viewing and Reception Poster
Posters are located in Hall B, Building B Building in Hall B, located are Posters Tuesday, September 24 September Tuesday, p.m. 10:00 a.m. – 5:00 Monday, September 23 September Monday, a.m. – 5:00 p.m. 10:00 Sunday, September 22 September Sunday, a.m. – 5:00 p.m. 10:00 Poster Viewing Viewing Hours Poster Poster Presentations Poster INSIDE: Poster Presentations Special thanks to the following companies for supporting ASTRO’sSpecial thankstothefollowing companies forsupporting 55th Annual Meeting with an unrestricted educational Meetingwithanunrestricted 55th Annual grant. 2013 ANNUAL MEETING SUPPORTERS SUPPORTERS (AS OF AUGUST & 26, 2013) Poster Presentations by Track
BREAST CANCER 2008 Jinli Ma 2018 Bree Eaton A Linac IMRT Technique versus Long-term Outcomes Following 2001 Naoki Nakamura Conventional Technique for Oncoplastic Reduction Mammaplasty: Fatigue During Breast Radiation Post-mastectomy Irradiation of Chest Implications for Radiation Therapy Therapy and Its Predictive Factors Wall and Regional Nodes: A Case-Control Study of Acute Toxicities 2019 Dominihemberg 2002 Christiane Matuschek Ferreira Long-term Outcome After 2009 Ya Zhu Correlation Between Dose in the Neoadjuvant Chemoradiation Lymphedema After Radical Hypopharynx and Cervical Esophagus Therapy in Locally-Advanced Mastectomy For Breast Cancer In and Odynophagia in Patients Noninfl ammatory Breast Cancer and Chinese Women Undergoing Regional 3DCRT for Predictive Factors for a Pathologic Breast Cancer Complete Remission: Results of a 2010 Nitesh Paryani Multivariate Analysis The Incidence Of Fat Necrosis In 2020 Jyoti Mayadev Balloon-based Breast Brachytherapy The Role of a Post Mastectomy 2003 Eric Mellon Radiation Boost: Does a Higher Dose Impact of Radiation Treatment 2011 V. Elayne Arterbery Improve Survival? Parameters and Adjuvant Systemic Accelerated Partial Breast Irradiation Therapy on Cosmetic Outcomes after with Electronic Brachytherapy for 2021 Julian Jacob Accelerated Partial Breast Treatment of Early Stage Breast Cardiotoxicity of the Association Irradiation using 3-Dimensional Cancer - Short-term Clinical and Trastuzumab-Locoregional Breast Conformal Radiation Therapy Cosmetic results Radiation Therapy: A Prospective Technique Monocentric Study 2012 Anna Petoukhova 2004 Naoto Shikama Optimal Registration Method of MRI 2022 Juergen Dunst Validation of the Utility of and CT for Delineation in Radiation Adjuvant Hypofractionated Radiation Cranio-Caudal Clip Distance (CCD) for Therapy Planning of Breast Cancer Therapy With Simultaneous Boost Identifying Candidates for Patients Treated With Breast After Breast-Conserving Therapy: First Accelerated Partial Breast Irradiation Conserving Therapy Results of a Multicentric Phase 2 Study (APBI) Using 3-dimensional Conformal External Beam 2014 Yasuhiro Ogawa 2023 Sameer Nath Radiotherapy (3D-CRT) PET-CT-guided Non-surgical Using Skin Dose Parameters Predicts Chemo-radiosensitization Treatment Low Skin Toxicity in a Phase 2 Trial of 2005 Mayuraa Vaiduriam (KORTUC II) for Patients with Locally Multiple Dwell Position Single Lumen Dosimetric Comparison Between Advanced Breast Cancer Device Brachytherapy Electrons And Tangential Photons In Postmastectomy Chest Wall 2015 Pierre-Yves Bondiau 2024 Yasser Abo-Madyan Irradiation Final Result of Phase 1 Clinical Trial of Cosmetic Outcome of Stereotactic Body Radiation Therapy Hypofractionated Breast Cancer 2006 Shariq Khwaja Concomitant With Neoadjuvant Intensity Modulated Radiation Long-term Cosmesis and Toxicity Chemotherapy for Breast Cancer Therapy: A Preliminary Report of a Profi le Following Accelerated Prospective Trial Partial Breast Irradiation (APBI): Final 2016 Yun Ding Analysis of the American Society of Comparative Study On The 2025 Radhika Sreeraman Breast Surgeons Single Lumen Device Displacement Of Surgical Cavity Preliminary Toxicity Analysis of Breast Brachytherapy Registry Trial Center Defi ned Separately By Clips 3D-Conformal and Intraoperative And Seroma Based On 4dct Scan For Accelerated Partial Breast Irradiation 2007 Naoto Shikama External-beam Partial Breast Preliminary Results From a Irradiation After Breast Conserving 2026 Jose Pardo Multi-center Prospective Study Surgery Radiation Recall Dermatitis (JROSG 05-5) on Postoperative Development. An Observational Radiation Therapy for Patients With 2017 Charles Rutter Study In 350 Breast Cancer Patients High-Risk Ductal Carcinoma In Situ Dosimetric and Clinical Predictors of (DCIS) With Involved Margins or the Development of Moist Margin Widths Not More Than 1 mm Desquamation in Breast Cancer Irradiation
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 127 2027 Marco Trovo 2036 Thierry Muanza 2047 Ashraf Youssef Delivering Adjuvant Radiation Does the Breast Cancer Molecular Does Accelerated Partial Breast Irradi- Therapy beyond Six Months after Subtype Aff ect the Post Radiation ation Decreases Scattered Fetal Dose Breast-conserving Surgery does not Therapy Pattern of Recurrence? in Pregnant Women as compared to Jeopardize the Loco-regional Control External Beam Radiation? in Early Stage Breast Cancer Patients 2037 Debra Yeboa Impact of the Recession on Radiation 2048 Masahiro Yoshida 2028 Marco Trovo Therapy After Lumpectomy for Is Re-excision Necessary For Patients Loco-Regional Failure in Early-Stage Invasive Breast Cancer With Positive Surgical Margin (0 Mm) Breast Cancer Patients Treated with Before Post-operative Breast Breast Conserving Therapy: Which 2038 Ronny Kalash Radiation Therapy? Patients Benefi t from Supraclavicular Breast Cancer Luminal Status Predicts Nodal Irradiation? Survival Following Stereotactic 2049 Adam Reese Radiosurgery of Brain Metastasis Marriage is Associated with Choice 2029 Sua Yoo of Mastectomy in Patients Eligible for Comparison Of Pre-operative Partial 2039 Jeff rey Kuo Breast Conservation Therapy Breast Radiosurgery Treatment In-Vivo Dose Measurements in the Techniques: 3D-CRT, Non-coplanar Post-Mastectomy Irradiation Of a 2050 Pierfrancesco Franco IMRT, Coplanar IMRT, and VMAT Patient With a Gas-Based Tissue Hypofractionated Adjuvant Breast Expander Radiation and Simultaneous 2030 Huma Chaudhry Integrated Boost Delivered With Static A Prospective Trial of Preoperative 2040 Adam Ferro Angle Tomotherapy: A Prospective Accelerated Partial Breast Irradiation Prevention of Radiation Dermatitis in Phase 2 Trial (APBI): Predictors of Asymptomatic Breast Cancer Patients and Symptomatic Seroma Formation 2051 Peter Chen 2041 Kimberly Thomas Brachytherapy-Based Accelerated 2031 Juan Yu Survey on Radiation Practice Patterns Partial Breast Irradiation Versus A Predictive Clinical Metric to Among US Radiation Oncologists for Canadian Whole Breast Quantitate Radiation Dose to the Post-mastectomy Breast Cancer and Hypofractionation: A Matched-Pair Heart and the Left Anterior Reconstruction Analysis of Comparative Eff ectiveness Descending Artery in Left-sided Breast Cancer Patients 2042 Alexander Geng 2052 Olivia Barrett Early Results of a Prospective Cohort The Infl uence of Race on Locoregional 2032 Adam Liss Study on Intraoperative Radiation Recurrence (LRR) in BRCA Decline of Cosmetic Outcomes Therapy for Early Breast Cancer at a Mutation-Positive Triple Negative Following Accelerated Partial Breast Single Institution Breast Cancer Patients Irradiation (APBI) Using Intensity Modulated Radiation Therapy (IMRT): 2043 Catheryn Yashar 2053 Monica Shukla Results of a Single-Institution Outcomes For APBI With Strut-based Infl uence of Receptor Status and Prospective Clinical Trial Brachytherapy: 101 Patients At 4.5 Response to Neoadjuvant Years Median Follow-up Chemotherapy on Outcomes of 2033 Tae Ryool Koo Patients Treated with Mastectomy for Prognostic Value of Nodal Ratio and 2044 Su Jung Shim Invasive Breast Cancer Ki-67 Expression in Breast Cancer The Role of Postmastectomy Patients Treated With Radiation Therapy(PMRT) in Clinical 2054 Masahiko Oguchi Postmastectomy Radiation Therapy Stage II-III Breast Cancer Patients With Radiation Therapy For Breast Cancer pN0 After Neoadjuvant Chemothera- After Chemotherapy Induced 2034 Karolien Verhoeven py: A Multicenter, Retrospective Study Pneumonitis Is There Benefi t of Using a (KROG 12-05) Preoperative Computed Tomography 2055 Sameer Nath to Reduce the Interobserver 2045 Patience Obasaju Immediate DIEP Breast Variability of the Boost CTV National Surgical Patterns of Care: Reconstruction and Postmastectomy Delineation for Breast Radiation Racial Disparities in the Surgical Radiation Therapy: Clinical Experience Therapy? Staging of Women with Breast Cancer at a Tertiary Care Institution
2035 Himanshu Nagar 2046 Reshma Jagsi 2056 Samuel Marcrom Predictors of All Recurrence for Breast Use of Breast Reconstruction Partial Breast Radiation Using Strut Cancer Patients Treated with and Early Complication Rates in Adjusted Volume Implant: Radiation Neoadjuvant Chemotherapy and a Working-Age, Insured, National Necrosis Is Associated With Surgery With and Without Radiation Cohort of Breast Cancer Patients Dosimetric Parameters and Can Therapy Undergoing Mastectomy with and Induce Biopsy without Radiation
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
128 ASTRO 2013 / 55TH ANNUAL MEETING 2057 Jeff rey Eshleman 2066 Qian Zhang 2077 Siavash Atrchian Retrospective Study of Ipsilateral Both Anti-HER2 Treatment and Improvement Of Consistency In Breast Tumor Recurrence in Patients Chemotherapy After Whole-Brain Delineating Breast Lumpectomy Undergoing Accelerated Partial Breast Radiation Therapy Improve Survival in Cavity Using Surgical Clips Irradiation Delivered via Patients With Brain Metastases From Balloon Brachytherapy in a HER2-Positive Breast Cancer 2078 Manjeet Chadha Community Hospital Evaluating a role for Oncotype Dx 2067 Mariam Korah Breast cancer Assay in the 2058 Steven Register The Impact of Postmastectomy management of Ductal Carcinoma Deep Inspiration Breath Hold Radiation Therapy in Intermediate in situ Technique in Women with Left Sided Risk Breast Cancer Patients with Breast Cancer: An Analysis of OAR Limited Axillary Disease 2079 Olivier Riou Sparing Accelerated Partial Breast 2068 Yu Chen Irradiation With Volumetric 2059 Linda Smith The Impact Of Breast Modulated Arc Therapy: A Comparison of Acute and Subacute Reconstruction On Post-mastectomy Feasibility And Early Clinical Results At Toxicity for High Upper Outer Radiation Therapy The Montpellier Cancer Institute Quadrant Breast Cancers Treated by Whole Breast Irradiation (WBI) Versus 2069 Jay Reiff 2080 Julie Bradley Accelerated Partial Breast Irradiation Dosimetric Analysis of 1007 Pilot Study of Proton Therapy for (APBI) Strut-Based APBI Treatments Treatment of Regional Lymphatics in Breast Cancer Patients 2060 Quan Chen 2070 Nalini Rao Static Angle Tomotherapy 3DCRT for Patterns of FDG PET CT use in Breast 2081 Tiff any Chow Accelerated Whole Breast Irradiation Cancer and its Impact on Treatment Radiation-Induced Lung Injury With Concomitant Boost Decisions: Experience from a Following Neoadjuvant Concurrent Developing Country Chemoradiation Therapy for 2061 Mina Shenouda Locally-Advanced Breast Cancer Clinical Outcome of Isolate 2071 Gabor Jozsef Local-Regional Recurrence in Breast Tangential Breast Fields Placement: 2082 Kunal Saigal Cancer Patients According to their Evaluation of Two Automatic Beam Traditional Risk Factors For Primary Local Treatment Placement Algorithms Locoregional Recurrence May Not Be Predictive In Post-Menopausal 2062 Sharad Goyal 2072 Randi Cohen Women With ER Positive Breast Three-Year Outcomes of a Once-Daily Adjuvant Radiation Improves Breast Cancer Treated With Neoadjuvant Fractionation Scheme for Accelerated Cancer Specifi c Survival in the Eldest Therapy Partial Breast Irradiation (APBI) Using Early-Stage Breast Cancer Patients 3-D Conformal Radiation Therapy 2083 Martin Hinse (3D-CRT) 2073 Mariska Den Hartogh Achieving a Uniform Breast Junction Small Treatment Volumes and a Low With the 160 Leaf Multileaf Collimator 2063 Allen Li Interobserver Variability in An Analysis of Rapid Review Cases Preoperative MRI-guided Target 2084 Sigolene Galland That Failed to Meet the RTOG 1005 Volume Delineation for Accelerated Long-term Outcomes in Breast Cancer Contouring and Dose-Volume Criteria Partial Breast Irradiation Patients With 10 or More Positive Axillary Nodes: Is Conservative 2064 Bradford Perez 2074 Kenneth Merrell Treatment an Optimal Option? Evaluating Radiation Dose to the A Comparison of Standard Heart With Left Whole Breast Fractionation and Stereotactic Body 2085 Anneyuko Saito Radiation Therapy in Prone, Supine Radiotherapy in the Treatment of Is Bra Cup Size a Reliable Confounding Breath-Hold, and Supine Free- Metastatic Breast Cancer Factor for the Evaluation of Acute Skin Breathing Positions Toxicity Caused by Radiation Therapy 2075 Jiho Nam in Breast Therapy? 2065 Janet Horton Quantitative Analysis of Lung CT Preoperative Single-Fraction Partial Density Changes in Early Breast Can- 2086 Olga Vujovic Breast Radiation Therapy: A Novel cer Patients Treated With The Time Interval From Conservative Phase 1 Dose-Escalation Protocol and Hypofractionated Whole Breast Breast Surgery To Breast Irradiation Exploration of Breast Cancer Radiation Therapy In Early Stage Node Negative Breast Radiation Response Cancer: 17-Year Follow-Up Results 2076 Robert Hong And Patterns Of Recurrence Outcomes for APBI with the Strut-Based Brachytherapy Applicator in 430 Patients
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 129 2087 Tian Liu 2097 Peng Zhou 2106 Robert Kuske Acute Toxicity Can Be Used to Factors Aff ecting Contra-Lateral Utility of A Novel 3-D Marker in Predict Late Toxicity in Breast-Cancer Breast Dose in Radiation Therapy of Postoperative Treatment Planning for Radiation Therapy: A Prospective Breast Cancer Breast Cancer Longitudinal Study With Quantitative Ultrasound Imaging 2098 Fatimah Alfaraj 2107 Marcio Fagundes Incidence And Factors Associated Cardiac-Sparing Postmastectomy 2088 Niranjan Bhandare With The Development Of Proton Radiation Therapy for Women A Comparison of the Early Toxicities of Extremity And Truncal Lymphedema With Stage III, Loco-Regional, Breast a Single Lumen Device and In A Prospective Cohort Of Women Cancer: A Dosimetric Comparison Intraoperative Radiation Therapy With Locally Advanced Breast Cancer Study Receiving Multimodality Therapy 2089 Shariq Khwaja 2108 Abhishek Solanki Analysis of Locally Advanced Breast 2099 Matthew C. Bradbury Predictive Model for the Utilization Cancer in Young Women Factors Eff ecting Breast of Radiation Therapy in the Adjuvant Reconstruction in Post-Mastectomy Therapy of Women With Breast 2090 Bethany Anderson Radiation Therapy Patients Cancer Following Breast Conserving Accelerated Partial Breast Irradiation Surgery: Results From a National for Ductal Carcinoma In Situ: Single 2100 David Pearson Commercial and Supplemental Institution Experience With Median Dose Modifi cation Factor Analysis of Medicare Claims Database Follow-up Time of Over 5 Years Multi-Lumen Brachytherapy Applicator with Monte Carlo 2109 Shane Stecklein 2091 Michael Roach Simulation Utilization and Outcomes of Upper Extremity Toxicity with Post-Mastectomy Radiation Therapy Adjuvant Comprehensive Radiation 2101 Petra Grendarova for Locally-Advanced Invasive Lobular Therapy for Locally Advanced Breast Low Risk of Locoregional Recurrence Carcinoma: A SEER Study Cancer in the Absence of Regional Radiation Therapy in Node-Positive Breast 2110 Abhishek Solanki 2092 Victor Pernin Cancer Patients Treated With Predictive Factors in the Utilization Early and Late Toxicity of Adjuvant Chemotherapy, Breast Conserving of Intensity Modulated Radiation Radiation Therapy Associated With Surgery, and Adjuvant Breast Therapy Among Young Women Concurrent Bevacizumab in Patients Radiation Therapy Following Breast Conserving Surgery With Breast Cancer in the United States: Analysis of a 2102 Shihfan Lai National Commercial and 2093 Michael Roach Brain Re-irradiation for Breast Cancer Supplemental Claims Database Early Results of 3D Conformal External Patients With Brain Metastasis After Beam Accelerated Partial Breast Whole Brain Radiation Therapy: Eff ect 2111 John Einck Irradiation of Epidermal Growth Factor Residual Disease in the Breast or Receptor-2 Status on Clinical Outcome Lymph Nodes Following Neoadjuvant 2094 Jayant Vaidya Chemotherapy for Triple-Negative The Lower Non-Breast Cancer 2103 Sophia Edwards- Breast Cancer Results in a High Risk of Mortality With TARGIT in the TARGITA Bennett Locoregional Failure Despite the Use Trial Could Be a Systemic Eff ect of Is there Justifi cation for the Utilization of Radiation Therapy TARGIT on Tumor of IMRT in the Treatment of Early Microenvironment Stage Right Breast Cancer? 2112 Lindsay Burt Comparison of Treatments for Breast 2095 Xiao Zhao 2104 David Horowitz Cancer Arising after Radiation Acute Radiation Induced Skin Toxicity Implications of Prone Versus Supine Treatment for Hodgkin Lymphoma in Breast Intensity Modulated Positioning on Breast and Target Radiation Therapy (IMRT): A Volume Delineation in Partial Breast Dosimetric Analysis Irradiation CENTRAL NERVOUS SYSTEM 2096 Frederik Wenz 2105 Jay Reddy Local Recurrence and Survival for Antiepileptic Drug Use Improves 2113 Kazuhiro Miwa The German Centers in the TARGIT-A Overall Survival in Breast Cancer Metabolically Positive Lesion Before (TARGeted Intraoperative Radiation Patients With Brain Metastases in Hypofractionated Radiation Therapy Therapy - Alone) Trial the Setting of Whole Brain Radiation and Its Impact on Outcome for Therapy Patients With Glioblastoma Multiforme
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
130 ASTRO 2013 / 55TH ANNUAL MEETING 2114 Christine Chang- 2123 Yujin Lim 2133 Sophie Zerounian Halpenny Hypofractionated Chemoradiation Evaluation Of Survival And Prognostic Elderly Patients With Glioblastoma Therapy With Temozolomide for Factors For Elderly Patients Of 65 With Multiforme Treated With Concurrent Glioblastoma Patients With Poor Glioblastoma Multiforme Temozolomide and Standard Prognostic Features Radiation Therapy or 2134 Radka Stoyanova Hypofractionated Radiation Therapy 2125 Haresh Kunhiparambath 3D Spectroscopy Evaluation of GBM With Subset MGMT Analysis A Dosimetric Comparison Of VMAT, Treatment Volumes IMRT and 3DCRT In The Reirradiation 2115 Lawrence Kleinberg Of Recurrent Gliomas 2135 Ayal Aizer Adult Brain Tumor Consortium (ABTC) Adjuvant Radiation Therapy Is Prospective Dose Finding Trials Of 2126 Shravan Kandula Associated With Survival Benefi t in I-125 Balloon Brachytherapy In Patterns Of Presentation And Failure WHO Grade 3 Astrocytomas But Not Glioblastoma (GBM): The Problems In In Patients With Gliomatosis Cerebri Oligodendrogliomas: Results From a Trial Design When MRI Treatment Treated With Partial Brain Radiation Population-Based Study Eff ect And Recurrence Appear Similar Therapy 2136 Stefanie Lazow 2116 Sridhar Susheela 2127 Sabin Motwani Temporal Changes in MRI Edema and Characterization of Glioblastoma Glioblastoma Multiforme of the Resection Cavity Dynamics Multiforme Non-Distant Failures Elderly: A Multi-institutional Subsequent to Implantation of After Intensity Modulated Radiation Experience Comparing Conventional Cesium-131 (Cs-131) Brachytherapy Therapy in Relation to Pre-irradiation Versus Accelerated Radiation Therapy in Patients with Brain Metastases: a Carbon 11-Methionine Positron With Concurrent Temozolomide Volumetric Analysis from a Emission Tomography Prospective Study 2128 Dante Amelio 2117 Kiyoshi Nakamatsu Intensity-modulated Radiation 2138 Timothy Harris High-Dose Intensity Modulated Therapy (IMRT) Vs Re-Irradiation for Recurrent Glioma: A Radiation Therapy (IMRT) Using a Intensity-modulated Proton Therapy Single Institution Review Simultaneous Integrated Boost (SIB) (IMPT) In Low-grade Gliomas: A Method Combined With Dosimetrical Study 2139 David Corwin Temozolomide (TMZ) For Malignant Using A Patient-specifi c Gliomas 2129 Christopher Corso Mathematical Model And A Factors Predicting Survival In Grade Multi-objective Imrt Optimization 2118 Steven Oh I-III Astrocytomas Algorithm In Treatment Planning For Reirradiation of Recurrent Gliomas Human Glioblastoma 2130 Menachem Yondorf 2119 Jason Ye NTCP Modeling Proves 2140 Melissa LeMieux Hypofractionated Stereotactic Dose-Escalation (DE) Racial Diff erences in Mortality in Radiation Therapy (HFSRT) With Hypofractionated Stereotactic Patients with Glioblastoma Concurrent Chemotherapy (CTX) in Radiation Therapy (HSRT) a Safe Multiforme in the Pre- and Patients With Newly Diagnosed Poor Treatment Option for Patients with Post-Temozolomide Eras Prognosis GBM: Early Results Subtotal Resection of WHO Grade II-III Meningioma 2141 Martha Hosotani 2120 Edward Marchan Patterns of Failure: Detailed Impact of FACBC PET in Imaging and 2131 Chandler Sours Dosimetric Analysis of Glioblastoma GTV Design of Cerebral Gliomas Feasibility Study Testing the Recurrence in the Era of Modern Incorporation of Resting State fMRI Chemoradiation Therapy 2121 James Cordova Data in Radiation Therapy Planning The Development of an Unbiased, to Limit Dose to Cognitive Function 2142 Erin Murphy Semi-automated Method for Networks in Patients with Primary Impact of 1p Status and Radiation Perioperative Tumor Volume Brain Tumors Therapy Timing on Long-term Measurement Using VelocityAI in Outcomes for Adults With Grade 2 Glioblastoma 2132 Weining Zhen Glioma Treated at a Single Institution MRI Based Volumetric Analysis of 2122 Lee Jeongshim Postoperative Disease Progression of 2143 Srinivas Chilukuri Re-irradiation for Recurrent Gliomas: Glioblastoma Prior to the Radiation Is It Time To Revise Imaging Treatment Outcomes and Prognostic Therapy Guidelines For Response Assessment Factors After Temoradiation And Surgery For GBM ? Sensitivity, Specifi city And Predictive Value Of MR Spectroscopy And Perfusion for the detection of Tumor Progression after temoradiation Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 131 2144 Elizabeth Kuhn 2156 Prashant Desai 2166 Maged Ghaly Adverse Toxicity After Feasibility Study of Toxicity and The Role Of Spine Radiosurgery In Stereotactic Radiosurgery for Effi cacy of Hypofractionated The Management Paradigm Of Spine Treatment of Meningiomas Stereotactic Radiation Therapy Metastases (HFSRT) for Patients With Meningioma 2145 Ryan Nowak Based on NTCP Modeling: Early 2167 Sophia Kamran Factors Associated With Hearing Loss Clinical Results Outcomes of Proton Therapy for the in Patients With Vestibular Treatment of Uveal Metastases Schwannomas Treated With 2157 Daniel Wattson Fractionated Stereotactic Radiation Outcomes of Proton Radiation 2168 Di Zhou Therapy Therapy for Patients With Functional 103Pd versus 125I Plaque Radiation Pituitary Adenomas Dose to Normal Ocular Structures in 2146 Craig Grossman the Treatment of 319 Uveal A Population-Based Characterization 2158 Rasim Meral Melanomas of Meningiomas in Breast Cancer Symptomatic Improvement in Patients Patients With Pituitary Adenoma 2169 Blake Currier Diagnosed as Acromegaly Versus Dosimetric Evaluation of a Shielded 2148 Leoncio Arribas Cushing’s Disease With Fractionated Applicator for use with Low Energy Radiosurgery Outcomes In Vestibular Stereotactic Radiation Therapy High Dose Rate Brachytherapy for Schwannoma: Eff ect Of New Treatment of Ocular Melanoma Technologies 2159 Ameen Al-Omair Postoperative Stereotactic Body 2170 Jacqueline Esthappan 2149 Koshi Tatewaki Radiation Therapy (SBRT) for Patients Post-Implant Magnetic Resonance Long-term Outcome of Robotic With Spinal Metastasis: Predictive and Imaging for Episcleral Plaque Stereotactic Radiosurgery for Prognostic Factors Analysis Brachytherapy Vestibular Schwannomas 2160 Kosj Yamoah 2171 Anshu Jain 2150 William Wilson A Pilot Study on Spine Stereotactic Malignant Tumors of the Lacrimal Gamma Radiosurgery (GRS) for Body Radiation Therapy Residual Gland: A SEER Analysis Acoustic Neuroma: A Single Setup Errors and Intrafraction Motion Institution Experience using Stereotactic X-ray Image Guid- 2172 Malay Rao ance Verifi cation System MRI-Guided Laser Ablation for 2151 Emily Tanzler Post-SRS Locally Recurrent Meningiomas: A Retrospective 2161 Nehaw Sarmey Metastases: Initial Experience and Outcomes Analysis of the University Adjacent or Same Vertebral Body Outcomes of Florida Proton Institute Experience Retreatment With Repeat SBRT (Stereotactic Body Radiation Therapy) 2173 Johnny Kao 2152 Menachem Yondorf Is Safe Despite High Cumulative Dose Pilot Study of Tumor Directed, Scalp NTCP Modeling of Hypofractionated to the Spinal Cord or Cauda Equina Sparing IMRT for Brain Metastases Stereotactic Radiation Therapy (HSRT) for Patients with Subtotal Resection 2162 Maha Jawad 2174 Arjun Sahgal (STR) of WHO Grade I Meningioma: A Dosimetric Evaluation of Target MRI Perfusion Biomarkers Predicting A Toxicity-Sparing More Convenient Coverage as a Predictor of Local Early Response for Brain Metastasis Treatment Method Failure Following Stereotactic Body Treated With High-Dose Radiation Radiation Therapy for Spinal Tumors Therapy 2153 Nathalie Nguyen Impact of Radiation Therapy on 2163 Omar Mian 2175 Kyle Arneson Clinical Outcome of Meningiomas Timely Radiosurgery for Spine A Phase I Trial of Concurrent Sorafenib Metastases per RTOG 0613 Guidelines and Stereotactic Radiosurgery for 2154 Jennifer Shah using a Rapidly Deployable Patients with 1-4 Brain Metastases Evaluation of Tumor Expansion Automated Planning Script (FastPlan) Following 3-Fraction Stereotactic 2176 Xueying Qiao Radiosurgery for Vestibular 2164 Eva Christensen Whole Brain Radiation Therapy With Schwannomas Patterns of Failure in Stereotactic Local Simultaneous Integrated Boost Body Radiation Therapy for Spinal Conformal Radiation Therapy in the 2155 Yoshimasa Mori Tumors Treatment for Patients With 1-3 Brain Stereotactic Radiosurgery As A Metastases Salvage Treatment For Recurrent 2165 Chia-Lin Tseng Skull Base Chordoma After Surgical Spinal Cord Tolerance Specifi c to Resection Re-irradiation Spine Stereotactic Body Radiation Therapy (SBRT) Following at Least 2 Courses of Prior Radiation
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
132 ASTRO 2013 / 55TH ANNUAL MEETING 2177 Grant Clark 2188 Roshan Sethi 2199 Matthew Johnson Phase 1 Dose Escalation/ Proton Radiation Therapy for Pediatric Analysis of Risk Factors for De-escalation Study of Preoperative Central Nervous System Development of Radiation Necrosis Stereotactic Radiosurgery for Brain Ependymoma: Clinical Outcomes for Following Stereotactic Radiosurgery Metastases: Preliminary Acute Toxicity 70 patients for Brain Metastases and Dosimetric Analysis 2189 Selvan Rajakesari 2200 Nicholas Zaorsky 2178 Allan Chen Hypofractionated Stereotactic Treatment Of Brain Arteriovenous Frame versus Frameless Stereotactic Radiation Therapy for Brain Malformations With Stereotactic Radiosurgery for Drug-Refractory Metastases Radiosurgery Following Embolization Idiopathic Trigeminal Neuralgia 2190 Arie Dosoretz 2201 Bhisham Chera 2179 Taro Murai Long-Term Survivors After Eff ect of Node and Beam-Reduction Fractionated Stereotactic Radiation Treatment of Intracranial Metastases Optimization on the Integral Dose to Therapy Using Robotic Radiosurgery with Radiosurgery the Brain for Robotic Radiosurgery for the Treatment of Large Brain Brain Cases Metastases 2191 Rafael Moleron Emerging Role of Fractionated 2202 Tamara Santos 2180 Charles Rutter Stereotactic Radiation Therapy in Predictive Factors For Local Control Of Prognostic Factors in Patients with Brain Metastasis Treatment: Single Brain Metastases After Radiosurgery Brain Metastases at Initial Non-Small Institution Early Experience Cell Lung Cancer Diagnosis 2203 David Ly 2192 Julia Compton Local Control After Stereotactic 2181 Steven Lau Total Tumor Volume Predicts Radiosurgery (SRS) for Brain Clinical Outcomes Of Single Isocenter Mortality Following Radiosurgery for Metastases (BM) in Melanoma Frameless Radiosurgery For Multiple 5 or More Brain Metastases Patients With and Without BRAF Brain Metastases Mutation and Treatment 2193 Sara Alcorn 2183 Isabelle Thibault A Comparison of Clinical Outcomes of 2204 Christian Okoye Local Control, Patterns of Failure, and Adult and Pediatric Medulloblastoma Is Monte Carlo Calculation Necessary Vertebral Compression Fracture After in Patients With Thoracic Spinal Spine Stereotactic Radiation Therapy 2194 Mark McDonald Tumors Treated With Robotic for Metastatic Renal Cell Cancer Initial Results of Proton Therapy for Stereotactic Body Radiation Therapy Clival Chordoma (SBRT)? 2184 Hong-Yiou Lin Gamma Knife Radiosurgery for Renal 2195 Kevin Shiue 2205 Maria Luisa Figueiredo Cell Carcinoma and Melanoma Brain Lack of Response is a Risk Factor for Focal Hypofractionated Stereotactic Metastases-Higher Doses to Treat Radiation Necrosis after Radiosurgery Radiation Therapy After Resection of Melanoma <4ml to Improve Local for Brain Metastases Brain Metastases Control 2196 Dong-Soo Lee 2206 Waleed Mourad 2185 Henrique Faria Braga Patterns of Failure Following Linac-Based SRS Dose-Volume Validation Of The Score Index For Multimodal Treatment for Relationship for Optimal Local Control Radiosurgery (SIR) In Predicting Medulloblastoma: A Single of Brain Metastases Survival Of Patients With Brain Institution Experience with Metastases Submitted To Long-Term Follow-Up 2207 Guy Savir Radiosurgery Experience Using Fractionated 2197 Wei Heng Kao Stereotactic Radiosurgery to Treat 2186 Charles Rutter Whole Brain Radiation Therapy With Large CNS Metastases Infl uence of BRAF and NRAS Simultaneously Integrated Boost for Mutations on Distant Intracranial Patients With Multiple Brain 2208 Lauren Tait Recurrence and Survival in Metastatic Metastases by VMAT Enhanced Radiographic Response Melanoma Following Radiosurgery and Re-Treatment Rates Following 2198 Kyung Hwan Kim Whole Brain Irradiation among 2187 Rachel Jimenez Whole Brain Radiation Therapy With Non-Small Cell Lung Cancer Patients The Impact of Diff erent Hippocampus-Sparing Simultaneous with EGFR Activating Mutations Hypofractionated Stereotactic In-fi eld Boost Using Helical Radiation Therapy Regimens for Brain Tomotherapy for Brain Metastases 2209 Haoming Qiu Metastases on Local Control and From Lung Adenocarcinoma: Early Optimization of Stereotactic Toxicity Volume Response and Dosimetric Radiosurgery Plans for Brain Evaluation Metastasis
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 133 GASTROINTESTINAL CANCER 2219 Keisuke Tamari 2228 Jun Wang Impact of Clinical and Dosimetric Overexpression Of Epidermal Growth 2210 Keiichi Jingu Factors on Pericardial Eff usion in Factor Receptor And Its Prognostic Factors for Patients With Patients With Stage I Esophageal Clinicopathological Signifi cance: A Loco-Regional Recurrent Cancer Treated With Defi nitive Meta Analysis Of 1118 Cases With Esophageal Cancer Who Were Treated Chemoradiation Therapy Esophageal Squamous Cell Carcinoma With Chemoradiation Therapy: Results of Multivariate Analysis 2220 Gen Kawaguchi 2229 Yuji Murakami A New Choice of Treatments for Twenty Years Treatment Results 2211 Chiramana Haritha Invasive Superfi cial Esophageal Of Radiation Therapy For T1N0M0 Quantifi cation of Swallowing-Induced Squamous Cell Carcinoma: Esophageal Cancer Motion in Esophageal Cancers Using Investigation of Effi cacy of Volume Shuttle Imaging Analysis Prophylactic Chemoradiation Therapy 2230 Yufeng Cheng After Endoscopic Submucosal Cancer-associated Fibroblasts, a 2212 Minghuan Li Dissection Parameter of the Tumor Determine the Involved Lymph Microenvironment, is Associated With Node Station for Cervical and Upper 2221 Masakazu Hori Poor Prognosis in Esophageal Thoracic Esophageal Carcinoma in Overexpression Of XRCC4 Predicts Squamous Cell Cancer After Surgery Non-surgical Patients -A Data Analysis Poor Clinical Outcome Of Patients Based on CT With Esophageal Squamous Cell 2231 Junichi Fukada Carcinoma Treated With Defi nitive Symptomatic Pericardial Eff usion 2213 Minghuan Li Radiation Therapy After Chemoradiation Therapy for Pretreatment CT Perfusion Predicts Esophageal Cancer: A Historical Early Response of Advanced 2222 Huiming Liu Comparison Esophageal Carcinoma Treated With Long-term Outcome of Cf-252 Chemoradiation Therapy Neutron Intracavitary Brachytherapy 2232 Rei Umezawa Combined With External Beam Magnetic Resonance Imaging 2214 Ravi Shridhar Radiation Therapy and Concurrent Findings of Radiation-induced Survival Impact of Esophagectomy Chemotherapy for Esophageal Myocardial Damage in Patients With After Chemoradiation for Squamous Cell Carcinoma Esophageal Cancer Adenocarcinoma of the Esophagus 2223 Xin Huang 2233 Jun Liang 2215 Chun Han The Negative Expression of Annexin Nimotuzumab Combined With The Application Value Study of A1 in Esophageal Squamous Cell Radiation Therapy on Esophageal Diff usion-weighted Magnetic Carcinoma is Association with Poor Cancer: Preliminary Study of a Phase 2 Resonance Imaging(DWI) in Target Outcome Clinical Trial Volume Determination of Esophageal Carcinoma Treatment using 3DCRT 2224 Hunter Boggs 2234 Sagar Patel or IMRT Predictors of Pathologic Complete Small Cell Carcinoma Of The Response Rates in Patients Receiving Esophagus: The (SEER) Experience 2216 Shuchai Zhu Trimodality Therapy for Esophageal From 2000-2009 Investigation of Using Cancer Diff usion-weighted Magnetic 2235 Abraham Wu Resonance Imaging(DWI) to Evaluate 2225 Jun Wang Generation of Consensus Contour the Therapeutic Eff ect and Prognosis Prognostic Analysis In 182 Thoracic Atlas for Esophageal Cancer IMRT of Esophageal Carcinoma Treatment Esophageal Carcinoma Patients With using 3DCRT Atypical Hyperplasia In Esophageal 2236 Miyako Myojin Stump And Esophageal Stump Cancer The Common Late Toxicities 2217 Lan Wang After Esophagectomy Observed After Defi nitive Prognosis Analysis of Diff erent Site Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma 2226 Che-yu Hsu Esophageal Cancer Received 3-Dimensional Radiation Defi nitive Concurrent Therapy Chemoradiation Therapy via Intensity 2237 Lotte Lutkenhaus Modulated Radiation Therapy for Reduction in Cardiac Volume During 2218 Changsheng Ma Synchronous Esophageal Cancer in Chemoradiation Therapy for Patients Quantitative Study of 18F- Patients With Head-and-Neck Cancer With Esophageal Cancer: Magnitude fl uorodeoxyglucose and 18F- and Possible Implications for Adaptive fl uorothymidine PET Characteristics in 2227 Qi Liu Radiation Therapy Esophageal Squamous Cell Carcinoma Pattern of Failure After Radical Staging Surgery in Patients With Thoracic 2238 Hitoshi Ishikawa Esophageal Squamous Cell Preliminary Results of Concurrent Carcinoma: Implications for Chemoradiation Therapy Using Postoperative Radiation Therapy Proton Beam Therapy for Esophageal Cancer
134 ASTRO 2013 / 55TH ANNUAL MEETING 2239 Wencheng Zhang 2250 Steven Seyedin 2259 Guichao Li Postoperative Intensity Modulated Benefi t of Adjuvant Chemoradiation Radiation Induced Liver Injury In Radiation Therapy Improved Survival Therapy for Gastric Adenocarcinoma: Three Dimensional Radiation Therapy of Lymph Node Positive or Stage III A SEER Population Analysis (3d-rt) For Postoperative Or Squamous Cell Carcinoma Esophagus Locoregional Recurrent Gastric 2251 Alexander Stessin Cancer: The Risk Factors And Dose 2240 Aditya Juloori Does Adjuvant Radiation Benefi t Limitation Dosimetric Predictors for Nausea Patients with Diff use Type Gastric and Anorexia in Esophageal Cancer Cancer? Results from the Surveillance, 2260 Ronica Hazariwala Patients Treated with Neoadjuvant Epidemiology, and End Results (SEER) Neoadjuvant FOLFIRINOX and Chemoradiation Database Radiation Therapy Improves Resectability of Pancreas 2241 Faisal Siddiqui 2252 Qiwen Li Adenocarcinoma Overall Survival Analysis of Lymph Node Status as Predictive Neoadjuvant Chemoradiation Factor for Selective Adjuvant 2261 Eric Mellon Therapy and Esophagectomy for Chemoradiation in Patients with Survival Benefi ts of Adjuvant Esophageal Cancer Locally Advanced Gastric Cancer with Radiotherapy and Lymph Node D2 Dissection Dissection in Pancreatic Cancer 2242 Shuchai Zhu Treated with Surgery and Eff ect Of Rnai Against 53bp1 Gene On 2253 NingNing Lu Chemotherapy Radiosensitivity Of Human Safety And Clinical Outcome For Esophageal Carcinoma Eca109 Cell Phase II Study Of Nimotuzumab And 2262 Tingyi Xia Concurrent Capecitabine And Dose Escalation to Target Volumes of 2243 Christopher Anker Radiotherapy For Patients With Helical Tomotherapy for Pancreatic The Eff ect Of Stents On Acute Toxicity Locally Advanced Inoperable Or Cancer in the Phase I-II Clinical Trial In Esophageal Cancer Relapsed/ Residual Gastric Cancer 2263 Michael Baine 2244 Kyung Hwan Kim 2254 Hua Ren Radiation Therapy Improves Survival Is Postoperative Radiation Therapy Prospective Effi cacy Evaluation Of Outcome in Pancreatic Eff ective for Patients With Esophageal Intensity-modulated Radiotherapy Adenocarcinoma: Comparison of a Cancer?: An 8-Year Follow-up Study (imrt) Combined With Capecitabine 15-year institutional experience at As Adjuvant Concurrent the University of Nebraska Medical 2245 Shaleen Kumar Chemoradiation In Stage II/III Gastric Center with SEER data Clinical Target Volumes (CTV) for Cancer Squamous Cell Cancer (SCC) of 2264 Sophie Cai Esophagus Treated With 2255 Cem Misirlioglu Long-Term Outcomes and Prognostic Chemoradiation Therapy (CRT) Adjuvant Radiotherapy For Gastric Factors for Locally Advanced Carcinoma: 10 Years Follow-up Pancreatic Cancer Patients Treated 2246 Yuxin Shen Update Of 244 Cases From A Single with Intraoperative Radiation Therapy Management of Primary Thoracic Institution Small Cell Esophageal Carcinoma: 2265 Brandon Mancini analysis of 20 consecutive cases 2256 Jennifer Shah Induction FOLFIRINOX Prior to Clinical And Dosimetric Predictors Of Chemoradiation for Borderline or 2247 Jiancheng Li Peri-operative Pulmonary Locally Advanced Pancreatic Cancer Analysis Of Relative Infl uencing Complications In Esophageal Cancer Factors About Recurrence Of Patients Treated With Neoadjuvant 2266 David Sherr Esophageal Carcinoma After Chemoradiation Do Socio-Demographic Factors Aff ect Three-fi eld Lymph Node Dissection Overall Survival in Patients with 2257 Andre Chen Unresectable Pancreatic Cancer? 2248 Qi Liu Liver Irradiation Increases Results of a Secondary Analysis of Characteristics of Lymph Node Relapse-free Survival In Adjuvant RTOG Data Recurrence After Radical Surgery and Gastric Cancer Treatment Their Value in Target Volume 2267 Cato Chan Delineation in Postoperative 2258 Rajal Patel Anemia During Radiotherapy Radiation Therapy for Thoracic A Multi-Institutional Correlates With Outcomes In Esophageal Squamous Cell Carcinoma Retrospective Study of Radiation Pancreatic Cancer Therapy Parameters and Outcomes in 2249 Ling Yipeng Patients with Gastroesophageal 2268 Angelo Tozzi Pattern of Lymph Node Metastases Junction Adenocarcinoma Sbrt In Unresectable Advanced and its Implication in Pancreatic Cancer. Preliminary Results Radiotherapeutic Clinical Target Of A Monoinstitutional Experience Volume in Patients With Upper Thoracic Esophageal Squamous Cell Carcinoma Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 135 2269 Raphael Yechieli 2279 Natalie Ausborn 2288 Ajay Patel Stereotactic Body Radiotherapy for 53BP1 Expression is a Modifi er of the Postoperative Interval between the Treatment of Elderly Patients Prognostic Value of Lymph Node Surgery and Initiation of Adjuvant with Medically Inoperable Pancreatic Ratio and CA 19-9 in Pancreatic Therapy Corresponds to Local Cancer Adenocarcinoma Recurrence in Resected Pancreatic Cancer 2270 William Hall 2280 Maged Ghaly The Infl uence of Radiation Therapy Duodenal Sparing Stereotactic Body 2289 Abhijeet Bhirud Dose Escalation on Overall Survival in Radiation Therapy For Locally Dosimetric Analysis Of Kidney Toxicity Unresectable Pancreatic Advanced Pancreatic Cancer: After Stereotactic Body Radiation Adenocarcinoma Technique, Toxicity, and local Therapy For Pancreatic Cancer Response 2271 Lisette Nixon 2290 Kotaro Terashima The SCALOP trial Plan Assessment 2281 Hao Wang Carbon-ion Radiotherapy for Patients Form (PAF) as a tool for Radiotherapy Prognostic Factors for Intraoperative With Isolated Local Recurrence of Trials Quality Assurance (RTTQA) 125I Seeds Implantation for Primary Resected Pancreatic Cancer Treatment of Locally Advanced 2272 Aryavarta Kumar Pancreatic Carcinoma 2291 Sanjay Chandrasekaran Infl uence of Adjuvant Treatment on Neoadjuvant Therapy for Achieving Outcomes in Resectable Pancreatic 2282 Reid Thompson Margin Negative Resection in Cancer Linear Quadratic Extrapolated Borderline Resectable Pancreatic Dosimetric Analysis of Proton Therapy Ductal Adenocarcinoma 2273 Shreya Prasad and IMRT in Unresectable Cancer of Intensity Modulated Radiotherapy the Head of Pancreas: Implications for 2292 Dandan Zheng Reduces Gastrointestinal Toxicity in Dose Escalation Respiratory-Correlated Duodenum Locally Advanced Pancreas Cancer Motion and Its Implications in 2283 Andre Konski Pancreatic SBRT 2274 Antonino Romeo Preliminary Results of a Phase I Study Hypofractionated of Hyperfractionated Low-Dose 2293 David Shultz Radio-chemotherapy With Radiotherapy (RT) as a Ca 19-9 Kinetics Following Gemcitabine Plus Oxaliplatin For Chemotherapy sensitizer in Radiotherapy Correlate With Unresectable Nonmetastatic Locally Combination With Gemcitabine (G) Outcomes In Patients With Pancreatic Advanced Pancreatic Cancer and Erlobtinib (E) in Advanced Adenocarcinoma Pancreatic Cancer 2275 Jessica Freilich 2294 Alex Cruz Outcomes of Adjuvant Radiotherapy 2284 John Lukens Outcomes And Toxicities In Post- and Lymph Node Dissection in Elderly Acute Toxicity of Proton vs. Photon operative Pancreatic Cancer Treated Pancreatic Cancer Patients Treated Chemoradiotherapy for Pancreatic With Chemotherapy And IMRT Vs. with Surgery and Chemotherapy Adenocarcinoma: a Cohort Study 3DCRT
2276 Huma Chaudhry 2285 Jennifer Wo 2295 Sonia Skamene Radiation Therapy in Pancreatic Tolerability of Dose Painted Resectability After Concurrent Neuroendocrine Tumors: Favorable Neoadjuvant Chemoradiation to Gemcitabine-based Outcomes and Low Toxicity in a Regions of Vessel Involvement in Chemoradiotherapy For Patients With Multi-Institutional Experience Borderline or Locally Advanced Locally Advanced Pancreatic Cancer Pancreatic Cancer 2277 Avani Dholakia 2296 Jenny Que 18Flurodeoxyglucose-PET Baseline 2286 Mediha Ahmad The Effi cacy of Stereotactic Body Avidity Predicts for Inferior Outcomes Is Ca19-9 Response Following Radiation Therapy For Unresectable in Patients with Locally Advanced Chemoradiation Therapy For Huge Hepatocellular Carcinoma Not Pancreatic Cancer Treated with Borderline Resectable Pancreatic Eligible For Other Local Modalities Gemcitabine and Stereotactic Body Cancer An Early Surrogate For Radiotherapy Eventual Survival Outcomes? 2297 Brandon Barney Stereotactic Body Radiotherapy after 2278 Takero Hirata 2287 Joong Yeol Woo Other Minimally-Invasive Local Dose-volume Analysis For Predicting Evaluation Of Dose Summation Therapies for Liver Tumors Histological Eff ects And Method Using Deformable Gastrointestinal Complications After Registration In Adaptive Planning For 2298 Kyung Su Kim Preoperative Chemoradiotherapy For Locally Advanced Pancreatic Cancer Clinical Characteristics And Pancreatic Cancer Prognostic Factors Of Brain Metastases From Hepatocellular Carcinoma
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
136 ASTRO 2013 / 55TH ANNUAL MEETING 2299 Jim Zhong 2309 Hideomi Yamashita 2320 Iris Ernst Patterns of failure for Stage I Ampulla Comparison Bwtween Stereotactic Individualized Stereotactic Body of Vater Adenocarcinoma: a Single Body Radiotherapy For Liver Radiation Therapy (SBRT) by Institutional Experience Metastases And Hepatocellular Tomotherapy or VMAT in Liver Carcinoma Malignancies - only Rank 3rd after 2300 Jinhong Jung Surgery and Interventional Normalization of Alpha-fetoprotein 2310 Naoko Sanuki Radiology? Level in Patients with Hepatocellular Stereotactic Ablative Body Radiation Carcinoma after Stereotactic Body Therapy for Small Hepatocellular 2321 Joseph Evans Radiation Therapy: A Prognostic Carcinoma: Outcomes in 185 Patients Safety and LC of Repeat Liver Surrogate of Progression and Survival Stereotactic Body Radiotherapy 2311 Toshiyuki Okumura 2301 Marie-Laure Camborde Long-term Survival in Patients with 2322 May Abdel-Wahab Mean Liver Dose Evaluation By Lyman Hepatocellular Carcinoma Initially Assessment of Hepatocellular NTCP Modeling With Stereotactic Treated with Defi nitive Proton Beam Carcinoma Recurrence Risk after Body Radiotherapy To Minimize Therapy Primary Treatment using Predictive Radiation-induced Liver Disease For Nomograms Inoperable Hepatocellular Carcinoma 2312 Seung Won Seol Treatment Outcome of Hepatic 2323 Claudia Menichelli 2302 Alejandra Mendez Re-irradiation in Patients with HCC Sbrt For Crc Liver Metastases: Romero Prognostic Factors Aff ecting Lc And Inter- and Intra-observer Variability in 2313 Jun Won Kim Os Daily Tumor Set-up using Radiologic-Pathologic Correlation Contrast-enhanced CT-scans for in HCC Patients Undergoing Radical 2324 Saumil Gandhi Patient Positioning during Radiotherapy Followed by Surgical Development of a Decision Tree Stereotactic Body Radiation Therapy Resection Analysis Tool for Optimal Delivery for Liver Metastases of Liver Stereotactic Body Radiation 2314 Kenneth Merrell Therapy: Photons versus Protons 2303 Erik Lappinen An Institutional Review of Stereotactic Stereotactic Body Radiation Therapy Body Radiotherapy for Liver Tumors 2325 Joseph Waller (SBRT) as a Bridge to Orthotropic Liver Outcomes of Stereotactic Body Transplant (OLT) for 2315 Katherine Fan Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC): Neuroendocrine Tumor Liver Hepatocellular Carcinoma (HCC) Evaluation of Explant Pathology and Metastases Treated with Yttrium-90 the Factors That Predict Outcomes Radioembolization 2326 Pawel Dyk Analysis Of Abdominal And Chest Wall 2304 Seth Blacksburg 2316 Jenny Shaff er Toxicity Following Liver SBRT Combined Transarterial Predicting Liver Volume Changes Chemoembolization (TACE) And After Stereotactic Body Radiotherapy 2327 Navesh Sharma Stereotactic Body Radiation Therapy for Liver Tumors Association Between K-ras Mutation (SBRT) For Management Of Primary Status And Survival In mCRC Patients Hepatocellular Carcinoma (HCC) 2317 Edward Mannina Undergoing Selective Internal Role of Stereotactic Body Radiation Therapy (SIRT) to the 2305 Anand Mahadevan Radiotherapy as a Bridge to Liver Using Yttrium-90 Coated Resin Stereotactic Body Radiotherapy for Orthotopic Liver Transplantation. Microspheres Unresectable Large and Multiple Evaluation of Pathological Response Hepatocellular Carcinoma and Outcome: Indiana University 2329 Tony Wang Experience Selective Internal Radiation Therapy 2306 Sang Min Yoon to the Liver: High Tumor Dose and Clinical Outcomes of Stereotactic 2318 Charles Fang Normal Liver Tolerance Body Radiation Therapy for Primary or Biliary Stricture After Radiotherapy for Recurrent Hepatocellular Carcinoma Hepatocellular Carcinoma 2330 Evan Osmundson Risk of Hepatobiliary Toxicity After 2307 Christina Speirs 2319 Yilin Liu SBRT to the Liver for Central Liver 90Y Microsphere Hepatic Distribution 4D-MRI using Sagittal Acquisition and Tumors Can Be Evaluated Following Body Area as Respiratory Surrogate Radioembolization With PET/MRI 2331 Martin Fuss Outcomes of Hypofractionated 2308 Atsuya Takeda Radiation Therapy (HFxRT) for Stereotactic Ablative Body Hepatocellular Carcinoma (HCC) Radiotherapy For Previously Untreated Solitary Hepatocellular Carcinoma In Patients With Liver Disease Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 137 2332 Michael Lock 2341 Joo Ho Lee 2351 Maureen Rolfo Phase I Study of Image-guided and The Infl uence of the Treatment Simple Segment IMRT: Dosimetric and Radiobiologically-guided Response on the Impact of Resection Resource Implications of an Stereotactic Body Radiotherapy for Margin Status after Preoperative Innovative Rectal Cancer Hepatic Lesions Chemoradiotherapy in Rectal Cancer Technique
2333 Maria Fernanda Diaz 2342 Ovidiu Marina 2352 Claudio Sole Vazquez Whole-Mount Pathologic Evaluation Presacral Evolutive Events (Soft Tissue Clinical Comparison of IMRT With of Specimens Following Preoperative Mass) After Neoadjuvant 3D-CRT in Preoperative Radiotherapy (RT) for Rectal Cancer Chemoradiation With or Without Chemoradiotherapy for Locally Identifi es More Lymph Nodes and Intraoperative Electron Beam Advanced Rectal Cancer (LARC) Greater Tumor (T) Stage Radiation Therapy Boost For Locally Advanced Rectal Cancer 2334 Annemarie Fernandes 2343 Ane Appelt Predicting Outcomes In Dose-response Of Acute Bladder Side 2353 Shigeru Yamada Locally-advanced Rectal Cancer Using Eff ects Of Long-course Preoperative Carbon-ion Therapy For Patients With Pretreatment FDG-PET Imaging Radiotherapy For Rectal Cancer Locally Recurrent Rectal Cancer
2335 Yong Cai 2344 Tzu-I Jonathan Yang 2354 Jing Jin Clinical Analysis Of Comparing Impact of Clinical and Dosimetric A Phase I Study Of Postoperative Volumetric Modulated Arc Therapy Factors on Weekly Toxicity Scores Capecitabine With Concurrent With Fixed Field Dynamic during Pelvic Radiotherapy for Rectal Radiotherapy In Elderly Patients With Intensity-modulated Radiation Cancer Rectal Cancer Therapy On Preoperative Chemoradiotherapy For Locally 2345 Albert DeNittis 2355 Xin Lei Advanced Rectal Cancer Treatment Of Distal Rectal Cancer The Combination of 252Cf Neutron With Preoperative Intensity Intracavitary Brachytherapy Using 2336 Sung Uk Lee Modulated Radiation Therapy (IMRT) Off -Axis 4-Channel Intrarectal Comparison of Two Preoperative Combined With Chemotherapy And Applicators and External Beam Chemoradiotherapy Regimens for Transanal Endoscopic Microsurgery: 5 Radiation Therapy on Low-Lying Locally Advanced Rectal Cancer: Year Results Of 12 Patients Rectal Adenocarcinoma (Phase 2a Short-term Tumor Response and trial): The 3 Year Result for 118 Patients Long-term Clinical Outcome of 2346 Alexander Falk Capecitabine with or without High-dose Rate Interstitial 2356 Dolores M. De La Mata Irinotecan Brachytherapy as Boost for Anal Canal Molecular Imaging (FDG-PET/CT) Carcinoma : Dosimetric Results and Response to Neoadjuvant Oxaliplatin 2337 Evan White Clinical Outcome and Chemoradiation in Rectal Cancer Intensity-Modulated Radiation as Prognostic Factor in Surveillance Therapy for Anal Canal Cancer: 2347 Joelle Helou A Large Single-Institution Experience Vaginal Sparing Using A Mold In Anal 2358 Bindu Manyam Cancer Female Patients Treated With The Impact of Radiation Therapy on 2338 Daniel Yang Intensity Modulated Radiotherapy: A Locoregional Recurrence (LRR) in Changes In Early And Late Stage Dosimetric Feasibility Study Patients with Stage IV Rectal Cancer Colorectal Cancer Incidence During Treated with Defi nitive Surgical The Era Of Screening: 1976-2009 2348 Diana Rothenstein Resection and Modern Chemotherapy Predictors of Outcome and Toxicities 2339 Andrzej Wojcieszynski of Defi nitive Chemoradiation with 2359 Jekwon Yeh Uncertainty in Rectal Tumor Intensity Modulated Radiotherapy for Primary Adenocarcinoma of the Anal Localization During Preoperative Anal Cancer Canal: A Single-Institutional Report Radiation and the Impact of Distal on a Rare Malignancy Tumor Delineation on Normal Tissue 2349 Susannah Yovino Dosimetry Sparing Circulating Lymphocyte 2360 Hao Li Populations with Endorectal Eff ects of PET Reconstruction 2340 Qin Xiao Brachytherapy Parameters on Region-of-Interest Using Apparent Diff usion Coeffi cient Contouring by SUV Threshold to Predict Outcome of 2350 Phuong Nguyen Preoperative Chemoradiotherapy for Prolonging Surgical Resection after 2361 Olivier Riou Locally Advanced Rectal Carcinoma Neoadjuvant Chemoradiation for Brachytherapy For Anal Canal Cancer: Rectal Cancer Is Associated with A Goco Multicenter Study Increased Risk of Distant Failure and Decreased Survival
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
138 ASTRO 2013 / 55TH ANNUAL MEETING 2362 Abdullah Alsuhaibani 2373 Ron Allison 2383 Jennifer Logan External Beam Radiotherapy Versus PSA Nadir Predicts Outcome Salvage MR-guided Focal Laser Image-guided High Dose Rate Following Radiation Therapy for Ablation of Prostate Cancer after Endorectal Brachytherapy In The Gleason 8, 9, 10 Prostate Cancer Brachytherapy Management Of Rectal Cancer A Retrospective Study 2374 Bradford Hoppe 2384 Eberechukwu Comparative Eff ectiveness Study of Onukwugha 2363 Sonny Batra Proton Therapy versus IMRT for Variation in the Length of Radiation Pencil Beam Scanning Proton Therapy Defi nitive Treatment of Prostate Therapy among Men Diagnosed with In The Treatment Of Rectal Cancer Cancer Based on Patient-reported Incident Metastatic Prostate Cancer Outcomes 2364 Abdullah Alsuhaibani 2385 Whoon Kil Eff ect Of Circumferential Resection 2375 Kasra Badiozamani Patient-reported Hip symptoms Margin (crm) On Local Recurrence Does Pd-103 Prostate Brachytherapy following Treatment with Proton And Distant Metastases In Patients Lead to High Rates of Urinary Therapy for Prostate Cancer Treated With Neoadjuvant Retention and Morbidity? Chemo-radiation For Rectal Cancer 2386 Jonathan Andrew Haas Updated Analysis 2376 Hiromichi Ishiyama Stereotactic Body Radiotherapy for A Prospective Quasi-randomized Organ Confi ned Localized Prostate 2365 Margaret Kozak Comparison Of Intraoperatively Built Cancer SMAD4 Inactivation and Prognosis in Custom Linked Seeds Vs. Loose Seeds Colorectal Cancer For Prostate Brachytherapy 2387 Donald Fuller HDR-like SBRT For Post-radiotherapy 2366 May Abdel-Wahab 2377 Toshio Ohashi Locally Recurrent Prostatic The Impact of Radiation Therapy after Preliminary Report of Urinary and Carcinoma: PSA Response, DFS And Resection on Survival in Squamous Rectal Toxicity Profi les after Toxicity Assessment and Adenosquamous Cell Carcinoma Permanent Iodine-125 Implant of the Rectum Brachytherapy in Japanese Men: 2388 Gaurav Marwaha J-POPS Multi-Institutional Cohort Gleason Pattern 5: Is Adverse Really 2367 Min Rex Cheung Study Worse? Racial And Socioeconomic Disparities In Malignant Carcinoid Cancer Cause 2378 Xu Tong 2389 Adam Holtzman Specifi c Survival: An Analysis Of A Real-time Measurement of Prostate Proton Therapy as Salvage Treatment National Cancer Registry Intrafractional Motion during External for Local Relapse of Prostate Cancer Beam Radiotherapy following Cryosurgery or HIFU 2368 Jean-Claude Rwigema Stereotactic Body Radiation Therapy 2379 Michael Pinkawa 2390 Akane Sekiguchi for Abdominal and Retroperitoneal Learning Curve In The Application Eight-Year Experience of Iodine-125 Oligometastases Of A Hydrogel Spacer To Protect The Monotherapy for Japanese Men With Rectal Wall During Radiotherapy Of Localized Prostate Cancer 2369 Mira Shah Localized Prostate Cancer Stereotactic Radiation Therapy for 2391 Atsunori Yorozu Adrenal Metastases 2380 Joen Sveistrup Dose Escalation Impacts Improvement in Toxicity in High Risk Biochemical Outcomes of Inadequate Prostate Cancer Patients Treated with PSA Nadir during Neoadjuvant Image Guided Intensity-Modulated Hormone Therapy before GENITOURINARY CANCER Radiotherapy compared to Brachytherapy for Intermediate-risk Non-Image Guided Conformal Prostate Cancer 2370 Kara Leonard Radiotherapy Eff ect Of Modern Radiotherapy 2392 Jason Slater Techniques On Hematocrit In Patients 2381 John Kalapurakal The Prognostic Value Of Percentage With Prostate Cancer Improved Biochemical Control Of Positive Biopsies, Percentage Of (<0.2ng/ml) Following Androgen Cancer Volume, And Maximum 2371 Toshio Ohashi Deprivation Therapy And Adjuvant Involvement Of Biopsy Cores In Outcomes Following I-125 Prostate Or Salvage Whole Pelvis Radiation Prostate Cancer Patients Receiving Brachytherapy as Monotherapy Therapy After Prostatectomy Proton Beam Therapy
2372 Bettina Hentschel 2382 Harold Wallace 2393 Haruo Inokuchi Comparison of Intensity Modulated Transperineal Ultrasound for Image Impact Of Mlc Leaf Width On Single Arc Therapy (VMAT) and Guidance in the Treatment of Prostate Incidence Of The Late Rectal Standard IMRT: GI and GU Toxicity in Cancer: A Comparison to Bleeding After Intensity-modulated the Pelvic Nodal Treatment of Fiducial-Based Imaging Radiotherapy For Localized Prostate High-Risk Prostate Cancer Carcinoma Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 139 2394 Andrea Lo 2403 Ajaykumar Patel 2412 Julia Luisa Munoz Garcia Prognostic Utility Of The Prostate PSA Half-Life after Salvage Radiation Whole Pelvic Radiotherapy versus Specifi c Antigen (PSA) Value 4-5 Years Therapy for Biochemical Failure of Prostate Only in Patients with After 125I Brachytherapy Prostate Cancer after Radical Intermediate, High and Very High Risk Prostatectomy Prostate Cancer according NCCN 2395 Shea Wilcox Criteria Treated with Radical Intention: Dose Escalated, Image-guided IMRT 2404 Jeff rey Kittel Recap Data Base And Androgen Deprivation As A Signifi cant Cause of Variability in Treatment For Gleason Pattern 5 Prostate Brachytherapy Outcomes as 2413 Hannah Nguyen Prostate Cancer: Encouraging Results Demonstrated from a Single Common Errors found in Low Dose With Modern Techniques Institution Suggesting a Method for Rate (LDR) Prostate Credentialing Uniform Reporting among 2396 Daniel Krauss Institutions 2414 Yuting Lin Results of Image-Guided, The Non-Gaussian Nature of Prostate Dose-Escalated Radiotherapy for 2405 Dong Wook Nathan Kim Motion Based on Real-Time Localized Prostate Cancer: 10-Year Predictors of High Grade Rectal Intra-fraction Tracking Results Using an Off -Line, Adaptive Toxicity Observed in a Phase I/II Trial Technique of Stereotactic Body Radiotherapy for 2415 Michael Hughes Prostate Cancer The Long Term Eff ect of Defi nitive, 2397 Richard Lee High-Dose IG-IMRT on Urinary Update of Risk Factors for Biochemical 2406 Takashi Hanada Function in Patients with High AUA Recurrence of Prostate Cancer after Assessment Of Release Criteria For Scores Prior to Treatment Salvage Radiotherapy Post-Radical Patients Based On Various Dose Rate Prostatectomy Measurements Following 125I 2416 Yuting Lin Prostate Brachytherapy Respiratory Induced Prostate Motion 2398 Jeremy Price Using Wavelet Decomposition of the Predictive Factors And Management 2407 Bryan Macrie Real-time Electromagnetic Tracking Of Rectal Bleeding Side Eff ects Implantation of Row One Needles Signal Following Prostate Cancer 1-2mm Anterior to the Posterior Brachytherapy Margin of the Prostate Gland Results 2417 Bridget Koontz in Excellent PSA Control and Minimal Image Guidance aff ects Biochemical 2399 Julia Luisa Munoz Garcia Rectal Toxicity After I-125 Outcome for Post-Prostatectomy Cross-sectional Observational Study Brachytherapy Radiotherapy About Prevalence Of Metabolic Syndrome And Osteoporosis In 2408 Kiyoshi Nakamatsu 2418 Akihiro Hayashi Prostate Cancer Treated With Intensity Modulated Radiation Dose Volume Histogram Comparison Androgen Deprivation Therapy And Therapy (IMRT) For High-risk Prostate Between Static 5-fi eld IMRT with Their Impact On Quality Of Life Cancer: Eff ects Of Total Dose On Psa 18-MX X Rays and Helical (SIMBOSPROST): GICOR Group Failure Tomotherapy with 6-MX X Rays
2400 Colin Murphy 2409 Yutaka Shiraishi 2419 Wu Liu Infl ammatory Bowel Disease is not an A Novel Parameter Predicting Grade Continuous Threshold-based Absolute Contraindication to 2 Rectal Bleeding After I-125 Prostate Monitoring vs. Periodic Surveillance Defi nitive Radiation Therapy for Brachytherapy Combined With For Prostate Intrafraction Motion Prostate Cancer External Beam Radiotherapy Management
2401 Mack Roach 2410 Kentaro Ishii 2420 Ziad Fawaz Radiation Therapy Oncology Group A Treatment Planning and Acute Complication Rates in Fiducial Marker (RTOG) 9408: A Secondary Analysis Toxicity of RapidArc in the Treatment Implantation for Prostate Radiation Of The Risk Of Death From Second of High-risk Prostate Cancer with Therapy Cancers Comparing Whole Pelvic (WP) Whole Pelvic Radiotherapy Radiotherapy (RT) To Prostate Only 2421 Alex Boychak (PO) RT & Neoadjuvant Hormonal 2411 Tomer Heres Phase II study: Feasibility and Acute Therapy (NHT) + RT To RT Alone Perineal Biodegradable Balloon is Toxicity of Dose Escalated Eff ective for both Sparing the Rectum Hypofractionated Intensity- 2402 Raphael Yechieli and as a Fiducial Marker in Prostate Modulated Radiotherapy with Segmental Analysis of Permanent Cancer Patients Treated with Mild Concurrent Treatment of Pelvic Prostate Implant Dosimetry and Hypofractionation Lymph Nodes in High-Risk Prostate Eff ects on Long-Term Clinical Cancer Patients Outcomes
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
140 ASTRO 2013 / 55TH ANNUAL MEETING 2422 Natsuo Tomita 2432 Jay Ciezki 2442 Yeona Cho Evaluation of Urinary Outcomes by Patterns of Care for the Defi nitive Is There Benefi t of Radiotherapy for International Prostate Symptom Management of Prostate Cancer in Primary Tumor in the Treatment of Scores (IPSS) in Intensity Modulated the U.S. Patients with Metastatic Prostate Radiation Therapy Combined with Cancer? Androgen Deprivation Therapy for 2433 Tamim Niazi Prostate Cancer Is Daily orthogonal KvKv images 2443 Yu-Wei Lin suffi cient for Image Guided The Early Result of Stereotactic Body 2423 Alison Tree Radiotherapy of Prostate Cancer Radiotherapy Boost for High-risk Successful Patient Acceptance Of Patients Post Radical Prostatectomy? Localized Prostate Cancer Randomization Within The Pace Study Final Analysis of a Pilot Phase II Study (prostate Advances In Comparative 2444 Mark Gooding Evidence) 2434 Seth Blacksburg Assessment Of Contour Fusion Predicting Long-term Disease State Methods For Auto-contouring Of The 2424 Feliciano Garcia-Vicente Outcomes in Patients with Prostate Male Pelvis Predictors for Late Urinary Toxicity Cancer Treated with Defi nitive after High-Dose Radiotherapy for Radiation 2445 Almudena Zapatero Localized Prostate Cancer Reduced Rectal And Urinary 2435 Angiolo Tagliagambe Toxicity Following High-Dose 2425 Joan Lozano Phase I study of Stereo-Ablative Intensity Modulated Radiotherapy A New Dietary and Laxative Protocol Radiotherapy with the use of Using Intra-Prostate Gold Fiducial Reduces Rectal Distension and Acute SpaceOAR hydrogel as Defi nitive Markers For Localized Prostate Cancer Rectal Toxicity in Prostate Cancer Treatment of Prostate Cancer: Patients Treated by Radiotherapy Preliminary Experience 2446 Ferran Ferrer Quality of Life Impact of Treatments 2426 Nor Shazrina Sulaiman 2436 Mekhail Anwar for Localized Prostate Cancer Effi cacy of Salvage Radiotherapy in Hypofractionated SBRT versus Men with Biochemical Recurrence Conventionally Fractionated EBRT for 2447 Shiho Ayakawa After Radical Prostatectomy: A Prostate Cancer: Comparison of PSA Volumetric Modulated Arc Therapy Comparison with Endocrine Therapy Slope and Nadir (VMAT) Versus Helical Tomotherapy (HT) for Localized Prostate Cancer: 2427 Viviana Carillo 2437 Yuefeng Wang Dosimetric Comparison by Using the Dosimetric and Clinical Predictors Infl uence of Vascular Comorbidities Identical Prescription Dose to the of Acute Urinary Symptoms after and Race on Erectile Dysfunction after Prostate Radiotherapy for Prostate Cancer: Prostate Cancer Radiotherapy Preliminary Results of a Prospective 2448 Junsu Park Cohort Study (DUE-01) 2438 Kevin Stephans Suggestion for Target Volume in High Risk Prostate Cancer: Radiation Salvage Radiation Therapy for 2428 Alfonso Gomez-Iturriaga or Surgery? Locally-Recurrent Prostate Cancer Multi-institutional outcomes After Radical Prostatectomy following External Beam Radiation 2439 Xiaofeng Yang Therapy and Androgen Deprivation Integration Of Intra-operative 2449 Tonnis Nuver Therapy in patients with Extreme-Risk Ultrasound-volume Into CT-based HDR Prostate Brachytherapy Based on Prostate Cancer Treatment Planning In Prostate HDR Registered TRUS and In-Room Brachytherapy: A Pilot Study Cone-Beam CT Images 2429 William Wilson Re-implantation of Prostate 2440 Charlene Kan 2450 Edwin Crandley Brachytherapy Seeds for Salvage A Single Institution Experience with Treatment Related Toxicity Of Therapy: A Single Institution Prostate Interstitial Brachytherapy Radiation Therapy After Radical Experience (1999-2009): Biochemical Outcomes Prostatectomy (RP): Comparative With and Without Molecular Image Eff ectiveness Of Intensity Modulated 2430 Zvi Symon Guided Dose Escalation (IMRT) Versus Conformal Radiation Rising Psa Following Prostatic Fossa Therapy (CRT) Only (PFO) Radiotherapy: Technique 2441 Aparna Surapaneni And Results Of Salvage Pelvic Node Radiation Therapy For Clinically 2451 Dominika Hempel Radiation Therapy Localized Prostate Cancer: Long Term Testicular Doses In Image-guided Results From The Ny Harbor Step-and-shoot Intensity-modulated 2431 Lynn Chang Department Of Veteran’S Radiotherapy Of Prostate Cancer Toxicity And Biochemical Failure Administration In The Era Of Dose Patients Following Image-guided Prostate Escalation Intensity-modulated Radiotherapy: Fiducial Markers Versus Electromagnetic Transponders Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 141 2452 Brandon Stone 2462 Tiziana Rancati 2472 Cem Onal Inferior Clinical Outcomes in External Validation of a Model for Testicular Doses in Prostate Intermediate and High Grade Prostate the Prediction of Radiation-Induced Intensity-Modulated and Cancer with Neuroendocrine Acute GI Toxicity in Prostate Cancer Volumetric-Arc Radiotherapy with Diff erentiation is Not Solely Conferred Patients Diff erent Energy Levels by Resistance to Androgen Deprivation 2463 Michael Zelefsky 2473 Amarjit Sen Predictors of Post Radiotherapy Stereotactic Body Radiation Therapy 2453 Lawrence Scharf Hip-Related Toxicity after (SBRT) for Low-Risk Prostate Cancer: Correlation Between Bladder Filling Radiotherapy for Prostate Cancer A 3 Way Comparison Between VMAT, And Changes in IPSS Following High Helical Tomotherapy and Robotic Dose Prostate Radiation Therapy 2464 Dorin Todor Radiosurgery Plans Towards A Meaningful Prescription 2454 Manuj Agarwal For Focal Treatments In Prostate 2474 Shakir Shakir Concordance of Gleason Score Brachytherapy Migration Evaluation of Gold on Biopsy and Prostatectomy in a Markers Implanted in a Prostate Bed Contemporary Cohort of U.S. Veterans 2465 Jesse Alexander for Salvage Focal Irradiation Undergoing Radical Prostatectomy Pre-plan Dosimetry As A Predictor Of Change In Urinary Symptoms After 2475 Benjamin Guix 2455 Colin Murphy 125I Permanent Prostate Implants Quality of Life After IMRT or Improved Outcomes in Men Treated (PPI) IMRT+ HDR Brachytherapy for with Adjuvant or Early Salvage Intermediate or High-Risk Prostate Post-Prostatectomy IMRT or 3DCRT at 2466 Qingyang Shang Cancer: 8-Year Results of a a Single Institution Assessment Of Inter-fractional Prospective Trial Seminal Vesicle Motion And Planning 2456 Hiram Gay Margin Using Daily Diagnostic Quality 2476 Madeera Kathpal Evaluation of 3T Pelvic MRI Imaging CT For Prostate Cancer Diff erences Between in Prostate Cancer Patients Receiving Beacon-Localized and Cone-Beam CT Post-Prostatectomy IMRT 2467 Edward Obedian (CBCT)-Localized Radiation Therapy The Risk of Urosepsis in Patients to the Prostatic Fossa 2457 Yi Le Undergoing Fiducial Marker Dynamic Dosimetry Using Placement for Image Guided 2477 Sarah Hegarty Ultrasound-Fluoroscopy Registration Radiation Therapy (IGRT) of Prostate Does Post-prostatectomy Radiation Identifi es Cold Spots Intraoperatively Cancer Therapy Expose Patients To Higher During LDR Prostate Brachytherapy Complications? A Large Medicare 2468 Anusha Kalbasi Patient Cohort Study 2458 Akash Parekh Early Outcomes and Treatment Gastrointestinal And Genitourinary Toxicity of Whole Pelvis 2478 Nathan Tennyson Toxicity And Quality Of Life After Intensity-Modulated Radiotherapy Short Term Androgen Deprivation Post-prostatectomy Radiation (WP IMRT) in Node-Positive Prostate Therapy Does Not Cause Long Term Therapy: Are Normal Tissue Dvh Cancer (PCa) Testosterone Suppression Or Parameters For Intact Prostate Cancer Increased Acute Side Eff ects In Applicable? 2469 Mark Ashamalla Patients Treated With Brachytherapy Dosimetric Outcome of LDR For Prostate Cancer 2459 William Jackson Brachytherapy and Infl uence on Combining Prostate-specifi c Antigen Long-Term Tumor Control and 2479 Seungtaek Choi Nadir And Time To Nadir Allows For Toxicity Outcomes in Patients Treated Proton Therapy for Prostate Cancer Early Identifi cation Of Patients At for Localized Prostate Cancer Does Not Aff ect Testosterone Level Highest Risk For Development Of after Treatment Metastasis And Death Following 2470 Sean McGuire Salvage Radiation Therapy The Association Of Patient, Tumor 2480 Ferran Ferrer And Treatment Characteristics With Early Toxicity Assessment Of Pelvic 2460 Kenshiro Shiraishi Biochemical Response To Volumetric Modulated Arc Therapy Volumetric Modulated Arc Therapy Neoadjuvant Androgen Deprivation (vmat) With Hypofractionated (VMAT) in the Treatment of Localized Therapy In Prostate Cancer Patients Simultaneous Integrated Boost To Prostate Cancer: Initial Experience in Prostate For High-risk Prostate Cancer 200 Patients 2471 Ross Zeitlin Fiducial Markers, Rectal Saline, and 2481 Ragini Sindhwani 2461 Zachary Nicholas Rectal Balloons as Prostate Quantitative Evaluation Of Comparison Of Intra-operative And Localization and Stabilization Neurovascular Bundle Doses In Post-operative Dosimetric Parameters Strategies in Patients Receiving Low-dose-rate Prostate For The Urethra And Prostate In Proton Therapy Brachytherapy Using I-125 Seeds Patients Undergoing Low-dose-rate Prostate Brachytherapy
142 ASTRO 2013 / 55TH ANNUAL MEETING 2482 Shruthi Arora 2491 Oleg Sostin 2502 Skyler Johnson Primary Radiation Therapy Is IPSS and SHIM Score Trends in The Interval to Biochemical Failure is Equivalent To Robotic Prostatectomy Prostate Cancer Patients after IMRT: Prognostic for Metastasis, Prostate Plus Adjuvant Radiation Therapy Eff ects of Pretreatment Urinary Cancer Specifi c and Overall Mortality In Patients With High Risk Prostate Function and Electromagnetic Following Salvage Radiotherapy for Cancer Tracking Prostate Cancer
2483 Andrew McDonald 2493 Constantine Mantz 2503 Caspian Oliai Psa Response To Neoadjuvant Real-Time Target Tracking Prostate Prospective Quality Of Life And Androgen Deprivation Is An SBRT Utilizing Varian Trilogy and Effi cacy Of High-dose-rate Independent Prognostic Marker And the Calypso 4D Localization System: Brachytherapy Salvage For Recurrent May Identify Patients Who Benefi t 5-Year Quality of Life and Disease Prostate Cancer From Pelvic Lymph Node Irradiation Outcomes 2504 Kentaro Nishioka 2484 Parvesh Kumar 2494 Jay Ciezki Safety, Stability, and Location of Preliminary Results of an On-Going Salvage Brachytherapy for Prostate Implantation of Multiple Gold Markers Phase I/II Trial of Tri-Modality Therapy Bed Recurrence following Radical into the Soft Bladder Wall by Rigid using Hormonal Therapy, Radiation Prostatectomy Cystoscopy Therapy (RT) and concurrent Docetaxel in Patients with High Risk 2495 Takuya Shimizuguchi 2505 Julie Jung Kang Pathologic T2-3N0M0 Prostate Cancer The Benefi t Of IMRT On Rectal Late Defi nitive Chemoradiation in Bladder Toxicity Following Defi nitive Cancer: Whole Bladder vs. Partial 2485 Stephanie Markovina Radiotherapy For Prostate Bladder Image-Guided IMRT Risk of Biochemical Failure in Patients with High Risk Prostate Cancer 2496 Prachi Jain 2506 Daniel Lindsay Treated Defi nitively or Active Surveillance for Prostate Toxicities and Survival of Elderly Post-operatively With Intensity Cancer: A Single Institution Patients with Muscle-invasive Bladder Modulated Radiation Therapy Experience Cancer Treated with Defi nitive Bladder Preservation Therapy 2486 Maria Kelly 2497 Daniel Shasha Intraprostatic Placement of Markers Very High Potency Preservation Rates 2507 E.M. Van der and/or Electromagnetic Transponders in Young Men (< 60) after Radiation Steen-Banasi in the Radiation Oncology Therapy for Prostate Cancer Laparoscopic Bladder Implantations Department is Associated with In Solitary Bladder Cancer. Inevitable Minimal Morbidity 2498 Oren Cahlon Evolution? Diff erences in Baseline Patient 2487 David Paul D’Souza Characteristics in Patients Receiving 2508 Curtis Bryant Prostate Cancer Brachytherapy: Proton Beam Therapy and IMRT for Bladder-preservation Therapy for Does Real-Time Dynamic Ultrasound Prostate Cancer Small Cell Carcinoma of the Bladder Planning with Continuous Feedback Produce Dosimetry Predictive of the 2499 William Hartsell 2509 Francesca Caparrotti Subsequent CT/MRI Dose Prostate Size Does Not Correlate With Conservative Trimodality Treatment Distribution? Acute Genitourinary Symptoms In For Invasive Bladder Cancer: A Patients Treated With Proton Beam Comparative Non-randomized 2488 Kevin Stephens Therapy Study Of Two Chemoradiotherapy Salvage Radiation Therapy after Schedules Post-Prostatectomy Failure: Benefi ts 2500 Sarah Grabowski of Hormonal Therapy and Pelvic Androgen Deprivation Therapy is 2510 Dayssy Diaz Pardo Nodal Radiation Are Not Necessarily Associated with a Signifi cant Change Neoadjuvant Radiotherapy Improves Limited to “High-Risk” Cases in Prostate Volume Throughout Survival In Patients With T2b/T3 Defi nitive Radiotherapy for Localized Invasive Bladder Cancer 2489 Akash Parekh Prostate Cancer No Diff erence In Late Toxicity With 2511 Guy Turgeon Postoperative Radiation Therapy 2501 Skyler Johnson Hypofractionation IMRT in Combined Following Open Or Robotic The Impact Of Anticoagulant Use On Modality Treatment for Bladder Prostatectomy Clinical Outcomes In Men Treated Preservation in Elderly Patients With With Defi nitive And Salvage Invasive Bladder Cancer 2490 Matthew Schutzer Radiotherapy Simultaneous Integrated Boost for 2512 Javier Lopez-Araujo Biochemical Failure after Bladder Preservation using Prostatectomy with a Recurrent Neoadjuvant Chemotherapy and Nodule on Multiparametric MRI Continuous Defi nitive Chemoradiotherapy for Muscle Invasive Bladder Cancer
ASTRO 2013 / 55TH ANNUAL MEETING 143 2513 William Baquero 2522 Guangyu Zhang 2532 Masaru Wakatsuki Is There Still A Role For Postoperative Adjuvant Pelvic Intensity-Modulated Carbon Ion Radiotherapy For Locally Radiotherapy In High Risk Stage III Radiotherapy and Concurrent Advanced Adenocarcinoma Of The Renal Cell Carcinoma? A Docetaxel and Cisplatin Uterine Cervix Retrospective Study Chemotherapy for Postoperative Cervical Cancer With Adverse Risk 2533 Goura Rath 2514 Aamer Mahmud Factors: A Retrospective Report on Role Of Pet-ct In Predicting Clinical Management of Nodes in Patients Toxicity and Outcomes Outcome In Patients With Recurrent diagnosed With Penile Cancer Based Carcinoma Cervix Following Defi nitive on Pathologic Indicators 2523 Alexander Whitley Radiation Therapy Eff ects of Full vs Empty Bladder on 2515 Yohann Rouscoff Total Equivalent Dose to Organs at 2534 Jinyi Lang High-dose Rate Interstitial Risk in 3D Image-Based Planning of Preliminary Clinical Outcomes and Brachytherapy For T1-2 Penile Cancer: High-Dose-Rate Intracavitary Dosimetry Study on Adaptive IMRT A Real Alternative Brachytherapy for Cervical Cancer Integrated HDR Brachytherapy in Local Advanced Uterine Cervical 2516 Roger Macklis 2524 Yoo Kang Kwak Cancer Comparative Review of Radium Comparison of IMRT versus Toxicity and Physiology Data Conventional Radiotherapy 2535 Dominique Rash Obtained From Historical DOE Concerning Acute Toxicities in Lumbosacral Plexus Dose with High Archives Analyzed in Reference to Cervical Cancer Treatment Dose Rate (HDR) Brachytherapy for Recent Clinical Info For ALSYMPCA Locally Advanced Cervical Cancer HRPC Bone Mets Ra223 Trial 2525 Emily Dunn Risk And Benefi t Analysis Of 2536 Yang Bo 2517 Abhilasha Patel Concurrent Chemoradiation (CRT) Dosimetric Comparison Of Volumetric Clinical Outcomes of Primary Urethral Versus Radiotherapy Alone (RT) For Arc Modulation With Rapidarc And Cancer Treated with Multi-Modality Cervical Cancer In Patients Age 60 Fixed Field IMRT For Cervix Uteri Therapy: A Single Institution And Older Radiotherapy Experience 2526 Jehee Choi 2537 Daisuke Irie 2518 Sigolene Galland Radiobiological Evaluation of Cervical Dose Escalation Study of Carbon Ion Multimodality Management In Cancer Treatments with HDR Radiotherapy for Locally Advanced Primary Urethral Cancer: The Role Of Brachytherapy Squamous Cell Carcinoma of the Radiation Therapy Uterine Cervix 2527 Takahiro Oike Can Combined Intracavitary/ 2538 Hilary Bagshaw interstitial Approach Be An Patterns of Care with Brachytherapy GYNECOLOGICAL CANCER Alternative To Interstitial for Cervical Cancer Brachytherapy In Computed 2519 Igor Sirak Tomography-guided Adaptive 2539 Mary Dean Incidence of Retroperitoneal Failure Brachytherapy For Gynecological Outcomes of Cervical Cancer Patients after Pelvic Chemoradiation in Malignancies: A Dosimetric Study with PET Positive Lymph Node Cervical Carcinoma with Negative Metastases and Bulky Tumors PET/CT Staging of Retroperitoneum 2528 Matthew Chin following PET Guided Intensive Outcomes for High Dose Rate (HDR) Radiation Therapy and Chemotherapy 2520 Tamer Refaat Brachytherapy in the Treatment of Two-dimensional Volume Based Cervical Cancer 2540 Rafi Kabarriti Pulsed Dose Rate Brachytherapy Intensity Modulated Radiation Boosting with Concurrent 2529 Robert Kim Therapy in the Treatment of Intact Chemoradiation As A Defi nitive Image-Guided Brachytherapy for Cervical Cancer Gives a Low Toxicity Treatment Modality For Bulky Cervical Cervical Cancer: 3-D Analysis of D2cc Profi le Cancer and Anatomical Factors Aff ecting D2cc in OARs 2541 Takashi Uno 2521 Omar Chibani Failure Pattern in Patients with Heterogeneity Eff ects on 2530 Marie-Anne Froment Intermediate to High Risk Cervical Dose-Volume Parameters used for Evolution of the Incidence Cervical Cancer Treated with Postoperative Planning Gynecologic High-Dose- Cancer among Hispanics and Asians Chemoradiation Using CT-based Rate Brachytherapy: A retrospective in California between 1990 and 2004 Nodal-CTV Delineation CT-based Monte Carlo study 2531 Goro Kasuya Geometric Factors Predicting High D2cc Values In Organs At Risk In Patients With Cervical Cancer Treated With Image-guided Brachytherapy
144 ASTRO 2013 / 55TH ANNUAL MEETING 2542 Ravindra Yaparpalvi 2552 Nancy El-Bared 2563 Yuko Kaneyasu Contouring and Constraining Bowel Robotic Radiosurgery Boost for Ultrasound Sonographic Guided on a Full-bladder CT-scan as per RTOG Cervical Cancer: A Dosimetric Study High-Dose Rate Intracavitary Protocol Guidelines May Not Refl ect Brachytherapy for Medically Bowel Position and Dose Certainty In 2553 Min Rex Cheung Inoperable Uterine Endometrial Gynecological EBRT African American Race And Low Cancer Income Neighborhoods Decreased 2543 Wenjuan Chen Cause Specifi c Survival Of 2564 William Magnuson Large Tumor Volume Shrinkage For Endometrial Cancer: A Seer Analysis Impact of Adjuvant Pelvic Cervical Cancer During Imrt Radiotherapy in Stage I Uterine Treatment 2554 Himanshu Nagar Sarcoma Administration of Concurrent Vaginal 2544 Fumiaki Isohashi Brachytherapy During Chemotherapy 2565 Tosol Yu Dose-volume Analysis Of Predictors for Treatment of Endometrial Cancer The Role Of Adjuvant Therapy In For Gastrointestinal Complications In Uterine Sarcomas After Defi nitive Patients With Cervical Cancer Treated 2555 Audrey Tetreault Surgery With Postoperative Pelvic Adjuvant Chemotherapy and Vaginal Radiotherapy And Concurrent Vault Brachytherapy for Stage 1 2566 Adam Huddleston Nedaplatin-based Chemotherapy Papillary Serous or Clear Cell Stage III Endometrial Cancer Treated Endometrial Cancer With Consolidative Pelvic Radiation: 2545 Aki Kanazawa The Impact of Additional Dose With Outcomes of Concurrent 2556 Sean Szeja Vaginal Brachytherapy Chemoradiotherapy for Effi cacy of Radiotherapy for Stage Neuroendocrine Carcinoma of Cervix III-B Endometrial Carcinoma: A SEER 2567 Shari Damast Analysis 7Gy x 2- An Eff ective Brachytherapy 2546 Jenny Ling-Yu Chen Regimen for Stage I-II Uterine Preliminary Clinical Outcomes of 2557 Sebastia Sabater Papillary Serous Carcinoma Defi nitive Intensity-Modulated Reduction Of Rectal Doses By Radiation Therapy in Locally Removal Of Gas In The Rectum During 2568 Robyn Banerjee Advanced Cervical Cancer with Vaginal Cuff Brachytherapy An Assessment of Organ At Risk Fusion of Full and Empty Bladder at Dose and Inter-Fraction Variability Computed Tomography Simulation as 2558 Rashmi Jadon Using Four Diff erent Applicators Internal Target Volume The Impact of Rectal & Bladder Filling For Intracavitary Gynecologic HDR on Internal Target Volume Margins in Brachytherapy 2547 Neeta Pandit-Taskar Postoperative Endometrial & Cervical FDG PET Imaging in Cervical Cancer Cancer Patients 2569 Michael Dominello Patients Treated with Chemoradiation Predictors of Outcome in Early Stage Therapy 2559 David Guttmann Papillary Serous and Clear Cell Outcomes of Patients with Endometrial Cancer 2548 Lei Ding Carcinosarcoma Treated with Volumetric Dose Summation Between Combined External Beam Radiation, 2570 Jelena Lukovic Brachytherapy Fractions In Patients Brachytherapy, and Chemotherapy Volumetric Modulated Arc Therapy Treated For Cervical Cancer: Versus Four-fi eld Box Radiotherapy Feasibility Of Using Deformable 2560 Christopher Platta For Postoperative Gynecologic Registration Daily Variation in Bladder and Rectal Cancer: Are They Covering The Same Volume During Post-Operative Whole Planning Target Volume Adequately? 2549 Emma Fields Pelvic Intensity Modulated Radiation Dosimetric Comparison Of Tandem Therapy 2572 Mariwan Baker And Ovoids Versus Tandem Alone Three-dimensional Ultrasound Intracavitary Applicators For 2561 Mohamed Elshaikh Assessment For Inter-fractional Treatment Of Locally Advanced The Impact of Adjuvant Radiation Motion Of Uterus Cervical Cancer Treatment on Survival of Patients with High-Risk, Early Stage Endometrial 2573 Israel Deutsch 2550 Craig Baden Carcinoma Minimal Vaginal Displacement with Institutional Outcomes for Paraaortic use of a Rectal Balloon During Pelvic Node-Positive Cervical Cancer 2562 Shushan Rana IMRT for Gynecologic Malignancies Patients Treated with a Novel The Role Of Adjuvant Radiation Dynamic Field-Matching Technique Therapy In Patients With 2574 Christine Chang- Carcinosarcoma Of The Uterus: A Halpenny 2551 Eva Lee Single Institution Analysis Early Stage Papillary Serous or Clear TCP-driven Biological Planning For Cell Carcinoma Confi ned to or High-dose Rate Brachytherapy Involving Endometrial Polyp: Outcomes With and Without Adjuvant Chemotherapy or Radiation Therapy
ASTRO 2013 / 55TH ANNUAL MEETING 145 2576 Neil Desai 2587 Xiaofeng Yang 2597 Pinaki Dutta Patterns Of Relapse In Stage I-II Multi-parametric Ultrasound Imaging To Evaluate the Role of PET/CT Uterine Papillary Serous Carcinoma Of Vaginal Fibrosis Following Imaging in the Post-Operative Set- Treated With Adjuvant Intravaginal Radiotherapy For GYN Malignancies ting of Oral Cavity Squamous Cell Radiation (IVRT) Cancers Prior to Adjuvant Radiation 2588 Audrey Roux Therapy 2577 Nikhilesh Patil Inter-Fraction Variation in Cylinder Image Guided Re-irradiation With Position and Dosimetry in Vaginal Cuff 2598 Jessika Contreras High Dose Rate Interstitial HDR Brachytherapy Limited Neck Volumes in Brachytherapy For Locally Recurrent Post-Operative Radiotherapy for Vaginal Tumors Squamous Cell Carcinomas of the Oral Cavity 2578 Sang-June Park HEAD AND NECK CANCER Optimal Design and Development of 2599 Jae Hong Han a New Vaginal Multichannel Cylinder 2589 Naoki Kai The Incidence and Patterns of Failure Applicator for Gynecologic Assessment of Cervical Nodal-level in Patients with Stage I/II Squamous Brachytherapy Involvement in Patients with Cell Carcinoma of the Oral Cav- Advanced Oral Cancer Treated with ity (SCC-OC) Treated with Surgery 2579 Larissa Lee Preoperative Concurrent Alone: Implications for Adjuvant Salvage Radiotherapy For Chemoradiation Therapy Radiotherapy Recurrent Vulvar SCC: Presentation And Outcome 2590 Yi-Liang Shen 2600 Niranjan Bhandare Can The Contralateral Lower Neck Be The Eff ect of Pre-existing 2580 Sujith Baliga Spared From Postoperative Hypertension on Parameters for Sterotactic Body Radiation Therapy in Radiotherapy For N0-1 Oral Tongue Radiation-induced Optic Neuropathy Oligo-Metastatic Recurrent Ovarian Cancer? Cancer 2601 Edwin Boelke 2591 Jean Hamker Prediction Of Requirement Of 2581 Robert Taylor Supersaturated Calcium Phosphate Artifi cial Nutrition By Dosimetric And High Dose Rate Interstitial Rinse on Oral Mucositis in Head and Clinical Factors In Head And Neck Brachytherapy for Gynecologic Neck Patients Receiving Radiation Cancer Patients Cancer: Diff erential Dose Tolerance and/or Chemotherapy Between Proximal and Distal Vagina 2602 Tamer Refaat 2592 Roshan Prabhu Whole Field Sequential 2582 John Boyle Association of Preoperative Intensity-modulated Radiotherapy Initial Safety and Feasibility of Dose Radiographic Nodal Status in Addition (s-imrt) For Local-regional Advanced Escalation Using a Simultaneous to Traditional Pathologic Factors with Head-and-neck Squamous Cell Integrated Boost in Patients with Outcomes in Patients with Laryngeal Carcinomas Locally Advanced Gynecologic or Oral Cavity Cancer Managed with Malignancies Initial Surgery 2603 Andy Chen Clinical Outcomes Associated with 2583 Mazen Mislmani 2593 Mira Goldberg Evolving Treatment Modalities and Gastrointestinal Toxicity After Robotic A Preliminary Series of The Use of Radiation Techniques for Stereotactic Ablative Radiotherapy Stereotactic Radiosurgery (SBRT) In Base-of-Tongue Carcinoma (SABR) For Treatment Of Metastatic High Risk Head And Neck Cancer Gynecologic Malignancies 2604 Takeshi Yanagi 2594 Michael Herman Usefulness of Induction 2584 Abhilasha Patel Evidence of Effi cacy from Radiation Chemotherapy Followed by Comparison of Conditional Survival in Therapy following Surgery for Oral Chemoradiation in the Treatment of Patients with Gynecologic Cavity Squamous Cell Carcinoma Oropharyngeal Carcinoma Malignancies Treated with Radiation: A Population-based Analysis 2595 Juliette Thariat 2605 Re-I Chin Proton Therapy In Uveal Melanomas: Outcomes of Diabetic Metformin 2585 Charles Wooten How Relevant Is It To Spare The versus Non-Metformin Users with Low Dose Rate (LDR) Interstitial Macula When The Optic Disk Is Oropharynx Carcinoma Treated with Radiation for Gynecologic Involved? IMRT Malignancies: A Single Institution Experience 2596 Takamasa Mitsuyoshi 2606 Edwin Crandley Should The Contra-lateral Lower Neck Analysis Of Treatment Costs And 2586 Indranil Mallick Nodes Be Irradiated In Postoperative Outcomes With The Addition Of Prospective Evaluation Of Radiotherapy For Tongue Cancer? Induction Chemotherapy (IC) To Dose-volume Parameters Concurrent Chemoradiation (CRT) Predicting Acute Diarrhea During For Oropharyngeal Squamous Cell Pelvic Radiotherapy Carcinoma (OPSCC)
146 ASTRO 2013 / 55TH ANNUAL MEETING 2607 Ben Durkee 2617 Shahrokh Iganej 2626 Murat Surucu Adaptive Replanning Does Not Triweekly Carboplatin Alone as Decision Tree Predicting the Tumor Inherently Improve Dose to Concurrent Chemothearpy for Shrinkage for H&N Cancer: Pharyngeal Constrictors in Patients Oropharyngeal Carcinoma Treated Implications for Adaptive with Cancer of the Oropharynx with Defi nitive Chemoradiation: Radiotherapy Outcomes of 120 Unselected patients 2608 Rebekah Maymani and a Comparison to the RTOG 0129 2627 Patrick Richard Unusual Metastatic Follow-Up Seen in Regimen Results Discrepancy Between HPV Positive Squamous Cell Three-Dimensional Imaging and Carcinoma of the Oropharynx Treated 2618 Umamaheswar Duvvuri Nasoendoscopy Exam for Head and with Defi nitive Therapy Transoral Robotic Surgery And The Neck Cancer: Implications for Staging Cervical Unknown Primary: The Utility and Radiotherapy Target Delineation 2609 Farzan Siddiqui Of Discovering Occult Primary Lesions Oropharyngeal Cancer In Young 2628 Wei Liu Adults: An Alarming National Trend 2619 Junlin Yi Eff ectiveness of Robust Optimization Signifi cant Reduction of Salivary in Oropharynx IMPT Planning 2610 Jeff rey Vainshtein Gland Volumes After the fi rst Utility of Post-Chemoradiotherapy two-week standard fractionation 2629 Uttam Sinha FDG-PET/CT Response for Prediction IMRT For Head and Neck Cancer Eff ects Of UES Dilatation On Head of Locoregional Control in HPV- And Neck Cancer Patients Post related Oropharyngeal Cancer 2620 Wendy Gao Radiotherapy Local Recurrence And Progression Is 2611 Jeff rey Vainshtein Spatially Correlated With Focal 2630 Wenyong Tan Molecular Markers and Imaging: Pretreatment Fmiso Pet Uptake In Target Volume And Position Variations Prognostic Implications for Head And Neck Scc During Intensity-modulated HPV-related Oropharyngeal Cancer Radiotherapy For Patients With 2621 Yao Yu Locally Advanced Nasopharyngeal 2612 Moses Tam T-stage and Presence of Level III-V Carcinoma Sparing Low-risk Nodes In Node Cervical Lymph Node Metastasis Positive (n+) Oropharyngeal Predict for Submandibular Nodal 2631 Su Qiu Carcinoma (OPC) Improves Dysphagia Involvement in Patients with Re-irradiation Treatment In 168 Outcomes And Chronic PEG Rates Oropharyngeal Carcinoma: Cases Recurrent T1-2 Nasopharyngeal Implications for Submandibular Carcinoma 2613 Moses Tam Gland-Sparing Intensity-Modulated Sparing Bilateral Ib And Contralateral Radiotherapy 2632 Takeshi Kodaira High Level II Nodes In Node Positive Clinical Effi cacy Of Helical (n+) Oropharyngeal Carcinoma 2622 Laurence Bernier Tomotherapy For Nasopharyngeal (OPC) Improves Quality Of Life On A Regional Outcome In N2-N3 Patients Cancer Treated With Defi nite Prospective Self-reported Xerostomia With Head And Neck Carcinoma In Concurrent Chemoradiotherapy Questionnaire Function Of FDG PET/CT Results 2633 Julie Greenwalt 2614 Abhinav Dewan 2623 Patrick Richard Primary Radiation Therapy for A Comparative Dosimetric Analysis Incidence and Impact of Dental Adolescent and Young Adult Patients By Delivery Of Adaptive Radiotherapy Amalgam Artifact on Radiotherapy with Nasopharyngeal Cancer In Locally Advanced Head And Neck Target Volumes in Oropharyngeal and Cancer Oral Cavity Cancer 2634 Brandon Barney External Beam Radiotherapy Followed 2615 Tobin Strom 2624 Hasan Husaini by Stereotactic Stereotactic Prophylactic PEG Tube Placement Eortc Qol Rating, Performance Status Radiosurgery for Primary Does Not Decrease the Risk of And Oral Outcomes In Head And Neck Nasopharyngeal Carcinoma with Hospitalization in Patients with Cancer Patients Treated With Intracranial Extension Oropharyngeal Squamous Cell Chemoradiotherapy Carcinoma Treated with 2635 Pin-I Huang Chemoradiotherapy 2625 Susan Guo Effi cacy And Factors Aff ecting Patterns of Metastases in Patients Outcomes Of Re-irradiation Using 2616 Todd Carpenter with Human Papillomavirus/ Conformal Radiotherapy In Patients Prevalence Of Histopathologic p16-Associated (HPV+) Squamous With Locally Recurrent Indications For Adjuvant Radiation Cell Carcinoma of the Oropharynx Nasopharyngeal Carcinoma Following Transoral Robotic Surgery (SCC-OP) (TORS) For Oropharyngeal Cancer (OPC) And Its Relation To HPV Status
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 147 2636 Sarah Hamilton 2646 Qichao Zhou 2656 Jolanta Mrochem- Nasopharyngeal Carcinoma (NPC) in Tumor Control Probability After Kwarciak British Columbia (BC): a Population Re-Irradiation Using Intensity- Potential Role Of Albumin And Based Comparison of Asian and Modulated Radiotherapy For Locally C-reactive Protein As Prognostic Non-Asian Patients (pts) Recurrent Nasopharyngeal Carcinoma Factors For Radiotherapy (RT) In Patients With Head And Neck Cancer 2637 Qi Shi 2647 Hassan Iqbal (HNC) Preliminary Results of 18F-FLT PET Gemcitabine Cisplatin with and 18F-FDG PET in Evaluating Tumor Concurrent Chemoradiation in 2657 Parag Sevak Proliferation and Metabolism and Locally Advanced Nasopharyngeal Intensity Modulated Radiation Predicting Response to Carcinoma Therapy for T1 Glottic Cancer: Initial Chemoradiotherapy in Clinical Outcomes Nasopharyngeal Carcinoma 2648 Fiori Alite Need for Monte Carlo Treatment 2658 Michael Scott 2638 Lin Ma Planning in Nasopharyngeal Tumors Toxicities of Radiation Therapy for Treatment of Nasopharyngeal the Defi nitive Treatment of Early Carcinoma with Helical Tomotherapy: 2649 Charles Woods Stage Glottic Carcinoma Comparing A Retrospective Study of 190 Cases Comparison Between IMRT and 3D Conventionally and Hypofractionated in China CRT in Laryngeal Cancer Patients Regimens Treated on RTOG 0522 2639 Tomohiro Matsuura 2659 Niranjan Bhandare Clinical Outcomes Of Imrt Planned 2650 Antonin Levy Voice Rehabilitation after Total With Or Without Pet/ct Simulation For Squamous Cell Carcinoma Of The Laryngectomy and Postoperative Patients With Pharyngeal Cancers Larynx With Subglottic Extension: Is Radiation Therapy Larynx Preservation Possible? 2640 Chiahsuan Lai 2660 Vasanthan Sakthivel Estimation of Life Expectancy and 2651 Kurt Meyer Comparison Of Biological Based And Quality Adjusted Life Expectancy Patterns of Local Failure in Locally Physical Based Optimization in Non-metastatic Nasopharyngeal Advanced Larynx and Hypopharynx Algorithm In Treatment Of Cancer Patients Treated by Intensity Cancers Hypopharyngeal Tumors using VMAT Modulated Radiotherapy With or Technique Without Chemotherapy 2652 Jeff rey Lemons Can It Stay Or Should It Go? A 2661 Jason Sun 2641 Feng Jin Comparison Of T4 Laryngeal Cancer Anatomic And Dosimetric Induction Chrono-chemotherapy Plus Management Correlation In The Treatment Of Radiotherapy For Nasopharyngeal Advanced Larynx Cancer - When Is Carcinoma: A Phase Ii Prospective 2653 Sherry Zhao The Brachial Plexus At Risk? Randomized Study 3DCRT and IMRT Improve Local Control Versus Opposed Laterals In 2662 Chunying Shen 2642 Qichao Zhou Early-stage Squamous Cell Outcomes of Primary Mucosal Radiation-Induced Trismus After Carcinoma Of The Larynx Melanoma Originated from Re-Irradiation With IMRT For Locally Sinonasal Tract Recurrent Nasopharyngeal Carcinoma 2654 Jun Won Kim Comparison of Treatment 2663 Kaitlin Christopherson 2643 Qin Lin Outcome between Organ-Preserving Radiation Therapy for Sinonasal The Value of FDG PET/CT for Early Chemoradiation and Radical Surgery Undiff erentiated Carcinoma Predicting the Effi cacy of followed by Radiotherapy in Stage III/ Radiotherapy in Nasopharyngeal IV Hypopharyngeal Cancer 2664 Justin Peacock Carcinoma Risk of Delayed Lymph Node 2655 Newton Hurst Metastasis in Cases of 2644 Qichao Zhou Radiographic Evidence of Cartilage Esthesioneuroblastoma With a Radiation-Induced Massive Invasion Does Not Predict Outcomes Clinically N0 Neck Hemorrhage After Re-Irradiation Of for Patients Treated with Locally Recurred Nasopharyngeal Laryngectomy and Adjuvant 2665 Yukiko Hattori Carcinoma Chemoradiation versus Improved Prognosis of Patients with Organ-Preservation Therapy Nasal N/K T-cell Lymphoma Treated 2645 Feng Mei by Chemoradiotherapy Tumor Volume Is An Independent Prognostic Factor For Local Control Of 2666 Marcher Thompson Nasopharyngeal Carcinoma Patients A Single Institution’s Experience with Treated With Intensity-modulated Maxillary Sinus Cancer Radiotherapy
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
148 ASTRO 2013 / 55TH ANNUAL MEETING 2667 Andrea Russo 2676 Jeanny Kwon 2688 Abimbola Orisamolu Long Term Outcomes after Proton Role of Adjuvant Postoperative Setup Uncertainty as Determined by Beam Therapy for Sinonasal External Beam Radiotherapy for Well Daily Image-Guided Radiotherapy Squamous Cell Carcinoma Diff erentiated Thyroid Cancer (IGRT) for Head and Neck Cancer (HNC): Evaluation of Safety and 2668 Makoto Saito 2677 Natasha Townsend Implications on Defi ning Planning Treatment Outcome Of Combined When do I Radiate? Age Implications Target Volume (PTV) Margins Radiation Therapy And Intra-arterial for Diff erentiated Thyroid Cancer (IA) Chemotherapy For Advanced Management 2689 Vinita Takiar Maxillary Sinus Carcinoma Reirradiation of Head and Neck 2678 Juliette Thariat Cancers: An MD Anderson Update 2669 Mauricio Gamez External Beam Radiotherapy Excellent Outcomes and Orbital Experience In Non-anaplastic Thyroid 2690 Marija Popovic Preservation for Advanced T4 Carcinoma, A Rare Cancer Network Three-Dimensional Rendering of Sino-Nasal Cancers using Combined Study Mandibular Dose Distribution: an Aid Chemotherapy, Intensity Modulated in Long-Term Dental Care Radiation Therapy and Surgery 2679 Katsuyuki Karasawa Radioactive Treatment in Patients 2691 Ziwei Wang 2670 Jeff rey Wu with Metastatic Well-diff erentiated Prospective Analysis of Measured Excellent Long-term Outcomes for Thyroid Cancer Oral Mucosal Dose and Oral Mucositis Patients with Localized Low/ (OM) in Head and Neck Cancer (HNC) Intermediate Grade Parotid Cancers 2680 Vangipuram Shankar Patients During IMRT with Close/Positive Margins Deglutition Induced Dose Deformations In Head And Neck 2692 Masaru Takagi 2671 Xiaofeng Yang Cancer IMRT Treatments - Volume Treatment Outcomes of Proton or Quantitative Ultrasound Evaluation Shuttle Imaging Analysis Carbon Ion Radiotherapy for Adenoid of Post-Radiotherapy Sialadenitis Cystic Carcinoma of the Head and and Fibrosis of the Parotid Glands in 2681 Christiane Matuschek Neck Patients following Head-and-Neck Feasibility Of 6 Months Maintenance Radiotherapy Cetuximab After Adjuvant Concurrent 2693 Michael Mix Chemoradiation Plus Cetuximab In Randomized, Double-Blind, 2672 Cheng-En Hsieh Squamous Cell Carcinoma Of The Placebo-Controlled, Multi-Center Postoperative Radiotherapy for Head And Neck Phase II Trial of Selenomethionine as Salivary Gland Malignancies: Risk a Modulator of Effi cacy and Toxicity of Stratifi cation for the Impact of 2682 Bhishamjit Chera Chemoradiation in Locally-Advanced Concurrent Chemotherapy External Beam Radiotherapy is Squamous Cell Carcinoma of the Head Associated With Increased Variability and Neck 2673 Aileen Kim in Retinal Venous Oxygenation Adaptive Treatment Planning with 2694 Waleed Mourad F-18 FDG-PET and CT Scans to 2683 John Vargo Lower Cranial Nerves contouring Atlas Optimize Parotid Sparing in Head and Postoperative Adjuvant Stereotactic for Head and Neck Cancer Radio- Neck Cancer Body Radiotherapy (SBRT) ± therapy Cetuximab Following Salvage Surgery 2674 Osamu Muraoka in Previously Irradiated Head and 2695 Martin Vallieres Functional Outcomes Of The Facial Neck Cancer FDG-PET Image-derived Features can Nerve After Post Operative Radiation Determine HPV Status in Head and Therapy For High Risk Parotid Gland 2684 Dawn Owen Neck Cancer Malignancies Underwent Radical Stereotactic Radiosurgery for Head Surgery With Facial Nerve Resection and Neck Malignancies 2696 Vinita Takiar And Reconstructive Surgery Disease Control and Toxicity 2685 Yingjie Wang Outcomes Comparing Ruthenium and 2675 Nagy Elsayyad The Inspiring Treatment of Body Iodine Eye Plaque Brachytherapy in Clinico-Epidemiological Gamma Knife for Patients with the Treatment of Intraocular Characteristics and Patterns of Pulmonary Metastases Derived From Melanoma Locoregional Treatment of Soft Tissue Adenoid Cystic Carcinoma of the Sarcomas (STS) of the Major Salivary Head and Neck 2697 Randa Tao Glands: A Surveillance Outcomes and Patterns of Recurrence Epidemiology and End Results (SEER) 2687 Abhishek Solanki of Orbital Carcinomas Treated with Database Analysis Similar Outcomes in Hispanics and IMRT Non-Hispanics After Radiotherapy for Head and Neck Squamous Cell Carcinoma
ASTRO 2013 / 55TH ANNUAL MEETING 149 2698 Maria Aguirre 2709 Jacob Rasmussen 2719 Cessal Kainickal Survival Outcomes of Reirradiation Prognostic Value Of 18F- Phase IIB Randomized Trial with Intensity-Modulated Radiation Fluorodeoxyglucose SUVmax in Head Comparing Concurrent Therapy (IMRT) for Recurrent Head and Neck Cancer Depends On The Chemoradiation To Six Fractions A and Neck Squamous Cell Carcinoma Gross Tumor Volume Week Accelerated Radiotherapy In Advanced Squamous Cell Carcinomas 2699 Kang-Hsing Fan 2710 Charlotte Brouwer Of Head And Neck Treatment Result of Advanced Diff erences In Delineation Guidelines Synchronous Head and Neck and For Head & Neck Cancer Result In 2720 Nevine Hanna Esophageal Cancer Inconsistent Dose And Corresponding Relationship of Osteoradionecrosis NTCP-values of the Mandible to Radiation Dose, 2700 Evrim Bayman Dmax, and Age in Oropharyngeal Patterns of Failure After 2711 Richard Cardoso Cancer Patients Intensity-Modulated Radiotherapy A Retrospective Review of for Head and Neck Squamous Cell Radiation-Induced Trismus In Head 2721 Shinn-yn Lin Carcinoma And Neck Cancer: An M.D. Anderson Comparison of Repositioning Experience Accuracy and Comfort Survey in Two 2701 Mark Ranck Head Supports Used inside the Same Improved Local Control In Head And 2712 Lauren Herman Available Immobilization Systems for Neck Cancer With Post-Radiotherapy Improved Outcomes With Treatment of Head and Neck Target Neck Dissection Carboplatin-Paclitaxel Compared to Docetaxel-Cisplatin-5-Fluorouracil 2722 Andrew Hoover 2702 Henrique Faria Braga Induction Chemotherapy in Locally Sensitivity of 3 Month Surveillance Radiotherapy in Very Advanced and Advanced Squamous Cell Cancer of PET/CT Imaging Among Head and Unresectable Head and Neck Cancer the Head and Neck Neck Cancer Patients Decreases (IVB/IVC): When to Avoid Radical with Increasing Length of Clinical Treatments? 2713 Christopher Chapman Follow Up Dose-eff ect Relationship of MRI 2703 Xiangrong Qi Perfusion Changes in the Pharyngeal 2723 Indranil Mallick Feasibility of Margin Reduction for Constrictors After Head and Neck The Planning Target Volume Is An Level II and III Planning Target Volume Radiation Therapy Important Predictive Factor For in Head-and-Neck Image Guided Weight Loss During Curative Head Radiotherapy 2714 Bahman Emami And Neck Cancer Radiotherapy - A NTCP Based Adaptive Radiotherapy in Derivation And Validation Study 2704 Nigel Anderson Head and Neck Cancers: A New Look Creating Guidelines for Reactive Into the Old Bottle 2724 An Liu and Prophylactic Enteral Feeding in Eff ect Of CT Contrast On Volumetric Defi nitive (Chemo) IMRT for Head and 2715 Hee Ji Han Arc Therapy Planning For Head And Neck Cancer Outcome Of Dental Implants In Neck Cancer Patients With Previous Radiation 2705 Jonathan Glanzman History To The Head And Neck Area 2725 Adavikolanu Kesava Long Term Outcome and Toxicity of Ramgopal Patients With Head and Neck Cancer 2716 Charlene Kan Comparitive Study Of Response, and Coexisting HIV Infection Treated Intensity-Modulated Radiotherapy Toxicity And Quality Of Life In With Radiation Allows Better Swallowing Function Locally Advanced Head And Neck than Conventional Radiation in Cancers With Concurrent 2706 Azusa Hasegawa Patients with Advanced Head and Chemoradiotherapy With Three Carbon Ion Radiotherapy for Neck Squamous Cell Carcinoma Weekly Cisplatin Vs Weekly Cisplatin Adenocarcinoma of the Head-and- (HNSCC) Regimen Neck 2717 Jonathan Glanzman 2726 Madhava Kanakamedala 2707 Roel Kierkels Patterns of Local Failure in Locally Central Necrosis In Lymph Nodes On Optimizing Treatment Plans with Advanced Head and Neck Cancers CT Scan Predicting Extra Capsular Multivariable NTCP Models Reduces Treated Using PET-CT Based IMRT Extension In Nodes With Biopsy Complication Probabilities in Head Planning: Does Area of Recurrence Proven Head And Neck Malignancies and Neck Cancer Correlate With Pre-Radiation PET? 2727 Madhava Kanakamedala 2708 Daisuke Miyawaki 2718 Jihye Cha Reirradiation Of Head And Neck Radiation Induced Hypothyroidism Cancer Of The External Auditory Cancers: Volume Reirradiated Predicts in Squamous Cell Carcinoma of the Canal: Long-term Clinical Outcomes For Long Term Complications Head and Neck: Comparison between Of T4 Patients Using External-beam Concurrent Chemoradiotherapy and Radiotherapy From 1990 To 2012 Radiation Therapy Alone Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
150 ASTRO 2013 / 55TH ANNUAL MEETING 2728 Shivank Garg 2738 Shilpen Patel 2748 Abigail Berman Re-irradiation For Second Primary Primary Tracheal Malignant Standardizing the Radiation Oncology Or Recurrent Cancers Of The Head Neoplasms: a Single Institution Medical Student Elective: A Novel And Neck: Composite Dosimetric Retrospective Analysis of Treatment Curriculum and Evaluation of Student Measures To Evaluate Dose To The and Outcomes Satisfaction Carotid Arteries 2749 Marie Andree Fortin 2729 Jennifer Logue HEALTH SERVICES RESEARCH Assessing The Benefi ts Of Comparing Acute Toxicity Outcome Implementing An Oncology of Chemoradiotherapy Regimens in 2739 Ruben Quek Electronic Medical Record In A New Head and Neck Cancer Determinants Of The Combined Use Cancer Center Of External Beam Radiation Therapy 2730 Clementina Ramos And Brachytherapy For Low-risk 2750 Aidan Leong Bilateral Neck Irradiation Confers a Localized Prostate Cancer Integration Of A 3D Virtual Higher Risk of Developing Radiotherapy Environment System Hypothyroidism in Patients with Head 2740 Andrew Pearce For Clinical Patient Education and Neck Cancer Evaluation of Canada’s First Radiation Oncology Treatment Facility Operated 2751 Timothy Robinson 2731 Manpreet Tiwana by Telemedicine Longitudinal Trends In Costs For Head and Neck Cancers as Second Palliative Radiation For Metastatic Primary Following an Index Head 2741 Ruben Quek Prostate Cancer and Neck Cancer: Population-Based The Role Of The Urologist In Whether Outcomes over a 25 Years Period Locoregional Prostate Cancer Patients 2752 Joshua Elson Consult With A Radiation Oncologist Risk Of Unplanned Hospitalization 2732 Jasbir Jaswal During Treatment With Concomitant Teaching Oncology Residents 2742 Daniel Chang Radiochemotherapy Anatomy: A Novel, Hands-on Factors that Determine Academic Multidisciplinary Teaching versus Private Practice career interest 2753 David Grew Intervention in Radiation Oncology Residents in The Impact of Superstorm Sandy the United States: Results of a on the Care of Radiation Oncology 2733 Pretesh Patel Nationwide Survey Patients Reduced Volume Irradiation for Head and Neck Cancer of Unknown Primary 2743 Anand Shah 2754 Benjamin DiPardo (HNCUP) Malignant Pleural Mesothelioma Dramatic Variation in the Global Patients’ Willingness to Participate Burden of Esophageal Cancer: A 2734 Ava Golchin in a Randomized Controlled Trial of Disability-Adjusted Life Years Reduction In Tumor Volume Radical Pleurectomy With or Without Approach Following Induction Chemotherapy Intraoperative Photodynamic Therapy For Locally Advanced Squamous Cell 2755 Nadine Housri Carcinoma Of The Head And Neck 2744 Malcolm Mattes Non-white Women Are As Likely As Improves Parotid Dosimetry The Evolving Role of Regional White Women To Receive Radiation Oncology Societies in Hypofractionated Radiotherapy For 2735 Nataliya Kovalchuk Resident Education Breast Cancer, But Less Likely To Enroll Correlation between Long-Term In Hypofractionation Clinical Trials Outcome and Volumetric Changes 2745 Zachary Seymour in Primary and Nodal Tumors during Interval from Imaging and Treatment 2756 Abhilasha Patel Intensity Modulated Radiotherapy for in the Radiosurgery Era: How Long is Persistent Disparities in Hispanics Head and Neck Cancer Too Long? with Cervical Cancer in a Major City
2736 Lihong Zhu 2746 Shayna Rich 2757 Julie Carlson An Investigation of 125I Seed Off ering and Enrolling Patients in Improving Quality Of Life and Permanent Plantation for Recurrent Outcomes Tracking or Clinical Trials Increasing Cost Eff ectiveness For Carcinoma in the Head and Neck Cervical Cancer Patients after Surgery and External Beam 2747 Rebecca Clayman Radiotherapy Addressing The Growing Cancer 2758 Rishabh Kapoor Burden In The Wake Of The Aids Development of the Veteran Health 2737 Kaleigh Doke Epidemic In Botswana: A Administration - Radiation Oncology Quantitative Eff ects Of Head And Collaborative Partnership Quality and Safety initiative Neck Lymphedema Therapy (VHA-ROQSI)
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 151 2759 Gita Suneja 2769 Sachin Gulaya 2779 Heather Curry Cancer in Botswana: A Prospective Population-based Study Of Utilization of Hypofractionation in an Cohort Study of Cancer Type, Comorbidity And Non-cancer Insured Population Treatment, and Outcomes Mortality In Head And Neck Cancer 2780 John Greskovich 2760 Justin Bekelman 2770 Nathan Sheets Improving Healthcare Value in The National Radiation Oncology Two-Year and Lifetime Cost- Patients with Stage III-IV Squamous Registry: Approaches to Eff ectiveness of Intensity Modulated Cell Carcinoma of Head and Neck Regulatory Compliance to Promote Radiotherapy versus 3-D Conformal (HNSCC): Cost and Outcome Wide Participation Radiotherapy for Head and Neck Comparison of Two Arms of a Cancer Randomized, Phase III Trial of 2761 Archie Bleyer Defi nitive ChemoRadiation Breast Cancer Mortality Reduction in 2771 Mark Sittig (ChemoRT) the United States between 1969-2009 Intensity Modulated Radiation was Independent of Screening Therapy Represents a Cost-Eff ective 2781 Ewa Szumacher Mammography in the Nine Modality to Deliver Whole Breast Decisional Support For Women 60 Geographically Disperse SEER Irradiation: A Toxicity Analysis Years And Older During Their Regions: More Evidence for Less Treatment For Stage I And Ii Breast Benefi t of Screening Mammography 2772 Christine Min Cancer - Single Institutional Study Whole Brain Radiation Therapy with 2762 Christina Cramer Stereotactic Radiosurgery Boost 2782 Eli Furhang Decreased Radiation Utilization versus Stereotactic Radiosurgery Emergency Preparation For Radiation During The Economic Crisis Of Alone for Brain Metastases: A Oncology: Lessons Learned From A 2008-2009 Cost-eff ectiveness Analysis Natural Disaster
2763 Ajay Kapur 2773 Joseph Hodges 2783 Nicolas Goldstein Inter-rater Variability in the Cost-Eff ectiveness Analysis of Impact of Expected Survival On Assessment of Skin Reactions in Stereotactic Ablative Radiotherapy Decision Analysis For Single Versus Breast Cancer Radiation Versus Single-Fraction External Beam Multiple Fractions of Palliative Therapy-Impact of Grading Scales Radiation in Painful Vertebral Body Radiation For Bone Metastases Metastases 2764 Jason Efstathiou Practice-based Evidence To 2774 Jeff rey Vainshtein Evidence-based Practice: Initial Collaborative Quality Initiative in the HISTORY Challenges In Building The Nror Treatment of Breast and Lung Cancer: An Important Step Toward High 2784 Emma Holliday 2765 Benjamin Mou Quality Cost-Eff ective Care Standing on the shoulders of giants: Eff ect of Radiation Therapy on Initial Results from the Radiation Survival in Rectal Cancer Patients in a 2775 Thomas Lanni Oncology Academic Development Canadian Province: A Cost Analysis of Alternative and Mentorship Assessment Project Population-based Analysis Treatment Modalities Utilized in the (ROADMAP) Management of Early-Stage Testicular 2766 Nitika Thawani Seminoma 2785 Gurleen Dhami Utilization Of Lean Process Gender Distributions in Radiation Improvement During Introduction Of 2776 Elayne V. Arterbery Oncology Residency Compared to Stereotactic Body Radiotherapy And Total Societal Cost Of Care: Analysis Of Other Specialty Residencies: A 20-year Radiosurgery To Decrease Patient Partial Breast With Apbi Or Iort Versus Perspective Rescheduling Conventional Versus Accelerated External Beam Regimens For Breast 2786 Ann Morris 2767 Nirav Kapadia Conservation The Radiation Oncology In-Training SBRT And Surgery For Stage I NSCLC Exam: An Appeal for Better Testing are Associated with Comparably Low 2777 Jennifer Dorth Rates Of Acute Toxicity A Decision Analysis of Primary 2787 Sudha Amarnath Radiotherapy and Androgen Publication Misrepresentation Among 2768 Timothy Showalter Deprivation Therapy Versus Radical Radiation Oncology Residency Complications of post-prostatectomy Prostatectomy for High-Risk Prostate Applicants radiation therapy for prostate cancer: Cancer Outcomes from Longitudinal Health 2788 Christina Chapman Care Utilization Database of the 2778 Arie Dosoretz United States Radiation Oncology Regione Emilia-Romagna, Italy Cost-Eff ectiveness Research and Residency Diversity Over the Past Radiation Oncology: An Analysis of Twenty Years the Published Literature
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
152 ASTRO 2013 / 55TH ANNUAL MEETING INFORMATICS 3098 Lindsey Appenzoller 2792 Kaori Asai Applicability of a General Predictive Spontaneous Pneumothorax After 3088 Rogier Janssen DVH (pDVH) Model to Rare Treatment Stereotactic Body Radiotherapy For Development Of A Protocol-Driven Sites with No Prior Training Data Lung Tumor Script Content Management System For A Commercial Radiotherapy 3099 Lindsey Appenzoller 2793 Yongchun Song Treatment Planning System Effi cient Method to Train pDVH Studies On The Mobility Rules Of Lung Models with Plan Quality Variation Tumors And The Infl uencing Factors 3089 Faisal Vali Present in the Training Cohort A Software Architecture and 2794 Raymond Mak Application for Reporting on and 3100 Lulin Yuan Outcomes after Lung Stereotactic Analyzing Radiation Plans for Modeling Organs at Risk Dose Sparing Body Radiation Therapy in Patients Concordance with Ideal Dose in Head and Neck TomoTherapy and with KRAS-mutant Non-Small Cell Constraints as a Quality Assurance IMRT Plans: A Comparison Study Lung Cancer Parameter 3101 Marc-Andre Renaud 2795 Pengyue Shi 3090 Gary Walker WebTPS: A Complete Web The Relationship Of Serum Nse Level Prospective Randomized Application for Monte Carlo And Metabolic Tumor Volume Or Total Double-Blind Study of Atlas-Based Treatment Plan Recalculation Lesion Glycolysis As Determined By Autosegmentation Assisted Radiation Fdg Pet In Patients With Recurrent Treatment Planning in Head and Neck 3102 Mark Izadbakhsh Small Cell Lung Cancer Cancer Oncology Information system (OIS): Building a Large Integrated and 2796 Suzhen Wang 3091 Deshan Yang Centralized Oncology System to Correlation Of Mediastinal Metastatic A Computer Software Tool For Improve Quality and Safety of Patient Lymph Nodes Displacement With Comprehensive Plan Quality Care Primary Tumor Displacement And Evaluation Adjacent Organs Based On 4dct In 3103 Michael Fan Non-small Cell Lung Cancer 3092 Seth Blacksburg Design Of A Novel Django Web-based Characterizing the Adoption of Tool For IMRT/VMAT Treatment Plan 2797 Norio Katoh Automated, Decision-Based Verifi cation And Evaluation A Retrospective Multicenter Study of Electronic Checklists in a Busy Stereotactic Body Radiation Therapy Academic Practice 3104 Hao Zhang Using a Real-time Tumor-tracking Prostate Cancer Foci Detection and Radiotherapy System for Stage I 3093 Seth Blacksburg Aggressiveness Identifi cation Using Non-small Cell Lung Cancer Improving the Quality and Multi-parametric MRI/MRS and Composition of Electronic Supervised Learning 2798 Aruna Turaka Documentation in a Highly Utilized Twice-daily versus Once Daily Electronic Medical Record 3105 William Yuh Radiotherapy in an Unselected Topology of DCE MR Perfusion Limited-Stage Small Cell Lung Cancer 3094 Yuliang Jiang Pattern within Cervical Cancers Patients: “Medicine-Based” Evidence Normal Tissue Toxicity Criteria in during Radiation Therapy Radiation Therapy 2799 Maria Werner-Wasik 3106 Anil Pyakuryal A Phase II Study of Erlotinib (ERL) and 3095 Tobias Fechter Clinical Application of the Histogram Hypofractionated Thoracic Malignant Glioma Delineation in Analysis in Radiation Therapy (HART): Radiotherapy (HRT) in Patients (Pts) Amino Acid PET-Images Using a 3D An Open-Source Software System in with Non-Small-Cell Lung Cancer Random Walk Approach Radiation Oncology (NSCLC) and Comorbidities
3096 Joseph Moore 2800 Cameron Swanick Multi-institutional/technique Dose Toxicity and Local Control with Comparisons Using Overlap Volume LUNG CANCER Intensity-modulated Radiation Histograms For Diffi culty Therapy (IMRT) Using a Simultaneous Normalization 2790 Amar Kishan Integrated Boost (SIB) Correlation of Clinical and Dosimetric Hypofractionated Approach for 3097 Christine Ball Parameters with Radiographic Lung Non-small Cell Lung Cancer (NSCLC) Three Years of RTDS - A British Success Injury Following Stereotactic Body Story Radiotherapy 2801 Naamit Gerber Brain Metastases in EGFR-Mutated 2791 Lin Zhou Lung Cancer: Is Radiotherapy Radiation Pneumonitis following Necessary? Simplifi ed Intensity-modulated Radiation Therapy for Lung Cancer
ASTRO 2013 / 55TH ANNUAL MEETING 153 2802 Theo Sottero 2812 Victor Mangona 2822 Shalini Garg The Role of Radiation and Clinical Outcomes After Central versus Patterns Of Locoregional Failure In Trimodality Treatment for Malignant Peripheral Stereotactic Lung Stage III Non-small Cell Lung Cancer Pleural Mesothelioma Radiotherapy (SBRT): A Propensity Managed With Defi nitive Score Matched-Pair Analysis Chemoradiotherapy 2803 Bing Lu Concurrent Chemoradiotherapy For 2813 Marco Trovo 2823 Yu Men Stage Iv Non-small Cell Lung Cancer: Plasmatic Cytokine Levels in Lung Clinical Analysis And Role Of Results Of A Prospective, Cancer Patients Undergoing Radiotherapy In Combined Small Cell Single-center Study Defi nitive Radiation Therapy Lung Cancer - A Report Of 44 Patients
2804 Bing Lu 2814 Daniel Arsenault 2824 Aidan Cole The Role Of Thoracic Three- Are Insurance Companies Driving the Impact Of 4-Dimensional CT (4D-CT) dimensional Radiotherapy For Decision Making Process for Stage I On Toxicity, Outcomes And Dose Non-small Cell Lung Cancer Patients Non-Small Cell Lung Cancer (NSCLC) Escalation For Radical Lung Cancer With Bone Oligometastases Patients? Radiotherapy
2805 Diana Lu 2815 Matthew Orton 2825 Omar Mahmoud Comparison of Intensity-modulated Evaluation of Diabetes as a Risk Factor Thoracic-Only Extensive Stage Small Radiotherapy, Adaptive Radiotherapy, for the Development of Clinically Cell Lung Cancer: Assessment of the Proton Radiotherapy, and Adaptive Symptomatic Pneumonitis Following Benefi t of Thoracic and Brain Proton Radiotherapy for Small Cell Stereotactic Body Radiotherapy Radiotherapy Using the SEER Lung Cancer (SBRT) Database
2806 Tetsuo Saito 2816 Nicholas Zaorsky 2826 Richard Cattaneo Impact of Respiratory Gating on Identifi cation Of Kras Mutation In A Diff erentially Dosed Stereotactic Body Tumor Position Variability during Patient With Non-small Cell Lung Radiation Therapy for the Treatment Stereotactic Body Radiotherapy for Cancer Treated With of Lung Cancer with Limited Nodal Lung Cancer Chemoradiotherapy And Metastasis in Patients Unable to Panitumumab: A Possibility To Receive Chemotherapy 2807 Huanpeng Qi Personalize Cancer Therapy Comparative Study Of The Position 2827 Aruna Turaka and Volume Of Related Anatomical 2817 Joe Chang Eff ectiveness and Timing of Structures Between Quiet Clinical Outcome and Toxicity in Prophylactic Cranial Irradiation (PCI) End-inspiration and End-expiration Central Located Stage I or Isolated in Limited Stage Small Cell Lung Three Dimensional CT Assisted With Recurrent Non-Small Cell Lung Cancer Carcinoma (LS-SCLC) Patients: A Active Breathing Control and Treated with Stereotactic Ablative Single Institution Experience Corresponding Phases in Four Radiotherapy Dimensional CT 2828 Shaun Din 2818 Byounghyuck Kim Brachial Plexopathy After High Dose 2808 Jeremy Harris Factors Associated With Stereotactic Body Radiation Therapy Prognostic Metrics on Serial PET for Radiation Pneumonitis After (SBRT) Lung Tumors Treated with Concurrent Chemoradiation For Hypofractionated Radiation Non-small Cell Lung Cancer 2829 Nilan Naik High Local Failure Rates Despite 2809 Steven Lau 2819 Benjamin Hinton Dose Escalation May Support the Stereotactic Body Radiation Therapy SBRT Lung: Fiducial Migration Based Metastatic Self-Seeding Phenomenon in Octogenarians With Early Stage on Fiducial Type and Anatomic in Non-Small Cell Lung Cancer Lung Cancer Location 2830 Ellis Ziel 2810 Michael Milano 2820 Wenjue Zhang Survival Outcomes in Patients with Non-small Cell Lung Cancer (nsclc) Thoracic radiation and Prophylactic Non-Squamous Non-Small Cell Lung After Breast Cancer (bc): A Cranial Irradiation in Extensive Small Cancer Treated with Pemetrexed- vs Population-based Analysis Of Cell Lung Cancer: A Phase II Trial Non-Pemetrexed-based Clinicopathologic Features And Chemoradiotherapy Overall Survival (os) In 3,529 Women 2821 Zongmei Zhou 4D-CT-based Plan Target Volume 2831 Dhwani Parikh 2811 Ming Chen Defi nition In Imrt Of Lung Cancer: The Role of PET/CT in Radiation A Study of the Correlations Between Comparison With A Conventional Treatment Planning for Non-Small the Irradiated Dose to Lymph Node Technique Using General Margins Cell Lung Cancer: Results of a National Regions and Lymph Node Recurrence Survey When Involved Field Radiotherapy Was Used for Limited-stage Small Cell Lung Cancer
154 ASTRO 2013 / 55TH ANNUAL MEETING 2832 Chen Guanhao 2842 Chisa Hashizume 2852 Neil Woody Variation Of Background Activity Aggressive Treatment for T1/2N0M1 Non Small Cell Lung Cancer With Eff ect Pet-based Gross Tumor Volume Lung Cancer (LC) with Metastasis Single Brain Metastasis At Initial In Non-small-cell Lung Cancer: (MET) Only to the Brain: Stereotactic Presentation: Patterns Of Failure After Individual Information Is Needed Body Radiotherapy (SBRT) for Primary Radiosurgery Without Whole Brain Tumor Following Stereotactic Radiation Therapy 2833 Jaehyeon Park Radiosurgery (SRS) or Surgery for Postoperative Radiotherapy For Brain MET 2853 Jordan Torok Incompletely-resection Non-small Patterns of Distant Metastases in Cell Lung Cancer 2843 Kruti Patel Surgically Managed Early Stage Addition of 4D CT Simulation Non-Small Cell Lung Cancer 2834 Wen Feng Decreases Normal Tissue Irradiation Patterns of Local-regional Failure in and Target Exclusion Compared to 3D 2854 Stephanie Casey Completely Resected Stage IIIa(N2) CT Simulation Alone in NSCLC The Impact of Respiratory Gating Non-Small-Cell Lung Cancer Patients: on Toxicity Outcomes for Locally Implications for Postoperative 2844 Hannah Yoon Advanced Lung Cancer Treated With Radiotherapy Target Volumes Predictive Factors for Brain Radical Intensity Modulated Metastases and Relapse and Radiotherapy and Chemotherapy 2835 Izumi Tachibana Prognostic Factors for Survival in Clinical Results of Defi nitive Radiation Stage III-IV Non-Small Cell Lung 2855 Shaun Din Therapy for Postoperative Cancer Predictive Parameters of Stereotactic Loco-regional Recurrence of Body Radiation Therapy Induced Non-Small Cell Lung Cancer (NSCLC) 2845 Raj Rajpara Chest Wall Pain Increasing Pretreatment Tumor 2836 Wenyang Liu SUVmean is Associated with Local 2856 Yuki Mukai Functional Avoidance Of Lung In IMRT Regional Failure after Chemoradiation Comparison of Intensity Modulated Plan With SPECT Imaging for Locally Advanced Non-Small Cell Radiation Therapy planning using Lung Cancer TomoDirect and TomoHelical 2837 Yoshiyuki Shioyama methods in locally advanced Stereotactic Body Radiotherapy for 2846 Elisabetta Parisi Non-small Cell Lung Cancer Stage I Small-cell Lung Cancer: Tomotherapy In The Treatment Of Clinical outcomes in a Japanese Malignant Pleural Mesothelioma 2857 Hong-Qing Zhuang Multi-institutional Retrospective Primarily Analysis Of Radiation Study 2847 Stephen Bowen Pneumonitis And Its Risk Factors In Establishing Dose-volume Patients With Non-small Cell Lung 2838 Lauren Hertan Associations With Grade 3+ Radiation Cancer Treated With Concurrent Evolution of and Predictors for Pneumonitis Incidence: Implications Erlotinib And Thoracic Radiotherapy Pulmonary Fibrosis Following For VMAT Dose Painting Of Lung Defi nitive Thoracic Radiation Therapy Cancer 2858 Lujun Zhao The Effi cacy And Safety Of 2839 Zhouguang Hui 2848 Nicolas Christian- Simultaneous Integrated Boost Postoperative Radiotherapy for Phase II Study of Hypofractionated Intensity-modulated Radiotherapy In Elderly Patients with Resected Radiotherapy in the Treatment of Patients With Stage III Small Cell Lung Pathological Stage IIIA-N2 Non- Oligometastatic Non Small Cell Lung Cancer small-cell Lung Cancer Cancer 2859 Akihiro Haga 2840 Takaya Yamamoto 2849 Lu Bing What Respiratory-Phase CT Is Optimal Reassessing The Prognostic Value Of A Prospective Study with Concurrent In Treatment Planning Of Lung The Maximum Standardized Uptake Chemotherapy and Thoracic Cancer? Value (suvmax) In Fdg-pet By Three-dimensional Radiotherapy for Correcting For The Partial Volume Stage IV Non-small Cell Lung Cancer: 2860 Sudha Amarnath Eff ect And Respiratory Motion Blur In The Impact of Response on Survival Toxicity and Outcomes with the Use Stage I Non-small-cell Lung Cancer of Intensity Modulated Radiation Treated With Stereotactic Body 2850 Entesar Dalah Therapy in Locally Advanced Lung Radiotherapy Partial Volume Eff ect Corrected Cancer: The University of Washington Metabolically Active Tumor Volume Experience 2841 Lujun Zhao From PET For Early-stage Lung Cancer Is Postoperative Radiotherapy 2861 Zhe Ji Necessary for Patients With 2851 Hualei Li Thoracic Re-Irradiation May Be an Completely Resected Small-Cell Lung Automated Co-segmentation Of Option for Recurrent, Metastatic or Cancer: A Retrospective Analysis Tumor Volume And Metabolic Activity Secondary Primary Non-Small Cell Using PET-CT In Non-small Cell Lung Lung Cancer Cancer (NSCLC) Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 155 2862 Lu Bing 2872 Bradley Stish 2881 Dmitriy Meshkov The Study on Importance of Patterns of Intrathoracic Recurrence Pre-radiotherapy FDG PET Predicts Three-dimensional Radiotherapy For and the Impact of Adjuvant Thoracic Radiation Pneumonitis In Non-Small Elderly Patients With Stage IV Radiation in Patients Undergoing Cell Lung Cancer (NSCLC) Patients Non-small Cell Lung Cancer Defi nitive Resection of Small Cell Lung Cancer 2882 Elizabeth Garay 2863 Isabelle Thibault Prognostic Factors For Post-resection Stereotactic Body Radiotherapy 2873 Xiong Wei Recurrent NSCLC Treated With (SBRT) for Primary Non-Small Cell Improved 5-year Disease Free- Defi nitive Radiotherapy Lung Cancer (NSCLC) and Pulmonary Survival And Distant Metastasis-Free Metastases: Analysis of Outcomes and Survival For Patients WithLimited- 2883 Allison Ashworth Predictive Factors for Local Control Stage Small Cell Lung Cancer Who Is There an Oligometastatic State in Had 18F-fl uorodeoxyglucose Positron Non-small Cell Lung Cancer (NSCLC)? 2864 John Varlotto Emission Tomography (PET) Or PET/CT A Systematic Review of Outcomes and Is N-Level Associated with Local Before Chemoradiation Therapy Prognostic Factors Recurrence in Patients undergoing Surgical Resection of Non-Small Cell 2874 Jonathan Grant 2884 Maria Werner-Wasik Lung Cancer? Dosimetric Impact Of Induction Comparison of PET Contouring Chemotherapy On Subsequent Methods in Patients with Early Stage 2865 Kotoha Tatekawa Radiation Treatment Planning In Resected Non-Small Cell Lung Cancer Focal Radiotherapy for Pleural Patients With Inoperable Non-small (NSCLC): A Pathologic-Imaging Dissemination of Thymic Epithelial Cell Lung Cancer Correlation Tumors: Excellent Local Control and Favorable Prognosis 2875 Ritsuko Komaki 2885 Syed Haider Duration of Thoracic Radiotherapy Correlation of Survival to CBCT-based 2867 Fumiya Baba with concurrent chemotherapy is Tumor Response during Evaluation of the Reproducibility of important for the outcome of Patients Chemoradiation in Patients with Lung Tumor Position in with Limited Stage Small Cell Lung Stage III Non-Small-Cell Lung Cancer Respiratory-Gated Stereotactic Cancer (L-SCLC) Body Radiotherapy (SBRT) Using 2886 Mei Ling Yap Fluoroscopy of an On-Board Imager 2876 Tarun Podder Dosimetric Variations To Organs At (OBI) System Chest Wall and Rib Irradiation of Lung Risk Based On Serial 4D-CT Scans Cancer Patients Treated With Robotic During Radiotherapy Treatment For 2868 Daniel Schanne Radiosurgery SBRT Patients With Locally Advanced Pulmonary Changes In FDG-PET/CT Non-small Cell Lung Cancer After Cure Of Small Lung Tumors With 2877 Leonard Ong Stereotactic Ablative Radiotherapy Prognostic Value Of Pre And 2887 Min Li (SBRT): Which Imaging Features Can Post-radiotherapy [18F]FDG-PET/CT Deformable Registration of Lung Be Expected? Metrics In Limited-stage Small Cell Computed Tomography Images Using Lung Cancer Biomechanical Model 2869 Ben Fischer-Valuck Outcomes Following Stereotactic 2878 Inga Grills 2888 Nian Xiao Body Radiotherapy For Biopsy Proven Prospective Phase II Trial of Moderate Toward Individualized Fractionation Versus Radiographically Diagnosed Dose Image-guided Stereotactic Lung Schedule For Lung Cancer Early-stage Non-small Cell Lung Radiotherapy (SBRT) for Early Stage Radiotherapy Cancer Non-small cell lung cancer (NSCLC) and Pulmonary Metastases with Serial 2889 Yankhua Fan 2870 Dean Shumway 18FDG-PET Imaging and Pulmonary The Dependence of Optimal Assessing The Predictive Value of Function Testing (PFT) Fractionation Scheme on Dose Cytokine Levels for Radiation-induced Distribution, Tissue Damage Model Esophagitis In Combination With 2879 Nathan Cannon and Prescription Dose in Radiation Clinical and Dosimetric Parameters Stereotactic Ablative Radiotherapy Therapy of Lung Cancer In Patients Treated for Non-small Cell For Octogenarians With Lung Cancer: Lung Cancer A Single Institution Retrospective 2890 Mirjana Josipovic Review Deep Inspiration Breath Hold 2871 Anthony Michaud Radiotherapy for Advanced Stage Volumetric Changes in Gross Tumor 2880 ChengCheng Fan Lung Cancer is Feasible and Facilitates Volume during Thoracic Radiation Risk Factors For Locoregional Lung Toxicity Reduction Therapy for Small Cell Lung Cancer: Recurrence In Patients With Com- Implications for Adaptive Re-Planning pletely Resected N1 Non-small Cell 2891 Luis Larrea Lung Cancer And Implications For Experience In Stereotactic Adjuvant Radiotherapy Radiotherapy For Lung Cancer
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
156 ASTRO 2013 / 55TH ANNUAL MEETING 2892 Scott Lester 2902 Eric Xanthopoulos 2912 Mitsuhiko Oguri Salvage Radiation For Mediastinal Prophylactic Cranial Irradiation In Infl uence Of Interstitial Pneumonitis Relapse After Treatment With Extensive-stage Small-cell Lung In The Lung On Acute Exacerbation Of Accelerated Hypo-fractionated Cancer Interstitial Pneumonia In The Patients Radiotherapy (AHRT) Or Stereotactic Treated With Stereotactic Body Body Radiotherapy (SBRT) For Stage 2903 Michael Soike Radiation Therapy For Lung Cancers I/II NSCLC Image Guided Radiotherapy Results In Improved Local Control In Lung 2913 Katarina Petras 2893 Matthew Manning Cancer Patients Treated With Predicting Symptomatic Pneumonitis An Overall Survival Comparison of Fractionated Radiotherapy For Stage in Lung SBRT Patients Using Decision Sub-Lobar Resection with IIB-IIIB Disease Tree Analysis Brachytherapy versus Stereotactic Body Radiotherapy for Early Stage 2904 Megan Daly 2914 Shilpen Patel Non-Small Cell Lung Cancer Does Early Post-Treatment Clinical Outcomes of Radiotherapy for Surveillance Aff ect Subsequent Resected Thymoma 2894 Carey Myers Management Following SBRT for Early Inhibition of Aurora A Increases Stage Non-Small Cell Lung Cancer? 2915 Shilpen Patel Sensitivity to Radiotherapy in Improved Survival with Prophylactic Selected Lung Cancer Cell Lines 2905 Ling Li Cranial Irradiation in Modern Cohort Total Lesion Glycolysis (tlg) At of Limited Stage Small Cell Lung 2895 Trevor Lewis Baseline Fdg-pet/ct May Predict Cancer Patients with MRI Brain Predictors of Symptomatic Radiation Survival Better Than Maximum Imaging Pneumonitis (SRP) in Lung Cancer Standard Uptake Value (suvmax) In Patients Treated with Non-small Cell Lung Cancer (nsclc) 2916 Stefano Arcangeli Hypofractionated Radiotherapy Is Hypofractionated (Chemo) (H-RT) 2906 Fiori Alite Radiation Delivered with Helical Does Conformality Matter In Tomotherapy a Feasible Option to 2896 Carey Myers Evaluating Plans For SBRT For Tumors Escalate the Dose in Locally Advanced A Novel Radiation-Induced p53 Of The Lung? Inoperable NSCLC? Results from a Mutation is Not Implicated in the Phase II Trial Development of Radiation Resistance 2907 Abdullah Rasheed The Eff ects of Abdominal 2897 Julian Kim Compression on the Motion and Dose Escalated Hypofractionated Volume of the GTV, Lungs & Heart in LYMPHOMA Intensity Modifi ed Radiation Therapy Lung Cancer Patients (IMRT) with Concurrent 2917 Mehmet Koc Chemotherapy for Inoperable or 2908 Jeremy Kilburn 18F-Fluorodeoxyglucose Positron Unresectable Non-Small Cell Lung Is A Clinical Target Volume (CTV) Emission Tomography/Computed Cancer (NSCLC) Necessary In Treatment Of Thoracic Tomography (18F-FDG PET/CT) Malignancies Treated In The Modern Maximum Standardized Uptake Value 2898 Michael Binkley Era Combining 4-D Imaging And (SUVmax) As A Prognostic Factor In Lung Volume Reduction After Image Guided Radiotherapy (IGRT)? Adult Hodgkin’s Lymphoma Patients Stereotactic Ablative Radiotherapy of Lung Tumors: Potential Application to 2909 Nhu Tram Nguyen 2918 Fransisco Mestre Emphysema Pulmonary Function Test and its Prognostic Value Of Angiogenic Predictive Factors in Patients with And Invasion Markers In Hodgkin 2899 Todd Aguilera Lung Malignancies Treated with Lymphoma Novel Imaging Biomarkers In Stage I Stereotactic Radiotherapy: a Non-small Cell Lung Cancer Treated Retrospective Review from a Single 2919 Jianzhong Cao With Stereotactic Ablative Institution The Effi cacy Of Chop Regimen Based Radiotherapy Concurrent Chemoradiotherapy In 2910 Katsuyuki Karasawa Patients With Nasal Extranodal 2900 Matthew Schutzer Three Dimensional Non-coplanar Natural Killer/ T-cell Lymphoma: A Re-Irradiation for Locally Recurrent Conformal Radiotherapy with Comparison Among Treatment Non-Small Cell Lung Cancer with 75Gy/25fr/5w Regimen for the Modalities Stereotactic Body Radiotherapy as Treatment of Stage I NSCLC - 10-year Initial or Salvage Treatment Experience 2920 Rahul Parikh Long-term Outcomes and Patterns of 2901 Weijun Chen 2911 Haoming Qiu Failure in Orbital Lymphoma Treated The Impact of The CT Dataset Used Esophageal Toxicity in Lung SBRT: with Primary Radiotherapy for Dose Accumulation on Target When it Happens and How to and Normal Tissue Doses in Adaptive Prevent it Radiotherapy for Lung Cancer Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 157 2921 Jessica Freilich 2930 Piera Navarria 2940 Yoshiro Matsuo Combining Low-Dose Whole Brain Low Dose Total Marrow/total Impact of Symptom Rescue by Radiation with Radioimmunotherapy Lymphoid Irradiation (tmi/tli) Instead Fractionated Radiotherapy for Rare for Primary Central Nervous System Of Tbi Induce Full Donor Chimerism Angiogenetic Neoplasm of the Lymphoma Before T-replete Haploidentical Abdomen, Vertebra, and Head and Transplantation Neck Regions 2922 Xu Li-ming Dosimetric Evaluation And Treatment 2931 Reem Ujaimi 2941 Arshin Sheybani Outcome Of Intensity-modulated Pulmonary Toxicity Following Total The Risk of Radiation Induced Radiotherapy Following Body Irradiation for Acute Malignancy with Heterotopic Doxorubicin-based Chemotherapy Lymphoblastic Leukemia: The Ottawa Ossifi cation Prophylaxis: A Case For Primary Mediastinal Large B-cell Hospital Cancer Centre (TOHCC) Control Analysis Lymphoma Experience 2942 Michele Nedelka 2923 Qingfeng Liu 2932 John Mikell Radiotherapy For Early Stage Palmar Immunophenotypic Analysis And Similar Survival for Patients And Plantar Fibromatosis: A Clinical Heterogeneity In Patients Undergoing Reduced-Intensity TBI Treatment Option For Patients Who With Extranodal Nasal-type Nk/t-cell versus Myeloablative TBI as Wish To Avoid Disease Progression Lymphoma Of The Upper Conditioning for Allogeneic And Surgery Aerodigestive Tract Transplant in Acute Leukemia 2943 Waleed Mourad 2924 Ranh Voong 2933 Daniel Kim Clinically Predictive Nomogram for Radiation Therapy is a Very Eff ective Late Lung And Thyroid Toxicities From Heterotopic Ossifi cation Following Modality in the Treatment of Mantle Total Marrow And Lymphoid Surgical Repair and Radiotherapy for Cell Lymphoma, > 80% Complete Irradiation For Patients Undergoing Displaced Acetabular Fractures Disppearance of Disease SIte in Hematopoietic Stem Cell Heavily Pretreated Patients Transplantation
2925 Emiko Katayama 2934 Sung-Hsin Kuo PALLIATIAVE CARE FDG-PET May Be Useful In Clinicopathologic Features and Radiotherapy For Indolent MALT Responses to Radiotherapy of 2944 Sara Alcorn Lymphoma Granulocytic Sarcoma Patterns of Fractionation of Palliative Radiotherapy: A Single-Institution 2926 Mustafa Adli Experience 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed NON-MALIGNANT DISEASE 2945 Bryan Barriger Tomography (18F-FDG PET/CT) Poor Performance Status and Maximum Standardized Uptake Value 2935 Waleed Mourad Transportation Requirements Predict (SUVmax) As A Prognostic Factor In Twenty Five-year Outcome Of Benign for Failing to Complete a Course of Non-Hodgkin’s Lymphoma Patients Lymphoepithelial Cysts Of The Parotid Radiation Therapy Glands In Seropositive HIV Patients 2927 Chelsea Pinnix 2946 David Wilson Intensity Modulated Radiation 2936 Oliver Blanck A Phase II Pilot Single Arm Therapy using Frontal Technique with Cardiac Radiosurgery: Preliminary Prospective Clinical Trial of the STAT Active Breathing Control in the Results in a Porcine Model and RAD Workfl ow for Osseous treatment of Gastric MALT lymphoma: Possible Implications for the Metastases: Preliminary Results Implications for Normal Tissue Treatment of Atrial Fibrillation Sparing 2947 Shane Lloyd 2937 Juergen Dunst Radiation Oncologists’ Attitudes and 2928 Samuel Shin Adjvant HDR-Brachytherapy for Intentions Regarding Palliative Feasibility and Effi cacy of Local Treatment of Recurrent Keloids Radiation Therapy near the End of Life Radiotherapy with Concurrent Novel Agents in Patients with Multiple 2938 Jonathan Glanzman 2948 Jeff rey Friedman Myeloma Surgical Resection Followed by High From Whole Brain to Hospice: Patterns Dose Rate Brachytherapy With of Care in Radiation Oncology 2929 Shane Lloyd Iridium- 192 for Management of Acute Treatment Toxicity and the Risk Keloids at High Risk for Recurrence 2949 Ehsan Balagamwala of Infection during Total Skin Electron Which Factors Determine Pain Relief Beam Therapy for Mycosis Fungoides 2939 Florence Wright from Spine Radiosurgery in Patients A Renewed Application of with Spine Metastases? Results from a Intracoronary Brachytherapy for Large Single Institution Series In-Stent Restenosis at a High-Volume Catheterization Center
158 ASTRO 2013 / 55TH ANNUAL MEETING 2950 Jee Suk Chang PATIENT-REPORTED 2968 Chika Nwachukwu FDG-PET As A Predictor Of Outcome OUTCOMES Health Related Quality of Life in Following Radiotherapy For Bone Pediatric Patients with Low Grade Metastasis In Patients With 2960 Winnifred Wong Glioma Hepatocellular Carcinoma L-lysine In The Treatment Of Oral Mucositis In Head And Neck Cancer 2969 Sheema Chawla 2951 Kirtesh Patel Patients - A Pilot Study Geriatric Assessment In Radiation Intracranial Control for Adjuvant Oncology Clinic: A Pilot Study Whole Brain Radiotherapy Versus 2961 David Jung Stereotactic Radiosurgery Alone for Incidence and Risk Factors for Pain 2970 Abhilasha Patel Resected Brain Metastases Flare Following Spine Radiosurgery Quality of Life Outcomes in Patients with Prostate Cancer treated with 2952 Joshua Meyer 2962 Dan Ou Nodal Irradiation Pain Palliation Of Bone Metastases Magnetic Resonance Sialography to Using Magnetic Resonance Guided Evaluate Radiation-induced 2971 Chenyang Wang Focused Ultrasound - Analysis Of Xerostomia in Patients with Health State Utilities for Patients Factors Predicting Success Early-stage Nasopharyngeal Who Underwent Stereotactic Carcinoma Radiosurgery With or Without Whole 2953 Jinyu Xue Brain Radiotherapy Implication of Biological Doses in 2963 Jordan Kharofa Whole Brain Radiation and Patient Reported Outcomes in 2972 Daniel Bernad Radiosurgery of Multiple Metastases Patients with Non-Melanomatous Comparison of Bowel and Urinary Skin Cancers of the Head and Neck Function in Rectal Cancer Patients 2954 Rebecca Wong (NMSCHN) Treated with Superfi cial Undergoing Pre-Operative Endorectal Palliative Radiation For Spinal Radiation Therapy Brachytherapy Or External Beam Metastases: Does The Presence Of Radiotherapy and Total Mesorectal Soft Tissue Disease Aff ect The Choice 2964 Jessica Zhou Excision Of Treatment Dose And Fractionation? The Eff ect Of Resistance Exercise Training On Health-related Quality Of 2973 Terence Sio 2955 Isabel Prieto Life Of Head And Neck Cancer Dosimetric Correlate of Cancer and Fentanyl Pectin Nasal Citrate, To Patients Undergoing Defi nitive Cardiac-specifi c Survival in 231 Control Breakthrough Pain Provoked Chemoradiation: Results Of A Pilot Patients Who Received Both External By Routine Radiotherapy Procedures Study Beam Radiation Therapy (EBRT) and And Maneuvers In Advanced Cancer Percutaneous Coronary Intervention Patients 2965 Malolan Rajagopalan Initial Report of a Prospective Phase 2974 Robert Olson 2956 Alexandra Sherman II Study Including Patient-Reported Prospective Evaluation of Unmet Does Palliative Radiation Improve Quality of Life Data of Stereotactic Needs of Rural Cancer Survivors: Performance Status? Body Radiotherapy (SBRT) for Patients Comparison between Rural with Oligometastatic Disease Aboriginal and non-Aboriginal 2957 Luis Mariscal Communities Hypo-fractionated Stereotactic Body 2966 Ashlyn Tom Radiotherapy (SBRT) for Pelvic or Prevalence of Patient-Reported 2975 Frank Vicini Sacral Recurrence Gastrointestinal Symptoms and The Use of Bioimpedance Concordance with Clinician Toxicity Spectroscopy to Monitor Therapeutic 2958 Diandra Ayala-Peacock Assessments in Radiation Therapy for Intervention in Patients Treated for Stereotactic Body Radiotherapy Anal Cancer Breast Cancer Related Lymphedema (SBRT) and Image-Guided Accelerated Hypofractionated 2967 David Nowotnik 2976 Ankit Agarwal Radiotherapy (IGAHRT) for the Results From The Multi-institutional, Demographic Determinants of Treatment of Oligometastatic Cancers Randomized, Double-blind, Mortality in Prostate Cancer Patients Placebo-controlled Trial To Assess The at a Diverse Academic Medical Center 2959 Shilo Lefresne Effi cacy Of A Mucoadhesive Hydrogel A Multidisciplinary Rapid Access Rinse In Mitigating Oral Mucositis 2977 Divya Ahuja Clinic - Providing more than just Rapid (OM) In Chemoradiation-treated (CRT) Demographic Determinants Of Access Head And Neck Cancer (HNC) Patients Mortality In Breast Cancer Patients At A Diverse Academic Medical Center
2978 Daniel Simpson Racial Disparity In Consultation, Treatment, And The Impact On Survival In Metastatic Colorectal Cancer
ASTRO 2013 / 55TH ANNUAL MEETING 159 2979 Sommer Wild 2989 Annette Souranis 3000 Katherine Fan Screening Practices And Factors Comparison of Setup Accuracy by Impact of a Single-Day Impacting Screening Uptake In Breast Immobilization Type in Image-Guided Multidisciplinary Clinic on the And Prostate Cancer Survivors Lung Radiotherapy Management of Pancreatic Cancer: 3-Year Update 2990 Jason Molitoris Initial Findings With The Use Of A 3001 James Lamb PATIENT SAFETY Novel Performance Metric To Identify Automated Patient Identifi cation and Institutional Rates Of Radiation Localization Error Detection Using 2980 Yunfeng Cui Discontinuation X-Ray Setup Images Credentialing in Hippocampal (HC) Sparing Techniques for RTOG 0933: 2991 Lydia Handsfi eld 3002 Alexander Markovic Quality Assurance (QA) Report Pre- And Post-Treatment QA Using Multi-Criteria Plan Quality Procedures Proposed To Eliminate Metrics to Perform an Objective, 2981 Richard Valicenti Phantom-Based QA On Tomotherapy Retrospective Analysis of Complex Eff ectiveness Of Hospital-based Head and Neck Plan Quality Incident Reporting And Learning 2992 Ingrid Marshall Diff erences Between Diff erent VMAT System To Manage Radiation HDR Plan Verifi cation Of Source Vendors Treatment Errors Position And Dose Accuracy Using A Fluence Detector 3003 Musaddiq Awan 2982 Hui Geng Interdisciplinary Variation in The Impact of Thread Eff ect on 2993 Marjan Admiraal Segmentation of High-Risk Tomotherapy Quality Assurance With Enhancing Quality and Safety of Post-Operative Tumor Volumes in the Cylindrical Diode Detector Array VMAT using Failure Mode and Eff ect Head and Neck Analysis 2983 Daniel Letourneau 3004 David Rosenthal Linear Accelerator Performance 2994 Matthew Nyfl ot A Dosimetric Comparison of Monitoring and Improvement using Computerized End-of-planning Pharyngeal Constrictor Segmentation Semi-Automated Testing and Checks To Improve Patient Safety Methods During Radiation Treatment Statistical Process Control Based On One Year Of Near-miss for Head and Neck Cancer Incident Reporting Data 2984 Pirus Ghadjar 3005 David Eastham Use Of Eortc Target Defi nition 2995 Tingtian Pang The Impact of Standardized IMRT Guidelines For Dose Intensifi ed Quality Evaluation of An Automatic Templates on Treatment Plan Quality Salvage Radiotherapy For VMAT Planning Method For Head And Recurrent Prostate Cancer. Results Of Neck Cancer Cases 3006 James Mitchell The Quality Assurance Program Of Prospective Peer Review in a The Randomized Trial Sakk 09/10 2996 Danny Duplan Non-Academic Radiation Oncology Peer-review Chart Rounds as a 2985 Wai Wang Lam Component of the Automated 3007 Wanbao Gao Quality Assurance of Helical Workfl ow in a New Department Medical Event Threshold for Tomotherapy Stereotactic Permanent Brachytherapy Must be Radiosurgery Treatment Using 2997 Alexander Lin Greater Than 20% Cylindrical Diode Array System Image Approval Rates for Daily Image-Guided Radiotherapy (IGRT) 3008 Huong Pham 2986 Tony Quang in a Large, Academic Group Setting: Use of the Patient Safety Alert (PSA) Privilege and Immunity-An Variation by Physician Familiarity with System to Improve the Treatment Underutilized Tool in the Quality the Patient Verifi cation Process Improvement Program 2998 Rohan Deraniyagala 3009 Elayne V. Arterbery 2987 Katsunori Yogo Improving Patient Safety One Error at Lean Thinking: A Comprehensive Verifi cation Of A Commercial a Time: Implementing an Electronic Hospital Strategy for Implementing Monte-carlo Electron Error-reporting System in a Radiation State-of-the-Art Breast Intraoperative Dose-calculation Algorithm Under Oncology Clinic Radiation Therapy (IORT) in a Clinical Use For Treatment Of Breast Community Setting And Total Scalp Irradiation 2999 Hamid Ghaff ari Assessing Tumor Coverage and 3010 Neil Martin 2988 Bin Yang Organ-At-Risk Doses during Development And Implementation A Comparison of the Dosimetric Intra-Fraction Motion via Probability Of Customized Software For Physician Properties of a Plastic Scintillator-CCD Mass Function of Real-Time Peer-review And Clinical Care and a Fluorescent Screen-CCD System Respiratory Trajectories in QA of Radiotherapy Beams
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
160 ASTRO 2013 / 55TH ANNUAL MEETING 3011 Steve Braunstein 3021 Chia-Ho Hua 3032 Reid Thompson Increasing Compliance With Postoperative Metabolic Abnormality A Study Of Dosimetry And Documentation Using Modern in Craniopharyngioma Patients Before Radiation-induced Toxicity In The Electronic Health Record Systems Proton Therapy Developing Dentition Of Pediatric Towards Quality Improvement in Patients With Head And Neck Cancer Radiation Practice Medical Coding 3022 Kaitlin Christopherson Factors Impacting Long-term Local 3033 Christine Hill-Kayser 3012 Michael Gensheimer Control in Non-Metastatic Outcomes after Proton Therapy for Simple Rule for Prediction of Parotid Medulloblastoma Pediatric Patients with Cancers of the Gland Sparing Early in the Radiation Head & Neck Region Treatment Planning Process 3023 Andrew Hollander Pencil Beam Scanning (PBS) Proton 3034 Matthew Ladra 3013 Ryan Best Therapy in a Fixed Beam Room for Proton Radiation Therapy for Automated Evaluation of Radiation Treatment of Pediatric Brain Tumors Rhabdomyosarcoma: Preliminary Treatment Plans for Protocol Results From a Multicenter Constraints to Reduce Planning Time 3024 Benjamin Greenberger Prospective Study Mature Clinical Outcomes of Proton 3014 Zachary Lopater Radiation for Pediatric Low-Grade 3035 Amber Orman Selecting Ideal Patients to Gliomas The Essential Role of External Beam Replan - Novel Use of IMRT QA Radiotherapy in the Management of Software Aids in the Decision When 3025 Sean McBride Advanced Stage Retinoblastoma to Replan The Impact of Socioeconomic Factors on Health-Related Quality-of-Life 3036 Atmaram Pai Panandiker 3015 Pranshu Mohindra (HR-QoL) After Proton Radiotherapy Role of Radiotherapy in the Standardized Intensity Modulated for a Pediatric CNS cohort Management of Chemorefractory Radiotherapy (IMRT) Workfl ow to Distant Metastatic Disease in Children Allow Adequate Scheduling Notice for 3026 Noelle Williams with High-Risk Neuroblastoma Patients Treated at a Busy Academic Late Eff ects Following Radiotherapy Radiation Oncology Center: Results of for Childhood Low-Grade Glioma 3037 Shravan Kandula a Pilot Study Outcomes After Defi nitive Radiation 3027 Joseph Panoff Treatment Of Metastatic Sites In 3016 Brian E. Butler The Role of Radiation Therapy Patients With Stage IV Neuroblastoma Standardization and Implementation Technique and Dose for Pediatric of IMRT Among Multiple Institutions Patients with Diff use Intrinsic Pontine 3038 Atmaram Pai Panandiker and Multiple Countries Glioma 4DMRI Provides More Accurate Renal Motion Estimation for IMRT in Young 3017 Srinath Sundararaman 3028 Patrik Brodin Children Improving Patient Safety in the Impact of Treatment Margins and Radiation Oncology Setting Through Treatment Technique in Hippocampal 3039 Maja Maraldo Crew Resource Management Sparing Radiotherapy for Pediatric Estimated Doses and Late Eff ects Medulloblastoma Risks After Involved Node, Involved 3018 Shereef Elnahal Field and Mantle Field Treatment for Patient Factors that Predict Physician 3029 Adam Willson Pediatric Hodgkin lymphoma Room Time and Downstream Clinical Estimating the Excess Lifetime Risk of Encounters in a Pancreatic Radiation-Induced Secondary 3040 Mustafa Adli Multidisciplinary Clinic Malignancy (SMN) in Pediatric 18F-Fluorodeoxyglucose Positron Patients Treated With Craniospinal Emission Tomography/Computed 3019 Dawn Henrich Irradiation (CSI): Tomotherapy (Tomo) Tomography (18F-FDG PET/CT) An Innovative Collaboration And Versus Conventional (Conv) Beams Maximum Standardized Uptake Value Workfl ow Management Platform For (SUVmax) As A Prognostic Factor Surface Electronic Brachytherapy 3030 Joanna Yang In Pediatric Hodgkin’s Lymphoma Intensity-Modulated Radiation Patients Therapy with Dose-painting: A Brain-sparing Technique for 3041 Minh-Phuong Huynh-Le PEDIATRIC CANCER Intracranial Germ Cell Tumors A Comparison of Involved Field Radiation Therapy Treatment 3020 Rimpa Basu Achari 3031 Ashwin Ram Outcomes in Pediatric and Young Three Dimensional Conformal A Prospective Study of Corpus Adult Hodgkin Lymphoma Radiation Therapy, Volumetric Callosum Regional Volumes and Intensity Modulated Arc Therapy and Neurocognitive Outcomes Following Helical Tomotherapy for pediatric Cranial Radiation for Pediatric Brain craniospinal irradiation: Dosimetric Malignancies analysis of integral dose Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 161 3042 Steven Engel 3053 Jonathan Klein SARCOMA AND SKIN CANCER The Role of Low Dose Radiation Health Related Quality of Life in Therapy in Adolescents/Young Adults Head and Neck Cancer Treated with 3064 Daniel Adam Jones with Hodgkin’s Lymphoma Radiation Therapy With or Without Management Of Unplanned Excision Chemotherapy: A Systematic Review For Soft-tissue Sarcoma With 3043 Melissa LeMieux Pre-operative Radiotherapy Followed Decrease in the Incidence of Second 3054 Christina Son By Defi nitive Resection Malignancies in Patients with Early The Impact of Hormonal Therapy on Stage Hodgkins Disease Treated in the Sexual Quality of Life in Men 3065 John Vargo Modern Radiotherapeutic Era Receiving Intensity Modulated The Role of Radiation Therapy in Radiotherapy for Prostate Cancer Primary and Radiation Induced 3044 Omar Gayar Angiosarcoma of the Breast: Impact Pediatric Head And Neck Carcinoma: 3055 Tsz Kin Lee on Patterns of Failure Patient Demographics And Treatment Problems Encountered during Outcomes: A SEER Database Study Cultural Adaptation of the EPIC 3066 Hubert Pan Questionnaire for Prostate Cancer Acute Skin Toxicity of Electronic 3045 Milos Miljkovic into Punjabi and Chinese Brachytherapy for Non-Melanoma The Frequency, Severity, and Duration Skin Cancer of Treatment-Related Lymphopenia in 3056 Penny Fang Children with Cancer High BMI Associated with Worse 3067 Richard Cassidy Quality of Life in Breast Cancer Function Preservation after 3046 Stephanie Terezakis Patients Receiving Radiotherapy Conservative Resection and Clinical Practice Patterns of Pediatric Radiotherapy for Soft Tissue Sarcoma Image-Guided Radiation Treatment: 3057 Henry Wagner of the Distal Extremity as Evaluated Results from an International Pediatric Cancer Treatment Consent Forms Are by the Toronto Extremity Salvage Research Consortium Still Diffi cult to Read Score (TESS)
3047 David Barron 3058 Sarah Milgrom 3068 Michael Scott Radiation-induced Osteochondromas The Acute Eff ects of Pelvic Irradiation Radiotherapy for Revisited: A Retrospective Update on the Adult Uterus by Dynamic Hemangiopericytoma Contrast-Enhanced MRI 3048 David Westerly 3069 Tyler Hollen Proton Energy Requirements for 3059 Vipul Nautiyal Squamous Cell Carcinoma of the a Dedicated Pediatric Treatment Assessment Of Salivary Output And Lip: A Retrospective Analysis of the Machine Quality Of Life In Patients Of Locally University of Florida Experience Advanced Head And Neck Cancers Treated By Intensity Modulated 3071 Omar Mahmoud Radiotherapy (IMRT) Timing of Adjuvant Chemotherapy/ QUALITY OF LIFE External Beam Radiation Therapy and 3060 Yoshiya Yamada Its Impact on Extremity Soft Tissue 3049 Katherine Hutcheson Clinically Meaningful Improvement In Sarcomas Outcome Early Experience with IMPT for the Quality Of Life For Patients Who Have Treatment of Oropharyngeal Tumors: Undergone Stereotactic Radiosurgery 3072 Paul Menzel Acute Toxicities and Swallowing- For Spinal Metastases Combined Ipilimumab and related Outcomes Radiotherapy for Metastatic 3061 David Randolph Melanoma 3050 Zachary Seymour Impact of Radiosurgical Toxicity and Quality of Life After Management of Geriatric Patients 3073 Masaharu Hata Hypofractionated Stereotactic Body with Brain Metastases: Clinical and Radiation Therapy for Extramammary Radiotherapy for Low and Quality of Life Outcomes Paget’s Disease: Treatment Outcomes Intermediate Risk Prostate Cancer and Prognostic Factors 3062 Allen Chen 3051 Yu Tang Functional Outcomes and Quality of 3074 Adam Willson Quality of Life after Intensity Life after Defi nitive Chemoradiation Treatment Outcomes and Patterns of Modulated Radiation Therapy (IMRT) for Human Papillomavirus-Positive Failure for Desmoplastic Melanoma for Anal Cancer Oropharyngeal Cancer: Implications for Dose De-Escalation 3075 Alexander Falk 3052 Stephen Lewis Improved Outcomes with Iterative An International Survey of 3063 Dustin Boothe Local Treatments of Oligometastases Defi nitive SABR for Extra-cranial Qualitative and Quantitative Distress in Sarcomas: a French Sarcoma Group Limited Metastases Assessment of Cancer Patients Using Study the NCCN Distress Thermometer
162 ASTRO 2013 / 55TH ANNUAL MEETING 3076 Daya Nand Sharma 3087 Subhakar Mutyala 3116 Ji-Hong Hong Perioperative High-dose-rate Clinical outcomes for 3 Dimensional Temporal and Spatial Changes of Interstitial Brachytherapy in Patients Topographic Applicator Myeloid-derived Suppressor Cells with Soft Tissue Sarcomas Brachytherapy for Non-Melanoma (MDSCs) in the Tumors and Peripheral Skin Cancer Blood after High-dose Tumor 3077 Young Il Kim Irradiation Reproducibility Evaluation of Tissue Expander in Patients with 3117 Mary-Keara Boss Retroperitoneal Sarcomas Treated by RADIATION AND CANCER Radiation Induces Epithelial- Postoperative Radiotherapy BIOLOGY mesenchymal Transition In An In Vitro Mammary Carcinoma Tumor Model 3078 Laura Kollar 3107 Steve Braunstein Solitary Fibrous Tumors: A Operational Signaling Pathways in 3118 Norma Ybarra Multidisciplinary Approach Radiation-Induced Tumors In Vitro Analysis of HPV-Dependent Radiosensitivity of Head and Neck 3079 Keith Cengel 3108 Kalash Ronny Squamous Cell Carcinoma and External Beam Radiotherapy With Or Signifi cant Epigenetic Changes in Normal Tissue Cell Lines Without 131I-MIBG Systemic Irradiated Lungs of Fibrosis -Prone Radiotherapy In The Therapy Of C57BL/6NHsd Compared to Fibrosis- 3119 Frank Houghton Patients With Malignant Resistant C3Hf/Kam Mice Relative radiosensitivity of Human Pheochromocytoma And Inducible Pluripotent Stem Cells Paraganglioma 3109 Benjamin Greenberger (hiPSC) compared to parent fi broblast Characterizing Cell-Specifi c line and Cells of Diff erentiated Neural 3080 Beatriz Amendola Radiation Sensitization Induced by Rosettes High Dose Rate (HDR) Brachytherapy HDAC Inhibition for Facial Non Melanoma Skin Cancer 3120 Mahesh Kudrimoti (NMSC) Using Custom Made Molds 3110 ShengJun Ji Instantaneous Blood Flow And and a Shortened Fractionation Radiation-induced Hippocampal Oxygenation Changes Noted In Real Schedule Neurogenesis Impairment and Time During Radiation Therapy Cognitive Defi cits Is Associated with Delivery In Head/neck Squamous 3081 Jessica Rooney Inhibition of BDNF-Trk-B Signaling Cancers Local Control and Functional Outcomes of Limb Sparing 3111 Sophia Bornstein 3121 Sungjune Kim Multimodality Therapy for Hand and Investigation of the Tumor-Initiating Impact Of Radiation-induced Foot Soft Tissue Sarcoma: The Mayo Cell Microenvironmental Niche in Autophagy On The Effi cacy Of Clinic Experience Recurrent Head and Neck Squamous Combination Radiotherapy And Cell Carcinoma Using a Novel Immunotherapy 3082 Manpreet Bedi Microenvironment Microarray Evaluation of Neoadjuvant Therapy Platform 3122 Jin-lu Ma Response in Adult Soft Tissue Role Of Hgk In Vasculogenic Mimicry Sarcoma using Dynamic 3112 Jiang Ji Formation In Non-small Cell Lung Contrast-Enhanced MRI Ionizing Radiation Induces Cell Cycle Cancer G1 Arrest And Tumor Suppressor 3083 David Rainey Gene P16, P21, P27 Expression In 3123 Scott Bratman Treatment of Resectable Intrathoracic Keloid Fibroblasts Stromal Contributions To Radiation Sarcomas: A Single Institution Resistance Of Breast Cancer Stem Experience Over Twenty Years 3113 Encouse Golden Cells The Immunogenic Signature of 3084 Lindsay Warner Platinum and Radiation 3124 Encouse Golden Prognostic Value Of Tumor Response Radiation Promotes a Dose-Response In Pediatric And Adult Patients With 3114 Richard Bakst Induction of Immunogenic Cell Death Ewing Sarcoma Are Schwann Cells a Target in Radiation for Perineural Invasion? 3125 Encouse Golden 3085 Upendra Parvathaneni Paclitaxel Enhances the Immunogenic Non Regional Distant Nodal 3115 Anthony Apicelli Signature of Radiation Metastases in Merkel Cell Carcinoma- Reduced Brain Neurofi bromatosis A Common and Unappreciated Type 1 (Nf1) Tumor Suppressor Gene 3126 Encouse Golden Pattern of Failure Expression Confers Diff erential Circulating HMGB1 Levels Increase Sensitivity To Ionizing Radiation In in Locally Advanced Breast Cancer 3086 Upendra Parvathaneni Vivo Patients Treated on a Protocol of Novel Single Fraction Radiation Neoadjuvant Paclitaxel and Radiation Therapy approach on Merkel Cell Carcinoma Metastases - An Update Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 163 3127 Carmen Perez 3139 Ola Maria 3151 Robert Stewart Acute Innate Immune Response Investigation of Stem-like Cells Role in A Useful Strategy to Estimate Profi les Following Cranial Irradiation Regional Radiosensitivity of the Lung Tolerance Doses for Normal Tissues in Particle Therapy 3128 Theodore Braun 3140 Ippei Takahashi Glucocorticoid Signaling in Skeletal The Mechanism of A Novel 3152 Hasani Wooten Muscle Is Critical for Cancer and Radioprotector, 8-Quinolinol 3D Visualization Of Radiobiological Endotoxin-Induced Cachexia Derivative KH-3 Dose Distributions - A Novel Method For Assessment Of Composite 3129 Kristina Young 3141 Youssef Zeidan Treatment With Alternate Improved Effi cacy of Radiation in Botulinum Toxin Confers Fractionation Schemes Combination with Systemic Radioprotection In Murine Salivary Immunomodulatory Therapy in a Glands 3153 Masatoshi Hasegawa Syngeneic Mouse Model of Colorectal Cancer Stem Cell Markers and Gene Cancer 3142 Julie Goff Expression Profi les in Human Brain Reduction of Late Pulmonary Fibrosis Tumors Following Carbon Ion Beam 3130 Jin Wang in Thoracic-Irradiated C57bl/6hnsd Irradiation Rad51 In Regulating The Mice by a Water Soluble Radiation Radosensitivity Of Nsclc With Mitigator MMS-350 3154 Eric Diff enderfer Diff erent Egfr Status Personalized Space Radiation 3143 Hiroshi Igaki Dosimetry Using Monte Carlo 3131 Hiroaki Akasaka Inhibitory Eff ect Of Radiation-induced Simulations Of CT-based Geometries A Novel Radiosensitizer of the Pulmonary Fibrosis By Spironolactone Exposed To Solar Particle Event Functional Food Component, Radiation. Monogalactosyl Diacylglycerol 3144 Michael Epperly (MGDG) from Spinach, Enhanced the MMS350: A Water Soluble Radiation 3155 Koichi Yasuda Cytotoxic Eff ects for the Pancreatic Protector and Mitigator The Impact of FMISO-PET before Cancer In Vitro and In Vivo treatment in Nasopharyngeal Cancer 3145 Nobuhiko Yoshikawa Patients 3132 Tommy Sheu Sivelestat Sodium Hydrate Reduces Possible Failure Of The LQ Model With Radiation-induced Lung Injury in Mice 3156 Masayuki Matsuo Large Fraction Sizes by Inhibiting Neutrophil Elastase Hypoxic and Acute Hypoxic intra-tumor mapping by pO2 Imaging 3133 Andrea Fontana 3146 Ryohei Sasaki Proton versus Photon Radiotherapy: A Novel method of 3157 Jaden Evans Diff erential Demands on the Radioprotection for the Cardiac Isodose Distributions and Biological Level Gastointestinal System: Effi cacy of the Increases in Focal Reduced form of Coenzyme Q10 18F-Fluorodeoxyglucose Uptake 3134 Samuel Bakhoum on Positron Emission Tomography A Mitotic Pathway For 3147 Anita Aiyer after Thoracic Stereotactic Ablative Radiation-induced Genome Damage Human induced Pluripotent Stem Cell Radiotherapy (iPSC) Derived Intestinal Organoids 3135 Takeshi Nishioka (iHIOs) to Screen Radiation Mitigators 3158 Nils Arvold HIF-1alpha Post Transcriptional mRNA FMISO-PET as Biomarker of Early Regulation Under Normoxia: The 3148 Akifumi Miyakawa Response to Targeted Therapy in Signifi cance Of UTRs Applicability of the Linear-quadratic EGFR-Mutant Non-Small Cell Lung Model to Single and Fractionated Cancer (NSCLC) 3136 Marcher Thompson Radiotherapy Schedules: An Screening For BRCA1-pathway Experimental Study 3159 Olga Volotskova Inactivation In Sporadic Breast Cancer Development Of A Novel Optical Cell Lines 3149 Hiromitsu Iwata Imaging Probe For Cancer Detection: Relative Biological Eff ectiveness Of X-ray Activated Gold Nanoclusters 3137 Ang Qu Passive-scattering Proton Therapy Direct Eff ects of 125I Seeds Irradiation Using A Range Modulation Wheel At 3160 Magdalena Bazalova on A549 Lung Cancer Cells: G2/M The Nagoya Proton Therapy Center: X-ray Fluorescence Computed Arrest and Enhanced Cell Death An in vitro Study With Four Cell Lines Tomography (XFCT) For High- sensitivity Imaging Of Cisplatin 3138 Piotr Widlak 3150 Ken Ando Radiotherapy-related Changes in Eff ective Suppression of Pulmonary Serum Proteome Patterns Are Metastasis in Combined Carbon Ion Aff ected by Medium Doses of Radiotherapy With Dendritic-cell Radiation Delivered to Large Volumes Immunotherapy in Murine Tumor of Normal Tissue Models Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
164 ASTRO 2013 / 55TH ANNUAL MEETING 3161 Shin-ichiro Masunaga 3172 Steven Lin 3184 Bryan Allen Signifi cance of Daily Fractionated High Throughput Clonogenic Survival Pharmacological Ascorbate Enhances Administration of Wortmannin Screen Identifi es Novel Radiation NSCLC Chemo-Radio-Sensitization Combined with Gamma-Ray Sensitizers for KRAS Mutant Irradiation in Terms of Local Tumor Non-Small Cell Lung Cancer 3185 Justin Tang Response and Lung Metastatic Profi ling of Sonic Stress Eff ects on Potential 3173 Yu-Jen Chen Androgen Independent Prostate Design and Optimization for Cancer Cells with RNA 3162 In Ah Kim Combination of 188Re-Liposome and Sequencing: Implications for Low Inhibition of STAT3 Enhances the External Beam Radiotherapy against Intensity Focused Ultrasound Therapy Radiosensitizing Eff ect of Human Esophageal Adenocarcinoma Temozolomide in Malignant Glioma Xenograft 3186 Meng Welliver Cells Protein Arginine Methyltransferase-5 3174 Nicholas Nickols As A Novel Epigenetic Target In Lung 3163 Satoshi Harada Radiosensitization By High Affi nity Cancer Nanoparticle Imaging and Treatment Programmable Minor Groove Binders for Micrometastasis Using Targeted 3187 Mohammad Hedayati folate Receptor-Mediated 3175 Naritoshi Mukumoto Evaluation of Novel DNA Polymerase Endocytosis via Radiotherapy Normal Tissue Tolerance Of Beta Inhibitors as Potential Microplanar Beam X-ray : A Long-term Radiosensitizers of Prostate Cancer 3164 Adam Wolfe Observation Cells Targeting Radiation Resistant Breast Cancer Stem Cells With The 3176 Hendrick Soh 3188 France Carrier Combination Erlotinib And Elevated Serum HGF is Associated Investigation of Low Dose Simvastatin with Radioresistance and Local Fractionated Radiation Therapy as a Recurrence in Non-Small Cell Lung Chemopotentiator in Advanced/ 3165 John Thoms Cancer Metastatic Gastrointestinal YM155, a novel small-molecule Carcinoma Survivin Suppressant, Combined with 3177 Monica Kotler Radiation Therapy in Prostate Cancer Application Of Silicon Nanoparticles 3189 Austin Kirschner Cell Lines (SI-NPs) For Radiation Induced Pim Kinase Inhibitor AZD1208 For Cytotoxicity Via Generation Of Treatment Of c-MYC-driven Prostate 3166 Manish Sethi Reactive Oxygen Species (ROS) Cancer Nanoparticle Chemosensitization 3178 Andre Konski 3190 Adam Smith 3167 Brittany Simone The Mechanism Of Metformin Preclinical Investigation of a Novel Caloric Restriction Coupled with Induced Radiosensitization Of Redox Modulator, Parthenolide, as a Radiation Increases Overall Survival in Pancreatic Cancer Cells Cytotoxic and Potential a Metastatic Breast Cancer Model Radiosensitizing Agent in Glioblas- 3179 Jin Ho Kim toma Multiforme 3168 Thierry Muanza Infl uence Of ATM on DNA EGFR/DNA Targeting Molecule Methyltransferase Inhibitor-induced 3191 Edina Wang Potentiates Radiation Response in a Radiosensitization Diff erential Cellular Response To Murine Breast Cancer Model Nanoparticle Docetaxel And 3180 Heon Joo Park Docetaxel At Sub-therapeutic Dose 3169 Andrew Baschnagel Metformin Potentiates The Eff ects Of Range c-Met as a Target for Radiation Radiation On Cancer Cells And Cancer Enhancement in Head and Neck Stem Cells By Activating Ampk 3192 Tatiana Marques Squamous Cell Carcinomas Enhanced Radiosensitization by 3181 Ahmed Salem Tumor-Targeting Gold Nanoparticles- 3170 Javier Maldonado High-content, High-Throughput A Paradigm for Energy Modulated Targeting CD44high/ID1+ Patient Screening For Novel Double-Strand Radiation Therapy (EMRT) Glioma Initiating Cells By TGFβ Break Repair Inhibitors Receptor I Inhibitor Could 3193 Tim Lautenschlaeger Radiosensitize Glioblastoma 3182 Ye Yuan Cilengitide Inhibits Proliferation And EGFR-mediated Nuclear Delivery Shows Combined Eff ects With 3171 Cody Schlaff Improves the Genotoxic Eff ect of Radiation In Breast Cancer Cell Lines Radiosensitization Eff ects of Novel Fe3O4@TiO2 Nanoparticles Triple-Inhibitor CUDC-101 in 3194 Harold Swartz Glioblastoma Multiforme and Breast 3183 Jennifer Yu Repeated Direct Measurements of Cancer Cells In Vitro Thermoradiotherapy Targets Tumor Oxygen to Determine the Glioblastoma Initiating Cells Through Therapeutic Potential of Hyperoxic Downregulation of AKT Therapy Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 165 3195 Aaron Wild 3205 Melvin Lee Kiang Chua 3215 Yuji Seo Twist1 Overexpression Induces Comparison Of In Vivo Skin And In Association between Linear- Increased Tumor Cell Aggressiveness Vitro Blood Lymphocyte Models For Quadratic Model Parameters and and Resistance to Sorafenib in The Prediction Of Late Normal Tissue Basal Gene Expression Profi les in the Hepatocellular Carcinoma Cells Responses In Breast Radiotherapy NCI-60 Cancer Cell Line Panel Patients 3196 Eleni Liapi 3216 Andrew Trister Preliminary Assessment Of 3206 Jinyi Lang Gene Expression Changes At Nanoparticle-lipiodol Formulation Expression of mEGFR, pEGFRThr654 Recurrence After Radiation In Patients For Image-guided Thermal Therapy In and pPKN1Thr774 Predict Response With High Grade Gliomas Predicts Animal Models Of Liver Cancer to Chemoradiation and Prognosis in Survival Patients with Cervical Cancer 3197 Xin Qian 3217 Mahesh Varia Precise Targeting for Small Animal 3207 Timothy Robinson Hypoxia and Diff erentiation - Study Using An Image-Guided Detection of Novel Hypoxia Induced Contrast Between Pimonidazole Micro-Irradiation Platform Changes in Alternative mRNA Binding and CK19 Expression in Processing Associated with Clinical Tumors Derived from Stratifi ed and 3198 Marlon Veldwijk Prognosis in Adenocarcinoma of the Simple Epithelia A Novel Method for Effi cient Transfer Lung of Small Gold Nanoparticles for the 3219 Jonathan Pai Radiosensitization of Cells 3208 Zhen-Yu Hong Plasma SPARC Following Stereotactic An Experimental Model-based Body Radiotherapy (SBRT) Predicts for 3199 Justin Tang Biomarker Exploration Of Progression-Free Survival in Locally Sonic Stress Down-Regulates STAT3 Radiation-induced Lung Injury In Vivo Advanced Pancreatic Cancer Activation in Prostate Cancer Cells And In Vitro through Cytoskeleton Disruption 3220 Krishinima Jeyaseelan 3209 Corbin Jacobs Copy Number Variations As Predictors 3200 Jasmina Cerne Tumor Status of DAB2IP but Not EZH2 Of Late Toxicities In Prostate Cancer Protein Kinase C Inhibitors As Novel Correlates With Biochemical Failure, Radiosensitizing Agents In The Castrate Resistance, and Distant 3221 Krishnan Thirumoorthy Treatment Of Primary GNAQ Mutant Metastases in High-risk Prostate Radiation Induced Metabolome Uveal Melanoma Cancer Patients Treated With Delineates Glioblastoma And Radiation Therapy Glioblastoma Stem Cell Subtypes And 3201 Zhiyong He Correlate With Their Relative A Novel Regulatory Role Of CITED2 In 3210 William Hall Radiation Sensitivities Non-Small-Cell Lung Cancer (NSCLC) Chromodomain Helicase DNA Binding Stem Cells And In Modulating The Protein 5 (CHD5) is Associated with 3222 Rachel Jimenez Eff ect Of HDACi Treatment On NSCLC Improved Overall Survival in Patients Feasibility of Gene Expression Undergoing Adjuvant Therapy for Signature Analysis in Prostate Cancer 3202 Tithi Biswas Resected Pancreatic Adenocarcinoma Biopsy Specimens To Predict Enhanced Radiosensitization Of Lung Outcomes Following Radiation Adenocarcinoma Cells By Pemetrexed 3211 Laurence Court Therapy When Combined With Methoxyamine Pre-treatment CT Image Features of To Inhibit Base Excision Repair the Primary Tumor are a Signifi cant Predictor for Overall Survival in 3203 Almudena Zapatero Esophageal Cancer RADIATION PHYSICS The Prognostic Value of Expression of HIF1α, Pak-6 and PSMB4, in 3212 Andrew Baschnagel 3223 Tobias Wissel Intermediate and High Risk Localized Comparison of Gene Expression Skin Thickness Estimation For High Prostate Cancer Patients Treated with Profi les of Pre-treatment and Precession Optical Head Tracking Androgen Deprivation and Dose Recurrent Locally Advanced Head During Cranial Radiation Therapy - Escalation Radiation Therapy and Neck Squamous Cell Carcinomas A Simulation Study Treated with Chemoradiation 3204 Chiaojung Jillian Tsai 3224 Karen Mooney Tgf-β1 Single Nucleotide 3213 Erik Sulman A Population-based Treatment Polymorphism At Rs1982073:t869c A Molecular Signature To Predict Margin for Respiratory Motion of Is Predictive Of Osteoradionecrosis Meningioma Recurrence And Lung Tumors After Defi nitive Radiotherapy For Progression Oropharyngeal Carcinoma 3225 Xiaoli Tang 3214 Sung-Wei Lee Quantitative Assessment of the STMN1 Overexpression as a Poor Accuracy and Practicality of Deep Prognostic Factor in Patients With Inspiration Breath Hold Using Surface Nasopharyngeal Carcinoma Monitoring Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
166 ASTRO 2013 / 55TH ANNUAL MEETING 3226 Bo Zhao 3238 Guang Li 3249 Charles Baron Assessment of Breast Motion during Development and Validation of 6-DOF The eff ect of Larynx Motion on Set Hypofractionated Robotic Patient Setup Using 2D Onboard Up/Delivery Error during Radiation Radiotherapy Imaging Treatment for Head and Neck Cancer
3227 Hiromitsu Iwata 3239 Jun Li 3250 Benjamin Cooper Evaluation of Dose Uncertainty Evaluation of 4D Cone-beam CT A Clinical Planning Tool to Predict Left Associated With Real-Time Tracking Based Automatic Image Anterior Descending Coronary Artery IMRT Using Robotic Radiosurgery Registration for Radiation Treatment Maximum Dose Based on Distance to System of Lung Cancer the Tangent Field Edge
3228 Clemens Bos 3240 Brittany Simone 3251 Victor Gonzalez MR Image Guidance of Brachytherapy Evaluation of Treatment Planning Impact of Prone vs Supine Positioning Needle Placement: Potential of 2D Modalities for Early Stage Left Sided on Small Bowel Dose with Pelvic IMRT Ultrashort Echo Time Imaging Breast Cancers Reveals Deep Inspiration Breath Hold Comes Out 3252 Ruggero Ruggieri 3229 Daniel Low on Top Adaptive Re-planning after Five A New 4DCT Technique Treatment Fractions in Prostate 3241 Sathiya Narayanan Patients with Implanted Markers 3230 Wensha Yang Vatyam Impacts on Setup Accuracy Dosimetric Eff ects of Rotational Comparison of PTV Margins for Uncertainties in Fiducial-based Contouring Using MVCBCT and 3253 Koilpillai Joseph Maria Treatment Setup for Pancreas SBRT Carbon Target Imaging: A Pilot Study Das Tracking Target Motion during 3231 Tracy Bray 3242 Itaru Ikeda delivery of 3DCRT and IMRT Prospective Evaluation of Oblique Relationship Between Intra-fraction Treatment Dual-Energy Imaging in Patients Prostate Motion And Rectal Dilatation Undergoing Image-Guided 3254 Kathryn Turner Radiotherapy for Lung Cancer 3243 Michael Cheung Breathing Irregularity Induced Geometric Accuracy Verifi cation of Uncertainties In Patient Positioning Of 3232 Youngmin Choi a Respiratory Gating System Using Lung Sbrt: An Investigation Based On Prostate Intrafraction Motion During Gated KV-CBCT and Gated MV-CBCT A Digital Human Phantom Image Guided Radiotherapy After Rectal Emptying 3244 Pietro Mancosu 3255 Vorakarn Chanyavanich Dosimetric Eff ects Of Involuntary Optical Imaging for Patient-Specifi c 3233 Rongmao Li Motion For Total Marrow Treatment Planning and Collision Control of Respiratory Motion by Irradiation With Volumetric Avoidance Hypnosis Intervention During Modulated Arc Therapy Radiotherapy of Lung Cancer 3256 Tom Catron 3245 Ho Jin Jeong Does Abdominal Compression 3234 Hsiang-Chi Kuo Estimation Of Optimal Margin For Through Prone Patient Position Tumor Bed Variation During Intra-fraction Movements During Reduce Respiratory Motion In Lung Accelerated Partial Breast Frameless Brain Radiosurgery Cancer Radiotherapy? Brachytherapy 3246 Lauren Douglass 3257 Matthew Abramowitz 3235 Nicos Nicolaou Utility of Remarking Regimens for Noninvasive Real-time Prostate Is An Immobilization Device Improving Setup Accuracy in Tracking Using A Transperineal Necessary For Prostate Irradiation, In Defi nitive Lung Radiotherapy Ultrasound: A Clinical Trial The Era Of Image Guided Volumetric Comparision to RF Transponders Modulated Arc Therapy (VMAT)? 3247 Tianye Niu with Visual Confi rmation Accelerated Barrier Optimization 3236 Xiang Li Compressed Sensing (ABOCS) For 3258 Alexandra Bourgouin An Investigation Of Patient-specifi c Ct Reconstruction With Improved Reducing Radiation Doses Received Respiratory Motion Eff ect In Lung Convergence By Cardiac Devices CBCT Imaging 3248 Tianye Niu 3259 Prithima Reddy Mosaly 3237 Abigail Stockham Quantitative Cone-beam CT In Applying Human Factors Analysis and Inter-Fraction Prostate Motion with Radiation Therapy: GPU Classifi cation System (HFACS) to the Endorectal Balloon Placement Implementation And Comprehensive Analysis of Good Catches in Radiation Evaluations On The State-of-the-art Oncology On-board Imager
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 167 3260 David Asher 3271 Almut Troeller 3282 Geoff rey Zhang Bite Blocks can reduce Setup Normal Tissue Complication Normalization Of 4D-CT Derived Uncertainty Related to Weight Loss Probability (NTCP) Modeling of Ventilation Data To Facilitate during Head and Neck IMRT: Chronic Hematuria in Prostate Cancer Intra-patient Comparisons Preliminary Results of a 3-Modality Patients Treated With 3D Conformal Image Guidance Protocol Radiation Therapy 3283 Reshma Munbodh A Novel Method to Quantify Cell 3261 Lichung Ku 3272 Jiankui Yuan Migration Distance and Determine Implementing In-room Visual Validation Of A Virtual Source Model its Contribution to the Guidance Using A Digital Projector For Monte Carlo Simulations Of Development of Rectal Toxicity after For Breath-hold Treatment Of Left Tomotherapy Prostate Radiotherapy Breast Cancer 3273 Dan Liu 3284 Cungeng Yang 3262 Lonika Majithia 18F-FLT Uptake Kinetics In Head And Dose Dependent CT Number Changes Novel Tissue Compensation with Neck Squamous Cell Carcinoma: A Pet in Both Tumor And Normal Lung Photon Irradiation for Cutaneous Imaging Study Observed During Radiotherapy for T-cell Lymphoma with Irregular Lung Cancer Surfaces 3274 Zhang Quanshi The Preliminary Study for Detecting 3285 Ishmael E. Parsai 3263 Paikin Leung Hypoxia With PET Imaging In Situ Dosimetric Analysis of Irregular Use of Diagnostic Quality CT for Daily Using 45MV X-ray Photonuclear Surfaces Treated With the Leipzig and Prostate Localization with Soft Tissue Reaction 16O(γ , N)15O in Tumor Valencia HDR Skin Applicators Registration 3275 Christopher Chapman 3286 Haksoo Kim 3264 Reshma Munbodh Diff usion Imaging Biomarkers for Case Studies Presenting Dosimetric Submillimeter 2D-3D Registration Predicting Brain Normal Tissue Uncertainties Using Fuzzy Set Theory for Brain Radiation Therapy using 3D Radiation Necrosis Cone-beam CT Data and a Single, 3287 Kristy Brock Limited Field-of-View 2D kV 3276 Maria Carmen De Santis Biomechanical Modeling of Radiograph Spectrophotometric Evaluation Of Therapeutic Response in the Liver Skin Erythema In Patients Undergoing 3265 Weihua Mao Breast Irradiation 3288 Joseph Deasy Real Time 3D Markerless Lung Tumor A New Tumor Control Probability Tracking 3277 Hualiang Zhong Model Fitted To Head And Neck And Can We Use TCP to Predict Tumor Lung Local Control Data And 3266 Benjamin Williams Local Control? Resulting Implications For The Impact Rotational Patient Positioning Of Dose Heterogeneity Corrections for Cervical Spine SBRT; 3278 An Tai Evaluation of 6DOF Couch A method to determine Individualized 3289 ChihYao Cheng Applicability Prescription for Biologically Adaptive Radiobiological Impact Of Planning Radiation Therapy of Lung Cancer Techniques For Prostate Cancer In 3267 Madeera Kathpal Terms Of Tumor Control Probability Inter-Fraction Displacement of 3279 Alexander Spektor And Normal Tissue Complication Electromagnetic Beacons in Patients Early Volumetric Response to Probability Receiving Post-Prostatectomy Preoperative Chemoradiation for Radiation Therapy Rectal Cancer Predicts for Pathologic 3290 Yujiro Fujita Complete Response, Allowing for Interobserver and Intraobserver 3268 Karen Mooney Selective Treatment Intensifi cation Variability in Image Registration for An Approximate Entropy-based Image-Guided Radiotherapy Method for Prediction of 4D-CT 3280 Naomi Shin Quality from Respiratory Signals Risk of Radiation-Induced Late 3291 Kai Yang Eff ects for Pediatric Patients Receiving Treatment Dose Evaluation of IGRT 3269 Tianyu Zhao Craniospinal Irradiation Comparing and Adaptive Plan Modifi cations for A Novel Algorithm to Eliminate 3D-CRT, IMRT, and IMPT Head-and-Neck Cancer Radiation Motion Artifacts from Thoracic PET Therapy Images 3281 Hualin Zhang Evaluation of Tumor Control 3292 Adam Riegel 3270 Andreas Richter Probability of Stereotactic-Body Deformable Image Registration Development of a Voxel Based NTCP Radiation Therapy (SBRT) for Primary Accuracy in the Head-and-Neck Algorithm for Treatment Planning Liver Cancers region: Comparison with Interobserver Variation
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
168 ASTRO 2013 / 55TH ANNUAL MEETING 3293 Guang Han 3304 Nobuhide Wakai 3316 Angela Mohr A Dosimetric Study of Impact of Motion Interplay Eff ect on Accelerated GPU Based Intensity-modulated Radiotherapy Step and Shoot IMRT Tomotherapy-Planning for Locally Advanced Nasopharyngeal Carcinoma With or Without 3305 Farzan Siddiqui 3317 Daniel Yeung Hippocampal Sparing CT-to-CT Contour Propagation Using A Web Application For The Deformable Image Registration For Management Of Clinical Workfl ow In 3294 Yoshiko Doi Head And Neck Cancer Radiotherapy: Image Guided And Adaptive Proton Functional Image-Guided Investigation For Clinical Application Therapy For Prostate Cancer Radiotherapy Planning in Volumetric Treatments Modulated Arc Therapy for Malignant 3306 Irina Vergalasova Pleural Mesothelioma Patients with Feasibility Of Using A Fourier 3318 Yan Ping Pulmonary Emphysema Markerless Technique For Clinical Clinical Confi rmation of Direct 4D-CBCT Reconstruction Non-invasive Ultrasonography 3295 Lili Zhou Respiration Monitoring System in Accelerating Popular CBCT 3307 Keisuke Usui Improving Organ Motion Artifact of Reconstruction Algorithms on GPGPU A Study of 4D CBCT Reconstruction 4DCT Using OpenCL using Detection of the Target Position from 2D Projection Images 3319 Susu Yan 3296 Ping Wang A Simulation Study Of Treatment Comparative Study Of Tumor 3308 Ilker Catan Verifi cation Using On-board Heterogeneity Modeling In [18f]fdg The Evaluation of Rectum Dose Multi-pinhole SPECT Pet Images Associated by kV-CBCT Imaging in IGRT 3320 Ellen Day 3297 Yuanjie Cao Intrafraction Motion During Lung Optimization Of Treatment Planning 3309 Sohyun An SBRT: Patient Motion Or Tumor Parameters Used In Tomotherapy For Design and Development of a Motion? A Megavoltage Cone Beam Prostate Cancer: Using Dosimetric Practical Scatter Correction System CT (MVCB) Study Physical Index And Plan Evaluation in CBCT Scoring Index 3321 Zheng Wang 3310 Suk Lee A New Algorithm for Tri-modality 3298 Feng Li Development of Patient Specifi c 3D Image Fusion for Target Delineation in Comparison of Gross Target Volumes Dose Evaluation Solution for Dose Radiotherapy Based on 3-Dimensional CT, 4- Guided Adaptive Radiotherapy Dimensional CT, and Cone Beam CT 3322 David Jaff ray Images of Non-Small Cell Lung Cancer 3311 Winky Wing Ki Fung Clinical Implementation of Can Planned Dose Shifting Method Be Automated Tangential Breast 3299 Malcolm Mattes Used In Place Of Dose Intensity Modulated Radiation A Patient-Specifi c Approach To Recalculation Method For Dose Therapy Prostate Cancer Contouring Through Evaluation In Adaptive Radiotherapy Assessment of the Overlap Volume Of Head And Neck Cancer? 3323 Jing Jing Ye Between PTV and OARs Dosimetric Impact Of Treatment 3312 HongSeok Jang Couch On Volumetric Modulated Arc 3300 Pengpeng Zhang Evaluation Novel Look Up Table Therapy (VMAT) Incorporating the Prediction of Method For Mri-based Radiotherapy Residual Tumor Location into Treatment Planning 3324 Guang-Pei Chen Prospective Dose Painting for Optimizing Ct Acquisition For Prostate Locally Advanced Non-Small-Cell 3313 Kyung-Hwan Chang Cancer Radiation Treatment Planning Lung Cancer Which Is An Optimal Dosimeter To And Delivery New Optical CT Scanner (P3DS) 3301 Jian Liang Between BANGkitTM And 3325 Junaid Pasha Variation of Parotid Delineation PRESAGETM A Feasibility Study For Deformable Contour Propagation in Utilizing Auto-Segmentation Brain SRT Case Adaptive Re-planning for Cancers of Technique the Head and Neck 3314 Chi-Yuan Yeh 3302 Kyoung-Dal Lim VMAT Radiation Therapy (VMAT) 3326 Gustavo Olivera Dose Verifi cation of 2D and 3D Versus Intensity Modulated Radiation Adaptive Dose Recalculation And Intra-fractional Tumor Motion for Therapy (IMRT) for Small-Sized Breast In-vivo Dosimetry As Clinical Tools Patient Specifi c Quality Assurance of To Tailor Daily IGRT: Experience After Respiratory-Gated Radiotherapy 3315 Jim Tol 100,000 Fractions Delivered Towards Automated Treatment 3303 Vladimir Feygelman Planning: Trade-off s in PTV Dynamic Dose Interplay Does Not Homogeneity and OAR Dose in Meaningfully Aff ect Target Dose in Complex IMRT Plans VMAT SBRT Treatments ASTRO 2013 / 55TH ANNUAL MEETING 169 3327 Hun-Joo Shin 3338 Mark Gooding 3349 Jonathan Piper A Comparison Between Pencil-beam Multi-center Clinical Assessment Of A Novel Framework for Deformable Versus Monte Carlo Calculations In Dir Atlas-based Auto-contouring Registration Evaluation and Quality Arc Therapy Assurance 3339 Lulin Yuan 3328 Qiao Qiao Incorporating Tradeoff in Knowledge 3350 Jonathan Piper Changes in the Lumpectomy Cavity Modeling of Parotid Dose Sparing in Evaluation of Deformable Prostate from Initial Whole Breast Irradiation to Head and Neck IMRT Cone-beam Computed Tomography Sequential Boost (CBCT) Contouring Methods for 3340 Feng Liu Adaptive Radiation Therapy 3329 Kazuhiro Arai Interfraction Relative Volume Comparison of Cumulative Dose in Changes and Independent Motions 3351 Yanle Hu the Spinal Cord Using Rigid between Multiple Targets in Lung Improved Dosimetric Accuracy of Bulk Registration and Non-rigid Cancer Radiotherapy Density Overridden Plans for Prostate Registration for Two-step Adaptive Patients using Tissue Population Intensity-modulated Radiotherapy for 3341 Lalit Chaudhari Average Electron Densities Obtained Head and Neck Cancer Ideal Input Parameters For Organs within Radiation Beam Paths at risk On Monte-carlo Optimizer - 3330 Siu Keung Chan Should It Be DVH Based Or Biologic 3352 Meredith Semon An Application of Trajectory Log for Based? Adaptive Radiotherapy for Volumetric Intensity Modulated Intensity Modulated Radiation Arc Therapy(VIMAT) Plan Quality 3342 Antonio Damato Therapy (IMRT) Treatment of Prostate Assurance in a Digitally Integrated Planning of MR-Guided Gynecologic Adenocarcinoma And Controlled Linear Accelerator Interstitial Brachytherapy Insertions 3353 Scott Hadley 3331 Kyoungkeun Jeong 3343 Umesh Mahantshetty Diffi culty of Pancreas IGRT using CBCT CT Image Reconstruction From IMRT A Prospective Study To Generate Ctv Treatment Beam To Itv Margins Using Cone Beam 3354 Yasushi Ito Verifi cation Ct For Pelvic Imrt In Dose Reconstruction In Considering 3332 Yusuke Onozato Locally Advanced Cervical Cancers Of Respiratory Motion Of The Target Evaluation of On-board kV Cone Beam Using 4D-CT In VMAT CT-based Dose Calculation Using 3344 Guozhen Luo Deformable Image Registration and Advantages Of Treating Skin Lesions 3355 Joanne Zhung Modifi cation of HU Values With Vmat Compared To Static Imrt Does Rectal Distention Aff ect With Multiple Gantry Beams Interfractional Dose To Prostate And 3333 Michiel Van den Bosch Rectum In Prostate IMRT Treatment? Optimizing PTV For IMRT Of Cervical 3345 Mark Gooding Optimizing IGRT Techniques Cancer Using Structure-Specifi c Multi-center Assessment Of Margins Auto-contouring Using Deformable 3356 Yutaka Takahashi Image Registration For Adaptive Peripheral Dose Heterogeneity Due 3334 Ken-Pin Hwang Therapy To The Thread Eff ect In Total Marrow Development Of A Semi-automated Irradiation With Helical Tomotherapy Contouring Toolkit For Pelvic Organs 3346 Bernard Lachance On An MR Image Series Quantifying The Impact Of 3357 Krishni Wijesooriya Introducing Modulated Arc Therapy Comparison of 3D Dose Delivery 3335 Jinkoo Kim In The Clinic Accuracy and Effi ciency for VMAT A Novel Approach for Establishing Between 2 Linear Accelerators Using Benchmark CBCT/CT Deformable 3347 Xiaoming Chen Linac Log Files Image Registrations in Prostate CT-MRI Fusion Uncertainty in Prostate Cancer Radiotherapy Treatment Planning for Diff erent 3358 Henry Wang Image Guidance Techniques The Feasibility of Fully Automating 3336 Jason Pukala Treatment Planning Process Using Adaptive Radiotherapy Re-planning 3348 Richard Jennelle Knowledge Based System for Head-and-Neck Cancers and the Evaluation of PTV Margin in the Dosimetric Benefi t to the Parotid Treatment of Lung Cancer Simulated 3359 Gregory Perkins Glands with 4D CT and Validated with Daily MRI-based Radiotherapy Planning Of Cone Beam CT Guidance Prostate Cancer: Clinical 3337 Colleen Schinkel Feasibility And Assessment Of Dosimetric Eff ects of Daily Anatomic Dosimetric Accuracy For Diff erent Variations when Treating High Risk Treatment Techniques Prostate with Whole Pelvis IMRT using an Adaptive Strategy and Dual-Plan Superposition Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
170 ASTRO 2013 / 55TH ANNUAL MEETING 3360 Naruemon Tongtip 3371 Hairong Chen 3382 Mari Tsujii A Dosimetric Study of Volumetric An Optical Tracking System for Uveal Detectability of the Position of the Modulated Arc Therapy (VMAT) Melanoma Radiosurgery Diaphragm in the Exhale CBCT for versus Intensity Modulated Radiation Patient Positioning in Therapy (IMRT) in Locally Advanced 3372 Abhilasha Patel Respiratory-Gated Stereotactic Body Nasopharyngeal Cancer Involving Modeling the Loss of Tumor Control Radiation Therapy Base of Skull Probability (TCP) due to Small Geometrical Deviations of 3383 Alejandro Mut 3361 Ravinder Clayton LINAC-based Stereotactic Stereotactic Body Radiotherapy For Clinical Impact and Utility of Acuros Radiosurgery (SRS) Lung Cancer And Lung Metastases XB Dose Calculation Algorithm in Using Megavoltage Cone-beam Lung Stereotactic Body Radiation 3373 Dae Il Kim (MVCB) Therapy Comparison Of Monitoring Unit Effi ciency Between With And Without 3384 Lijun Ma 3362 Dawn Owen Flattening Filter Using Volumetric Adaptive Treatment Planning And Outcomes and Toxicities of Modulated Arc Therapy Online Setup Measurements To Guide Stereotactic Body Radiotherapy Decision Of Margin Size For (SBRT) for Non-Spine Osseous 3374 Maho Iwana Hypofractionated Intracranial Oligometastases Dose Prescription to 40% to 90% Radiosurgery Isodose Lines for the Target in 3363 Linda Hong Stereotactic Body Radiotherapy for 3385 Lucas Caussa Spine SBRT Plans: Achieving Dose Lung Tumors: Which Prescription Line Linac-based Stereotactic Coverage, Conformity and Dose Fall Is Optimal? Radiotherapy With Micromultileaf Off Collimators In The Treatment Of 3375 Siete Koch Vestibular Schwannoma: Technique 3365 Piera Navarria RapidArc or Multi-Angle Conformal And Preliminary Results Stereotactic Body Radiation Therapy Fields for Stereotactic Radiosurgery (sbrt) With Flattening Filter Free (ff f) 3386 Winnie Li Mode For Treatment Of Lung 3376 Wen Min Luo Deriving Planning Target Volume Metastases In Oligometastatic A Dosimetric Comparison of Helical Margins for Intracranial Stereotactic Patients Tomotherapy versus Radiotherapy Volumetric-modulated Arc Therapy in 3366 Virag Dandekar Radiosurgery for Multiple Intracranial 3387 Heming Zhen Dosimetric Comparison Of Volumetric Lesions Evaluation of Acuros XB for SAbR Modulated Arc Therapy And Helical Planning of Thoracic Spinal Tumors Tomotherapy For Spine Stereotactic 3377 Aysen Dizman Body Radiotherapy Re-irradiation with Robotic 3388 James Picone Stereotactic Body Radiotherapy for A Minimum Tumor To Spinal Cord 3367 Thomas Kole Locally Recurrent Nasopharyngeal Distance of 3-4mm Is Needed For A Dosimetric Comparison of Carcinoma Optimal Planning Of Spine SBRT Hypofractionated Passively-Scattered Proton Radiotherapy and 3378 Prashantkumar Shinde 3389 Gregg Goldin Stereotactic Body Radiotherapy Dosimetric Characteristics of Dynamic Stereotactic Body Radiotherapy for (SBRT) in the Defi nitive Treatment of Micro Multileaf Collimator Early Stage Lung Cancer: Quantifying Localized Prostate Cancer the Eff ect of Tracking with Respiratory 3379 Christopher McGuinness Motion on Chestwall Dosimetry 3368 Ruijiang Li Standard Fractionation IMRT With a Clinical Implementation of MLC Equipped Robotic Radiosurgery 3390 Tarek El Kaissi Intrafraction CBCT Imaging during System Evaluation of a 3d Pre-treatment Plan Lung Tumor SABR Verifi cation Process for Stereotactic 3380 Tae Gyu Kim Radiosurgery (SRS) Treatments 3369 Yasushi Nagata Stereotactic Body Radiotherapy For Survey of Stereotactic Body Radiation Spine Metastases From Hepatocel- 3391 Nima Nabavizadeh Therapy in Japan lular Carcinoma Heterogeneous Dose Prescription for Early Stage Lung Cancer Stereotactic 3370 Long Huang 3381 Khalil Mahjoubi Body Radiation Therapy (SBRT): Stereotactic Body Radiotherapy Preliminary Results Of A Randomized Implications on Dose Gradient (SBRT) for Spinal Tumors - Evaluation Study Comparing Two Immobilization of Three Treatment Techniques: Systems For Stereotactic Body HybridArc, VMAT and IMRT Radiation Therapy
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 171 3392 Haksoo Kim 3402 Witold Matysiak 3412 Eric Klein Small Animal Irradiation Using Evaluation Of Geant4 For Proton Therapy Delivery Uncertainties Robotic Radiosurgery and Micro-CT Experimental Data Quality for Single vs. Multiple Daily Fields Images Assessment In Commissioning Of Treatment Planning System For 3413 Lilie Lin 3393 Dustin Boothe Proton Pencil Beam Scanning Mode Proton Beam Versus Photon Beam The Dosimetric Advantage Of Dose to the Heart and Left Anterior Stereotactic Hypofractionation Over 3403 Shikui Tang Descending Artery for Left-Sided Conventional Radiation For A Quantitative Assessment of the Breast Cancer Post-prostatectomy Patients: NTCP Interplay Eff ect of Prostate Modeling Of Intensity Modulated Intrafraction Motion in Proton Pencil 3414 Yuanshui Zheng Radiotherapy (IMRT) And Volumetric Beam Scanning Clinical Assessment of a Commercial Modulated Arc Therapy (VMAT) Patient Positioning & Verifi cation Treatment Plans 3404 Ted Ling System in Proton Therapy A Dosimetric Comparison of 3394 Jingdong Li Hepatocellular Carcinoma Treated by 3415 Sandeep Dhanesar Evaluation of Dosimetric Accuracy of Protons and IMRT Study of Robustness of Passive Small Dynamic MLC Fields Using EPID Scattering Proton Therapy Plans for 3405 Rui Zhang Targets in Lung and Comparison with 3395 Isaac Kaufman Prediction of Relative Risks of IMRT Plans Single Fraction Stereotactic Body Radiogenic Second Cancer and Radiation Therapy (SBRT) for Spine Cardiac Toxicity for 17 Pediatric 3416 Marc-Andre Renaud Metastasis: A Dosimetric Medulloblastoma Patients Treated Pre-calculated Track Monte Carlo Comparison of Multiple Treatment With Photon or Proton Craniospinal using GPGPU Delivery Systems Irradiation 3417 Oren Cahlon 3396 Lilie Wang 3406 Wen Hsi Feasibility of Using 3D Uniform Dosimetric Eff ect of Onyx Image-Guided Method For TLD-based Conformal Scanning Proton Beam Embolization on Radiation Treatment In-vivo Rectal Dose Verifi cation With Therapy for Locally Advanced of Arteriovenous Malformations With Endorectal Balloon In Proton Therapy Oropharyngeal Carcinoma Requiring Robotic Radiosurgery: A Monte Carlo For Prostate Cancer Bilateral Neck Irradiation Simulation Study 3407 Yuanshui Zheng 3418 Ileana Iftimia 3397 David Shultz Is Density Override for Standardized Procedure For Skin The Eff ect of Arm Position on The Fiducial-induced CT Artifacts HDR Cases Using The Varian Catheter Dosimetry of Thoracic Stereotactic Necessary in Proton Treatment Flap Set Ablative Radiotherapy Planning of Prostate Cancer? 3419 Yun Yang 3398 Han Liu 3408 Chin-Cheng Chen Design Of An Internally Shielded Analysis of Local Failure of Lung A Method For In Vivo Intracavitary D-shaped Breast Brachytherapy Cancer Patients Treated with Surface Dose Validation Using Applicator Using Monte Carlo Stereotactic Body Radiotherapy Thermoluminescent Dosimeters (tlds) Methods Applied To Prostate Cancer Patients 3399 Matthew Harkenrider Treated With Protons 3420 Mostafa El-Haddad Should We Change Conformality A Simple Method to Unify Target Index Recommendations Based on 3409 Kenneth Merrell Volume Delineation and Plan Tumor Centricity for Lung SBRT? Dosimetric Eff ect of Intra-Treatment Optimization in Clinical Trials (The Target Volume Reduction in Bulky Boolean Method) 3400 Shu-Jung Yu Head and Neck Cancer with Intensity Lung Tumor Stereotactic Ablative Modulated Proton Therapy 3421 Kaveh Maghsoudi Radiotherapy With Individualized Dosimetric considerations of Total Anatomic Optimization 3410 Daniel Sanchez Body Irradiation Parcerisa 3401 Neil Jenkins Fast Range Switching Of Passively 3422 Lukasz Matulewicz Can Stereotactic Body Radiotherapy Scattered Proton Beams Using A Eff ective and Effi cient Technique for Be Used With Mediastinal Modulation Wheel And Dynamic Total Marrow Irradiation Chemoradiation For Stage III Beam Current Modulation Non-Small Cell Lung Cancer? A 3423 Nicole Schadewaldt Dosimetric Evaluation 3411 Caitlyn Yeager Artifact Correction on MR-Derived Feasibility of Intensity Modulated Bulk-Density Maps Proton Therapy for Base of Skull Chordomas
172 ASTRO 2013 / 55TH ANNUAL MEETING 3424 Kimiya Noto 3433 Yong Hum Na 3444 Zachary Wilson Comparison Of Dose Delivery Effi cient VMAT Treatment Plan Design, Development, And Between Original Arc And Split Short Optimization Using Non-Uniformly Characterization Of Small Animal Arcs Volumetric Modulated Arc Distributed Control Points Hemi-brain Irradiator Using 192Ir Hdr Therapy Source 3434 Charles Wooten 3425 Huma Chaudhry Permanent Interstitial Radiation with 3445 Jonathan Thompson The Dosimetric Eff ect of Tumor Size Cs-131 Implants for Gynecologic Trajectory-based Radiation Therapy and Position in Prone Radiation Malignancies: Analysis and Results of With Linear Couch Motion For Therapy of Breast Using a Novel an Initial 13 Applications Extended Spinal Treatments Stereotactic Breast Irradiation Device 3435 Partha Pratim Mohanty 3446 Lucy Nedialkova 3426 Nathalie Rochet Volumetric Modulated Arc Therapy Dosimetric Comparison of Cs-131 vs. Advances in Whole Abdominal (vmat) Versus Intensity Modulated I-125 Intraoperative Brachytherapy for Irradiation: What Protons, VMAT and Radiotherapy (imrt) In Pelvic Patients with Resected Brain IMRT using Multicriteria Optimization Malignancies: A Dosimetric Analysis Metastasis Renders Cs-131 More Can Off er Sparing of Normal Brain 3436 John Yordy Tissue - Clinical Relevance for 3427 Cheng Peng Stereotactic Ablative Radiotherapy Prevention of Radiation Necrosis From Dosimetric Comparison of Robotic (SAbR) and Limited Field IMRT Using a a Prospective Trial Radiosurgery and VMAT for Novel Treatment Delivery Platform Hypofractionated Prostate Radiation 3447 DooKee Cho Therapy 3437 Keiichi Nakagawa Optimizing 3D Conformal plans for Accuracy Verifi cation of 4D 4π Non-Coplanar Converging (4PiNC) 3428 Thomas Kole Cone-Beam CT (CBCT) Based Lung Beams using a Genetic Algorithm Improved Normal Tissue Sparing and Tumor Registration by Way of Reduced Treatment Time Using In-Treatment 4D CBCT Analysis 3448 Evangelos Pappas Multileaf Collimator Robotic An Innovative Method For Radiosurgery Stereotactic Body 3438 Ruijie Yang Patient-specifi c Pre-treatment-plan- Radiation Therapy (SBRT) Compared Feasibility Study Of Volumetric verifi cation (PTPV) In Head & Neck to Iris Collimator SBRT in Treatment of Modulated Arc Therapy With Radiotherapy Treatments: Preliminary Localized Prostate Cancer Constant Dose Rate For Endometrial Results Cancer 3429 Maria Clara Ferreira 3449 Angelica Perez-Andujar Dosimetry of Rhenium-188, 3 4 3 9 F l e m m i n g K j a e r - K r i s t o f Eff ect of Dose Gradient on the Praseodymium-142, and Yttrium-90 Fersen Incident Probability of Brain using Monte Carlo simulation for A Combination Of Volumetric Arc Metastases in Hippocampal-Sparing application in High Dose Rate Eye Therapy And Tangential Fields In Whole Brain Irradiation Plaque Brachytherapy Challenging Breast Cancer Cases 3450 Hanako Farol 3430 Lei Xing 3440 Liu Zhikai A Dosimetric Feasibility Study using An Adaptive Planning Strategy for Low Dose Area Constrained Helical Forward Planning Segmental Field Station Parameter Optimized Tomotherapy-based Whole Breast Technique for Stationary Craniospinal Radiation Therapy (SPORT): Radiotherapy And Dosimetric and Spinal-sacral Junctions in Segmentally Boosted VMAT Comparison With Tangential IMRT Craniospinal Axis Irradiation
3431 Ying Zhang 3441 Yu Ra Cho 3451 Andrew Camarata Are Photons In The Energy Range Of Development of Tissue Equivalent Gel Dosimetric Evaluation Of Single 1-6 Mv A More Optimum Choice Than Dosimeter for Clinical Radiotherapy Versus Multi-isocenter Frameless Higher Energy Photons For Delivering System Radiosurgery For Multiple Brain A Conformal Dose Distribution In The Metastases Target Volume With Better Quality In 3442 Niraj Mehta Portal Images? Focal Stereotactic Body Radiation 3452 William Watkins Therapy for Prostate Cancer: A The Eff ects Of Interplay On 3432 Daphne Levin Dosimetric Comparison Between Accumulated Dose In High-dose Rate A Dosimetric Comparison Between Whole and Hemi-Gland Treatment Stereotactic Body Radiotherapy Of Volumetric Modulated Arc and 3D Lung Cancer Treatment Plans for Synchronous 3443 Lynsey Rice Bilateral Breast Patients Using 3D Surface Imaging Technology to reduce Cardiac Dose in Left Breast Radiotherapy: Plan comparison of 5 patients
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
ASTRO 2013 / 55TH ANNUAL MEETING 173 3453 Frank Rafi e Fluctuations of Source Characteristics of Electronic Brachytherapy: The Importance of Quality Assurance
3454 Gwe-Ya Kim VMAT Technique for the Circumferential Treatment of a Limb with Leukemia Cutis
3455 Susan Leuthold 3d Helical Tomotherapy Planning: A Novel Technique With High Conformality And Short Treatment Times
3456 Gregory Warrell Experimental Verifi cation of Thermal Dose Distributions of a Novel Thermo Brachytherapy Seed for LDR Seed Implants
3457 Song Wang 4-Pi Non-Coplanar Converging Beams Yield Superior Therapeutic Ratio than Conventional Coplanar Beams
3458 Bin Wang Beam Selection For MLC-based Robotic Radiotherapy
3459 Shiv Khandelwal Helical 3D-Conformal Radiotherapy for Rectal Cancer
3460 Vishruta Dumane Comparison of VMAT, Partially Wide Tangents and Photon/Electrons for Treatment of Reconstructed Chestwall, Supraclavicular, Axillary and Internal Mammary Nodes
Poster # correlates with the abstract number listed in the Annual Meeting Proceedings
174 ASTRO 2013 / 55TH ANNUAL MEETING AMERICAN SOCIETY FOR RADIATION ONCOLOGY 2014Meetings Join Us at These Important Radiation Oncology Events
MULTIDISCIPLINARY HEAD AND NECK CANCER SYMPOSIUM February 20-22, 2014 JW Marriott Camelback Inn Resort and Spa, Scottsdale, Ariz.
SPRING REFRESHER COURSE March 7-9, 2014 The Roosevelt Hotel, New Orleans
STATE OF THE ART RADIATION THERAPY: Practical Treatment, Biology and Imaging May 16-18, 2014 Grand Hyatt San Antonio, San Antonio
ASTRO 56TH ANNUAL MEETING September 14-17, 2014 Moscone Convention Center, San Francisco
BEST OF ASTRO October 17-18, 2014 Eden Roc Hotel, Miami Beach
CHICAGO MULTIDISCIPLINARY SYMPOSIUM IN THORACIC ONCOLOGY October 31-November 2, 2014 Chicago Marriott Downtown Magnifi cent Mile, Chicago
TARGETING CANCER CARE
For more information visit www.astro.org. ASTRO 2013 / 55TH ANNUAL MEETING 175 NOTES
176 ASTRO 2013 / 55TH ANNUAL MEETING NOTES
ASTRO 2013 / 55TH ANNUAL MEETING 177 NOTES
178 ASTRO 2013 / 55TH ANNUAL MEETING INSIDE: Index by Author Index by Track Indexes
2014 Call for Abstracts Deadline: February 17, 2014 11:59 p.m. Eastern time Indexes Special thankstoASTRO’s Partners MeetingIndustry 55thAnnual 2013 CIVCO Solutions Medical INDUSTRY PARTNERS Sun Nuclear Vertual, Ltd. ANNUAL MEETING (AS OF AUGUST BRONZE COPPER SILVER GOLD 26, 2013)
Xoft, Inc.
Index by Author (Abstracts only)
A Arafat, Waleed 345 Beadle, Beth 193 Bravo, Stephen 1061 Arai, Kazuhiro 3329 Bedi, Manpreet 3082 Bray, Tracy 3231 Abazeed, Mohamed 340 Arcangeli, Stefano 2916 Bekelman, Justin 96 Bredel, Markus 240 Abdel-Wahab, May 2322 Arneson, Kyle 2175 Bekelman, Justin 2760 Brenner, David 1087 Abdel-Wahab, May 2366 Arora, Shruthi 2482 Berhane, Hebist 52 Brock, Kristy 3287 Abo-Madyan, Yasser 2024 Arribas, Leoncio 2148 Berhane, Hebist 1112 Brodin, Patrik 3028 Abramowitz, Matthew 3257 Arsenault, Daniel 2814 Berman, Abigail 2748 Brouwer, Charlotte 2710 Adli, Mustafa 2926 Arterbery, V. Elayne 2011 Bernad, Daniel 252 Brown, Lindsay 172 Adli, Mustafa 3040 Arterbery, V. Elayne 2776 Bernad, Daniel 2972 Bryant, Curtis 2508 Admiraal, Marjan 2993 Arterbery, V. Elayne 3009 Bernier, Laurence 2622 Burt, Lindsay 2112 Agarwal, Manuj 2454 Arvold, Nils 39 Bernstein, Michael 269 Butler, E. Brian 3016 Agarwal, Ankit 2976 Arvold, Nils 3158 Best, Ryan 3013 Byun, John 1075 Aguilera, Todd 2899 Asai, Kaori 2792 Bhandare, Niranjan 2088 Aguirre, Maria 2698 Ashamalla, Mark 2469 Bhandare, Niranjan 2600 Ahmad, Mediha 2286 Asher, David 3260 Bhandare, Niranjan 2659 C Ahn, Peter 140 Ashman, Jonathan 1095 Bhatnagar, Ajay 157 Cahlon, Oren 2498 Ahn, Sung-Ja 183 Ashworth, Allison 2883 Bhatt, Aashish 1048 Cahlon, Oren 3417 Ahuja, Divya 2977 Atkins, Katelyn 165 Bhirud, Abhijeet 2289 Cai, Sophie 2264 Ahunbay, Ergun 330 Atrchian, Siavash 2077 Bi, Nan 227 Cai, Yong 2335 Aitken, Katharine 129 Ausborn, Natalie 2279 Bi, Nan 1049 Camarata, Andrew 3451 Aiyer, Anita 270 Awan, Musaddiq 3003 Bing, Lu 2849 Camborde, Marie-Laure 2301 Aiyer, Anita 3147 Ayakawa, Shiho 2447 Bing, Lu 2862 Cannon, Nathan 2879 Aizer, Ayal 2135 Ayala-Peacock, Diandra 2958 Binkley, Michael 2898 Cao, Yue 62 Akasaka, Hiroaki 3131 Azcona, Juan Diego 361 Bishop, Andrew 1046 Cao, Jianzhong 2919 Akita, Shungo 1011 Biswas, Tithi 243 Cao, Yuanjie 3297 Alcorn, Sara 2193 Biswas, Tithi 3202 Caparrotti, Francesca 2509 Alcorn, Sara 2944 B Blacksburg, Seth 2304 Cardoso, Richard 2711 Alektiar, Kaled 152 Baba, Fumiya 2867 Blacksburg, Seth 309 Carillo, Viviana 2427 Alexander, Jesse 2465 Baden, Craig 2550 Blacksburg, Seth 2434 Carlson, Julie 2757 Alfaraj, Fatimah 2098 Badiozamani, Kasra 2375 Blacksburg, Seth 3092 Carmona, Ruben 100 Alite, Fiori 2648 Badiyan, Shahed 1121 Blacksburg, Seth 3093 Carpenter, Todd 2616 Alite, Fiori 2906 Bagshaw, Hilary 2538 Blanchard, Miran 313 Carrier, France 3188 Allen, Bryan 3184 Bahig, Houda 28 Blanck, Oliver 2936 Casey, Stephanie 2854 Allison, Ron 2373 Baine, Michael 2263 Bleyer, Archie 2761 Cassidy, Richard 3067 Al-Omair, Ameen 2159 Baker, Mariwan 2572 Bo, Yang 2536 Catan, Ilker 3308 Al-Qaisieh, Bashar 1008 Bakhoum, Samuel 3134 Bo, Chen 148 Catron, Tom 3256 Alshehri, Salem 1118 Bakst, Richard 3114 Boelke, Edwin 2601 Cattaneo, Richard 2826 Alsuhaibani, Abdullah 2362 Balagamwala, Ehsan 2949 Boggs, Hunter 2224 Caussa, Lucas 3385 Alsuhaibani, Abdullah 2364 Balagamwala, Ehsan 216 Bondiau, Pierre-Yves 2015 Cengel, Keith 3079 Aluwini, Shafak 201 Baliga, Sujith 2580 Boothe, Dustin 3063 Cerne, Jasmina 3200 Amarnath, Sudha 2787 Ball, Christine 3097 Boothe, Dustin 3393 Cha, Jihye 2718 Amarnath, Sudha 2860 Banerjee, Robyn 2568 Bornstein, Sophia 3111 Chadha, Manjeet 1125 Amelio, Dante 2128 Baquero, William 2513 Borst, Gerben 48 Chadha, Manjeet 2078 Amendola, Beatriz 3080 Barker, Christopher 221 Bos, Clemens 3228 Chan, Cato 2267 An, Sohyun 3309 Barney, Brandon 2297 Boss, Mary-Keara 3117 Chan, Siu Keung 3330 Anderson, Bethany 2090 Barney, Brandon 2634 Bourgouin, Alexandra 3258 Chandrasekaran, Sanjay 2291 Anderson, Carryn 233 Baron, Charles 3249 Bowen, Stephen 2847 Chandrasekaran, Sanjay 224 Anderson, Nigel 2704 Barrett, Olivia 2052 Boychak, Alex 2421 Chang, Daniel 2742 Ando, Ken 3150 Barriger, Bryan 2945 Boyle, John 2582 Chang, Jee Suk 2950 Aneese, Andrew 80 Barron, David 3047 Bracey, Daniel 1050 Chang, Joe 2817 Aneja, Sanjay 1132 Baschnagel, Andrew 3169 Bradbury, C. Matthew 2099 Chang, Kyung-Hwan 3313 Anker, Christopher 2243 Baschnagel, Andrew 3212 Bradley, Julie 2080 Chang, Lynn 2431 Anwar, Mekhail 43 Basu Achari, Rimpa 3020 Bratman, Scott 223 Chang-Halpenny, Christine 2114 Anwar, Mekhail 2436 Batra, Sonny 1126 Bratman, Scott 3123 Chang-Halpenny, Christine 2574 Apicelli, Anthony 3115 Batra, Sonny 2363 Braun, Theodore 3128 Chanyavanich, Vorakarn 3255 Appelt, Ane 2343 Baumann, Brian 199 Braunstein, Steve 1124 Chapet, Olivier 1065 Appenzoller, Lindsey 3098 Bayman, Evrim 2700 Braunstein, Steve 1026 Chapman, Christina 2788 Appenzoller, Lindsey 3099 Bazalova, Magdalena 3160 Braunstein, Steve 3011 Chapman, Christopher 2713 Bazan, Jose 229 Braunstein, Steve 3107 Chapman, Christopher 3275
ASTRO 2013 / 55TH ANNUAL MEETING 181 Chaudhari, Lalit 3341 Compton, Julia 2192 Dosoretz, Arie 2190 Fasola, Carolina 143 Chaudhary, Ahmed 350 Contreras, Jessika 2598 Dosoretz, Arie 2778 Fawaz, Ziad 2420 Chaudhry, Huma 2030 Cooper, Benjamin 3250 Douglass, Lauren 3246 Fechter, Tobias 3095 Chaudhry, Huma 2276 Cordova, James 2121 D’Souza, David Paul 2487 Feigen, Malcolm 280 Chaudhry, Huma 3425 Corso, Christopher 2129 Du, Shisuo 343 Feng, Felix 307 Chawla, Sheema 2969 Corwin, David 2139 Dumane, Vishruta 3460 Feng, Mary 63 Chen, Allan 2178 Court, Laurence 3211 Dunn, Emily 2525 Feng, Wen 2834 Chen, Allen 3062 Cox, Brett 289 Dunn, Kerry 282 Fernandes, Annemarie 2334 Chen, Andrew 2257 Craig, Timothy 34 Dunst, Juergen 2022 Fernandes, Annemarie 108 Chen, Andy 2603 Cramer, Christina 2762 Dunst, Juergen 2937 Ferreira, Dominihemberg 2019 Chen, Chin-Cheng 3408 Crandley, Edwin 2450 Duplan, Danny 2996 Ferreira, Maria Clara 3429 Chen, Guang-Pei 3324 Crandley, Edwin 2606 Durkee, Ben 2607 Ferrer, Ferran 203 Chen, Hairong 3371 Cruz, Alex 2294 Dutta, Pinaki 2597 Ferrer, Ferran 2446 Chen, Jenny Ling-Yu 2546 Cui, Yunfeng 2980 Duvvuri, Umamaheswar 2618 Ferrer, Ferran 2480 Chen, Jiayi 111 Currier, Blake 2169 Dyk, Pawel 2326 Ferris, Matthew 312 Chen, Linda 40 Curry, Heather 2779 Ferro, Adam 2040 Chen, Ming 2811 Feygelman, Vladimir 3303 Chen, Peter 2051 E Fidler, Mary 1140 Chen, Quan 2060 D Eastham, David 3005 Fields, Emma 2549 Chen, Ronald 1081 Dagan, Roi 1089 Eaton, Bree 2018 Figueiredo, Maria Luisa 2205 Chen, Weijun 2901 Dal Pra, Alan 1058 Edwards-Bennett, Sophia 2103 Fischer-Valuck, Ben 2869 Chen, Wenjuan 2543 Dalah, Entesar 2850 Efstathiou, Jason 2764 Fisher, Sarah 1098 Chen, Xiaoming 3347 Daly, Megan 2904 Einck, John 2111 Folkert, Michael 5 Chen, Yu-Jen 3173 Damast, Shari 2567 El Kaissi, Tarek 3390 Foltz, Warren 1066 Chen, Yu 2068 Damato, Antonio 3342 El-Bared, Nancy 2552 Fontana, Andrea 3133 Cheng, ChihYao 3289 Dan, Tu 114 El-Haddad, Mostafa 3420 Fortin, Marie Andree 2749 Cheng, Yufeng 2230 Dandekar, Virag 3366 Elicin, Olgun 76 Fotouhi Ghiam, Alireza 305 Chennupati, Sravana 1068 Danish, Hasan 44 Elliott, David 1069 Fowble, Barbara 94 Chera, Bhisham 2201 Day, Ellen 3320 Elnahal, Shereef 3018 Franco, Pierfrancesco 2050 Chera, Bhishamjit 2682 De La Mata, M. Dolores 2356 Elsayyad, Nagy 2675 Frank, Steven 354 Cheung, Michael 3243 De Santis, Maria Carmen 3276 Elshaikh, Mohamed 2561 Freilich, Jessica 2275 Cheung, Min Rex 2367 De Souza-Lawrence, Lana 302 Elson, Joshua 2752 Freilich, Jessica 2921 Cheung, Min Rex 2553 Dean, Mary 2539 Emami, Bahman 2714 Friedman, Jeff rey 2948 Cheung, Patrick 259 Deasy, Joseph 3288 Engel, Steven 3042 Froment, Marie-Anne 2530 Chibani, Omar 2521 Den Hartogh, Mariska 2073 Epperly, Michael 278 Fujita, Yujiro 3290 Chilukuri, Srinivas 2143 DeNittis, Albert 2345 Epperly, Michael 3144 Fukada, Junichi 2231 Chin, Matthew 2528 Denniston, Kyle 1037 Erickson, Kelly 1106 Fuller, Donald 2387 Chin, Re-I 2605 Deraniyagala, Rohan 2998 Ernst, Iris 2320 Fuller, Don 177 Chin, Alexander 35 Desai, Neil 2576 Eshleman, Jeff rey 2057 Fung, Winky Wing Ki 3311 Chino, Junzo 72 Desai, Prashant 2156 Esthappan, Jacqueline 2170 Furhang, Eli 2782 Cho, DooKee 3447 Deutsch, Israel 2573 Evans, Jaden 3157 Fuss, Martin 2331 Cho, Yeona 2442 Dewan, Abhinav 2614 Evans, Joseph 2321 Cho, Yu Ra 3441 DeWeese, Theodore 267 Choi, Jehee 2526 Dhami, Gurleen 2785 G Choi, Seungtaek 2479 Dhanesar, Sandeep 3415 F Gaff ney, David 71 Choi, Youngmin 3232 Dholakia, Avani 211 Fagundes, Marcio 2107 Galalae, Razvan 310 Chow, Edward 12 Dholakia, Avani 2277 Falchook, Aaron 95 Galland, Sigolene 1122 Chow, Tiff any 2081 Di Muzio, Nadia 1014 Falk, Alexander 2346 Galland, Sigolene 2084 Christensen, Eva 2164 Diaz Pardo, Dayssy 2510 Falk, Alexander 3075 Galland, Sigolene 2518 Christian, Nicolas 2848 Diaz Vazquez, Maria Fan, ChengCheng 2880 Gamez, Mauricio 2669 Christopherson, Kaitlin 2663 Fernanda 2333 Fan, Kang-Hsing 2699 Gan, Gregory 346 Christopherson, Kaitlin 3022 Dickie, Colleen 153 Fan, Katherine 2315 Gandhi, Saumil 2324 Chua, Melvin Lee Kiang 3205 Diff enderfer, Eric 3154 Fan, Katherine 3000 Gandhi, Ajeet 77 Chung, Peter 206 Din, Shaun 2828 Fan, Michael 3103 Gao, Wendy 2620 Ciezki, Jay 2432 Din, Shaun 2855 Fan, Qiyong 232 Gao, Wanbao 3007 Ciezki, Jay 2494 Dinan, Michaela 99 Fan, Yankhua 2889 Garay, Elizabeth 2882 Clark, Grant 2177 Ding, Yun 2016 Fang, Charles 2318 Garcia-Vicente, Feliciano 2424 Clayman, Rebecca 202 Ding, Lei 2548 Fang, Li-Ming Christine 166 Gardner, Stephen 363 Clayman, Rebecca 2747 DiPardo, Benjamin 2754 Fang, Penny 41 Garg, Shivank 2728 Clayton, Ravinder 3361 Dizman, Aysen 3377 Fang, Penny 3056 Garg, Shalini 2822 Cohen, Randi 2072 Doi, Yoshiko 3294 Faria Braga, Henrique 2185 Gay, Hiram 2456 Colbert, Lauren 225 Doke, Kaleigh 2737 Faria Braga, Henrique 2702 Gayar, Omar 3044 Cole, Aidan 2824 Dominello, Michael 2569 Farol, Hanako 3450 Geng, Alexander 2042 Combs, Stephanie E. 251 Dorth, Jennifer 2777 Farr, Jonathan 1094
182 ASTRO 2013 / 55TH ANNUAL MEETING Geng, Hui 2982 H Hodges, Joseph 2773 Iwata, Hiromitsu 3149 Gensheimer, Michael 141 Hoeller, Ulrike 158 Iwata, Hiromitsu 3227 Gensheimer, Michael 3012 Haas, Jonathan Andrew 2386 Hollander, Andrew 3023 Izadbakhsh, Mark 3102 Gentile, Michelle 1128 Hadley, Scott 3353 Hollen, Tyler 3069 Gerber, Naamit 2801 Haga, Akihiro 2859 Holliday, Emma 2784 Ghadjar, Pirus 2984 Haider, Syed 2885 Holtzman, Adam 2389 J Ghaff ari, Hamid 2999 Halasz, Lia 97 Hong, Ji-Hong 3116 Jackson, William 1024 Ghaly, Maged 2166 Hall, William 2270 Hong, Linda 3363 Jackson, William 2459 Ghaly, Maged 2280 Hall, William 329 Hong, Robert 2076 Jacob, Julian 2021 Ghi, Maria Grazia 4 Hall, William 3210 Hong, Theodore 65 Jacobs, Corbin 3209 Gilbride, Lucas 277 Hallman, Mark 127 Hong, Zhen-Yu 3208 Jadon, Rashmi 2558 Gill, Beant 73 Halyard, Michele Yvette 324 Hoopes, David 291 Jaff ray, David 29 Giordano, Frank 253 Hamilton, Sarah 2636 Hoover, Andrew 2722 Jaff ray, David 3322 Glanzman, Jonathan 2705 Hamker, Jean 2591 Hoppe, Bradford 2374 Jagsi, Reshma 2046 Glanzman, Jonathan 2717 Han, Bin 297 Hoppe, Bradford 1038 Jain, Anshu 2171 Glanzman, Jonathan 2938 Han, Chun 2215 Hori, Masakazu 2221 Jain, Prachi 2496 Glide-Hurst, Carri 167 Han, Guang 3293 Horowitz, David 2104 Jang, HongSeok 3312 Godley, Andrew 337 Han, Hee Ji 2715 Horton, Janet 2065 Janssen, Rogier 3088 Goff , Julie 3142 Han, Jae Hong 2599 Hosotani, Martha 2141 Jaswal, Jasbir 2732 Golchin, Ava 2734 Han, Kathy 70 Houghton, Frank 3119 Jawad, Maha 2162 Goldberg, Mira 2593 Hanada, Takashi 2406 Housri, Nadine 2755 Jegadeesh, Naresh 247 Golden, Encouse 3113 Hanasoge, Sheela 1111 Howell, David 217 Jenkins, Neil 3401 Golden, Encouse 3124 Handsfi eld, Lydia 2991 Hsi, Wen 3406 Jennelle, Richard 3348 Golden, Encouse 3125 Hanna, Nevine 2720 Hsieh, Cheng-En 2672 Jensen, Alexandra 138 Golden, Encouse 3126 Harada, Satoshi 3163 Hsu, Che-Yu 2226 Jeong, Ho jin 3245 Goldin, Gregg 3389 Harada, Keiichi 162 Hsu, Howard 1101 Jeong, Jeho 231 Goldsmith, Christy 1088 Hardie, John 255 Hu, Kenneth Shung 195 Jeong, Kyoungkeun 3331 Goldstein, Nicolas 2783 Harima, Yoko 230 Hu, Yanle 30 Jeongshim, Lee 2122 Gomez, Daniel 1139 Haritha, Chiramana 2211 Hu, Yanle 3351 Jeyaseelan, Krishinima 3220 Gomez-Iturriaga, Alfonso 2428 Harkenrider, Matthew 3399 Hua, Chia-Ho 3021 Ji, Jiang 3112 Gonzalez, Victor 3251 Harris, Timothy 2138 Huang, Kitty 1143 Ji, ShengJun 3110 Gooding, Mark 2444 Harris, Jeremy 24 Huang, Long 3370 Ji, Zhe 2861 Gooding, Mark 3338 Harris, Jeremy 2808 Huang, Pin-I 2635 Jiang, Yuliang 3094 Gooding, Mark 3345 Harris, Timothy 268 Huang, Xin 2223 Jimenez, Rachel 2187 Goodman, Ben 1107 Hartsell, William 2499 Huang, Zhibin 103 Jimenez, Rachel 3222 Goodman, Karyn 181 Hasegawa, Azusa 2706 Huddleston, Adam 2566 Jin, Jing 2354 Gottschalk, Alex 258 Hasegawa, Masatoshi 3153 Hughes, Michael 2415 Jin, Feng 2641 Goyal, Sharad 2062 Hashizume, Chisa 2842 Huguet, Florence 69 Jingu, Keiichi 2210 Grabowski, Sarah 2500 Hata, Masaharu 3073 Hui, Zhouguang 2839 Johnson, Matthew 2199 Hattori, Yukiko 2665 Grant, Jonathan 2874 Hurst, Newton 2655 Johnson, Skyler 1062 Gray, Phillip 200 Hayashi, Akihiro 2418 Husaini, Hasan 2624 Johnson, Skyler 2501 Grecula, John 1133 Hazariwala, Ronica 2260 Hutcheson, Katherine 352 Johnson, Skyler 2502 Green, Olga 32 Hazell, Irene 333 Hutcheson, Katherine 3049 Jones, Bernard 356 Greenberger, Benjamin 3024 He, Zhiyong 3201 Huynh-Le, Minh-Phuong 3041 Jones, Daniel Adam 3064 Greenberger, Benjamin 3109 Hearn, Jason 1021 Hwang, Ken-Pin 3334 Josipovic, Mirjana 2890 Greenberger, Joel 126 Hedayati, Mohammad 3187 Hymas, Richard 23 Jozsef, Gabor 2071 Greenwalt, Julie 321 Hegarty, Sarah 2477 Juloori, Aditya 2240 Greenwalt, Julie 2633 Helou, Joelle 2347 Jung, Jinhong 2300 Greer, Peter 295 Hempel, Dominika 2451 I Jung, David 2961 Grendarova, Petra 2101 Henderson, Randal 1017 Iftimia, Ileana 3418 Greskovich, John 2780 Henrich, Dawn 3019 Igaki, Hiroshi 3143 Grew, David 2753 Hentschel, Bettina 2372 Iganej, Shahrokh 2617 K Heres, Tomer 2411 Grills, Inga 2878 Ikeda, Itaru 3242 Kabarriti, Rafi 2540 Herman, Joseph 66 Grossman, Craig 2146 Indelicato, Daniel 90 Kabolizadeh, Peyman 319 Herman, Lauren 2712 Grover, Surbhi 182 Inokuchi, Haruo 2393 Kai, Naoki 2589 Hertan, Lauren 2838 Guanhao, Chen 2832 Iqbal, Hassan 2647 Kainickal, Cessal 2719 Herman, Michael 2594 Guckenberger, Matthias 249 Irie, Daisuke 2537 Kainz, Kristofer 1005 Hess, Clayton 192 Guix, Benjamin 2475 Ishii, Kentaro 2410 Kalakota, Kapila 1033 Hill-Kayser, Christine 288 Gujral, Dorothy 1117 Ishikawa, Hitoshi 2238 Kalapurakal, John 2381 Hill-Kayser, Christine 3033 Gulaya, Sachin 2769 Ishiyama, Hiromichi 2376 Kalash, Ronny 2038 Hiniker, Susan 92 Gunn, Brandon G. 285 Isohashi, Fumiaki 2544 Kalash, Ronny 275 Hinse, Martin 2083 Guo, Susan 2625 Ito, Yasushi 3354 Kalbasi, Anusha 2468 Hinton, Benjamin 2819 Guttmann, David 2559 Iwana, Maho 3374 Kamran, Sophia 2167 Hirata, Takero 2278 Ho, Alice 116
ASTRO 2013 / 55TH ANNUAL MEETING 183 Kamrava, Mitchell 55 Kim, Young Il 3077 Lally, Brian 188 Lian, Jun 134 Kan, Charlene 2440 Kincaid, Russell 362 Lam, Wai Wang 2985 Liang, Jun 2233 Kan, Charlene 2716 King, Martin 235 Lamb, James 3001 Liang, Jian 3301 Kanakamedala, Madhava 2726 Kirkpatrick, John 119 Lang, Jinyi 2534 Liao, Zhongxing 226 Kanakamedala, Madhava 2727 Kirschner, Austin 3189 Lang, Jinyi 3206 Liapi, Eleni 3196 Kanazawa, Aki 2545 Kishan, Amar 2790 Lanni, Thomas 2775 Lim, Yujin 2123 Kandula, Shravan 2126 Kittel, Jeff rey 2404 Lappinen, Erik 2303 Lim, Kyoung-Dal 3302 Kandula, Shravan 3037 Kjaer-Kristoff ersen, Larrea, Luis 2891 Li-Ming, Xu 2922 Kaneyasu, Yuko 2563 Flemming 3439 Lasley, Foster 64 Lin, Alexander 2997 Kang, Julie Jung 2505 Klein, Eric 3412 Lau, Steven 2181 Lin, Chi 68 Kann, Benjamin 326 Klein, Jonathan 3053 Lau, Steven 2809 Lin, Hong-Yiou 2184 Kao, Johnny 2173 Kleinberg, Lawrence 2115 Laufer, Marsha 1080 Lin, Lilie 3413 Kao, Wei Heng 2197 Koay, Eugene 318 Lautenschlaeger, Tim 3193 Lin, Mu-Han 1010 Kapadia, Nirav 2767 Koc, Mehmet 2917 Lazow, Stefanie 2136 Lin, Qin 2643 Kapoor, Rishabh 2758 Koch, Siete 3375 Le, Yi 2457 Lin, Shinn-Yn 2721 Kapur, Ajay 2763 Kodaira, Takeshi 2632 Lee, Andrew 179 Lin, Steven 274 Karasawa, Katsuyuki 2679 Kohutek, Zachary 27 Lee, Dong-Soo 2196 Lin, Steven 3172 Karasawa, Katsuyuki 2910 Kole, Thomas 3367 Lee, Eva 2551 Lin, Yuting 2414 Kasuya, Goro 2531 Kole, Thomas 3428 Lee, Joo Ho 2341 Lin, Yuting 2416 Katayama, Emiko 2925 Kollar, Laura 3078 Lee, Joseph 198 Lin, Yu-Wei 2443 Kathpal, Madeera 2476 Kollmeier, Marisa 222 Lee, Larissa 2579 Lin, Yu-Wei 1109 Kathpal, Madeera 3267 Komaki, Ritsuko 2875 Lee, Richard 2397 Lindsay, Daniel 2506 Katoh, Norio 2797 Kong, Feng-Ming 184 Lee, Suk 3310 Ling, Ted 3404 Katz, Alan 57 Konski, Andre 2283 Lee, Sung Uk 2336 Liss, Adam 2032 Kaufman, Isaac 3395 Konski, Andre 3178 Lee, Sung-Wei 3214 Liu, An 2724 Kawaguchi, Gen 2220 Koo, Tae Ryool 2033 Lee, Tsz Kin 3055 Liu, Dan 3273 Kawanaka, Takashi 320 Koontz, Bridget 2417 Lefresne, Shilo 2959 Liu, Feng 3340 Kazuhiko, Hayashi 1044 Korah, Mariam 2067 Lei, Rachel 1123 Liu, Gene-Fu 196 Kelly, Maria 2486 Korideck, Houari 1007 Lei, Xin 2355 Liu, Han 3398 Kerns, Sarah 327 Kotler, Monica 3177 LeMieux, Melissa 2140 Liu, Huiming 2222 Kersh, C. Ronald 248 Kovalchuk, Nataliya 2735 LeMieux, Melissa 3043 Liu, Qingfeng 2923 Keruakous, Amany 1129 Kozak, Margaret 2365 Lemons, Jeff rey 2652 Liu, Qi 2227 Kesava Ramgopal, Kozono, David 50 Leonard, Kara 2370 Liu, Qi 2248 Adavikolanu 2725 Krasin, Matthew 168 Leong, Aidan 2750 Liu, Tian 2087 Khan, Luluel 218 Krauss, Daniel 54 Lester, Scott 2892 Liu, Wei 2628 Khandelwal, Shiv 3459 Krauss, Daniel 2396 Lester-Coll, Nataniel 1076 Liu, Wenyang 2836 Kharofa, Jordan 1105 Kress, Marie-Adele 176 Letourneau, Daniel 2983 Liu, Wu 2419 Kharofa, Jordan 2963 Krishnan, Monica 220 Leung, Eric 74 Liu, Xiao 1102 Khwaja, Shariq 2006 Kriz, Jan 11 Leung, Paikin 3263 Liu, Xiao 1108 Khwaja, Shariq 2089 Ku, Lichung 3261 Leuthold, Susan 3455 Liu, Yilin 2319 Kierkels, Roel 2707 Kudrimoti, Mahesh 3120 Levin, Daphne 3432 Lloyd, Shane 2929 Kil, Whoon 2385 Kuhn, Elizabeth 2144 Levy, Antonin 2650 Lloyd, Shane 2947 Kilburn, Jeremy 2908 Kumar, Aryavarta 2272 Lewis, Stephen 3052 Lo, Andrea 2394 Kim, Aileen 2673 Kumar, Rachit 1097 Lewis, Trevor 2895 Lock, Michael 2332 Kim, Byounghyuck 2818 Kumar, Sanath 1053 Li, Allen 2063 Logan, Jennifer 2383 Kim, Dae Il 3373 Kumar, Shaleen 2245 Li, Feng 3298 Logue, Jennifer 2729 Kim, Daniel 2933 Kumar, Parvesh 2484 Li, Guang 3238 Lopater, Zachary 3014 Kim, Dong Wook Nathan 2405 Kunhiparambath, Haresh 2125 Li, Guichao 2259 Lopez-Araujo, Javier 2512 Kim, Gwe-Ya 3454 Kunnambath, Ramadas 353 Li, Hao 2360 Low, Daniel 357 Kim, Haksoo 3286 Kuo, Hsiang-Chi 3234 Li, Hualei 2851 Low, Daniel 3229 Kim, Haksoo 3392 Kuo, Jeff rey 2039 Li, Jiancheng 2247 Lozano, Joan 2425 Kim, In Ah 3162 Kuo, SUng-Hsin 2934 Li, Jingdong 3394 Lu, Bing 2803 Kim, Jin Ho 3179 Kuremsky, Jeff rey 1079 Li, Jun 3239 Lu, Bing 2804 Kim, Jinkoo 3335 Kusano, Aaron 298 Li, Ling 186 Lu, Diana 2805 Kim, Julian 2897 Kushnirsky, Marina 120 Li, Ling 2905 Lu, NingNing 2253 Kim, Jun Won 2313 Kuske, Robert 2106 Li, Min 2887 Lu, Shawn Shao-Lun 1099 Kim, Jun Won 2654 Kwak, Yoo Kang 2524 Li, Minghuan 2212 Lu, Weiguo 338 Kim, Kyung Hwan 2198 Kwon, Jeanny 2676 Li, Minghuan 2213 Lucas, John 124 Kim, Kyung Hwan 2244 Li, Qiwen 2252 Lukens, John 2284 Kim, Kyung Su 2298 L Li, Ruijiang 3368 Lukovic, Jelena 2570 Kim, Miranda 1022 Lachance, Bernard 3346 Li, Ruijiang 109 Luo, Guozhen 3344 Kim, Robert 2529 Ladra, Matthew 3034 Li, Rongmao 3233 Luo, Wen Min 3376 Kim, Sungjune 3121 Lai, Chiahsuan 2640 Li, Xiang 3236 Lutkenhaus, Lotte 2237 Kim, Tae Gyu 3380 Lai, Shihfan 2102 Li, Winnie 3386 Ly, David 2203
184 ASTRO 2013 / 55TH ANNUAL MEETING M Matysiak, Witold 3402 Mohr, Angela 3316 Nath, Sameer 2055 Mayadev, Jyoti 2020 Moleron, Rafael 2191 Nautiyal, Vipul 3059 Ma, Changsheng 2218 Maymani, Rebekah 2608 Molitoris, Jason 2990 Navarria, Piera 2930 Ma, Jinli 2008 Mayr, Nina 75 Monjazeb, Arta 272 Navarria, Piera 3365 Ma, Jin-lu 3122 Mazloom, Ali 175 Mooney, Karen 3224 Nedelka, Michele 2942 Ma, Lijun 3384 McBride, Sean 204 Mooney, Karen 3268 Nedialkova, Lucy 3446 Ma, Lin 2638 McBride, Sean 3025 Moore, Joseph 3096 Nedzi, Lucien 139 Macklis, Roger 2516 McDonald, Mark 2194 Moore, Joseph 335 Ng, Andrea 144 Macrie, Bryan 2407 McDonald, Andrew 2483 Mori, Yoshimasa 2155 Nguyen, Hannah 2413 Maghsoudi, Kaveh 3421 McGee, Lisa 1141 Morris, Ann 2786 Nguyen, Nathalie 2153 Magnan, Sindy 1023 McGuinness, Christopher 3379 Morris, Zachary 84 Nguyen, Nhu Tram 2909 Magnuson, William 2564 McGuire, Sean 2470 Mosaly, Prithima Reddy 290 Nguyen, Paul 261 Mahadevan, Anand 2305 Mehmood, Tahir 322 Mosaly, Prithima Reddy 3259 Nguyen, Phuong 2350 Mahantshetty, Umesh 3343 Mehta, Niraj 3442 Moskvin, Vadim 1096 Nguyen, Quynh 190 Mahjoubi, Khalil 3381 Mei, Feng 2645 Moteabbed, Maryam 1092 Nguyen-Tan, Phuc Felix 135 Mahmoud, Omar 2825 Meier, Robert 58 Motwani, Sabin 2127 Ngwa, Wilfred 1009 Mahmoud, Omar 332 Mellon, Eric 2003 Mou, Benjamin 2765 Niazi, Tamim 1020 Mahmoud, Omar 3071 Mellon, Eric 2261 Mourad, Waleed 2206 Niazi, Tamim 2433 Mahmud, Aamer 2514 Men, Yu 2823 Mourad, Waleed 2694 Nicholas, Zachary 2461 Mailhot Vega, Raymond 10 Mendenhall, Nancy 1019 Mourad, Waleed 2935 Nichols, R. Charles 308 Maity, Amit 1057 Mendez Romero, Mourad, Waleed 2943 Nickols, Nicholas 3174 Majithia, Lonika 3262 Alejandra 2302 Mouw, Kent 87 Nicolaou, Nicos 3235 Mak, Kimberley 122 Meng, Bowen 359 Movsas, Benjamin 2 Niermann, Kenneth 325 Mak, Raymond 2794 Menichelli, Claudia 2323 Mrochem-Kwarciak, Nishibuchi, Ikuno 51 Maldonado, Xavier 257 Menzel, Paul 3072 Jolanta 2656 Nishioka, Kentaro 2504 Maldonado, Javier 3170 Meral, Rasim 2158 Muanza, Thierry 2036 Nishioka, Takeshi 3135 Maletz, Kristina 93 Merchant, Thomas 91 Muanza, Thierry 3168 Niu, Tianye 3247 Mallick, Indranil 2586 Meredith, Ruby 1001 Mukai, Yuki 2856 Niu, Tianye 3248 Mallick, Indranil 2723 Merrell, Kenneth 2074 Mukumoto, Naritoshi 3175 Nixon, Lisette 2271 Mancini, Brandon 2265 Merrell, Kenneth 2314 Müller, Klaus 88 Noh, Jae Myoung 1130 Mancini, Brandon 26 Merrell, Kenneth 3409 Munbodh, Reshma 3264 Noto, Kimiya 3424 Mancosu, Pietro 3244 Meshkov, Dmitriy 276 Munbodh, Reshma 3283 Nowak, Ryan 2145 Mandeville, Henry 169 Meshkov, Dmitriy 2881 Munoz Garcia, Julia Luisa 2399 Nowotnik, David 2967 Mangona, Victor 2812 Mestre, Francisco 2918 Munoz Garcia, Julia Luisa 2412 Nuver, Tonnis 2449 Mangona, Victor 102 Meyer, Joshua 2952 Murai, Taro 2179 Nwachukwu, Chika 2968 Mannina, Edward 2317 Meyer, Kurt 2651 Murai, Taro 81 Nyfl ot, Matthew 2994 Manning, Matthew 2893 Mian, Omar 2163 Murakami, Yuji 2229 Mantz, Constantine 2493 Michalski, Jeff 265 Murphy, Colin 2400 Manyam, Bindu 2358 Michaud, Anthony 2871 Murphy, Colin 2455 O Mao, Weihua 3265 Mikell, John 2932 Murphy, Erin 2142 Obasaju, Patience 2045 Maraldo, Maja 3039 Milano, Michael 2810 Muraoka, Osamu 2674 Obayomi-Davies, Olusola 178 Marchan, Edward 2120 Milecki, Piotr 264 Murray, Louise 33 Obedian, Edward 2467 Marciscano, Ariel 1029 Milgrom, Sarah 314 Mut, Alejandro 3383 Ogawa, Yasuhiro 2014 Marcrom, Samuel 2056 Milgrom, Sarah 3058 Mutyala, Subhakar 3087 Oguchi, Masahiko 2054 Maria, Ola 3139 Miljkovic, Milos 3045 Myers, Carey 1135 Oguri, Mitsuhiko 2912 Maria Das, Koilpillai Joseph 3253 Miller, Luke 1043 Myers, Carey 2894 Oh, Steven 2118 Marina, Ovidiu 2342 Min, Christine 209 Myers, Carey 2896 Oh, Seungjong 300 Mariscal, Luis 2957 Min, Christine 2772 Myojin, Miyako 2236 Ohashi, Toshio 2371 Markovic, Alexander 3002 Ming, Xin 1012 Ohashi, Toshio 2377 Markovina, Stephanie 2485 Mirabeau-Beale, Kristina 180 Oike, Takahiro 2527 Marquardt, Michael 1120 Mirhadi, Amin 61 N Okoye, Christian 2204 Marques, Tatiana 3192 Mishra, Mark 1078 Na, Yong Hum 3433 Okumura, Toshiyuki 2311 Marshall, Ingrid 2992 Misirlioglu, Cem 2255 Nabavizadeh, Nima 3391 Oliai, Caspian 2503 Martin, Neil 3010 Mislmani, Mazen 2583 Nagar, Himanshu 2035 Olivera, Gustavo 3326 Marwaha, Gaurav 2388 Mitchell, James 3006 Nagar, Himanshu 2554 Olsen, Jeff 213 Masunaga, Shin-ichiro 3161 Mitsuyoshi, Takamasa 2596 Nagata, Yasushi 3369 Olson, Robert 215 Matsuo, Yoshiro 2940 Miwa, Kazuhiro 2113 Naik, Nilan 2829 Olson, Robert 2974 Matsuo, Masayuki 3156 Mix, Michael 2693 Nakagawa, Keiichi 3437 Onal, Cem 2472 Matsuura, Tomohiro 2639 Miyakawa, Akifumi 3148 Nakamatsu, Kiyoshi 2117 Ong, Leonard 2877 Mattes, Malcolm 2744 Miyawaki, Daisuke 2708 Nakamatsu, Kiyoshi 2408 Onimaru, Rikiya 22 Mattes, Malcolm 3299 Modh, Ankit 78 Nakamura, Naoki 2001 Onishi, Hiroshi 21 Mattonen, Sarah 25 Mohanty, Partha Pratim 3435 Nam, Jiho 2075 Onozato, Yusuke 3332 Matulewicz, Lukasz 3422 Mohindra, Pranshu 212 Narang, Amol 254 Onukwugha, Matuschek, Christiane 2002 Mohindra, Pranshu 3015 Nath, Sameer 2023 Eberechukwu 2384 Matuschek, Christiane 2681
ASTRO 2013 / 55TH ANNUAL MEETING 185 Orisamolu, Abimbola 2688 Patil, Nikhilesh 2577 R Rolfo, Maureen 2351 Orman, Amber 3035 Pavelic, Martin 1025 Romano, Mario 159 Raaijmakers, Cornelis 142 Orton, Matthew 2815 Peacock, Justin 2664 Romeo, Antonino 2274 Rabinovitch, Rachel Abrams 13 Osmundson, Evan 2330 Pearce, Andrew 2740 Romesser, Paul 1016 Rafi e, Frank 3453 O’Sullivan, Brian 136 Pearlstein, Kevin 1073 Romesser, Paul 323 Rahimian, Javad 1004 Otani, Keisuke 1100 Pearson, David 2100 Ronny, Kalash 3108 Rahn, Douglas 292 Ou, Dan 2962 Pellicciotta, Ilenia 344 Rooney, Jessica 3081 Rainey, David 3083 Owen, Dawn 2684 Peng, Cheng 3427 Rosenberg, Jennifer 1035 Rajagopalan, Malolan 2965 Owen, Dawn 132 Perez, Bradford 2064 Rosenthal, David 3004 Rajakesari, Selvan 2189 Owen, Dawn 3362 Perez, Carmen 1052 Rothenstein, Diana 2348 Rajan, Saju 185 Perez, Carmen 3127 Rouscoff , Yohann 2515 Rajpara, Raj 2845 Perez-Andujar, Angelica 3449 Roux, Audrey 2588 Raldow, Ann 1077 P Perkins, Gregory 3359 Ruggieri, Ruggero 3252 Ram, Ashwin 3031 Pai, Jonathan 1034 Pernin, Victor 2092 Russo, Andrea 19 Ramos, Clementina 2730 Pai, Jonathan 3219 Petersen, Peter 150 Russo, Andrea 2667 Rana, Shushan 2562 Pai Panandiker, Petoukhova, Anna 2012 Rutenberg, Michael 1104 Rancati, Tiziana 2462 Atmaram 3036 Petras, Katarina 2913 Rutter, Charles 2017 Ranck, Mark 2701 Rutter, Charles 2180 Pai Panandiker, Pham, Huong 3008 Randolph, David 3061 Rutter, Charles 2186 Atmaram 3038 Picone, James 3388 Rao, Nalini 2070 Rwigema, Jean-Claude 2368 Palma, David 7 Ping, Yan 3318 Rao, Malay 2172 Rwigema, Jean-Claude 83 Palmer, Joshua 1032 Pinkawa, Michael 2379 Rash, Dominique 2535 Ryu, Samuel 250 Pan, Elizabeth 156 Pinnix, Chelsea 2927 Rash, Dominique 1119 Pan, Hubert 3066 Piper, Jonathan 355 Rasheed, Abdullah 2907 Pandit-Taskar, Neeta 2547 Piper, Jonathan 3349 S Rasmussen, Jacob 2709 Pang, Tingtian 2995 Piper, Jonathan 3350 Sabater, Sebastia 2557 Rath, Goura 2533 Sabolch, Aaron 205 Panoff , Joseph 3027 Pisansky, Thomas 1 Raval, Raju 342 Sadek, Betro 20 Papachristofi lou, Alexandros 82 Pitroda, Sean 46 Recht, Abram 287 Sahai, Puja 2789 Pappas, Evangelos 3448 Platta, Christopher 2560 Reddy, Jay 2105 Sahgal, Arjun 2174 Parashar, Bhupesh 1142 Podder, Tarun 2876 Reddy, Srilakshmi 341 Saigal, Kunal 2082 Pardo, Jose 2026 Polishchuk, Alexei 174 Saito, Anneyuko 2085 Redmond, Kristin 89 Parekh, Akash 2458 Polo, Alfredo 1047 Saito, Makoto 2668 Reese, Adam 2049 Parekh, Akash 2489 Popovic, Marija 2690 Saito, Tetsuo 2806 Refaat, Tamer 2520 Parikh, Dhwani 2831 Poulsen, Per 107 Sakthivel, Vasanthan 2660 Refaat, Tamer 2602 Parikh, Rahul 2920 Prabhu, Roshan 2592 Salama, Joseph 306 Register, Steven 2058 Parikh, Ravi 1138 Prasad, Shreya 241 Salamekh, Samer 164 Reiff , Jay 2069 Parisi, Elisabetta 2846 Prasad, Shreya 2273 Salem, Ahmed 3181 Reinartz, Gabriele 1042 Park, Catherine 1060 Press, Robert 1027 Samuels, Stuart 79 Ren, Hua 2254 Park, Heon Joo 3180 Price, Jeremy 2398 Sanchez Parcerisa, Daniel 3410 Ren, Lei 358 Park, Jaehyeon 2833 Price, Jeremy 273 Santanam, Lakshmi 294 Renaud, Marc-Andre 3101 Park, Junsu 2448 Prieto, Isabel 2955 Santivasi, Wil 245 Renaud, Marc-Andre 3416 Park, Sang-June 2578 Prior, Phillip 239 Santos, Tamara 2202 Riaz, Nadeem 191 Parsai, E. Ishmael 3285 Pukala, Jason 3336 Sanuki, Naoko 2310 Rice, Lynsey 3443 Parvathaneni, Upendra 3085 Pyakuryal, Anil 3106 Sarabia-Estrada, Rachel 303 Rich, Shayna 2746 Parvathaneni, Upendra 3086 Saran, Frank 37 Richard, Patrick 2623 Paryani, Nitesh 2010 Sarmey, Nehaw 2161 Richard, Patrick 2627 Pasha, Junaid 3325 Q Sasaki, Ryohei 3146 Richter, Daniel 1090 Patel, Abhilasha 2517 Qi, Huanpeng 2807 Savir, Guy 2207 Richter, Andreas 3270 Patel, Abhilasha 2584 Qi, Xiangrong 2703 Sayre, George 301 Riegel, Adam 3292 Patel, Abhilasha 3372 Qi, Xiangrong 331 Schadewaldt, Nicole 3423 Rimner, Andreas 281 Patel, Abhilasha 2756 Qian, Xin 3197 Schanne, Daniel 2868 Riou, Olivier 2079 Patel, Abhilasha 2970 Qiao, Xueying 2176 Scharf, Lawrence 2453 Riou, Olivier 2361 Patel, Ajay 2288 Qiao, Qiao 3328 Schefter, Tracey 208 Rishi, Anupam 137 Patel, Ajaykumar 2403 Qin, An 336 Schinkel, Colleen 3337 Roach, Mack 260 Patel, Kirtesh 2951 Qiu, Haoming 2209 Schlaff , Cody 3171 Roach, Mack 2401 Patel, Kruti 2843 Qiu, Haoming 2911 Schmitt, Adam 45 Roach, Michael 2091 Patel, Nisha 86 Qiu, Su 2631 Schulte, Reinhard 105 Roach, Michael 2093 Patel, Pretesh 2733 Qu, Ang 3137 Schuster, Jessica 334 Robinson, Timothy 2751 Patel, Rajal 2258 Quang, Tony 2986 Schutzer, Matthew 2490 Robinson, Timothy 3207 Patel, Sagar 112 Quanshi, Zhang 3274 Schutzer, Matthew 2900 Rochet, Nathalie 1127 Patel, Sagar 2234 Que, jenny 2296 Schwartz, David Louis 1113 Rochet, Nathalie 3426 Patel, Shilpen 2914 Quek, Ruben 2739 Schwartz, David 286 Rodrigues, George 118 Patel, Shilpen 2915 Quek, Ruben 2741 Scott, Michael 2658 Rodrigues, Anna 296 Patel, Shilpen 2738 Quon, Harry 348 Scott, Michael 3068 Roeder, Falk 154 Patel, Suchit 189 Quon, Harvey 351 Sekiguchi, Akane 2390
186 ASTRO 2013 / 55TH ANNUAL MEETING Semon, Meredith 3352 Shumway, Dean 2870 Suh, Yelin 130 Thibault, Isabelle 2863 Sen, Amarjit 2473 Shvydka, Diana 1002 Sulaiman, Nor Shazrina 2426 Thiruganasambandam, Seo, Yuji 3215 Siddiqui, Faisal 2241 Sulman, Erik 3213 Sivarajan 1056 Seol, Seung Won 2312 Siddiqui, Farzan 2609 Sun, Jason 2661 Thirumoorthy, Krishnan 3221 Sethi, Roshan 2188 Siddiqui, Farzan 3305 Sundararaman, Srinath 3017 Thomas, Kimberly 2041 Sethi, Manish 3166 Siglin, Joshua 1030 Suneja, Gita 2759 Thomas, Charles 214 Sethukavalan, Perakaa 60 Simone, Brittany 3167 Sura, Karna 283 Thompson, Jonathan 3445 Setton, Jermey 347 Simone, Brittany 3240 Surapaneni, Aparna 2441 Thompson, Marcher 2666 Sevak, Parag 2657 Simpson, Daniel 2978 Suri, Jaipreet 173 Thompson, Marcher 3136 Seyedin, Steven 2250 Sindhwani, Ragini 2481 Surucu, Murat 2626 Thompson, Reid 2282 Seymour, Zachary 2745 Sinha, Uttam 2629 Susheela, Sridhar 2116 Thompson, Reid 3032 Seymour, Zachary 3050 Sio, Terence 2973 Sveistrup, Joen 2380 Thoms, John 3165 Shabason, Jacob 1084 Sio, Terence 328 Swanick, Cameron 2800 Tinkle, Christopher 121 Shaff er, Jenny 2316 Sirak, Igor 2519 Swartz, Harold 3194 Tiwana, Manpreet 2731 Shah, Anand 98 Sittig, Mark 2771 Swisher-McClure, Samuel 1074 Todor, Dorin 2464 Shah, Anand 2743 Skamene, Sonia 2295 Symon, Zvi 2430 Tokita, Kenneth 1064 Shah, Jennifer 2154 Slater, Jerry 59 Szeja, Sean 2556 Tol, Jim 3315 Shah, Jennifer 2256 Slater, Jason 2392 Szumacher, Ewa 2781 Tom, Ashlyn 2966 Shah, Mira 2369 Small, William 3 Tomita, Natsuo 2422 Shakir, Shakir 2474 Smith, Linda 2059 Tong, Xu 2378 Shang, Qingyang 2466 Smith, Tamara 1018 T Tong, William 170 Shankar, Vangipuram 2680 Smith, Adam 3190 Tachibana, Izumi 2835 Tongtip, Naruemon 3360 Sharabi, Andrew 1131 Soh, Hendrick 3176 Tadic, Tony 31 Tonlaar, Nathan 1072 Sharma, Navesh 2327 Soike, Michael 2903 Tagliagambe, Angiolo 2435 Torok, Jordan 2853 Sharma, Daya Nand 3076 Solanki, Abhishek 2108 Tai, An 3278 Townsend, Natasha 2677 Shasha, Daniel 2497 Solanki, Abhishek 2110 Tait, Lauren 2208 Tozzi, Angelo 2268 Sheets, Nathan 2770 Solanki, Abhishek 2687 Takagi, Masaru 2692 Tran, Phuoc 1055 Shen, Yuxin 2246 Solanki, Abhishek 145 Takahashi, Ippei 3140 Tree, Alison 2423 Shen, Yi-Liang 2590 Sole, Claudio 2352 Takahashi, Wataru 1093 Trister, Andrew 3216 Shen, Chunying 2662 Son, Christina 1070 Takahashi, Yutaka 3356 Troeller, Almut 3271 Sheng, Ke 299 Son, Christina 3054 Takanaka, Tsuyoshi 1006 Trovo, Marco 2027 Shenouda, Mina 2061 Song, Yongchun 2793 Takao, Seishin 161 Trovo, Marco 2028 Shenouda, George 1031 Sonke, Jan-Jakob 101 Takeda, Atsuya 2308 Trovo, Marco 279 Sher, David 1082 Soong, Chen-Pang 47 Takiar, Vinita 2689 Trovo, Marco 2813 Sherman, Alexandra 2956 Sostin, Oleg 2491 Takiar, Vinita 2696 Tsai, Chiaojung Jillian 3204 Sherr, David 2266 Sottero, Theo 2802 Tam, Moses 38 Tsai, Yu-Chen 18 Sheu, Tommy 3132 Souranis, Annette 2989 Tam, Moses 197 Tsang, Derek 160 Sheybani, Arshin 2941 Sours, Chandler 2131 Tam, Moses 2612 Tseng, Chia-Lin 2165 Shi, Qi 2637 Speers, Corey 244 Tam, Moses 2613 Tseng, Yolanda 219 Shi, Pengyue 2795 Speirs, Christina 2307 Tamari, Keisuke 2219 Tsujii, Mari 3382 Shi, Xiutao 163 Spektor, Alexander 3279 Tan, Wenyong 2630 Turaka, Aruna 2798 Shibamoto, Yuta 256 Spencer, Christopher 1110 Tang, Chad 187 Turaka, Aruna 2827 Shih, Helen 1028 Sperduto, Paul 123 Tang, Justin 3185 Turgeon, Guy 2511 Shikama, Naoto 2004 Spiotto, Michael 1059 Tang, Justin 3199 Turner, Kathryn 3254 Shikama, Naoto 2007 Spratt, Daniel 42 Tang, Shikui 3403 Shim, Su Jung 2044 Spratt, Daniel 311 Tang, Xiaoli 3225 Shimizuguchi, Takuya 2495 Spratt, Daniel 1071 Tang, Yu 3051 U Shin, Samuel 16 Sreeraman, Radhika 2025 Tanzler, Emily 2151 Ujaimi, Reem 2931 Shin, Jacob 315 Stanescu, Teo 104 Tao, Randa 2697 Umezawa, Rei 2232 Shin, Samuel 2928 Stanton, Paul 1137 Tarnawski, Rafal 1003 Uno, Takashi 2541 Shin, Naomi 3280 Stecklein, Shane 2109 Tatekawa, Kotoha 2865 Urbanic, James 85 Shin, Hun-Joo 3327 Steineck, Gunnar 131 Tatewaki, Koshi 2149 Usui, Keisuke 3307 Shinde, Prashantkumar 3378 Stenmark, Matthew 194 Taylor, Robert 2581 Shioyama, Yoshiyuki 2837 Stephans, Kevin 2438 Teckie, Sewit 147 Shiraishi, Yutaka 2409 Stephens, Kevin 2488 Tennyson, Nathan 2478 V Shiraishi, Kenshiro 2460 Stessin, Alexander 2251 Terashima, Kotaro 2290 Vaiduriam, Mayuraa 2005 Shiue, Kevin 2195 Stessin, Alexander 1051 Terezakis, Stephanie 3046 Vaidya, Jayant 15 Showalter, Timothy 2768 Stewart, Robert 3151 Terhaard, Chris 349 Vaidya, Jayant 2094 Shridhar, Ravi 2214 Stish, Bradley 2872 Tetreault, Audrey 2555 Vainshtein, Jeff rey 2610 Shukla, Monica 2053 Stockham, Abigail 3237 Thaker, Nikhil 317 Vainshtein, Jeff rey 2611 Shukla, Monica 263 Stone, Brandon 2452 Thariat, Juliette 2595 Vainshtein, Jeff rey 2774 Shukla, Gaurav 1063 Stoyanova, Radka 2134 Thariat, Juliette 2678 Valdes, Gilmer 237 Shultz, David 2293 Strom, Tobin 2615 Thawani, Nitika 2766 Vali, Faisal 3089 Shultz, David 3397 Strom, Tobin 146 Thibault, Isabelle 2183 Valicenti, Richard 2981
ASTRO 2013 / 55TH ANNUAL MEETING 187 Vallieres, Martin 2695 Warren, Laura 113 X Youssef, Ashraf 2047 Van den Bosch, Michiel 3333 Watkins, John 262 Yovino, Susannah 2349 Van Den Heuvel, Frank 236 Watkins, William 3452 Xanthopoulos, Eric 316 Yu, James 1015 Van der Steen-Banasi, E.M. 2507 Wattson, Daniel 2157 Xanthopoulos, Eric 2902 Yu, Jennifer 3183 Van Sornsen de Koste, John 360 Wattson, Daniel 1083 Xia, Tingyi 2262 Yu, Juan 2031 VanderWalde, Noam 1116 Waxweiler, Timothy 171 Xiao, Qin 2340 Yu, Tosol 2565 Vargo, John 2683 Wei, Xiong 2873 Xiao, Nian 2888 Yu, Naichang 304 Vargo, John 3065 Weiss, Elisabeth 36 Xing, Lei 3430 Yu, Shu-Jung 3400 Varia, Mahesh 3217 Weller, Michael 1013 Xu, Ting 228 Yu, Yao 2621 Varlotto, John 2864 Welliver, Meng 3186 Xue, Jinyu 2953 Yuan, Jiankui 3272 Vatner, Ralph 271 Wenz, Frederik 2096 Yuan, Lulin 3100 Vatyam, Sathiya Narayanan 3241 Werner-Wasik, Maria 2799 Y Yuan, Lulin 3339 Veldwijk, Marlon 3198 Werner-Wasik, Maria 2884 Yuh, William 3105 Vergalasova, Irina 3306 Westerly, David 3048 Yamada, Shigeru 2353 Yuan, Ye 3182 Verhoeven, Karolien 2034 White, Evan 2337 Yamada, Yoshiya 3060 Vicini, Frank 2975 Whitley, Alexander 2523 Yamamoto, Takaya 2840 Videtic, Gregory 6 Widlak, Piotr 3138 Yamashita, Hideomi 2309 Vinogradskiy, Yevgeniy 1136 Wijesooriya, Krishni 3357 Yamoah, Kosj 2160 Z Viswanathan, Akila 9 Wilcox, Shea 2395 Yan, Susu 3319 Zachman, Derek 49 Vlacich, Gregory 1054 Wild, Aaron 67 Yanagi, Takeshi 2604 Zaki, Bassem 1103 Volotskova, Olga 3159 Wild, Sommer 2979 Yang, Bin 2988 Zaorsky, Nicholas 2200 Voong, Ranh 1041 Wild, Aaron 3195 Yang, Cungeng 3284 Zaorsky, Nicholas 56 Voong, Ranh 2924 Wilkinson, Ben 117 Yang, Daniel 2338 Zaorsky, Nicholas 2816 Vujovic, Olga 2086 Willers, Henning 339 Yang, Deshan 3091 Zapatero, Almudena 2445 Vuong, Te 2357 Willett, Addison 1045 Yang, Joanna 3030 Zapatero, Almudena 3203 Williams, Benjamin 3266 Yang, Kai 3291 Zeidan, Youssef 3141 Williams, Eric 106 Yang, Ruijie 3438 Zeitlin, Ross 2471 W Williams, Noelle 3026 Yang, Tzu-I Jonathan 125 Zelefsky, Michael 2463 Wagner, Aaron 1067 Willson, Adam 3029 Yang, Tzu-I Jonathan 2344 Zeng, Jing 293 Wagner, Henry 3057 Willson, Adam 3074 Yang, Wensha 3230 Zerounian, Sophie 2133 Wakai, Nobuhide 3304 Wilson, David 2946 Yang, Xiaofeng 115 Zhang, Chi 242 Wakatsuki, Masaru 2532 Wilson, William 2150 Yang, Xiaofeng 2439 Zhang, Geoff rey 3282 Walker, Amanda 1039 Wilson, William 2429 Yang, Xiaofeng 2587 Zhang, Guangyu 2522 Walker, Gary 3090 Wilson, Zachary 3444 Yang, Xiaofeng 2671 Zhang, Hao 3104 Walker, Gary 149 Wissel, Tobias 3223 Yang, Yun 133 Zhang, Hualin 3281 Wallace, Harold 2382 Witek, Matthew 266 Yang, Yun 3419 Zhang, Lifei 234 Waller, Joseph 2325 Wo, Jennifer 207 Yap, Mei Ling 2886 Zhang, Pengpeng 3300 Wang, Bin 3458 Wo, Jennifer 2285 Yaparpalvi, Ravindra 2542 Zhang, Qian 2066 Wang, Chenyang 2971 Wobb, Jessica 14 Yashar, Catheryn 2043 Zhang, Rui 3405 Yasuda, Koichi 3155 Wang, Dian 151 Wojcieszynski, Andrzej 2339 Zhang, Wencheng 2239 Wang, Edina 3191 Wolfe, Adam 3164 Ybarra, Norma 3118 Zhang, Wenjue 2820 Wang, Hao 2281 Wong, Raimond 284 Ye, Jason 110 Zhang, Ying 3431 Wang, He 1040 Wong, Rebecca 2954 Ye, Jason 2119 Zhao, Bo 3226 Wang, Henry 3358 Wong, Winnifred 2960 Ye, Jing jing 3323 Zhao, Lujun 2841 Wang, Jianyang 155 Woo, Joong Yeol 2287 Yeager, Caitlyn 3411 Zhao, Lujun 2858 Wang, Jin 3130 Woods, Charles 2649 Yeboa, Debra 2037 Zhao, Sherry 2653 Wang, Jing 1085 Woodward, Wendy 246 Yechieli, Raphael 2269 Zhao, Tianyu 3269 Wang, Jingya 210 Woody, Neil 2852 Yechieli, Raphael 2402 Zhao, Xiao 2095 Wang, Jun 2225 Wooten, Charles 2585 Yeh, Chi-Yuan 3314 Zhen, Heming 3387 Wang, Jun 2228 Wooten, Charles 3434 Yeung, Daniel 3317 Zhen, Weining 2132 Wang, Lan 2217 Wooten, Hasani 3152 Yi, Junlin 2619 Zheng, Dandan 2292 Wang, Lilie 3396 Wright, Florence 2939 Yipeng, Ling 2249 Zheng, Yuanshui 3407 Wang, Ping 3296 Wu, Abraham 2235 Yogo, Katsunori 2987 Zheng, Yuanshui 3414 Wang, Ricardo 2359 Wu, Jeff rey 2670 Yondorf, Menachem 1036 Zhikai, Liu 3440 Wang, Shulian 17 Wu, Huanmei 1091 Yondorf, Menachem 2130 Zhong, Hualiang 3277 Wang, Song 3457 Wynne, Jacob 1134 Yondorf, Menachem 2152 Zhong, Jim 2299 Wang, Suzhen 2796 Yoo, Sua 2029 Zhou, Di 2168 Wang, Tony 2329 Yoon, Sang Min 2306 Zhou, Jessica 2964 Wang, XiaoShen 1114 Yoon, Hannah 2844 Zhou, Lili 3295 Wang, Yuefeng 2437 Yordy, John 3436 Zhou, Lin 2791 Wang, Ziwei 2691 Yorke, Ellen 128 Wang, Zheng 3321 Yorozu, Atsunori 2391 Warner, Lindsay 3084 Yoshida, Masahiro 2048 Warrell, Gregory 3456 Yoshikawa, Nobuhiko 3145 Young, Kristina 3129
188 ASTRO 2013 / 55TH ANNUAL MEETING Zhou, Peng 2097 Zhou, Qichao 2642 Zhou, Qichao 2644 Zhou, Qichao 2646 Zhou, Zongmei 2821 Zhu, Guangying 1144 Zhu, Goupei 1115 Zhu, Lihong 2736 Zhu, Shuchai 2216 Zhu, Shuchai 2242 Zhu, Ya 2009 Zhuang, Hong-Qing 2857 Zhung, Joanne 3355 Ziel, Ellis 2830 Zilli, Thomas 238 Zuliani, Antonio 8 Zumsteg, Zachary 53
ASTRO 2013 / 55TH ANNUAL MEETING 189 Index by Track (Abstracts only)
BREAST CANCER Sreeraman, Radhika 2025 Saito, Anneyuko 2085 Marciscano, Ariel 1029 Rabinovitch, Rachel Abrams 13 Pardo, Jose 2026 Vujovic, Olga 2086 Siglin, Joshua 1030 Wobb, Jessica 14 Trovo, Marco 2027 Liu, Tian 2087 Shenouda, George 1031 Vaidya, Jayant 15 Trovo, Marco 2028 Bhandare, Niranjan 2088 Palmer, Joshua 1032 Shin, Samuel 16 Yoo, Sua 2029 Khwaja, Shariq 2089 Kalakota, Kapila 1033 Wang, Shulian 17 Chaudhry, Huma 2030 Anderson, Bethany 2090 Pai, Jonathan 1034 Tsai, Yu-Chen 18 Yu, Juan 2031 Roach, Michael 2091 Rosenberg, Jennifer 1035 Russo, Andrea 19 Liss, Adam 2032 Pernin, Victor 2092 Yondorf, Menachem 1036 Sadek, Betro 20 Koo, Tae Ryool 2033 Roach, Michael 2093 Miwa, Kazuhiro 2113 Ye, Jason 110 Verhoeven, Karolien 2034 Vaidya, Jayant 2094 Chang-Halpenny, Christine 2114 Chen, Jiayi 111 Nagar, Himanshu 2035 Zhao, Xiao 2095 Kleinberg, Lawrence 2115 Patel, Sagar 112 Muanza, Thierry 2036 Wenz, Frederik 2096 Susheela, Sridhar 2116 Warren, Laura 113 Yeboa, Debra 2037 Zhou, Peng 2097 Nakamatsu, Kiyoshi 2117 Dan, Tu 114 Kalash, Ronny 2038 Alfaraj, Fatimah 2098 Oh, Steven 2118 Yang, Xiaofeng 115 Kuo, Jeff rey 2039 Bradbury, C. Matthew 2099 Ye, Jason 2119 Ho, Alice 116 Ferro, Adam 2040 Pearson, David 2100 Marchan, Edward 2120 Wilkinson, Ben 117 Thomas, Kimberly 2041 Grendarova, Petra 2101 Cordova, James 2121 Bredel, Markus 240 Geng, Alexander 2042 Lai, Shihfan 2102 Jeongshim, Lee 2122 Prasad, Shreya 241 Yashar, Catheryn 2043 Edwards-Bennett, Sophia 2103 Lim, Yujin 2123 Zhang, Chi 242 Shim, Su Jung 2044 Horowitz, David 2104 Kunhiparambath, Haresh 2125 Biswas, Tithi 243 Obasaju, Patience 2045 Reddy, Jay 2105 Kandula, Shravan 2126 Speers, Corey 244 Jagsi, Reshma 2046 Kuske, Robert 2106 Motwani, Sabin 2127 Santivasi, Wil 245 Youssef, Ashraf 2047 Fagundes, Marcio 2107 Amelio, Dante 2128 Woodward, Wendy 246 Yoshida, Masahiro 2048 Solanki, Abhishek 2108 Corso, Christopher 2129 Jegadeesh, Naresh 247 Reese, Adam 2049 Stecklein, Shane 2109 Yondorf, Menachem 2130 Badiyan, Shahed 1121 Franco, Pierfrancesco 2050 Solanki, Abhishek 2110 Sours, Chandler 2131 Galland, Sigolene 1122 Chen, Peter 2051 Einck, John 2111 Zhen, Weining 2132 Lei, Rachel 1123 Barrett, Olivia 2052 Burt, Lindsay 2112 Zerounian, Sophie 2133 Braunstein, Steve 1124 Shukla, Monica 2053 Stoyanova, Radka 2134 Chadha, Manjeet 1125 Oguchi, Masahiko 2054 Aizer, Ayal 2135 Batra, Sonny 1126 Nath, Sameer 2055 CENTRAL NERVOUS SYSTEM Lazow, Stefanie 2136 Rochet, Nathalie 1127 Marcrom, Samuel 2056 Saran, Frank 37 Harris, Timothy 2138 Gentile, Michelle 1128 Eshleman, Jeff rey 2057 Tam, Moses 38 Corwin, David 2139 Keruakous, Amany 1129 Register, Steven 2058 Arvold, Nils 39 LeMieux, Melissa 2140 Noh, Jae Myoung 1130 Smith, Linda 2059 Chen, Linda 40 Hosotani, Martha 2141 Sharabi, Andrew 1131 Chen, Quan 2060 Fang, Penny 41 Murphy, Erin 2142 Aneja, Sanjay 1132 Shenouda, Mina 2061 Spratt, Daniel 42 Chilukuri, Srinivas 2143 Nakamura, Naoki 2001 Goyal, Sharad 2062 Anwar, Mekhail 43 Kuhn, Elizabeth 2144 Matuschek, Christiane 2002 Li, Allen 2063 Danish, Hasan 44 Nowak, Ryan 2145 Mellon, Eric 2003 Perez, Bradford 2064 Rodrigues, George 118 Grossman, Craig 2146 Shikama, Naoto 2004 Horton, Janet 2065 Kirkpatrick, John 119 Arribas, Leoncio 2148 Vaiduriam, Mayuraa 2005 Zhang, Qian 2066 Kushnirsky, Marina 120 Tatewaki, Koshi 2149 Khwaja, Shariq 2006 Korah, Mariam 2067 Tinkle, Christopher 121 Wilson, William 2150 Shikama, Naoto 2007 Chen, Yu 2068 Mak, Kimberley 122 Tanzler, Emily 2151 Ma, Jinli 2008 Reiff , Jay 2069 Sperduto, Paul 123 Yondorf, Menachem 2152 Zhu, Ya 2009 Rao, Nalini 2070 Lucas, John 124 Nguyen, Nathalie 2153 Paryani, Nitesh 2010 Jozsef, Gabor 2071 Yang, Tzu-I Jonathan 125 Shah, Jennifer 2154 Arterbery, V. Elayne 2011 Cohen, Randi 2072 Kersh, C. Ronald 248 Mori, Yoshimasa 2155 Petoukhova, Anna 2012 Den Hartogh, Mariska 2073 Guckenberger, Matthias 249 Desai, Prashant 2156 Ogawa, Yasuhiro 2014 Merrell, Kenneth 2074 Ryu, Samuel 250 Wattson, Daniel 2157 Bondiau, Pierre-Yves 2015 Nam, Jiho 2075 Combs, Stephanie E. 251 Meral, Rasim 2158 Ding, Yun 2016 Hong, Robert 2076 Bernad, Daniel 252 Al-Omair, Ameen 2159 Rutter, Charles 2017 Atrchian, Siavash 2077 Giordano, Frank 253 Yamoah, Kosj 2160 Eaton, Bree 2018 Chadha, Manjeet 2078 Narang, Amol 254 Sarmey, Nehaw 2161 Ferreira, Dominihemberg 2019 Riou, Olivier 2079 Hardie, John 255 Jawad, Maha 2162 Mayadev, Jyoti 2020 Bradley, Julie 2080 Shibamoto, Yuta 256 Mian, Omar 2163 Jacob, Julian 2021 Chow, Tiff any 2081 Pavelic, Martin 1025 Christensen, Eva 2164 Dunst, Juergen 2022 Saigal, Kunal 2082 Braunstein, Steve 1026 Tseng, Chia-Lin 2165 Nath, Sameer 2023 Hinse, Martin 2083 Press, Robert 1027 Ghaly, Maged 2166 Abo-Madyan, Yasser 2024 Galland, Sigolene 2084 Shih, Helen 1028 Kamran, Sophia 2167
190 ASTRO 2013 / 55TH ANNUAL MEETING Zhou, Di 2168 Hsu, Howard 1101 Sherr, David 2266 Osmundson, Evan 2330 Currier, Blake 2169 Liu, Xiao 1102 Chan, Cato 2267 Fuss, Martin 2331 Esthappan, Jacqueline 2170 Zaki, Bassem 1103 Tozzi, Angelo 2268 Lock, Michael 2332 Jain, Anshu 2171 Rutenberg, Michael 1104 Yechieli, Raphael 2269 Diaz Vazquez, Rao, Malay 2172 Kharofa, Jordan 1105 Hall, William 2270 Maria Fernanda 2333 Kao, Johnny 2173 Erickson, Kelly 1106 Nixon, Lisette 2271 Fernandes, Annemarie 2334 Sahgal, Arjun 2174 Goodman, Ben 1107 Kumar, Aryavarta 2272 Cai, Yong 2335 Arneson, Kyle 2175 Liu, Xiao 1108 Prasad, Shreya 2273 Lee, Sung Uk 2336 Qiao, Xueying 2176 Jingu, Keiichi 2210 Romeo, Antonino 2274 White, Evan 2337 Clark, Grant 2177 Haritha, Chiramana 2211 Freilich, Jessica 2275 Yang, Daniel 2338 Chen, Allan 2178 Li, Minghuan 2212 Chaudhry, Huma 2276 Wojcieszynski, Andrzej 2339 Murai, Taro 2179 Li, Minghuan 2213 Dholakia, Avani 2277 Xiao, Qin 2340 Rutter, Charles 2180 Shridhar, Ravi 2214 Hirata, Takero 2278 Lee, Joo Ho 2341 Lau, Steven 2181 Han, Chun 2215 Ausborn, Natalie 2279 Marina, Ovidi 2342 Thibault, Isabelle 2183 Zhu, Shuchai 2216 Ghaly, Maged 2280 Appelt, Ane 2343 Lin, Hong-Yiou 2184 Wang, Lan 2217 Wang, Hao 2281 Yang, Tzu-I Jonathan 2344 Faria Braga, Henrique 2185 Ma, Changsheng 2218 Thompson, Reid 2282 DeNittis, Albert 2345 Rutter, Charles 2186 Tamari, Keisuke 2219 Konski, Andre 2283 Falk, Alexander 2346 Jimenez, Rachel 2187 Kawaguchi, Gen 2220 Lukens, John 2284 Helou, Joelle 2347 Sethi, Roshan 2188 Hori, Masakazu 2221 Wo, Jennifer 2285 Rothenstein, Diana 2348 Rajakesari, Selvan 2189 Liu, Huiming 2222 Ahmad, Mediha 2286 Yovino, Susannah 2349 Dosoretz, Arie 2190 Huang, Xin 2223 Woo, Joong Yeol 2287 Nguyen, Phuong 2350 Moleron, Rafael 2191 Boggs, Hunter 2224 Patel, Ajay 2288 Rolfo, Maureen 2351 Compton, Julia 2192 Wang, Jun 2225 Bhirud, Abhijeet 2289 Sole, Claudio 2352 Alcorn, Sara 2193 Hsu, Che-yu 2226 Terashima, Kotaro 2290 Yamada, Shigeru 2353 McDonald, Mark 2194 Liu, Qi 2227 Chandrasekaran, Sanjay 2291 Jin, Jing 2354 Shiue, Kevin 2195 Wang, Jun 2228 Zheng, Dandan 2292 Lei, Xin 2355 Lee, Dong-Soo 2196 Murakami, Yuji 2229 Shultz, David 2293 De La Mata, M. Dolores 2356 Kao, Wei Heng 2197 Cheng, Yufeng 2230 Cruz, Alex 2294 Vuong, Te 2357 Kim, Kyung Hwan 2198 Fukada, Junichi 2231 Skamene, Sonia 2295 Manyam, Bindu 2358 Johnson, Matthew 2199 Umezawa, Rei 2232 Que, Jenny 2296 Wang, Ricardo 2359 Zaorsky, Nicholas 2200 Liang, Jun 2233 Barney, Brandon 2297 Li, Hao 2360 Chera, Bhisham 2201 Patel, Sagar 2234 Kim, Kyung Su 2298 Riou, Olivier 2361 Santos, Tâmara 2202 Wu, Abraham 2235 Zhong, Jim 2299 Alsuhaibani, Abdullah 2362 Ly, David 2203 Myojin, Miyako 2236 Jung, Jinhong 2300 Batra, Sonny 2363 Okoye, Christian 2204 Lutkenhaus, Lotte 2237 Camborde, Marie-Laure 2301 Alsuhaibani, Abdullah 2364 Figueiredo, Maria Luisa 2205 Ishikawa, Hitoshi 2238 Mendez Romero, Alejandra 2302 Kozak, Margaret 2365 Mourad, Waleed 2206 Zhang, Wencheng 2239 Lappinen, Erik 2303 Abdel-Wahab, May 2366 Savir, Guy 2207 Juloori, Aditya 2240 Blacksburg, Seth 2304 Cheung, Min Rex 2367 Tait, Lauren 2208 Siddiqui, Faisal 2241 Mahadevan, Anand 2305 Rwigema, Jean-Claude 2368 Qiu, Haoming 2209 Zhu, Shuchai 2242 Yoon, Sang Min 2306 Shah, Mira 2369 Anker, Christopher 2243 Speirs, Christina 2307 Kim, Kyung Hwan 2244 Takeda, Atsuya 2308 GASTROINTESTINAL CANCER Kumar, Shaleen 2245 Yamashita, Hideomi 2309 GENITOURINARY CANCER Cao, Yue 62 Shen, Yuxin 2246 Sanuki, Naoko 2310 Pisansky, Thomas 1 Feng, Mary 63 Li, Jiancheng 2247 Okumura, Toshiyuki 2311 Zumsteg, Zachary 53 Lasley, Foster 64 Liu, Qi 2248 Seol, Seung Won 2312 Krauss, Daniel 54 Hong, Theodore 65 Yipeng, Ling 2249 Kim, Jun Won 2313 Kamrava, Mitchell 55 Herman, Joseph 66 Seyedin, Steven 2250 Merrell, Kenneth 2314 Zaorsky, Nicholas 56 Wild, Aaron 67 Stessin, Alexander 2251 Fan, Katherine 2315 Katz, Alan 57 Lin, Chi 68 Li, Qiwen 2252 Shaff er, Jenny 2316 Meier, Robert 58 Huguet, Florence 69 Lu, NingNing 2253 Mannina, Edward 2317 Slater, Jerry 59 Wo, Jennifer 207 Ren, Hua 2254 Fang, Charles 2318 Sethukavalan, Perakaa 60 Schefter, Tracey 208 Misirlioglu, Cem 2255 Liu, Yilin 2319 Mirhadi, Amin 61 Min, Christine 209 Shah, Jennifer 2256 Ernst, Iris 2320 Bekelman, Justin 96 Wang, Jingya 210 Chen, Andre 2257 Evans, Joseph 2321 Baumann, Brian 199 Dholakia, Avani 211 Patel, Rajal 2258 Abdel-Wahab, May 2322 Gray, Phillip 200 Mohindra, Pranshu 212 Li, Guichao 2259 Menichelli, Claudia 2323 Aluwini, Shafak 201 Olsen, Jeff 213 Hazariwala, Ronica 2260 Gandhi, Saumil 2324 Clayman, Rebecca 202 Thomas, Charles 214 Mellon, Eric 2261 Waller, Joseph 2325 Ferrer, Ferran 203 Kumar, Rachit 1097 Xia, Tingyi 2262 Dyk, Pawel 2326 McBride, Sean 204 Fisher, Sarah 1098 Baine, Michael 2263 Sharma, Navesh 2327 Sabolch, Aaron 205 Lu, Shawn Shao-Lun 1099 Cai, Sophie 2264 Wang, Tony 2329 Chung, Peter 206 Otani, Keisuke 1100 Mancini, Brandon 2265
ASTRO 2013 / 55TH ANNUAL MEETING 191 Maldonado, Xavier 257 Holtzman, Adam 2389 Scharf, Lawrence 2453 Macklis, Roger 2516 Gottschalk, Alex 258 Sekiguchi, Akane 2390 Agarwal, Manuj 2454 Patel, Abhilasha 2517 Cheung, Patrick 259 Yorozu, Atsunori 2391 Murphy, Colin 2455 Galland, Sigolene 2518 Roach, Mack 260 Slater, Jason 2392 Gay, Hiram 2456 Nguyen, Paul 261 Inokuchi, Haruo 2393 Le, Yi 2457 Watkins, John 262 Lo, Andrea 2394 Parekh, Akash 2458 GYNECOLOGICAL CANCER Shukla, Monica 263 Wilcox, Shea 2395 Jackson, William 2459 Zuliani, Antonio 8 Krauss, Daniel 2396 Viswanathan, Akila 9 Milecki, Piotr 264 Shiraishi, Kenshiro 2460 Lee, Richard 2397 Nicholas, Zachary 2461 Han, Kathy 70 Michalski, Jeff 265 Price, Jeremy 2398 Rancati, Tiziana 2462 Gaff ney, David 71 Fotouhi Ghiam, Alireza 305 Munoz Garcia, Julia Luisa 2399 Zelefsky, Michael 2463 Chino, Junzo 72 Salama, Joseph 306 Murphy, Colin 2400 Todor, Dorin 2464 Gill, Beant 73 Feng, Felix 307 Roach, Mack 2401 Alexander, Jesse 2465 Leung, Eric 74 Nichols, R. Charles 308 Yechieli, Raphael 2402 Shang, Qingyang 2466 Mayr, Nina 75 Blacksburg, Seth 309 Patel, Ajaykumar 2403 Obedian, Edward 2467 Elicin, Olgun 76 Galalae, Razvan 310 Kittel, Jeff rey 2404 Kalbasi, Anusha 2468 Gandhi, Ajeet 77 Spratt, Daniel 311 Kim, Dong Wook Nathan 2405 Ashamalla, Mark 2469 Blanchard, Miran 313 Ferris, Matthew 312 Hanada, Takashi 2406 McGuire, Sean 2470 Milgrom, Sarah 314 Weller, Michael 1013 Macrie, Bryan 2407 Zeitlin, Ross 2471 Shin, Jacob 315 Di Muzio, Nadia 1014 Nakamatsu, Kiyoshi 2408 Onal, Cem 2472 Xanthopoulos, Eric 316 Yu, James 1015 Shiraishi, Yutaka 2409 Sen, Amarjit 2473 Thaker, Nikhil 317 Romesser, Paul 1016 Ishii, Kentaro 2410 Shakir, Shakir 2474 Koay, Eugene 318 Henderson, Randal 1017 Heres, Tomer 2411 Guix, Benjamin 2475 Kabolizadeh, Peyman 319 Smith, Tamara 1018 Munoz Garcia, Julia Luisa 2412 Kathpal, Madeera 2476 Kawanaka, Takashi 320 Mendenhall, Nancy 1019 Nguyen, Hannah 2413 Hegarty, Sarah 2477 Greenwalt, Julie 321 Niazi, Tamim 1020 Lin, Yuting 2414 Tennyson, Nathan 2478 Sirak, Igor 2519 Hearn, Jason 1021 Hughes, Michael 2415 Choi, Seungtaek 2479 Refaat, Tamer 2520 Kim, Miranda 1022 Lin, Yuting 2416 Ferrer, Ferran 2480 Chibani, Omar 2521 Magnan, Sindy 1023 Koontz, Bridget 2417 Sindhwani, Ragini 2481 Zhang, Guangyu 2522 Jackson, William 1024 Hayashi, Akihiro 2418 Arora, Shruthi 2482 Whitley, Alexander 2523 Thiruganasambandam, Liu, Wu 2419 McDonald, Andrew 2483 Kwak, Yoo Kang 2524 Sivarajan 1056 Fawaz, Ziad 2420 Kumar, Parvesh 2484 Dunn, Emily 2525 Bravo, Stephen 1061 Boychak, Alex 2421 Markovina, Stephanie 2485 Choi, Jehee 2526 Johnson, Skyler 1062 Tomita, Natsuo 2422 Kelly, Maria 2486 Oike, Takahiro 2527 Shukla, Gaurav 1063 Tree, Alison 2423 D’Souza, David Paul 2487 Chin, Matthew 2528 Tokita, Kenneth 1064 Garcia-Vicente, Feliciano 2424 Stephens, Kevin 2488 Kim, Robert 2529 Chapet, Olivier 1065 Lozano, Joan 2425 Parekh, Akash 2489 Froment, Marie-Anne 2530 Foltz, Warren 1066 Sulaiman, Nor Shazrina 2426 Schutzer, Matthew 2490 Kasuya, Goro 2531 Wagner, Aaron 1067 Carillo, Viviana 2427 Sostin, Oleg 2491 Wakatsuki, Masaru 2532 Chennupati, Sravana 1068 Gomez-Iturriaga, Alfonso 2428 Mantz, Constantine 2493 Rath, Goura 2533 Elliott, David 1069 Wilson, William 2429 Ciezki, Jay 2494 Lang, Jinyi 2534 Son, Christina 1070 Symon, Zvi 2430 Shimizuguchi, Takuya 2495 Rash, Dominique 2535 Spratt, Daniel 1071 Chang, Lynn 2431 Jain, Prachi 2496 Bo, Yang 2536 Tonlaar, Nathan 1072 Ciezki, Jay 2432 Shasha, Daniel 2497 Irie, Daisuke 2537 Swisher-McClure, Samuel 1074 Niazi, Tamim 2433 Cahlon, Oren 2498 Bagshaw, Hilary 2538 Leonard, Kara 2370 Blacksburg, Seth 2434 Hartsell, William 2499 Dean, Mary 2539 Ohashi, Toshio 2371 Tagliagambe, Angiolo 2435 Grabowski, Sarah 2500 Kabarriti, Rafi 2540 Hentschel, Bettina 2372 Anwar, Mekhail 2436 Johnson, Skyler 2501 Uno, Takashi 2541 Allison, Ron 2373 Wang, Yuefeng 2437 Johnson, Skyler 2502 Yaparpalvi, Ravindra 2542 Hoppe, Bradford 2374 Stephans, Kevin 2438 Oliai, Caspian 2503 Chen, Wenjuan 2543 Badiozamani, Kasra 2375 Yang, Xiaofeng 2439 Nishioka, Kentaro 2504 Isohashi, Fumiaki 2544 Ishiyama, Hiromichi 2376 Kan, Charlene 2440 Kang, Julie Jung 2505 Kanazawa, Aki 2545 Ohashi, Toshio 2377 Surapaneni, Aparna 2441 Lindsay, Daniel 2506 Chen, Jenny Ling-Yu 2546 Tong, Xu 2378 Cho, Yeona 2442 Van der Steen-Banasi, E.M. 2507 Pandit-Taskar, Neeta 2547 Pinkawa, Michael 2379 Lin, Yu-Wei 2443 Bryant, Curtis 2508 Ding, Lei 2548 Sveistrup, Joen 2380 Gooding, Mark 2444 Caparrotti, Francesca 2509 Fields, Emma 2549 Kalapurakal, John 2381 Zapatero, Almudena 2445 Diaz Pardo, Dayssy 2510 Baden, Craig 2550 Wallace, Harold 2382 Ferrer, Ferran 2446 Turgeon, Guy 2511 Lee, Eva 2551 Logan, Jennifer 2383 Ayakawa, Shiho 2447 Lopez-Araujo, Javier 2512 El-Bared, Nancy 2552 Onukwugha, Eberechukwu 2384 Park, Junsu 2448 Baquero, William 2513 Cheung, Min Rex 2553 Kil, Whoon 2385 Nuver, Tonnis 2449 Mahmud, Aamer 2514 Nagar, Himanshu 2554 Haas, Jonathan Andrew 2386 Crandley, Edwin 2450 Rouscoff , Yohann 2515 Tetreault, Audrey 2555 Fuller, Donald 2387 Hempel, Dominika 2451 Szeja, Sean 2556 Marwaha, Gaurav 2388 Stone, Brandon 2452
192 ASTRO 2013 / 55TH ANNUAL MEETING Sabater, Sebastia 2557 Wang, XiaoShen 1114 Iqbal, Hassan 2647 Cardoso, Richard 2711 Jadon, Rashmi 2558 Zhu, Goupei 1115 Alite, Fiori 2648 Herman, Lauren 2712 Guttmann, David 2559 VanderWalde, Noam 1116 Woods, Charles 2649 Chapman, Christopher 2713 Platta, Christopher 2560 Gujral, Dorothy 1117 Levy, Antonin 2650 Emami, Bahman 2714 Elshaikh, Mohamed 2561 Alshehri, Salem 1118 Meyer, Kurt 2651 Han, Hee Ji 2715 Rana, Shushan 2562 Rash, Dominique 1119 Lemons, Jeff rey 2652 Kan, Charlene 2716 Kaneyasu, Yuko 2563 Kai, Naoki 2589 Zhao, Sherry 2653 Glanzman, Jonathan 2717 Magnuson, William 2564 Shen, Yi-Liang 2590 Kim, Jun Won 2654 Cha, Jihye 2718 Yu, Tosol 2565 Hamker, Jean 2591 Hurst, Newton 2655 Kainickal, Cessal 2719 Huddleston, Adam 2566 Prabhu, Roshan 2592 Mrochem-Kwarciak, Hanna, Nevine 2720 Damast, Shari 2567 Goldberg, Mira 2593 Jolanta 2656 Lin, Shinn-yn 2721 Banerjee, Robyn 2568 Herman, Michael 2594 Sevak, Parag 2657 Hoover, Andrew 2722 Dominello, Michael 2569 Thariat, Juliette 2595 Scott, Michael 2658 Mallick, Indranil 2723 Lukovic, Jelena 2570 Mitsuyoshi, Takamasa 2596 Bhandare, Niranjan 2659 Liu, An 2724 Baker, Mariwan 2572 Dutta, Pinaki 2597 Sakthivel, Vasanthan 2660 Kesava Ramgopal, Deutsch, Israel 2573 Contreras, Jessika 2598 Sun, Jason 2661 Adavikolanu 2725 Chang-Halpenny, Christine 2574 Han, Jae Hong 2599 Shen, Chunying 2662 Kanakamedala, Madhava 2726 Desai, Neil 2576 Bhandare, Niranjan 2600 Christopherson, Kaitlin 2663 Kanakamedala, Madhava 2727 Patil, Nikhilesh 2577 Boelke, Edwin 2601 Peacock, Justin 2664 Garg, Shivank 2728 Park, Sang-June 2578 Refaat, Tamer 2602 Hattori, Yukiko 2665 Logue, Jennifer 2729 Lee, Larissa 2579 Chen, Andy 2603 Thompson, Marcher 2666 Ramos, Clementina 2730 Baliga, Sujith 2580 Yanagi, Takeshi 2604 Russo, Andrea 2667 Tiwana, Manpreet 2731 Taylor, Robert 2581 Chin, Re-I 2605 Saito, Makoto 2668 Jaswal, Jasbir 2732 Boyle, John 2582 Crandley, Edwin 2606 Gamez, Mauricio 2669 Patel, Pretesh 2733 Mislmani, Mazen 2583 Durkee, Ben 2607 Wu, Jeff rey 2670 Golchin, Ava 2734 Patel, Abhilasha 2584 Maymani, Rebekah 2608 Yang, Xiaofeng 2671 Kovalchuk, Nataliya 2735 Wooten, Charles 2585 Siddiqui, Farzan 2609 Hsieh, Cheng-En 2672 Zhu, Lihong 2736 Mallick, Indranil 2586 Vainshtein, Jeff rey 2610 Kim, Aileen 2673 Doke, Kaleigh 2737 Yang, Xiaofeng 2587 Vainshtein, Jeff rey 2611 Muraoka, Osamu 2674 Patel, Shilpen 2738 Roux, Audrey 2588 Tam, Moses 2612 Elsayyad, Nagy 2675 Tam, Moses 2613 Kwon, Jeanny 2676 Dewan, Abhinav 2614 Townsend, Natasha 2677 HEALTH SERVICES RESEARCH HEAD AND NECK CANCER Strom, Tobin 2615 Thariat, Juliette 2678 Maletz, Kristina 93 Ghi, Maria Grazia 4 Carpenter, Todd 2616 Karasawa, Katsuyuki 2679 Fowble, Barbara 94 Berhane, Hebist 52 Iganej, Shahrokh 2617 Shankar, Vangipuram 2680 Falchook, Aaron 95 Nguyen-Tan, Phuc Felix 135 Duvvuri, Umamaheswar 2618 Matuschek, Christiane 2681 Halasz, Lia 97 O’Sullivan, Brian 136 Yi, Junlin 2619 Chera, Bhishamjit 2682 Shah, Anand 98 Rishi, Anupam 137 Gao, Wendy 2620 Vargo, John 2683 Dinan, Michaela 99 Jensen, Alexandra 138 Yu, Yao 2621 Owen, Dawn 2684 Carmona, Ruben 100 Nedzi, Lucien 139 Bernier, Laurence 2622 Wang, Yingjie 2685 Pearlstein, Kevin 1073 Ahn, Peter 140 Richard, Patrick 2623 Solanki, Abhishek 2687 Byun, John 1075 Gensheimer, Michael 141 Husaini, Hasan 2624 Orisamolu, Abimbola 2688 Lester-Coll, Nataniel 1076 Raaijmakers, Cornelis 142 Guo, Susan 2625 Takiar, Vinita 2689 Raldow, Ann 1077 Riaz, Nadeem 191 Surucu, Murat 2626 Popovic, Marija 2690 Mishra, Mark 1078 Hess, Clayton 192 Richard, Patrick 2627 Wang, Ziwei 2691 Kuremsky, Jeff rey 1079 Beadle, Beth 193 Liu, Wei 2628 Takagi, Masaru 2692 Laufer, Marsha 1080 Stenmark, Matthew 194 Sinha, Uttam 2629 Mix, Michael 2693 Chen, Ronald 1081 Hu, Kenneth Shung 195 Tan, Wenyong 2630 Mourad, Waleed 2694 Sher, David 1082 Liu, Gene-Fu 196 Qiu, Su 2631 Vallieres, Martin 2695 Shabason, Jacob 1084 Tam, Moses 197 Kodaira, Takeshi 2632 Takiar, Vinita 2696 Parikh, Ravi 1138 Lee, Joseph 198 Greenwalt, Julie 2633 Tao, Randa 2697 Quek, Ruben 2739 Setton, Jermey 347 Barney, Brandon 2634 Aguirre, Maria 2698 Pearce, Andrew 2740 Quon, Harry 348 Huang, Pin-I 2635 Fan, Kang-Hsing 2699 Quek, Ruben 2741 Terhaard, Chris 349 Hamilton, Sarah 2636 Bayman, Evrim 2700 Chang, Daniel 2742 Chaudhary, Ahmed 350 Shi, Qi 2637 Ranck, Mark 2701 Shah, Anand 2743 Quon, Harvey 351 Ma, Lin 2638 Faria Braga, Henrique 2702 Mattes, Malcolm 2744 Hutcheson, Katherine 352 Matsuura, Tomohiro 2639 Qi, Xiangrong 2703 Seymour, Zachary 2745 Kunnambath, Ramadas 353 Lai, Chiahsuan 2640 Anderson, Nigel 2704 Rich, Shayna 2746 Frank, Steven 354 Jin, Feng 2641 Glanzman, Jonathan 2705 Clayman, Rebecca 2747 Lin, Yu-Wei 1109 Zhou, Qichao 2642 Hasegawa, Azusa 2706 Berman, Abigail 2748 Spencer, Christopher 1110 Lin, Qin 2643 Kierkels, Roel 2707 Fortin, Marie Andree 2749 Hanasoge, Sheela 1111 Zhou, Qichao 2644 Miyawaki, Daisuke 2708 Leong, Aidan 2750 Berhane, Hebist 1112 Mei, Feng 2645 Rasmussen, Jacob 2709 Robinson, Timothy 2751 Schwartz, David Louis 1113 Zhou, Qichao 2646 Brouwer, Charlotte 2710 Elson, Joshua 2752
ASTRO 2013 / 55TH ANNUAL MEETING 193 Grew, David 2753 LUNG CANCER Harris, Jeremy 2808 Wei, Xiong 2873 DiPardo, Benjamin 2754 Videtic, Gregory 6 Lau, Steven 2809 Grant, Jonathan 2874 Housri, Nadine 2755 Palma, David 7 Milano, Michael 2810 Komaki, Ritsuko 2875 Patel, Abhilasha 2756 Onishi, Hiroshi 21 Chen, Ming 2811 Podder, Tarun 2876 Carlson, Julie 2757 Onimaru, Rikiya 22 Mangona, Victor 2812 Ong, Leonard 2877 Kapoor, Rishabh 2758 Hymas, Richard 23 Trovo, Marco 2813 Grills, Inga 2878 Suneja, Gita 2759 Harris, Jeremy 24 Arsenault, Daniel 2814 Cannon, Nathan 2879 Bekelman, Justin 2760 Mattonen, Sarah 25 Orton, Matthew 2815 Fan, ChengCheng 2880 Bleyer, Archie 2761 Mancini, Brandon 26 Zaorsky, Nicholas 2816 Meshkov, Dmitriy 2881 Cramer, Christina 2762 Kohutek, Zachary 27 Chang, Joe 2817 Garay, Elizabeth 2882 Kapur, Ajay 2763 Modh, Ankit 78 Kim, Byounghyuck 2818 Ashworth, Allison 2883 Efstathiou, Jason 2764 Samuels, Stuart 79 Hinton, Benjamin 2819 Werner-Wasik, Maria 2884 Mou, Benjamin 2765 Aneese, Andrew 80 Zhang, Wenjue 2820 Haider, Syed 2885 Thawani, Nitika 2766 Murai, Taro 81 Zhou, Zongmei 2821 Yap, Mei Ling 2886 Kapadia, Nirav 2767 Papachristofi lou, Alexandros 82 Garg, Shalini 2822 Li, Min 2887 Showalter, Timothy 2768 Rwigema, Jean-Claude 83 Men, Yu 2823 Xiao, Nian 2888 Gulaya, Sachin 2769 Morris, Zachary 84 Cole, Aidan 2824 Fan, Yankhua 2889 Sheets, Nathan 2770 Urbanic, James 85 Mahmoud, Omar 2825 Josipovic, Mirjana 2890 Sittig, Mark 2771 Ahn, Sung-Ja 183 Cattaneo, Richard 2826 Larrea, Luis 2891 Min, Christine 2772 Kong, Feng-Ming 184 Turaka, Aruna 2827 Lester, Scott 2892 Hodges, Joseph 2773 Rajan, Saju 185 Din, Shaun 2828 Manning, Matthew 2893 Vainshtein, Jeff rey 2774 Li, Ling 186 Naik, Nilan 2829 Myers, Carey 2894 Lanni, Thomas 2775 Tang, Chad 187 Ziel, Ellis 2830 Lewis, Trevor 2895 Arterbery, V. Elayne 2776 Lally, Brian 188 Parikh, Dhwani 2831 Myers, Carey 2896 Dorth, Jennifer 2777 Patel, Suchit 189 Guanhao, Chen 2832 Kim, Julian 2897 Dosoretz, Arie 2778 Nguyen, Quynh 190 Park, Jaehyeon 2833 Binkley, Michael 2898 Curry, Heather 2779 Lin, Steven 274 Feng, Wen 2834 Aguilera, Todd 2899 Greskovich, John 2780 Kalash, Ronny 275 Tachibana, Izumi 2835 Schutzer, Matthew 2900 Szumacher, Ewa 2781 Meshkov, Dmitriy 276 Liu, Wenyang 2836 Chen, Weijun 2901 Furhang, Eli 2782 Gilbride, Lucas 277 Shioyama, Yoshiyuki 2837 Xanthopoulos, Eric 2902 Goldstein, Nicolas 2783 Epperly, Michael 278 Hertan, Lauren 2838 Soike, Michael 2903 Trovo, Marco 279 Hui, Zhouguang 2839 Daly, Megan 2904 Feigen, Malcolm 280 Yamamoto, Takaya 2840 Li, Ling 2905 HISTORY Rimner, Andreas 281 Zhao, Lujun 2841 Alite, Fiori 2906 Holliday, Emma 2784 Grecula, John 1133 Hashizume, Chisa 2842 Rasheed, Abdullah 2907 Dhami, Gurleen 2785 Wynne, Jacob 1134 Patel, Kruti 2843 Kilburn, Jeremy 2908 Morris, Ann 2786 Myers, Carey 1135 Yoon, Hannah 2844 Nguyen, Nhu Tram 2909 Amarnath, Sudha 2787 Vinogradskiy, Yevgeniy 1136 Rajpara, Raj 2845 Karasawa, Katsuyuki 2910 Chapman, Christina 2788 Stanton, Paul 1137 Parisi, Elisabetta 2846 Qiu, Haoming 2911 Gomez, Daniel 1139 Bowen, Stephen 2847 Oguri, Mitsuhiko 2912 Fidler, Mary 1140 Christian, Nicolas 2848 Petras, Katarina 2913 McGee, Lisa 1141 Bing, Lu 2849 Patel, Shilpen 2914 INFORMATICS Parashar, Bhupesh 1142 Dalah, Entesar 2850 Patel, Shilpen 2915 Janssen, R. 3088 Huang, Kitty 1143 Li, Hualei 2851 Arcangeli, Stefano 2916 Vali, Faisal 3089 Zhu, Guangying 1144 Woody, Neil 2852 Walker, Gary 3090 Sahai, Puja 2789 Torok, Jordan 2853 Yang, Deshan 3091 Kishan, Amar 2790 Casey, Stephanie 2854 LYMPHOMA Blacksburg, Seth 3092 Zhou, Lin 2791 Din, Shaun 2855 Kriz, Jan 11 Blacksburg, Seth 3093 Asai, Kaori 2792 Mukai, Yuki 2856 Fasola, Carolina 143 Jiang, Yuliang 3094 Song, Yongchun 2793 Zhuang, Hong-Qing 2857 Ng, Andrea 144 Fechter, Tobias 3095 Mak, Raymond 2794 Zhao, Lujun 2858 Solanki, Abhishek 145 Moore, Joseph 3096 Shi, Pengyue 2795 Haga, Akihiro 2859 Strom, Tobin 146 Ball, Christine 3097 Wang, Suzhen 2796 Amarnath, Sudha 2860 Teckie, Sewit 147 Appenzoller, Lindsey 3098 Katoh, Norio 2797 Ji, Zhe 2861 Bo, Chen 148 Appenzoller, Lindsey 3099 Turaka, Aruna 2798 Bing, Lu 2862 Walker, Gary 149 Yuan, Lulin 3100 Werner-Wasik, Maria 2799 Thibault, Isabelle 2863 Petersen, Peter 150 Renaud, Marc-Andre 3101 Swanick, Cameron 2800 Varlotto, John 2864 Denniston, Kyle 1037 Izadbakhsh, Mark 3102 Gerber, Naamit 2801 Tatekawa, Kotoha 2865 Hoppe, Bradford 1038 Fan, Michael 3103 Sottero, Theo 2802 Baba, Fumiya 2867 Walker, Amanda 1039 Zhang, Hao 3104 Lu, Bing 2803 Schanne, Daniel 2868 Wang, He 1040 Yuh, William 3105 Lu, Bing 2804 Fischer-Valuck, Ben 2869 Voong, K.Ranh 1041 Pyakuryal, Anil 3106 Lu, Diana 2805 Shumway, Dean 2870 Reinartz, Gabriele 1042 Saito, Tetsuo 2806 Michaud, Anthony 2871 Wattson, Daniel 1083 Qi, Huanpeng 2807 Stish, Bradley 2872 Koc, Mehmet 2917
194 ASTRO 2013 / 55TH ANNUAL MEETING Mestre, Francisco 2918 Goodman, Karyn 181 Mitchell, James 3006 QUALITY OF LIFE Cao, Jianzhong 2919 Grover, Surbhi 182 Gao, Wanbao 3007 Movsas, Benjamin 2 Parikh, Rahul 2920 Sura, Karna 283 Pham, Huong 3008 Chow, Edward 12 Freilich, Jessica 2921 Wong, Raimond 284 Arterbery, V. Elayne 3009 Kress, Marie-Adele 176 Li-ming, Xu 2922 Gunn, Brandon G. 285 Martin, Neil 3010 Fuller, Don 177 Liu, Qingfeng 2923 Schwartz, David 286 Braunstein, Steve 3011 Balagamwala, Ehsan 216 Voong, Ranh 2924 Recht, Abram 287 Gensheimer, Michael 3012 Howell, David 217 Katayama, Emiko 2925 Hill-Kayser, Christine 288 Best, Ryan 3013 Kollmeier, Marisa 222 Adli, Mustafa 2926 Wong, Winnifred 2960 Lopater, Zachary 3014 Dunn, Kerry 282 Pinnix, Chelsea 2927 Jung, David 2961 Mohindra, Pranshu 3015 Romesser, Paul 323 Shin, Samuel 2928 Ou, Dan 2962 Butler, Brian E. 3016 Halyard, Michele Yvette 324 Lloyd, Shane 2929 Kharofa, Jordan 2963 Sundararaman, Srinath 3017 Niermann, Kenneth 325 Navarria, Piera 2930 Zhou, Jessica 2964 Elnahal, Shereef 3018 Kann, Benjamin 326 Ujaimi, Reem 2931 Rajagopalan, Malolan 2965 Henrich, Dawn Kerns, Sarah 327 Mikell, John 2932 Tom, Ashlyn 2966 Sio, Terence 328 Kim, Daniel 2933 Nowotnik, David 2967 Hall, William 329 Kuo, SUng-Hsin 2934 Nwachukwu, Chika 2968 PEDIATRIC CANCER Hutcheson, Katherine 3049 Chawla, Sheema 2969 Mailhot Vega, Raymond 10 Seymour, Zachary 3050 Patel, Abhilasha 2970 Patel, Nisha 86 Tang, Yu 3051 NONMALIGNANT DISEASE Wang, Chenyang 2971 Mouw, Kent 87 Lewis, Stephen 3052 Mourad, Waleed 2935 Bernad, Daniel 2972 Müller, Klaus 88 Klein, Jonathan 3053 Blanck, Oliver 2936 Sio, Terence 2973 Redmond, Kristin 89 Son, Christina 3054 Dunst, Juergen 2937 Olson, Robert 2974 Indelicato, Daniel 90 Lee, Tsz Kin 3055 Glanzman, Jonathan 2938 Vicini, Frank 2975 Merchant, Thomas 91 Fang, Penny 3056 Wright, Florence 2939 Agarwal, Ankit 2976 Hiniker, Susan 92 Wagner, Henry 3057 Matsuo, Yoshiro 2940 Ahuja, Divya 2977 Krasin, Matthew 168 Milgrom, Sarah 3058 Sheybani, Arshin 2941 Simpson, Daniel 2978 Mandeville, Henry 169 Nautiyal, Vipul 3059 Nedelka, Michele 2942 Wild, Sommer 2979 Tong, William 170 Yamada, Yoshiya 3060 Mourad, Waleed 2943 Waxweiler, Timothy 171 Randolph, David 3061 Brown, Lindsay 172 Chen, Allen 3062 PATIENT SAFETY Suri, Jaipreet 173 Boothe, Dustin 3063 PALLIATIVE CARE Cox, Brett 289 Polishchuk, Alexei 174 Olson, Robert 215 Mosaly, Prithima Reddy 290 Mazloom, Ali 175 Khan, Luluel 218 Hoopes, David 291 Basu Achari, Rimpa 3020 RADIATION AND CANCER Tseng, Yolanda 219 Rahn, Douglas 292 Hua, Chia-Ho 3021 BIOLOGY Krishnan, Monica 220 Zeng, Jing 293 Christopherson, Kaitlin 3022 Schmitt, Adam 45 Barker, Christopher 221 Santanam, Lakshmi 294 Hollander, Andrew 3023 Pitroda, Sean 46 Mehmood, Tahir 322 Greer, Peter 295 Greenberger, Benjamin 3024 Soong, Chen-Pang 47 Alcorn, Sara 2944 Cui, Yunfeng 2980 McBride, Sean 3025 Borst, Gerben 48 Barriger, Bryan 2945 Valicenti, Richard 2981 Williams, Noelle 3026 Zachman, Derek 49 Wilson, David 2946 Geng, Hui 2982 Panoff , Joseph 3027 Kozono, David 50 Lloyd, Shane 2947 Letourneau, Daniel 2983 Brodin, Patrik 3028 Nishibuchi, Ikuno 51 Friedman, Jeff rey 2948 Ghadjar, Pirus 2984 Willson, Adam 3029 Bratman, Scott 223 Balagamwala, Ehsan 2949 Lam, Wai Wang 2985 Yang, Joanna 3030 Chandrasekaran, Sanjay 224 Chang, Jee Suk 2950 Quang, Tony 2986 Ram, Ashwin 3031 Colbert, Lauren 225 Patel, Kirtesh 2951 Yogo, Katsunori 2987 Thompson, Reid 3032 Liao, Zhongxing 226 Meyer, Joshua 2952 Yang, Bin 2988 Hill-Kayser, Christine 3033 Bi, Nan 227 Xue, Jinyu 2953 Souranis, Annette 2989 Ladra, Matthew 3034 Xu, Ting 228 Wong, Rebecca 2954 Molitoris, Jason 2990 Orman, Amber 3035 Bazan, Jose 229 Prieto, Isabel 2955 Handsfi eld, Lydia 2991 Pai Panandiker, Atmaram 3036 Harima, Yoko 230 Sherman, Alexandra 2956 Marshall, Ingrid 2992 Kandula, Shravan 3037 Witek, Matthew 266 Mariscal, Luis 2957 Admiraal, Marjan 2993 Pai Panandiker, Atmaram 3038 DeWeese, Theodore 267 Ayala-Peacock, Diandra 2958 Nyfl ot, Matthew 2994 Maraldo, Maja 3039 Harris, Timothy 268 Lefresne, Shilo 2959 Pang, Tingtian 2995 Adli, Mustafa 3040 Bernstein, Michael 269 Duplan, Danny 2996 Huynh-Le, Minh-Phuong 3041 Aiyer, Anita 270 Lin, Alexander 2997 Engel, Steven 3042 Vatner, Ralph 271 PATIENT REPORTED Deraniyagala, Rohan 2998 LeMieux, Melissa 3043 Monjazeb, Arta 272 OUTCOMES Ghaff ari, Hamid 2999 Gayar, Omar 3044 Price, Jeremy 273 Small, William 3 Fan, Katherine 3000 Miljkovic, Milos 3045 Willers, Henning 339 Obayomi-Davies, Olusola 178 Lamb, James 3001 Terezakis, Stephanie 3046 Abazeed, Mohamed 340 Lee, Andrew 179 Markovic, Alexander 3002 Barron, David 3047 Reddy, Srilakshmi 341 Mirabeau-Beale, Kristina 180 Awan, Musaddiq 3003 Westerly, David 3048 Raval, Raju 342 Rosenthal, David 3004 Du, Shisuo 343 Eastham, David 3005 Pellicciotta, Ilenia 344
ASTRO 2013 / 55TH ANNUAL MEETING 195 Arafat, Waleed 345 Arvold, Nils 3158 RADIATION AND CANCER Godley, Andrew 337 Gan, Gregory 346 Volotskova, Olga 3159 PHYSICS Lu, Weiguo 338 Bi, Nan 1049 Bazalova, Magdalena 3160 Folkert, Michael 5 Piper, Jonathan 355 Bracey, Daniel 1050 Masunaga, Shin-ichiro 3161 Bahig, Houda 28 Jones, Bernard 356 Stessin, Alexander 1051 Kim, In Ah 3162 Jaff ray, David 29 Low, Daniel 357 Perez, Carmen 1052 Harada, Satoshi 3163 Hu, Yanle 30 Ren, Lei 358 Kumar, Sanath 1053 Wolfe, Adam 3164 Tadic, Tony 31 Meng, Bowen 359 Vlacich, Gregory 1054 Thoms, John 3165 Green, Olga 32 Van Sornsen de Koste, John 360 Tran, Phuoc 1055 Sethi, Manish 3166 Murray, Louise 33 Azcona, Juan Diego 361 Maity, Amit 1057 Simone, Brittany 3167 Craig, Timothy 34 Kincaid, Russell 362 Dal Pra, Alan 1058 Muanza, Thierry 3168 Chin, Alexander 35 Gardner, Stephen 363 Spiotto, Michael 1059 Baschnagel, Andrew 3169 Weiss, Elisabeth 36 Meredith, Ruby 1001 Park, Catherine 1060 Maldonado, Javier 3170 Sonke, Jan-Jakob 101 Shvydka, Diana 1002 Braunstein, Steve 3107 Schlaff , Cody 3171 Mangona, Victor 102 Tarnawski, Rafal 1003 Ronny, Kalash 3108 Lin, Steven 3172 Huang, Zhibin 103 Rahimian, Javad 1004 Greenberger, Benjamin 3109 Chen, Yu-Jen 3173 Stanescu, Teo 104 Kainz, Kristofer 1005 Ji, ShengJun 3110 Nickols, Nicholas 3174 Schulte, Reinhard 105 Takanaka, Tsuyoshi 1006 Bornstein, Sophia 3111 Mukumoto, Naritoshi 3175 Williams, Eric 106 Korideck, Houari 1007 Ji, Jiang 3112 Soh, Hendrick 3176 Poulsen, Per 107 Al-Qaisieh, Bashar 1008 Golden, Encouse 3113 Kotler, Monica 3177 Fernandes, Annemarie 108 Ngwa, Wilfred 1009 Bakst, Richard 3114 Konski, Andre 3178 Li, Ruijiang 109 Lin, Mu-Han 1010 Apicelli, Anthony 3115 Kim, Jin Ho 3179 Greenberger, Joel 126 Akita, Shungo 1011 Hong, Ji-Hong 3116 Park, Heon Joo 3180 Hallman, Mark 127 Ming, Xin 1012 Boss, Mary-Keara 3117 Salem, Ahmed 3181 Yorke, Ellen 128 Wang, Jing 1085 Ybarra, Norma 3118 Yuan, Ye 3182 Aitken, Katharine 129 Goldsmith, Christy 1088 Houghton, Frank 3119 Yu, Jennifer 3183 Suh, Yelin 130 Dagan, Roi 1089 Kudrimoti, Mahesh 3120 Allen, Bryan 3184 Steineck, Gunnar 131 Richter, Daniel 1090 Kim, Sungjune 3121 Tang, Justin 3185 Owen, Dawn 132 Wu, Huanmei 1091 Ma, Jin-lu 3122 Welliver, Meng 3186 Yang, Yun 133 Moteabbed, Maryam 1092 Bratman, Scott 3123 Hedayati, Mohammad 3187 Lian, Jun 134 Takahashi, Wataru 1093 Golden, Encouse 3124 Carrier, France 3188 Romano, Mario 159 Farr, Jonathan 1094 Golden, Encouse 3125 Kirschner, Austin 3189 Tsang, Derek 160 Ashman, Jonathan 1095 Golden, Encouse 3126 Smith, Adam 3190 Takao, Seishin 161 Moskvin, Vadim 1096 Perez, Carmen 3127 Wang, Edina 3191 Harada, Keiichi 162 Marquardt, Michael 1120 Braun, Theodore 3128 Marques, Tatiana 3192 Shi, Xiutao 163 Wissel, Tobias 3223 Young, Kristina 3129 Lautenschlaeger, Tim 3193 Salamekh, Samer 164 Mooney, Karen 3224 Wang, Jin 3130 Swartz, Harold 3194 Atkins, Katelyn 165 Tang, Xiaoli 3225 Akasaka, Hiroaki 3131 Wild, Aaron 3195 Fang, Li-Ming Christine 166 Zhao, Bo 3226 Sheu, Tommy 3132 Liapi, Eleni 3196 Glide-Hurst, Carri 167 Iwata, Hiromitsu 3227 Fontana, Andrea 3133 Qian, Xin 3197 Jeong, Jeho 231 Bos, Clemens 3228 Bakhoum, Samuel 3134 Veldwijk, Marlon 3198 Fan, Qiyong 232 Low, Daniel 3229 Nishioka, Takeshi 3135 Tang, Justin 3199 Anderson, Carryn 233 Yang, Wensha 3230 Thompson, Marcher 3136 Cerne, Jasmina 3200 Zhang, Lifei 234 Bray, Tracy 3231 Qu, Ang 3137 He, Zhiyong 3201 King, Martin 235 Choi, Youngmin 3232 Widlak, Piotr 3138 Biswas, Tithi 3202 Van Den Heuvel, Frank 236 Li, Rongmao 3233 Maria, Ola 3139 Zapatero, Almudena 3203 Valdes, Gilmer 237 Kuo, Hsiang-Chi 3234 Takahashi, Ippei 3140 Tsai, Chiaojung Jillian 3204 Zilli, Thomas 238 Nicolaou, Nicos 3235 Zeidan, Youssef 3141 Chua, Melvin Lee Kiang 3205 Prior, Phillip 239 Li, Xiang 3236 Goff , Julie 3142 Lang, Jinyi 3206 Rodrigues, Anna 296 Stockham, Abigail 3237 Igaki, Hiroshi 3143 Robinson, Timothy 3207 Han, Bin 297 Li, Guang 3238 Epperly, Michael 3144 Hong, Zhen-Yu 3208 Kusano, Aaron 298 Li, Jun 3239 Yoshikawa, Nobuhiko 3145 Jacobs, Corbin 3209 Sheng, Ke 299 Simone, Brittany 3240 Sasaki, Ryohei 3146 Hall, William 3210 Oh, Seungjong 300 Vatyam, Sathiya Narayanan 3241 Aiyer, Anita 3147 Court, Laurence 3211 Sayre, George 301 Ikeda, Itaru 3242 Miyakawa, Akifumi 3148 Baschnagel, Andrew 3212 De Souza-Lawrence, Lana 302 Cheung, Michael 3243 Iwata, Hiromitsu 3149 Sulman, Erik 3213 Sarabia-Estrada, Rachel 303 Mancosu, Pietro 3244 Ando, Ken 3150 Lee, Sung-Wei 3214 Yu, Naichang 304 Jeong, Ho jin 3245 Stewart, Robert 3151 Seo, Yuji 3215 Ahunbay, Ergun 330 Douglass, Lauren 3246 Wooten, Hasani 3152 Trister, Andrew 3216 Qi, Xiangrong 331 Niu, Tianye 3247 Hasegawa, Masatoshi 3153 Varia, Mahesh 3217 Mahmoud, Omar 332 Niu, Tianye 3248 Diff enderfer, Eric 3154 Pai, Jonathan 3219 Hazell, Irene 333 Baron, Charles 3249 Yasuda, Koichi 3155 Jeyaseelan, Krishinima 3220 Schuster, Jessica 334 Cooper, Benjamin 3250 Matsuo, Masayuki 3156 Thirumoorthy, Krishnan 3221 Moore, Joseph 335 Gonzalez, Victor 3251 Evans, Jaden 3157 Jimenez, Rachel 3222 Qin, An 336 Ruggieri, Ruggero 3252
196 ASTRO 2013 / 55TH ANNUAL MEETING Maria Das, Koilpillai Joseph 3253 Yeung, Daniel 3317 Tsujii, Mari 3382 Thompson, Jonathan 3445 Turner, Kathryn 3254 Ping, Yan 3318 Mut, Alejandro 3383 Nedialkova, Lucy 3446 Chanyavanich, Vorakarn 3255 Yan, Susu 3319 Ma, Lijun 3384 Cho, DooKee 3447 Catron, Tom 3256 Day, Ellen 3320 Caussa, Lucas 3385 Pappas, Evangelos 3448 Abramowitz, Matthew 3257 Wang, Zheng 3321 Li, Winnie 3386 Perez-Andujar, Angelica 3449 Bourgouin, Alexandra 3258 Jaff ray, David 3322 Zhen, Heming 3387 Farol, Hanako 3450 Mosaly, Prithima Reddy 3259 Ye, Jing Jing 3323 Picone, James 3388 Camarata, Andrew 3451 Asher, David 3260 Chen, Guang-Pei 3324 Goldin, Gregg 3389 Watkins, William 3452 Ku, Lichung 3261 Pasha, Junaid 3325 El Kaissi, Tarek 3390 Rafi e, Frank 3453 Majithia, Lonika 3262 Olivera, Gustavo 3326 Nabavizadeh, Nima 3391 Kim, Gwe-Ya 3454 Leung, Paikin 3263 Shin, Hun-Joo 3327 Kim, Haksoo 3392 Leuthold, Susan 3455 Munbodh, Reshma 3264 Qiao, Qiao 3328 Boothe, Dustin 3393 Warrell, Gregory 3456 Mao, Weihua 3265 Arai, Kazuhiro 3329 Li, Jingdong 3394 Wang, Song 3457 Williams, Benjamin 3266 Chan, Siu Keung 3330 Kaufman, Isaac 3395 Wang, Bin 3458 Kathpal, Madeera 3267 Jeong, Kyoungkeun 3331 Wang, Lilie 3396 Khandelwal, Shiv 3459 Mooney, Karen 3268 Onozato, Yusuke 3332 Shultz, David 3397 Dumane, Vishruta 3460 Zhao, Tianyu 3269 Van den Bosch, Michiel 3333 Liu, Han 3398 Richter, Andreas 3270 Hwang, Ken-Pin 3334 Harkenrider, Matthew 3399 Troeller, Almut 3271 Kim, Jinkoo 3335 Yu, Shu-Jung 3400 SARCOMA AND CUTANEOUS Yuan, Jiankui 3272 Pukala, Jason 3336 Jenkins, Neil 3401 TUMORS Liu, Dan 3273 Schinkel, Colleen 3337 Matysiak, Witold 3402 Wang, Dian 151 Quanshi, Zhang 3274 Gooding, Mark 3338 Tang, Shikui 3403 Alektiar, Kaled 152 Chapman, Christopher 3275 Yuan, Lulin 3339 Ling, Ted 3404 Dickie, Colleen 153 De Santis, Maria Carmen 3276 Liu, Feng 3340 Zhang, Rui 3405 Roeder, Falk 154 Zhong, Hualiang 3277 Chaudhari, Lalit 3341 Hsi, Wen 3406 Wang, Jianyang 155 Tai, An 3278 Damato, Antonio 3342 Zheng, Yuanshui 3407 Pan, Elizabeth 156 Spektor, Alexander 3279 Mahantshetty, Umesh 3343 Chen, Chin-Cheng 3408 Bhatnagar, Ajay 157 Shin, Naomi 3280 Luo, Guozhen 3344 Merrell, Kenneth 3409 Hoeller, Ulrike 158 Zhang, Hualin 3281 Gooding, Mark 3345 Sanchez Parcerisa, Daniel 3410 Miller, Luke 1043 Zhang, Geoff rey 3282 Lachance, Bernard 3346 Yeager, Caitlyn 3411 Kazuhiko, Hayashi 1044 Munbodh, Reshma 3283 Chen, Xiaoming 3347 Klein, Eric 3412 Willett, Addison 1045 Yang, Cungeng 3284 Jennelle, Richard 3348 Lin, Lilie 3413 Bishop, Andrew 1046 Parsai, E. Ishmael 3285 Piper, Jonathan 3349 Zheng, Yuanshui 3414 Polo, Alfredo 1047 Kim, Haksoo 3286 Piper, Jonathan 3350 Dhanesar, Sandeep 3415 Bhatt, Aashish 1048 Brock, Kristy 3287 Hu, Yanle 3351 Renaud, Marc-Andre 3416 Jones, Daniel Adam 3064 Deasy, Joseph 3288 Semon, Meredith 3352 Cahlon, Oren 3417 Vargo, John 3065 Cheng, ChihYao 3289 Hadley, Scott 3353 Iftimia, Ileana 3418 Pan, Hubert 3066 Fujita, Yujiro 3290 Ito, Yasushi 3354 Yang, Yun 3419 Cassidy, Richard 3067 Yang, Kai 3291 Zhung, Joanne 3355 El-Haddad, Mostafa 3420 Scott, Michael 3068 Riegel, Adam 3292 Takahashi, Yutaka 3356 Maghsoudi, Kaveh 3421 Hollen, Tyler 3069 Han, Guang 3293 Wijesooriya, Krishni 3357 Matulewicz, Lukasz 3422 Mahmoud, Omar 3071 Doi, Yoshiko 3294 Wang, Henry 3358 Schadewaldt, Nicole 3423 Menzel, Paul 3072 Zhou, Lili 3295 Perkins, Gregory 3359 Noto, Kimiya 3424 Hata, Masaharu 3073 Wang, Ping 3296 Tongtip, Naruemon 3360 Chaudhry, Huma 3425 Willson, Adam 3074 Cao, Yuanjie 3297 Clayton, Ravinder 3361 Rochet, Nathalie 3426 Falk, Alexander 3075 Li, Feng 3298 Owen, Dawn 3362 Peng, Cheng 3427 Sharma, Daya Nand 3076 Mattes, Malcolm 3299 Hong, Linda 3363 Kole, Thomas 3428 Kim, Young Il 3077 Zhang, Pengpeng 3300 Navarria, Piera 3365 Ferreira, Maria Clara 3429 Kollar, Laura 3078 Liang, Jian 3301 Dandekar, Virag 3366 Xing, Lei 3430 Cengel, Keith 3079 Lim, Kyoung-Dal 3302 Kole, Thomas 3367 Zhang, Ying 3431 Amendola, Beatriz 3080 Feygelman, Vladimir 3303 Li, Ruijiang 3368 Levin, Daphne 3432 Rooney, Jessica 3081 Wakai, Nobuhide 3304 Nagata, Yasushi 3369 Na, Yong Hum 3433 Bedi, Manpreet 3082 Siddiqui, Farzan 3305 Huang, Long 3370 Wooten, Charles 3434 Rainey, David 3083 Vergalasova, Irina 3306 Chen, Hairong 3371 Mohanty, P.P. 3435 Warner, Lindsay 3084 Usui, Keisuke 3307 Patel, Abhilasha 3372 Yordy, John 3436 Parvathaneni, Upendra 3085 Catan, Ilker 3308 Kim, Dae Il 3373 Nakagawa, Keiichi 3437 Parvathaneni, Upendra 3086 An, Sohyun 3309 Iwana, Maho 3374 Yang, Ruijie 3438 Mutyala, Subhakar 3087 Lee, Suk 3310 Koch, Siete 3375 Kjaer-Kristoff ersen, Fung, Winky Wing Ki 3311 Luo, Wen Min 3376 Flemming 3439 Jang, HongSeok 3312 Dizman, Aysen 3377 Zhikai, Liu 3440 Chang, Kyung-Hwan 3313 Shinde, Prashantkumar 3378 Cho, Yu Ra 3441 Yeh, Chi-Yuan 3314 McGuinness, Christopher 3379 Mehta, Niraj 3442 Tol, Jim 3315 Kim, Tae Gyu 3380 Rice, Lynsey 3443 Mohr, Angela 3316 Mahjoubi, Khalil 3381 Wilson, Zachary 3444
ASTRO 2013 / 55TH ANNUAL MEETING 197 NOTES
198 ASTRO 2013 / 55TH ANNUAL MEETING NOTES
ASTRO 2013 / 55TH ANNUAL MEETING 199 NOTES
200 ASTRO 2013 / 55TH ANNUAL MEETING Exhibitor rst-come, Ra 223 go® (radium dichloride) and Algeta Supported HealthCare Bayer by Group Lockwood The Contact: Phone: 203-817-0951 lunch provided Box September 24 Tuesday, 11:45 a.m. – 12:45 p.m. Therapy Quality in Radiation Increasing Supported ScandiDos by Marni Brown Contact: Phone: 608-630-9415 lunch provided Box Monday, September 23 Monday, – 1:15 p.m. 12:15 p.m. Time: In-depth Xofi An at Look ted in the Exhibit Hall. Seating is available on a fi Seating is available Hall. in the Exhibit ted exhibitor and not of ASTRO. exhibitor Rear of 100 Aisle, Exhibit Hall B1 of 100 Aisle, Rear INDUSTRY-EXPERT THEATER* INDUSTRY-EXPERT *Industry-Expert Theaters are not accredited for continuing medical education credits. continuing for not accredited *Industry-Expert are Theaters This activity allows companies to present their noteworthy products and services their noteworthy a live present activity to through This companies allows rst-served basis. The Industry-Expert Theater content and views expressed therein are those of the are therein expressed and views Industry-Expert content The Theater rst-served basis. fi
presentation in the Industry-Expert loca presentation Theater
Monday, September 23 Monday, a.m. 10:15 a.m. – 10:45 Time: Utilizing the Electronic Brachytherapy of Treatment the for System Xoft® Non-Melanoma Skin Cancer Supported A subsidiary Xoft, by of iCAD Inc. DonnaContact: Breault Phone: 978-337-2786 provided Refreshments Sunday, September 22 Sunday, – 1:45 p.m. 12:45 p.m. Time: in Motion Technology Dynamic Accuray: Supported Accuray by Jim Bilich Contact: Phone: 925-348-2082 lunch provided Box Floor Plan Floor Exhibitor Lists by Product/Service Lists Exhibitor Exhibitor Lists Exhibitor INSIDE: Exhibitor Exhibitor List (as of August 27, 2013)
EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
.decimal 1659 Advanced Shielding Technologies Inc. 823 American College of Radiology 413 121 Central Park Place 23355 L & N Turnpike, Building F 1891 Preston White Drive Sanford, FL 32771 West Point, KY 40177 Reston, VA 20191 Phone: 800-255-1613 Phone: 502-922-3009 Phone: 703-648-8900 Email: [email protected] Email: [email protected] Email: [email protected] Website: www.dotdecimal.com Website: www.advancedshieldingtech.com Website: www.acr.org
21st Century Oncology 757 Aktina Medical Corporation 2233 American Medical Accounting and 1022 2270 Colonial Boulevard 360 North Route 9W Consulting Fort Myers, FL 33907 Congers, NY 10920 2864 Johnson Ferry Boulevard, Suite 150 Phone: 239-931-7333 Phone: 845-268-0101 Marietta, GA 30062 Email: [email protected] R Phone: 770-693-6031 Website: www.21stCenturyOncology.com Email: [email protected] R Website: www.amac-usa.com Algeta 554 A2J Laser Technology 1535 210 Broadway Parc d’Activité des Vallières, 5 allée des Rousselets Cambridge, MA 02139 American Radium Society 616 Thorigny sur Marne, 77 77400 Phone: 617-225-2301 11300 West Olympic Boulevard, Suite 600 France Email: [email protected] Los Angeles, CA 90064 Phone: +33-(0)1-60-94-22-99 Website: www.algeta.com Phone: 310-437-0581 Email: [email protected] Email: [email protected] Website: www.a2jlaser.com Website: www.americanradiumsociety.org Alliance Oncology 712 100 Bayview Circle, Suite 400 Acceletronics 1913 Newport Beach, CA 92660 American Society of Radiologic 515 602 Gordon Drive Phone: 949-242-5497 Technologists Exton, PA 19341 Email: [email protected] 15000 Central Avenue SE Phone: 800-543-5144 Website: www.allianceoncology.com Albuquerque, NM 87123-3909 Email: [email protected] R Phone: 505-298-4500 Website: www.acceletronics.com Email: [email protected] R Alphatron Linac 2526 Website: www.asrt.org 3870-B Longview Drive AccuBoost 243 Douglasville, GA 30135 1 Industrial Way Phone: 678-838-3737 Anzai Medical Co. Ltd. 2755 Tyngsboro, MA 01879 Email: [email protected] 3-6-25 Nishi-ShinagawaShinagawa-ku Phone: 978-649-0007 Website: www.alphatronlinac.com Tokyo, 141-0033 Email: ryan.fl [email protected] Japan Website: www.accuboost.com Phone: 81-337-791-611 R American Association of Medical 432 Email: [email protected] Dosimetrists Website: www.anzai-med.co.jp Accuray Inc. 1842 2201 Cooperative Way, Suite 600 1310 Chesapeake Terrace Herndon, VA 20171 Sunnyvale, CA 94089 Phone: 703-677-8071 AQUILAB 2732 Phone: 408-716-4600 Email: [email protected] Parc Eurasante, 250 rue Salvador Allende Email: [email protected] Website: www.medicaldosimetry.org Loos Les Lille, 59120 Website: www.accuray.com R France R A Phone: 00-333-696-1515-1 Email: [email protected] American Chillers and Cooling Tower 522 Website: www.aquilab.com LEGEND Systems Inc. R 15 Rest Master Lane A Ambassador North Augusta, SC 29860 P Platinum Sponsor Phone: 803-278-1463 architection 1621 Email: [email protected] 425 W. Market Street G Gold Sponsor Website: www.amchiller.com Louisville, KY 40202 S Silver Sponsor Phone: 502-561-1024 B Bronze Sponsor Email: [email protected] American College of Radiation Oncology 241 Website: www.architection.com C Copper Sponsor 5272 River Bend, Suite 630 R R Enhanced RO MarketPlace Bethesda, MD 20816 Listing Phone: 301-718-6533 Corporate members in bold. Email: [email protected] Website: www.acro.org
ASTRO 2013 / 55TH ANNUAL MEETING 203 EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
ASCO 733 Biocompatibles Inc. 926 Buck Engineering & Consulting 2853 2318 Mill Road, Suite 800 115 Hurley Road, Building 3 GMBH Alexandria, VA 22314 Oxford, CT 06478 Gartenstrasse 11 Phone: 888-282-2552 Phone: 203-262-4198 Reutlingen, 72764 Email: [email protected] Email: [email protected] Germany Website: www.asco.org Website: www.biocompatiblesinc.com Phone: 49-7121-930-721-0 R Email: [email protected] Website: www.b-e-c.net ASTRO Resource Center 543 8280 Willow Oaks Corporate Drive, Suite 500 Bionix Radiation Therapy 1653 Fairfax, VA 22031 5154 Enterprise Boulevard C&G Technologies 519 Phone: 703-502-1550 Toledo, OH 43612 6209 Gheens Mill Road Email: [email protected] Phone: 419-727-8421, ext. 262 Jeff ersonville, IN 47130 Website: www.astro.org Email: [email protected] Phone: 812-280-0048 Website: www.bionixrt.com Email: [email protected] Website: www.cgtscan.com Augmenix 343 204 2nd Avenue, Lower Level BK Medical Systems 918 Waltham, MA 02451 8 Centennial Drive C.R. Bard Inc. 2030 Phone: 781-895-3235 Peabody, MA 01960 8195 Industrial Boulevard Email: [email protected] Phone: 978-326-1300 Covington, GA 30014 Website: www.augmenix.com Email: [email protected] Phone: 770-784-6223 Website: www.bkmed.com Email: [email protected] Website: www.crbard.com Azimuth Therapy 327 68 B Amal Street Bogardus Medical Systems Inc. 820 Petach Tikva, 49513 3555 N. W. 58th Street, Suite 500 Cancer CarePoint Inc. 1722 Israel Oklahoma City, OK 73112 17 Executive Park Drive, Suite 520 Phone: 97-2-3-92-781-11 Phone: 405-917-0500 Atlanta, GA 30329 Email: [email protected] Email: [email protected] Phone: 800-998-5859 Website: www.azimutherapy.com Website: www.oncochart.com Email: [email protected] R Website: www.cancercarepoint.com R Bayer HealthCare 554 6 West Belt Boiron 2613 Wayne, NJ 07470 6 Campus Boulevard Cancer Treatment Centers of America 2712 Phone: 973-305-5000 Newtown Square, PA 19073-3267 2610 Sheridan Road Email: [email protected] Phone: 610-325-7464 Zion, IL 60099 Website: www.pharma.bayer.com Website: www.boironusa.com Phone: 847-746-4441 A Email: [email protected] Website: www.cancercenter.com Brainlab 1243 Best Medical International Inc. 2261, 2715, 2819 3 Westbrook Corporate Center, Suite 400 Cangene Corporation 2112 7643 Fullerton Road Westchester, IL 60154 920 Cassatt Road, Suite 100 Springfi eld, VA 22153 Phone: 708-409-1343 Berwyn, PA 19312 Phone: 703-451-2378 Email: [email protected] Phone: 215-778-4743 Website: www.teambest.com Website: www.brainlab.com Email: [email protected] R A R Website: www.cangene.com
Bristol-Myers Squibb 1635 Carbon Medical Technologies 2716 P.O. Box 4500 1290 Hammond Road Princeton, NJ 08543 St. Paul, MN 55110 Phone: 609-897-2000 Phone: 651-653-8512 Email: [email protected] Email: [email protected] Website: www.bms.com Website: www.carbonmed.com LEGEND A Ambassador BSD Medical 2852 Carl Zeiss Meditec Inc. 627 P Platinum Sponsor 2188 W. 2200 S. 5160 Hacienda Drive G Gold Sponsor Salt Lake City, UT 84119 Dublin, CA 94568 S Silver Sponsor Phone: 801-972-5555 Phone: 925-557-4100 Website: www.bsdmedical.com Email: [email protected] B Bronze Sponsor Website: www.zeiss.com C Copper Sponsor R R Enhanced RO MarketPlace Listing CorporateCorporate membersmembers inin bold.bold.
204 ASTRO 2013 / 55TH ANNUAL MEETING EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
CDR Systems Inc. 613 CompHealth 2515 DOSIsoft 2612 #33, 235105 Wrangler Drive, SE 6440 South Millrock Drive, Suite 175 45-47 Avenue Carnot Calgary, AB T1X 0K3 Salt Lake City, UT 84121 Cachan, 94230 Canada Phone: 800-453-3030 France Phone: 403-850-7035 Email: [email protected] Phone: 33-141-242-626 Email: [email protected] Website: www.comphealth.com Website: www.cdrsys.ca R Dynasource LLC 2428 Computerized Radiation Scanners Inc. 717 7362 Futures Drive, Suite 15 Cemar Electro Inc. 514 140 Sopwith Drive Orlando, FL 32819 1370 55th Avenue Vero Beach, FL 32968 Phone: 407-792-8490 Lachine, QC H8T 3J8 Phone: 772-562-0405 Email: [email protected] Canada Email: [email protected] Phone: 514-631-5807 Website: www.beamscanners.com Email: [email protected] e+CancerCare 2113 Website: www.cemarelectro.com 104 Woodmont Boulevard, Suite 500 C-RAD Inc. 661 Nashville, TN 37205 70 SE 4th Avenue Phone: 615-467-7407 Churchill Consulting Inc. 920 Delray Beach, FL 33483 Email: [email protected] 384 Route 148 Phone: 561-742-9260 Website: www.epluscancercare.com Killingworth, CT 06419 Email: [email protected] Phone: 860-663-5630 Website: www.c-rad.se Email: [email protected] e2v 2528 Website: www.ChurchillConsulting.com 520 White Plains Road R Cura Medical Technologies 2714 Tarrytown, NY 10591 23 Rancho Circle Phone: 914-592-6050 Lake Forest, CA 92630 Email: [email protected] Cianna Medical 542 Phone: 949-716-2447 Website: www.e2v.com 6 Journey, Suite 125 Aliso Viejo, CA 92656 Phone: 949-360-0059 CYRPA America LLC 455 Eckert & Ziegler BEBIG 1758 Email: [email protected] 6725 Mesa Ridge Road, Suite 100 Robert-Rössle-Strasse 10 Website: www.ciannamedical.com San Diego, CA 92121 Berlin, 13125 Germany Phone: 49-30-94-10-84-272 CIRS 2219 D3 Oncology Solutions 1023 Email: [email protected] 2428 Almeda Avenue, Suite 316 5750 Centre Avenue, Suite 500 Website: www.bebig.eu Norfolk, VA 23513 Pittsburgh, PA 15206 R Phone: 757-855-2765 Phone: 412-365-0719 Email: [email protected] Email: [email protected] Website: www.cirsinc.com Website: www.d3onc.com Elekta 942 R R 400 Perimeter Center Terrace, Suite 50 Atlanta, GA 30346 Phone: 770-670-2592 CivaTech Oncology 2929 Dara BioSciences 1020 Email: [email protected] 104 T W Alexander Drive, #4 8601 Six Forks Road, Suite 160 Website: www.elekta.com Res Triangle Park, NC 27709 Raleigh, NC 27615 A R Phone: 919-314-5515 Phone: 919-861-0236 Website: www.civatechoncology.com ELSEVIER 1617 Demos Medical Publishing 513 1600 JFK Boulevard 11 West 42nd Street, 15th Floor Philadelphia, PA 19103 CIVCO Medical Solutions 1826 New York, NY 10036 Phone: 702-260-4628 1401 8th Street SE Phone: 212-683-0072, ext. 217 Website: www.us.elsevierhealth.com Orange City, IA 51041 Website: www.demosmedpub.com Phone: 712-737-8688 Email: [email protected] Equal-Estro Inc. 245 Website: www.civco.com Desert Harvest 2450 Place de l’Alama 3 B R 20070 Roaming Drive Brussels, 1200 Colorado Springs, CO 80908 Belgium Phone: 719-592-0223 Phone: +32-277-681-59 Cold Shot Chillers 417 Email: [email protected] 14020 Interdrive West Website: www.equalestro.com Houston, TX 77032 DIACOR 2034 R Phone: 281-227-8400 2550 Decker Lake Boulevard Email: [email protected] West Valley, UT 84119 Website: www.waterchillers.com Phone: 763-227-2256 R Email: [email protected] Website: www.diacorinc.com R
ASTRO 2013 / 55TH ANNUAL MEETING 205 EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
Equicare Health Inc. 2653 Genomic Health Inc. 1817 Hitachi Aloka Medical 2421 201-2020 Yukon Street 301 Penobscot Drive 10 Fairfi eld Boulevard Vancouver, BC V5Y 3N8 Redwood City, CA 94063 Wallingford, CT 06492 Canada Phone: 866-662-6897 Phone: 800-872-5652 Phone: 604-398-2956 Email: [email protected] Email: [email protected] Email: [email protected] Website: www.OncotypeDX.com Website: www.hitachi-aloka.com Website: www.equicarehealth.com
GMV Soluciones Globales Internet 422 Hitachi America Ltd. 2520 Everson Tesla Inc. 1120 S.A.U 50 Prospect Avenue 615 Daniels Road Isaac Newton, 11 Tarrytown, NY 10591 Nazareth, PA 18064 Tres Cantos, MADRID 28760 Phone: 914-524-6654 Phone: 610-216-6279 Spain Email: [email protected] Email: [email protected] Phone: 34-918-072-100 Website: www.hitachi-america.us Website: www.eversontesla.com Email: [email protected] Website: www.gmv.com Hologic Inc. 734 Focal Therapeutics 423 35 Crosby Drive 4370 Alpine Road, Suite 101 Gold Anchor 622 Bedford, MA 01730 Portola Valley, CA 94028 Vassvagen 21 Phone: 781-999-7300 Phone: 949-521-4949 Huddinge, 14139 Website: www.hologic.com Sweden S Phone: 46-706-105-411 Foss Therapy Services Inc. 719 Email: [email protected] 8794 Avalon Street Website: www.FineNeedleMarker.com HyperDrive Medical 563 Alta Loma, CA 91701 R 1110 Sunset Drive Phone: 909-980-6229 Salt Spring Island, British Columbia Email: [email protected] V8K1E6 Canada Website: www.fosstherapyservices.net Guangzhou Renfu Medical Equipment Co. Ltd. 2514 Email: [email protected] No. 2 Zhiye RD Dalong Street, Panyu Website: www.hyperdrivemed.com Guangzhou, Guangdong 511450 Gammex Inc. 1435 China 7600 Discovery Drive Phone: 86-203-839-1508 IBA SA 1543 Middleton, WI 53562 Email: [email protected] Chemin du Cyclotron, 3 ES1 Phone: 608-828-7000 Website: www.renfumed.com Louvain-la-Neuve, 1348 Email: [email protected] Belgium Website: www.gammex.com Phone: 32-470-048-622 R Healthcare Administrative Partners 2353 Email: [email protected] 112 Chesley Drive Website: www.iba-worldwide.com GE Healthcare 2242 Media, PA 19063 R P.O. Box 414 Phone: 610-892-8889 Milwaukee, WI 53201 Email: [email protected] Imaging Technology News 921 Phone: 262-544-3011 Website: www.hapusa.com 3030 West Salt Creek Lane, Suite 201 Website: www.gehealthcare.com R Arlington Heights, IL 60005 Phone: 847-391-1000 Email: [email protected] GeneDx Inc. 416 Healthcare Global Enterprises 426 Website: www.ITNonline.com 207 Perry Parkway #8, P Kalinga Rao Road, Tower IV, HCG, Gaithersburg, MD 20877 Sampaniramnagar Phone: 800-229-5227, ext. 8205 Bangalore, Karnataka 560027 ImpediMed Inc. 420 Website: www.genedx.com India 5900 Pasteur Court, Suite 125 Phone: 91-804-020-6058 Carlsbad, CA 92008 Website: www.hcgoncology.com Phone: 877-247-0111 Email: [email protected] Website: www.impedimed.com Heritage Capital Group 334 R LEGEND 4811 Beach Boulevard, Suite 300 A Ambassador Jacksonville, FL 32207 Phone: 904-394-3525 INSYS Therapeutics Inc. 1916 P Platinum Sponsor Website: www.heritagecapitalgroup.com 10220 S. 51st Street G Gold Sponsor Chandler, AZ 85224 S Silver Sponsor Phone: 602-910-2617, ext. 9020 Hermes Medical Solutions Inc. 2420 B Bronze Sponsor 710 Cromwell Drive, Suite A C Copper Sponsor Greenville, NC 27858 Integrated Oncology Network 2843 R Enhanced RO MarketPlace Phone: 866-437-6372 2865 E. Coast Hwy, Suite 210 Listing Email: [email protected] Corona del Mar, CA 92625 Website: www.hermesmedical.com Phone: 949-933-8800 CorporateCorporate members members in in bold. bold. Website: www.ion-llc.com
206 ASTRO 2013 / 55TH ANNUAL MEETING EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
IntraOp Medical 821 Kyoto Kagaku Co. Ltd. 523 Lippincott Williams & Wilkins 1716 570 Del Rey Avenue 3109 Lomita Boulevard Two Commerce Square, 2001 Market Street Sunnyvale, CA 94085 Torrance, CA 90505 Philadelphia, PA 19103 Phone: 408-636-1020 Phone: 310-325-8860 Phone: 215-521-8300 Website: www.intraopmedical.com Email: [email protected] Email: [email protected] Website: www.kyotokagaku.com Website: www.lww.com
IOP Publishing 418 150 S. Independence Mall West, Suite 929 Landauer Inc. 2333 Locumtenens.com 729 Philadelphia, PA 19106 2 Science Road 2655 Northwinds Parkway Phone: 215-627-0880 Glenwood, IL 60425 Alpharetta, GA 30009-2280 Email: [email protected] Phone: 877-476-8433 Phone: 770-643-5559 Website: www.ioppublishing.org Email: [email protected] Email: [email protected] Website: www.landauermp.com Website: www.locumtenens.com R IOS Consultants LLC 2422 7770 West Chester Road, Suite 150 West Chester, OH 45069 LAP of America LLC 2142 MACROMEDICS BV 447 Phone: 888-870-1780 161 Commerce Road, Suite 3 Kouwe Hoek 18 Email: mckinneyf@innovativeoffi cesolutions.net Boynton Beach, FL 33426 Waddinxveen, 2741 PX Website www.innovativeoffi cesolutions.net Phone: 561-416-9250 Netherlands Email: [email protected] Phone: 31-018-238-9777 Website: www.lap-laser.com/medical-systems Website: www.macromedics.com R Iron Medical Systems Inc. 428 3104 E. Camelback Road, #562 Math Resolutions LLC 335 Phoenix, AZ 85016 Leoni CIA Cable Systems S.A.S. 1663 5975 Gales Lane Phone: 602-343-6440 1, Ave Louis Pasteur, Zone Industrielle de Gellainville Columbia, MD 21045 Email: [email protected] Gellainville, 28630 Website: www.MathResolutions.com Website: www.ironmedicalsystems.com France Phone: 0033-237333204 Email: [email protected] IsoAid 2427 Website: www.leoni-healthcare.com Max Medical Co. Ltd. 2454 7824 Clark Moody Boulevard 4-5-1, Nishinakajima, Yodogawa-ku Port Richey, FL 34668 Osaka, 532-0011 Phone: 727-207-5973 Liberty Medical Inc. 2448 Japan Email: [email protected] 22135 Davis Drive, #112 Phone: +81-6-6886-7351 Website: www.isoaid.com Sterling, VA 20164 Email: [email protected] R Phone: 888-257-2408 Website: www.maxmedical.co.jp R
IsoRay Medical Inc. 2736 McKesson Specialty Health 2513 350 Hills Street, Suite 106 LifeLine Software Inc. 2743 10101 Woodloch Forest Richland, WA 99354 2407 Pemberton Place The Woodlands, TX 77380 Phone: 509-375-1202 Austin, TX 78703 Phone: 832-601-6208 Email: [email protected] Phone: 866-592-1343 Email: [email protected] Website: www.isoray.com Email: [email protected] R Website: www.lifelinesoftware.com R medPhoton GMBH 2853 Muellner Hauptstrasse 48 James L. Davis 1017 Salzburg 5020 Austria 13521 Walsingham Road LinaTech LLC 1762 Phone: +43-662-4482-3928 Largo, FL 33774 1294 Kifer Road, Suite 705 Email: [email protected] Phone: 727-596-0408 Sunnyvale, CA 94086 Email: [email protected] Phone: 408-733-2051 Website: www.jld-radcon.com Email: [email protected] Medspira LLC 521 R Website: www.linatech.com 2718 Summer Street NE R Minneapolis, MN 55413 Phone: 612-789-0013 Klarity 2343 Website: www.medspira.com 80 Westgate Drive Linbeck Group LLC 2955 Newark, OH 43055 3900 EssexSuite 1200 Phone: 740-788-8107 Houston, TX 77027 Mevion Medical Systems 1253 Email: [email protected] Phone: 713-621-2350 300 Foster Street Website: www.klaritymedical.com Littleton, MA 01460 Phone: 978-540-1500 Email: [email protected] Kobold 2352 Website: www.mevion.com P.O. Box 1994 G R Veradale, WA 99037 Phone: 509-703-5090 ASTRO 2013 / 55TH ANNUAL MEETING 207 EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
Miaderm Radiation Relief at Aiden 443 Mission Search 715 NELCO 2026 Industries LLC 2203 N. Lois Avenue, Suite 1225 2 Burlington Woods Drive, Suite 300 2412 Calle San Miguel Tampa, FL 33607 Burlington, MA 01803 Encinitas, CA 92024 Phone: 813-870-9500 Phone: 781-933-1940 Phone: 617-461-5959 Email: [email protected] Website: www.nelcoworldwide.com Email: [email protected] Website: www.MissionSearchUSA.com R Website: www.miaderm.com R Mitsubishi Electric 2934 Network Imaging System 517 3124 Fox Creek Drive 8100-C Arrowridge Boulevard Mick Radio Nuclear-Instruments Inc. 1334 Danville, CA 94506 Charlotte, NC 28273 521 Homestead Avenue Phone: 925-890-8935 Phone: 704-619-0290 Mount Vernon, NY 10550 Email: [email protected] Phone: 914-667-3999 Website: www.mitsubishi-presentations.com Email: [email protected] Neurologica 249 Website: www.micknuclear.com 14 Electronics Avenue R Mobius Medical Systems 2519 Danvers, MA 01923 906 Hutchins Street Phone: 978-564-8533 Houston, TX 77003 Website: www.neurologica.com Micropos Medical AB 559 Phone: 713-234-0123 Stena Center 1 Email: [email protected] Gothenburg, 41292 Website: www.doselab.com Novocure 2615 Sweden 1500 Broadway, 29th Floor Phone: +46-31-772-80-99 New York, NY 10036 Email: [email protected] Modus Medical Devices Inc. 2633 Website: www.novocure.com Website: www.micropos.se 1570 North Routledge Park R London, ON N6H 5L6 Canada OiService CT & MR 2349 Phone: 519-438-2409 64 Union Way Email: [email protected] Vacaville, CA 95687 MIM Software 433 Website: www.modusmed.com Phone: 888-673-5151 25800 Science Park Drive, Suite 180 Email: [email protected] Cleveland, OH 44122 Website: www.oxford-instruments.com/ct-mr Phone: 216-455-0600 MPM Medical Inc. 819 Email: [email protected] 2301 Crown Court Website: www.mimsoftware.com Irving, TX 75038 Oncolink-University of Pennsylvania 1021 Phone: 972-893-4090 Perelman Center for Advanced Medicine Email: [email protected] 3400 Civic Center Boulevard Ministry Health Care 2426 Website: www.mpmmed.com Radiation Oncology Admin Offi ces, Suite 2338 900 Illinois Avenue R Philadelphia, PA 19104 Stevens Point, WI 54481 Phone: 215-349-8895 Phone: 715-342-7772 Email: [email protected] Email: [email protected] MuCheck-Oncology Data Systems 633 Website: www.oncolink.upenn.edu Website: www.ministryhealth.org 1601 SW 89th Street, E-100 Oklahoma City, OK 73159 Phone: 405-680-5222 Mirada Medical 2733 Email: [email protected] Oncology Services International 727 Oxford Centre for Innovation, New Road Website: www.mucheck.com 400 Rella Boulevard, Suite 123 Oxford, OX1 1BY Montebello, NY 10901 United Kingdom Phone: 845-357-6560 Phone: 44-(0)-1865-261-410 Multidata Systems International Corp. 1235 Email: [email protected] Email: [email protected] 10816 Indian Head Industrial Boulevard Website: www.thinkosi.com Website: www.mirada-medical.com St. Louis, MO 63132 R R Phone: 314-968-6880 Website: www.multidata-systems.com Oncology Systems Limited 763 14 Longbow Professional Centre LEGEND Shrewsbury, SY1 3GZ A Ambassador United Kingdom Myriad Genetic Laboratories 331 Phone: +44-(0)1743-462694 P Platinum Sponsor 320 Wakara Way Email: [email protected] G Gold Sponsor Salt Lake City, UT 84108 Website: www.osl.uk.com S Silver Sponsor Phone: 801-584-3535 Email: [email protected] B Bronze Sponsor Website: www.myriad.com Orfi t Industries America 2543 C Copper Sponsor 350 Jericho Turnpike, Suite 101 R Enhanced RO MarketPlace Jericho, NY 11753 Listing Phone: 516-935-8500 Email: martinj.ratner@orfi t.com CorporateCorporate members members in in bold. bold. Website: www.orfi t.com
208 ASTRO 2013 / 55TH ANNUAL MEETING EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
P-Cure Ltd. 2554 ProNova Solutions 1863 Radiation Business Solutions 923 500 Lake Cook Road 1450 Dowell Springs Boulevard, Suite 230 1044 Jackson Felts Road Deerfi eld, IL 60015 Knoxville, TN 37909 Joelton, TN 37080 Phone: 847-874-7771 Phone: 865-684-2616 Phone: 615-746-4711 Email: [email protected] Email: [email protected] Website: www.p-cure.com Website: www.radiationbusiness.com
ProTom International Inc. 1561 Perioperative Services LLC 445 1100 Parker Square, Suite 230 111 Continental Drive, Suite 412 Flower Mound, TX 75028 Radiation Oncology Resources 721 Newark, DE 19713 Phone: 972-410-3551 P.O. Box 76 Phone: 302-709-4502 Email: [email protected] Goshen, IN 46527 Website: www.protominternational.com Phone: 574-364-2474 R Email: [email protected] Phantom Laboratory 917 Website: www.roresources.com P.O. Box 511 R Salem, NY 12865 Prowess Inc. 2135 Phone: 518-692-1190 1844 Clayton Road Email: [email protected] Concord, CA 94520 Radiation Products Design Inc. 816 Website: www.phantomlab.com Phone: 925-356-0360 5218 Barthel Industrial Drive Email: [email protected] Albertville, MN 55301 Website: www.prowess.com Phone: 763-497-2071 Philips Healthcare 1832 Email: [email protected] 3000 Minuteman Road Website: www.rpdinc.com Andover, MA 01810 PTW 2435 R Phone: 800-229-6417 205 Park Avenue Website: www.philips.com/healthcare Hicksville, NY 11801 A Phone: 516-827-3181 Radiation Therapy Oncology Group 618 Email: [email protected] 1818 Market Street, Suite 1600 Website: www.ptwny.com Philadelphia, PA 19103 Pioneer Bioscience Publishing Company 516 Phone: 215-717-0843 3/F, 1st Building, Le Su Science Park, 1526, Email: [email protected] Chunbo Rd., Binjiang District Qfi x 1627 Website: www.rtog.org Hangzhou, Zhejiang Province 310052 440 Church Road China Avondale, PA 19311 Phone: +86-571-28182610 Phone: 800-526-5247, ext. 713 Radiological Imaging Technology - RIT 2443 Email: [email protected] Website: www.q-fi x.com 5065 List Drive Website: www.thepbpc.org R Colorado Springs, CO 80919-3321 Phone: 719-590-1077 QLRAD Inc. 412 Email: [email protected] Pitts Little Corp. 1116 80 S.W. 8th Street, Suite 2000 Website: www.radimage.com 2711 Alton Road Miami, FL 33130 Birmingham, AL 35210 Phone: 770-335-5601 Phone: 205-833-5911 Email: [email protected] Email: [email protected] Website: www.QLRAD.com Radiology Oncology Systems Inc. 751 Website: www.pittslittle.com 6725 Mesa Ridge Road, Suite 100 San Diego, CA 92121 Phone: 858-454-8100 Precise Construction Inc. 2318 RAD Technology Medical Systems 743 Email: [email protected] 5026 Trenton Street 20801 Biscayne Boulevard, Suite 403 Website: www.oncologysystems.com Tampa, FL 33619 Aventura, FL 33180 Phone: 813-241-2403, ext. 20 Phone: 305-898-2544 Website: www.preciseconstruction.com Email: [email protected] RADMAX Ltd. 827 Website: www.radtechnology.com 3304 S. Broadway Avenue, Suite 200 Tyler, TX 75701 Precision X-Ray 2751 Phone: 903-531-2371 15 Commerce Drive, Unit 1 RadiaDyne 2213 Email: [email protected] North Branford, CT 06471 3801 Kirby Drive, Suite 710 Website: www.radmaxonline.com Phone: 203-484-2011 Houston, TX 77098 R Email: [email protected] Phone: 713-807-9100 Website: www.pxinc.com Website: www.radiadyne.com R RaySearch Laboratories AB 1453 150 N. Michigan Avenue, Suite 1950 Progenics Pharmaceuticals 332 Chicago, IL 60601 777 Old Saw Mill River Road Radia-Guard 512 Phone: 877-778-3849 Tarrytown, NY 10591 419 Erin Drive, Suite 5 Email: [email protected] Phone: 914-789-2800 Knoxville, TN 37919 Website: www.raysearchlabs.com Phone: 866-400-8080 R
ASTRO 2013 / 55TH ANNUAL MEETING 209 EXHIBITOR NAME BOOTH#EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
Remetronix 453 Siemens Medical Solutions USA Inc. 929 Sun Nuclear Corporation 2116 2190 N.W. Reserve Park Trace 51 Valley Stream Parkway 3275 Suntree Boulevard Port Saint Lucie, FL 34986 Malvern, PA 19355 Melbourne, FL 32940 Phone: 800-875-0856 Phone: 610-448-4252 Phone: 321-259-6862, ext. 275 Website: www.remetronix.com Website: www.medical.siemens.com Email: [email protected] A R Website: www.sunnuclear.com C R Sky Factory 732 Revenue Cycle Inc. 612 801 N. 18th Street, P.O. 1177 1817 West Braker Lane, Building F, Fairfi eld, IA 52556 Suite 200 Phone: 641-472-1747 superDimension Inc. 434 Austin, TX 78758 Email: [email protected] 161 Cheshire Lane, Suite 100 Phone: 512-583-2000 Website: www.SkyFactory.com Plymouth, MN 55441 Email: [email protected] Phone: 763-210-4013 Website: www.revenuecycleinc.com Email: [email protected] R SonaCare Medical LLC 2850 Website: www.superdimension.com 801 E. Morehead Street, Suite 201 Charlotte, NC 28202 RS&A Inc. 442 Phone: 704-817-1170 Suremark Company 430 465 Forum Parkway Website: www.sonacaremedical.com 4645 Industrial Street, 2C Rural Hall, NC 27045 Simi Valley, CA 93063 Phone: 336-969-0583 Phone: 800-406-3399 Email: [email protected] Sordina IORT Technologies S.p.A 353 Email: [email protected] Website: www.rsa-inc.com 14530 Falling Waters Drive Website: www.suremark.com Jacksonville, FL 32258
S+S Par Scientifi c 1118 Teva CNS 2827 10625 Telge Road SPEC MED 2452 41 Moores Road Houston, TX 77095 113 Teal Street Frazer, PA 19355 Phone: 281-815-1300 St. Rose, LA 70087 Phone: 610-786-7213 Email: tj@parscientifi c.com Phone: 504-464-9471 Email: [email protected] Website: www.ParScientifi c.com Website: www.spec-med.com Website: www.tevapharm.com
ScandiDos 653 Spectrum Pharmaceuticals Inc. 546 The Red Journal/Practical Radiation Oncology 1619 Uppsala Science Park 11500 S. Eastern Avenue, #240 1600 JFK Boulevard Uppsala, SE-751 83 Henderson, NV 89052 Philadelphia, PA 19103 Sweden Phone: 702-835-6300 Phone: 702-260-4628 Phone: 46-018-472-3030 Email: [email protected] Website: www.us.elsevierhealth.com Email: [email protected] Website: www.sppirx.com Website: www.scandidos.com R Theragenics Corporation 2527 5203 Bristol Industrial Way Springer 1016 Buford, GA 30518 Sensus Healthcare 427 233 Spring Street Phone: 770-271-0233 851 Broken Sound Parkway, #215 New York, NY 10013 Email: [email protected] Boca Raton, FL 33487 Phone: 212-460-1500 Website: www.theragenics.com Phone: 800-324-9890 Email: [email protected] R Email: [email protected] Website: www.springer.com Website: www.sensushealthcare.com R Top Grade Medical Equipment Co. Ltd. 2160 Standard Imaging 833 No. 11 Yongchang North Road, BDA 3120 Deming Way Beijing, P.R.C. 10076 Shandong Xinhua Medical Instruments Co. Ltd. 2627 Middleton, WI 53562 China No.7 Taimei Road, Zibo New & Hi - Tech Zone Phone: 800-261-4446 Phone: 86-106-788-5599, ext. 398 Shandong, 255086 Email: [email protected] Email: [email protected] China Website: www.standardimaging.com Website: www.topgradehc.com Phone: 86-533-358-7719 R Email: [email protected] Website: www.shinva.com Sumitomo Heavy Industries Ltd. 2553 Toshiba Medical Systems 227 Think Park Tower 1-1, Osaki 2-chome, Shinagawa 2441 Michelle Drive Shielding Construction Solutions Inc. 1135 Tokyo, 141-6025 Tustin, CA 92780-7043 4620 S. Coach Drive Japan Phone: 714-669-4190 Tucson, AZ 85714 Phone: 61-079-167-16 Email: [email protected] Phone: 520-917-0661 Email: [email protected] Website: www.medical.toshiba.com Email: [email protected] Website: www.shi.co.jp/english/index.html Website: www.shieldingconstruction.com R
210 ASTRO 2013 / 55TH ANNUAL MEETING EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH# EXHIBITOR NAME BOOTH#
TRG Oncology Equipment 1122 Vision RT Ltd. 2227 Xoft 2449 5318 E. 2nd Street, #682 Dove House, Arcadia Avenue 101 Nicholson Lane Long Beach, CA 90803 London, UK N3 2JU San Jose, CA 95134 Phone: 949-622-0022 United Kingdom Phone: 408-493-1500 Website: www.oncologyequipment.com Phone: 00-44-771-432-7781 Email: [email protected] R Email: [email protected] Website: www.xoftinc.com Website: www.visionrt.com B R
Universal Health Network 735 32 Broadway VisionTree Software Inc. 446 Hornell, NY 14843 8885 Rio San Diego Drive, #220 Xstrahl Ltd. 619 Website: www.uhnllc.com San Diego, CA 92108 480 Brogdon Road, Suite 100 Phone: 619-295-2800 Suwanee, GA 30024 Website: www.visiontree.com Phone: 678-482-6800 Email: [email protected] Vantage Oncology 2313 Website: www.xstrahl.com 1500 Rosecrans Avenue, Suite 400 S Manhattan Beach, CA 90266 VOA Associates 620 Phone: 310-335-4074 722 12th Street N.W., Suite 100 Website: www.vantageoncology.com Washington, DC 20005 Phone: 202-822-8227 Email: [email protected] Website: www.voa.com Varian Medical Systems 1115, 1335 3100 Hansen Way Palo Alto, CA 94304 Water-Jel Technologies 336 Phone: 650-424-5927 50 Broad Street Email: [email protected] Carlstadt, NJ 07072 Website: www.varian.com Phone: 201-507-8300 A R Email: [email protected] Website: www.Radiaderm.com R Velocity Medical Solutions 1461 1350 Spring Street, Suite 275 Atlanta, GA 30309 Wells Fargo Equipment Finance Inc. 2455 Phone: 404-907-1705 733 Marquette Avenue, N9306-070, 7th Floor Email: [email protected] Minneapolis, MN 55402 Website: www.velocitymedical.com Phone: 612-667-1674 Email: [email protected] Website: www.wellsfargo.com/healthcarefi nancing Veritas Medical Solutions 2150 5 Great Valley Parkway, Suite 210 Wiley 415 Malvern, PA 19355 350 Main Street Phone: 888-242-6760 Malden, MA 02148 Email: [email protected] Phone: 781-388-8313 Website: www.veritas-medicalsolutions.com Email: [email protected] R Website: www.wiley.com/WileyCDA
Vertual Ltd. 1263 Willmed Corporation 658 Logistics Institute 51 Valley Stream Parkway Hull, UK HU6 7RX Malvern, PA 19355 United Kingdom Phone: 821-051-9084, ext. 41 Phone: 44-148-234-7572 Email: [email protected] Website: www.vertual.co.uk C Xecan 731 275 Grove Street, Building 2, Suite 400 Newton, MA 02466 ViewRay Inc. 2126 Phone: 617-686-9953 2 Thermo Fisher Way Oakwood Village, OH 44146 Phone: 408-368-2244 Email: [email protected] Website: www.viewray.com S R
ASTRO 2013 / 55TH ANNUAL MEETING 211 Exhibitor Listing by Product/Service
ACCELERATOR Sun Nuclear Corporation 2116 INFORMATION/TECHNOLOGY Acceletronics 1913 Varian Medical Systems 1115, 1335 Bogardus Medical Systems Inc. 820 Dynasource LLC 2428 Hermes Medical Solutions Inc. 2420 Hitachi America Ltd. 2520 MIM Software 433 ELECTRONIC MEDICAL RECORDS IBA SA 1543 MuCheck-Oncology Data Systems 633 LAP of America LLC 2142 Bogardus Medical Systems Inc. 820 Philips Healthcare 1832 Mevion Medical Systems 1253 Churchill Consulting Inc. 920 Siemens Medical Solutions USA Inc. 929 Mitsubishi Electric 2934 Elekta 942 Varian Medical Systems 1115, 1335 Oncology Services International 727 Equal-Estro Inc. 245 Velocity Medical Solutions 1461 ProTom International Inc. 1561 Equicare Health Inc. 2653 VisionTree Software Inc. 446 Radiology Oncology Systems Inc. 751 Healthcare Administrative Partners 2353 RS&A Inc. 442 Siemens Medical Solutions USA Inc. 929 Shandong Xinhua Medical Instruments Co. Ltd. 2627 Varian Medical Systems 1115, 1335 MEDICAL DEVICE Shielding Construction Solutions Inc. 1135 VisionTree Software Inc. 446 .decimal 1659 Siemens Medical Solutions USA Inc. 929 A2J Laser Technology 1535 Sumitomo Heavy Industries Ltd. 2553 AccuBoost 243 FACILITY CONSTRUCTION AND DESIGN Top Grade Medical Equipment Co. Ltd. 2160 Accuray Inc. 1842 TRG Oncology Equipment 1122 Advanced Shielding Technologies Inc. 823 Augmenix 343 Varian Medical Systems 1115, 1335 architection 1621 Best Medical International Inc. 2261, 2715, 2819 IBA SA 1543 Biocompatibles Inc. 926 James L. Davis 1017 BK Medical Systems 918 BRACHYTHERAPY NELCO 2026 C&G Technologies 519 21st Century Oncology 757 Precise Construction Inc. 2318 Carbon Medical Technologies 2716 AccuBoost 243 RAD Technology Medical Systems 743 Carl Zeiss Meditec Inc. 627 Best Medical International Inc. 2261, 2715, 2819 Shielding Construction Solutions Inc. 1135 DIACOR 2034 Biocompatibles Inc. 926 Sky Factory 732 e2v 2528 BK Medical Systems 918 Veritas Medical Solutions 2150 Eckert & Ziegler BEBIG 1758 BSD Medical 2852 Elekta 942 C.R. Bard Inc. 2030 Foss Therapy Services Inc. 719 FINANCIAL SERVICES Cianna Medical 542 Gammex Inc 1435 CIRS 2219 Alliance Oncology 712 GE Healthcare 2242 CIVCO Medical Solutions 1826 Churchill Consulting Inc. 920 Gold Anchor 622 DIACOR 2034 Radiation Business Solutions 923 Hitachi Aloka Medical 2421 Dynasource LLC 2428 Siemens Medical Solutions USA Inc. 929 Hitachi America Ltd. 2520 Eckert & Ziegler BEBIG 1758 Wells Fargo Equipment Finance Inc. 2455 Hologic Inc. 734 Hologic Inc. 734 ImpediMed Inc. 420 IsoAid 2427 IsoRay Medical Inc. 2736 IMAGING PRODUCTS IsoRay Medical Inc. 2736 Klarity 2343 LifeLine Software Inc. 2743 Acceletronics 1913 LinaTech LLC 1762 Mick Radio Nuclear-Instruments Inc. 1334 AQUILAB 2732 Medspira LLC 521 MIM Software 433 Best Medical International Inc. 2261, 2715, 2819 Mevion Medical Systems 1253 MuCheck-Oncology Data Systems 633 BK Medical Systems 918 Mick Radio Nuclear-Instruments Inc. 1334 Prowess Inc. 2135 Buck Engineering & Consulting GMBH 2853 Micropos Medical AB 559 PTW 2435 C&G Technologies 519 MIM Software 433 QLRAD Inc. 412 C-RAD Inc. 661 OiService CT & MR 2349 Shandong Xinhua Medical Instruments Co. Ltd. 2627 Gammex Inc 1435 Oncology Services International 727 Siemens Medical Solutions USA Inc. 929 GE Healthcare 2242 P-Cure Ltd. 2554 SPEC MED 2452 Hermes Medical Solutions Inc. 2420 Philips Healthcare 1832 Standard Imaging 833 Hitachi Aloka Medical 2421 ProTom International Inc. 1561 Theragenics Corporation 2527 Kyoto Kagaku Co. Ltd 523 Qfi x 1627 Varian Medical Systems 1115, 1335 MIM Software 433 QLRAD Inc. 412 Xoft 2449 OiService CT & MR 2349 RS&A Inc. 442 Oncology Systems Limited 763 S+S Par Scientifi c 1118 P-Cure Ltd. 2554 Sensus Healthcare 427 DOSIMETRY/DETECTORS Phantom Laboratory 917 Shandong Xinhua Medical Instruments Co. Ltd. 2627 Best Medical International Inc. 2261, 2715, 2819 Philips Healthcare 1832 SPEC MED 2452 Equal-Estro Inc. 245 PTW 2435 Standard Imaging 833 Gammex Inc 1435 Radiology Oncology Systems Inc. 751 Sun Nuclear Corporation 2116 IBA SA 1543 Siemens Medical Solutions USA Inc. 929 superDimension Inc. 434 Micropos Medical AB 559 Top Grade Medical Equipment Co. Ltd. 2160 Theragenics Corporation 2527 Multidata Systems International Corp. 1235 Toshiba Medical Systems 227 Toshiba Medical Systems 227 Phantom Laboratory 917 Velocity Medical Solutions 1461 Varian Medical Systems 1115, 1335 PTW 2435 Vision RT Ltd. 2227 ViewRay Inc. 2126 QLRAD Inc. 412 Xoft 2449 Vision RT Ltd. 2227 Radiological Imaging Technology - RIT 2443 Xstrahl Ltd. 619 Xstrahl Ltd. 619 Shandong Xinhua Medical Instruments Co. Ltd. 2627 Standard Imaging 833
212 ASTRO 2013 / 55TH ANNUAL MEETING OTHER PROFESSIONAL SOCIETY Anzai Medical Co. Ltd. 2755 Advanced Shielding Technologies Inc. 823 American Association of Medical Dosimetrists 432 Augmenix 343 Alphatron Linac 2526 American College of Radiology 413 Best Medical International Inc. 2261, 2715, 2819 American College of Radiation Oncology 241 American College of Radiation Oncology 241 Biocompatibles Inc. 926 American Radium Society 616 American Radium Society 616 Bionix Radiation Therapy 1653 BSD Medical 2852 American Society of Radiologic Technologists 515 Brainlab 1243 CDR Systems Inc. 613 ASTRO Resource Center 543 Buck Engineering & Consulting GMBH 2853 CIVCO Medical Solutions 1826 Carbon Medical Technologies 2716 Cold Shot Chillers 417 CDR Systems Inc. 613 Foss Therapy Services Inc. 719 PUBLISHER Cianna Medical 542 Gammex Inc 1435 Demos Medical Publishing 513 CIRS 2219 Healthcare Administrative Partners 2353 ELSEVIER 1617 CIVCO Medical Solutions 1826 ImpediMed Inc. 420 Imaging Technology News 921 Computerized Radiation Scanners Inc. 717 Iron Medical Systems Inc. 428 IOP Publishing 418 C-RAD Inc. 661 Landauer Inc. 2333 Lippincott Williams & Wilkins 1716 e2v 2528 MIM Software 433 Pioneer Bioscience Publishing Company 516 Eckert & Ziegler BEBIG 1758 Myriad Genetic Laboratories 331 Springer 1016 Elekta 942 Oncology Services International 727 The Red Journal/Practical Radiation Oncology 1619 Equal-Estro Inc. 245 Radiation Therapy Oncology Group 618 Wiley 315 Foss Therapy Services Inc. 719 RADMAX Ltd. 827 GMV Soluciones Globales Internet S.A.U 422 Revenue Cycle Inc. 612 QUALITY ASSURANCE Gold Anchor 622 RS&A Inc. 442 American College of Radiation Oncology 241 Guangzhou Renfu Medical Equipment Co. Ltd. 2514 Sky Factory 732 American College of Radiology 413 Hologic Inc. 734 Vertual Ltd. 1263 AQUILAB 2732 HyperDrive Medical 563 VOA Associates 620 Churchill Consulting Inc. 920 IBA SA 1543 Water-Jel Technologies 336 CIRS 2219 IsoAid 2427 CIVCO Medical Solutions 1826 IsoRay Medical Inc. 2736 PATIENT HANDLING/POSITIONING Computerized Radiation Scanners Inc. 717 Klarity 2343 A2J Laser Technology 1535 D3 Oncology Solutions 1023 Landauer Inc. 2333 Best Medical International Inc. 2261, 2715, 2819 Dynasource LLC 2428 LAP of America LLC 2142 Bionix Radiation Therapy 1653 Equal-Estro Inc. 245 LifeLine Software Inc. 2743 Brainlab 1243 Foss Therapy Services Inc. 719 MASEP Infi ni Medical Science Technology Buck Engineering & Consulting GMBH 2853 Gammex Inc 1435 Development Co. Ltd. 135 CDR Systems Inc. 613 Hermes Medical Solutions Inc. 2420 Max Medical Co. Ltd. 2454 Cemar Electro Inc. 514 IBA SA 1543 Medspira LLC 521 CIVCO Medical Solutions 1826 LifeLine Software Inc. 2743 Mevion Medical Systems 1253 C-RAD Inc. 661 Mick Radio Nuclear-Instruments Inc. 1334 Miaderm Radiation Relief at Aiden Industries LLC 443 DIACOR 2034 Micropos Medical AB 559 Micropos Medical AB 559 Elekta 942 Modus Medical Devices Inc. 2633 MIM Software 433 Equicare Health Inc. 2653 MuCheck-Oncology Data Systems 633 Mirada Medical 2733 Gold Anchor 622 Multidata Systems International Corp. 1235 Mitsubishi Electric 2934 Guangzhou Renfu Medical Equipment Co. Ltd. 2514 Phantom Laboratory 917 Modus Medical Devices Inc. 2633 Klarity 2343 PTW 2435 MPM Medical Inc. 819 LAP of America LLC 2142 Radiation Oncology Resources 721 MuCheck-Oncology Data Systems 633 Leoni CIA Cable Systems S.A.S. 1663 Radiation Therapy Oncology Group 618 OiService CT & MR 2349 Micropos Medical AB 559 Radiological Imaging Technology - RIT 2443 Oncolink-University of Pennsylvania 1021 Philips Healthcare 1832 ScandiDos 653 Oncology Services International 727 Qfi x 1627 Sun Nuclear Corporation 2116 Oncology Systems Limited 763 QLRAD Inc. 412 Oncure Medical Corp. 421 S+S Par Scientifi c 1118 RADIATION PROTECTION/SHIELDING Orfi t Industries America 2543 Vision RT Ltd. 2227 Advanced Shielding Technologies Inc. 823 P-Cure Ltd. 2554 architection 1621 Phantom Laboratory 917 PHARMACEUTICAL Augmenix 343 Philips Healthcare 1832 Bayer HealthCare 554 James L. Davis 1017 Precision X-Ray 2751 Bristol-Myers Squibb 1635 NELCO 2026 PTW 2435 Cangene Corporation 2112 Pitts Little Corp. 1116 Qfi x 1627 Miaderm Radiation Relief at Aiden Industries LLC 443 PTW 2435 QLRAD Inc. 412 Spectrum Pharmaceuticals Inc. 546 Radiation Products Design Inc. 816 RadiaDyne 2213 Teva CNS 2827 Shielding Construction Solutions Inc. 1135 Radiation Products Design Inc. 816 Siemens Medical Solutions USA Inc. 929 Radiation Therapy Oncology Group 618 PRACTICE MANAGEMENT Veritas Medical Solutions 2150 Radiological Imaging Technology - RIT 2443 21st Century Oncology 757 Radiology Oncology Systems Inc. 751 Alliance Oncology 712 RADIATION THERAPY RaySearch Laboratories AB 1453 e+CancerCare 2113 21st Century Oncology 757 RS&A Inc. 442 Healthcare Administrative Partners 2353 A2J Laser Technology 1535 S+S Par Scientifi c 1118 Mission Search 715 Acceletronics 1913 Shandong Xinhua Medical Instruments Co. Ltd. 2627 Radiation Business Solutions 923 AccuBoost 243 Siemens Medical Solutions USA Inc. 929 VisionTree Software Inc. 446 Accuray Inc. 1842 Standard Imaging 833 Alliance Oncology 712 Sumitomo Heavy Industries Ltd. 2553 American College of Radiology 413 Sun Nuclear Corporation 2116
ASTRO 2013 / 55TH ANNUAL MEETING 213 Top Grade Medical Equipment Co. Ltd. 2160 GE Healthcare 2242 TRG Oncology Equipment 1122 GMV Soluciones Globales Internet S.A.U 422 Varian Medical Systems 1115, 1335 HyperDrive Medical 563 Vertual Ltd. 1263 LinaTech LLC 1762 ViewRay Inc. 2126 Max Medical Co. Ltd. 2454 Xoft 2449 Medspira LLC 521 Xstrahl Ltd. 619 MIM Software 433 Mirada Medical 2733 Mission Search 715 RADIOISOTOPE SOURCE MANUFACTURER Mitsubishi Electric 2934 IBA SA 1543 OiService CT & MR 2349 IsoAid 2427 Oncolink-University of Pennsylvania 1021 Theragenics Corporation 2527 Oncology Systems Limited 763 Phantom Laboratory 917 Philips Healthcare 1832 SEARCH FIRM/STAFFING/RECRUITMENT Precision X-Ray 2751 Cancer CarePoint Inc. 1722 Prowess Inc. 2135 Cancer Treatment Centers of America 2712 Radiation Oncology Resources 721 CompHealth 2515 Radiology Oncology Systems Inc. 751 Landauer Inc. 2333 RaySearch Laboratories AB 1453 Locumtenens.com 729 Shandong Xinhua Medical Instruments Co. Ltd. 2627 Ministry Health Care 2426 Siemens Medical Solutions USA Inc. 929 Mission Search 715 Toshiba Medical Systems 227 Varian Medical Systems 1115, 1335 TREATMENT ACCESSORIES Velocity Medical Solutions 1461 Alphatron Linac 2526 ViewRay Inc. 2126 Best Medical International Inc. 2261, 2715, 2819 BSD Medical 2852 CDR Systems Inc. 613 Dynasource LLC 2428 Eckert & Ziegler BEBIG 1758 Guangzhou Renfu Medical Equipment Co. Ltd. 2514 Hitachi America Ltd. 2520 Max Medical Co. Ltd. 2454 Medspira LLC 521 Miaderm Radiation Relief at Aiden Industries LLC 443 MIM Software 433 QLRAD Inc. 412 Radiation Products Design Inc. 816 RS&A Inc. 442 S+S Par Scientifi c 1118 Shandong Xinhua Medical Instruments Co. Ltd. 2627 Siemens Medical Solutions USA Inc. 929 Sky Factory 732 Suremark Company 430
TREATMENT PLANNING Accuray Inc. 1842 AQUILAB 2732 Best Medical International Inc. 2261, 2715, 2819 Brainlab 1243 Cangene Corporation 2112 Carbon Medical Technologies 2716 CIRS 2219 CIVCO Medical Solutions 1826 D3 Oncology Solutions 1023 Eckert & Ziegler BEBIG 1758 Elekta 942 Equicare Health Inc. 2653
214 ASTRO 2013 / 55TH ANNUAL MEETING Stop by the ASTRO Resource Center Booth #543 LEARN ABOUT ASTRO’S NEWEST PRODUCTS AND SERVICES.
2013 SURVIVOR CIRCLE Stop by the Survivor Circle in the Resource Center. Meet this year’s Survivor Circle Award winner and VISIT THE RESOURCE CENTER TO: the 2013 Survivor Circle Grant recipients. Plus, don’t forget to drop • Receive training on the ROhub, ASTRO’s exclusive off your stamped Passport for a online community. chance to win great prizes. • Have your photo taken for the ASTRO member directory. • Learn about APEx, ASTRO’s new practice accreditation program. • Pick up information on the latest changes to the MOC process. • Ask about RO-ILS: Radiation Oncology Incident Learning System, ASTRO’s new patient safety organization. • Get information on the 2013 ASTRO PQRIwizard, the online tool that reduces the burden of PQRS reporting. • Pick up free patient brochures and browse our patient website RTAnswers.org. • Purchase the ASTRO/ACR Guide to Radiation Oncology Coding supplement and multi-year Web subscription. • Apply online for ASTRO membership. • Search for job openings and job seekers on the ASTRO Career Center site. • Get your questions answered by ASTRO’s knowledgeable staff .
ANNUAL MEETING SCIENCE BASED, PATIENT DRIVEN NOTES Mark Your Calendars! ASTRO 56TH ANNUAL MEETING
TARGETING CANCER: Technology Biology
Meeting Dates: September 14 -17, 2014 • Exhibit Dates: September 14 -16, 2014 • Moscone Center • San Francisco
Call for abstracts site opens: December 17, 2013 Closes: February 17, 2014
TARGETING CANCER CARE
www.astro.org/annualmeeting 2013 ASTRO Annual Meeting | Georgia World
Meeting Dates: September 22-25, 2013 Exhibition Dates: September 22-24, 2013
218 ASTRO 2013 / 55TH ANNUAL MEETING Congress Center | Halls B1 - B4
EXHIBIT HALL HOURS
Sunday: 10:00 a.m. – 5:00 p.m. Monday: 10:00 a.m. – 5:00 p.m.. Tuesday: 10:00 a.m. – 5:00 p.m
ASTRO 2013 / 55TH ANNUAL MEETING 219 RecognizingThank ASTRO’s 2013 Corporateyou Members .decimal Gold Anchor (Naslund Medical) Radiation Oncology Resources 21st Century Oncology Healthcare Administrative Radiation Products Design Inc. Acceletronics/Rad Parts Partners Radiological Imaging Accuray Incorporated Hologic Inc. Technology (RIT) Advanced Particle Therapy IBA Radiology Oncology Systems Inc. a-fabco Inc. InSightec RADMAX Ltd. Aktina Medical Corporation IntraOp Medical Corporation RaySearch Laboratories, AB Alliance Oncology IsoRay Medical Inc. RC Billing AMAC James L. Davis Inc. Revenue Cycle Inc. Amgen Inc. Klarity Medical Products, LLC ScandiDos AB architection PLLC Landauer Inc. Sensus Healthcare Bayer HealthCare LAP of America LLC Shielding Construction Pharmaceuticals Mevion Medical Systems Solutions Inc. The Bergendahl Institute LLC Mick Radio-Nuclear Siemens Healthcare Biocompatibles Inc. Instruments, Inc. Spectrum Pharmaceuticals Bionix Radiation Therapy MIM Software Inc. Standard Imaging Boehringer Ingelheim Mirada Medical Sun Nuclear Corporation Pharmaceuticals Mobius Medical Systems LP Theragenics Corporation Bogardus Medical Systems Inc. Modus Medical Devices Inc. TRG Oncology Equipment Brainlab AG MRP Inc. Vantage Oncology Bristol-Myers Squibb NELCO Varian Medical Systems C. R. Bard Inc. New Bedford Corporation Veritas Medical Solutions Cancer CarePoint Inc. Oncology Services International Vertual Ltd. Cangene Corporation Oncology Systems Limited ViewRay Inc. Cianna Medical Oncure Medical Corporation Vision RT CivaTech Oncology Inc. Philips Healthcare VisionTree CIVCO Medical Solutions Pitts Little Corp. Weatherby Healthcare CompHealth Locum Tenens ProNova Solutions Xoft Inc. D3 Radiation Planning ProTom International Inc. Xstrahl Ltd. Diacor Inc. Prowess Inc. Eckert & Ziegler BEBIG PTW ELEKTA Qfi x Equicare Health Inc. RAD Technology Medical Systems Gammex Inc. Radiation Business Solutions Genomic Health Inc.
CORPORATE MEMBER